Official Journ alof the EuropeanUnion L 342/59
REGULATION (EC) No 1223/2009 OF  THE EUROPEAN PARLIAMENT AND  OF THE COUNCIL
of 30 November 2009
on cosmetic produ cts
(recast)
(Text with EEA relevance)
THE 
EUROPEAN 
PARLIAMENT 
AND THE  
COUNCIL 
OF THE 
EURO­
PEAN 
UNION,
Having regard to the Treaty estab lishing the European Commu­
nity, 
and 
in 
particular Article 95 thereof,
Having 
regard 
to the proposal from the Commission ,
Having 
regard 
to the opin ion 
of the European 
Economic 
and 
Social 
Committee
(1) OJ C 27, 3.2.2009, p. 34. (1),
Acting 
in 
accordance 
with the procedure laid down  
in 
Article 251 
of the Treaty
(2) Opinion of the E uropean Parliamen t of 24 March 2009 (n ot yet pub­
lished 
in 
the Official Journ al) 
and 
Council 
Decision 
of 20 Novemb er
2009
. (2),
Whereas:
(1) Council Directive 76/768/E EC of 27  July 1976 on  the 
approximation  
of the laws of the Memb er 
States relatin g 
to 
cosmetic products
(3) OJ L 262, 27.9.1976, p. 169. (3) has been significantly amended on 
several 
occasions. 
Since 
further amen dments 
are to be 
made,
 in this particular case it should b e
 recast as on e
 
single 
text in 
the interests 
of clarity.
(2) A Regulation is the appropriate leg al instrument as it 
imposes 
clear and 
detailed rules which do n ot 
give 
room 
for diverg ing 
transposition 
by 
Member 
States. Moreover, a 
Regulation
 ensures
 that legal
 requiremen ts
 are imple­
mented 
at the same time throug hout 
the Commun ity.
(3) This Reg ulation aims at simplifyin g procedures an d 
streamlining 
terminology, 
thereby 
reducing 
administrative 
burden
 and
 ambiguities.
 Moreover, it stren gthens
 certain 
elements 
of the reg ulatory 
framework  
for cosmetics, such 
as in-market 
control, 
with a view to en suring 
a high 
level 
of protection  
of human  
health.
(4) This Regulation comprehen sively harmonises the rules in  
the 
Community 
in 
order to achieve an  
internal 
market 
for 
cosmetic products while en suring
 a high
 level of protec­
tion 
of human  
health.(5) The environmental concerns that substances used in cos­
metic 
products may raise are con sidered 
through
 the appli­
cation 
of Regulation 
(EC) 
No 1907/2006 of the E uropean 
Parliamen t 
and 
of the Coun cil 
of 18 Decemb er 
2006 con ­
cerning 
the Registration, 
Evaluation, 
Authorisation  
and 
Restriction  
of Chemicals (RE ACH) 
and 
establishing 
a Euro­
pean 
Chemicals Ag ency
(4) OJ L 396, 30.12.2006, p. 1. (4), which en ables the assessmen t 
of 
environmental 
safety in 
a cross-sectoral man ner.
(6) This Regulation relates on ly to cosmetic products an d not 
to
 medicinal
 products, medical devices or b iocidal
 prod­
ucts. The delimitation follows in particular from the 
detailed defin ition 
of cosmetic products, which refers b oth 
to
 their areas of application an d
 to the purposes of their 
use.
(7) The assessmen t of whether a product is a cosmetic prod­
uct
 has to be
 made on the b asis
 of a case-b y-case
 assess­
ment, 
taking 
into 
account 
all characteristics of the product. 
Cosmetic products may in clude 
creams, emulsion s, 
lotions, 
gels 
and 
oils for the sk in, 
face mask s, 
tinted 
bases 
(liquids, 
pastes, powders), mak e-up
 powders, after-b ath
 powders, 
hygienic 
powders, toilet soaps, deodoran t 
soaps, perfumes, 
toilet waters an d 
eau de Colog ne, 
bath 
and 
shower prepa­
rations
 (salts, foams, oils, g els),
 depilatories, deodoran ts
 
and 
anti-perspirants, 
hair coloran ts, 
products for wavin g, 
straightening
 and
 fixing
 hair, hair-settin g
 products, hair-
cleansing
 products (lotion s,
 powders, shampoos), hair-
conditioning 
products (lotion s, 
creams, oils), hairdressin g 
products 
(lotions, 
lacquers, b rilliantines), 
shaving 
products 
(creams, foams, lotion s), 
make-up 
and 
products removin g 
make-up,
 products in tended
 for application to the lips, 
products for care of the teeth an d 
the mouth, products for 
nail
 care and
 make-up,
 products for extern a
l intimate 
hygiene, 
sunbathing 
products, products for tan ning 
with­
out sun,
 skin-whitening
 products an d
 anti-wrinkle
 
products.
(8) The Commission  should defin e the categories of cosmetic 
products 
which are relevan t 
for the application  
of this 
Regulation.
(9) Cosmetic products should b e safe under normal or reason­
ably
 foreseeab le
 conditions
 of use. I n
 particular, a risk -
benefit 
reasoning 
should not 
justify a risk  
to human  
health.N E 9 0 0 2 . 2 1 . 2 2Official Journ alof the EuropeanUnion 22.12.2009
(10) The presen tation of a cosmetic product an d in particular its 
form, 
odour, colour, appearan ce, 
packaging, 
labelling, 
vol­
ume or size should n ot 
endanger 
health and 
safety of con ­
sumers 
due to con fusion 
with foodstuffs, in  
accordance 
with 
Council 
Directive 87/357/E EC 
of 25 June 
1987 on 
the 
approximation  
of the laws of the Memb er 
States con ­
cerning
 products which, appearin g
 to be
 other than they 
are, endanger 
the health or safety of con sumers
(1) OJ L 192, 11.7.1987, p. 49. (1).
(11) In order to estab lish clear respon sibilities, each cosmetic 
product
 should b e
 linked
 to a respon sible
 person estab­
lished within  
the Commun ity.
(12) Ensuring traceability of a cosmetic product throug hout the 
whole 
supply chain  
helps to mak e 
market 
surveillance sim­
pler and
 more efficien t.
 An efficien t
 traceability
 system 
facilitates mark et
 surveillan ce
 authorities’ task of tracin g
 
economic 
operators.
(13) It is necessary to determin e under which con ditions a dis­
tributor 
is to be 
considered 
as the respon sible 
person.
(14) All legal or natural persons in the wholesale trade as well 
as 
retailers sellin g 
directly to the con sumer 
are covered b y 
reference 
to the distrib utor. 
The obligations 
of the distrib u­
tor 
should therefore b e 
adapted to the respective role an d 
part 
of the activity of each of these operators.
(15) The European cosmetics sector is on e of the industrial 
activities
 affected b y
 counterfeiting,
 which may in crease
 
risks 
to human  
health. Memb er 
States should pay particu­
lar attention 
to the implemen tation 
of horizontal Commu­
nity
 legislation
 and
 measures reg arding
 counterfeit
 
products in the field of cosmetic products, for example 
Council
 Regulation
 (EC)
 No 1383/2003 of 22 July 2003  
concerning 
customs action  
against 
goods 
suspected of 
infringing 
certain 
intellectual 
property rig hts 
and 
the mea­
sures to b e
 taken
 against
 goods
 found
 to have in fringed
 
such rights
(2) OJ L 196, 2.8.2003, p. 7. (2) and Directive 2004/48/E C of the European 
parliamen t
 and
 of the Coun cil
 of 29 April 2004  on the 
enforcement
 of intellectual
 property rig hts
(3) OJ L 157, 30.4.2004, p. 45. (3). In-market 
controls 
represent 
a powerful mean s 
of identifying 
prod­
ucts that do n ot 
comply with the requiremen ts 
of this 
Regulation.
(16) To ensure their safety, cosmetic products placed on the 
market
 should b e
 produced accordin g
 to good
 manufac
­
turing 
practice.(17) For the purpose of effective mark et surveillan ce, a product 
information 
file should b e 
made readily accessib le, 
at one 
single
 address within the Commun ity,
 to the competen t
 
authority of the Memb er 
State where the file is located.
(18) In order to b e comparab le and of high quality, the results 
of
 the non-clinical
 safety studies carried out for the pur­
poses of assessin g 
the safety of a cosmetic product should 
comply with the relevan t 
Community 
legislation.
(19) It should be made clear which in formation is to be made 
available
 to the competen t
 authorities. That in f
ormation 
should include 
all the necessary 
particulars relatin g 
to iden­
tity, 
quality, safety for human  
health and 
the effects claimed 
for the cosmetic product. I n 
particular, this product in for­
mation 
should in clude 
a cosmetic product safety report 
documenting 
that a safety assessmen t 
has been 
conducted.
(20) To ensure the uniform application  and control of the 
restriction s
 for substances,
 sampling
 and
 anal
ysis should 
be 
carried out in  
a reproducib le 
and 
standardised 
manner.
(21) The term ‘mixture’ as defined  in this Reg ulation  should 
have the same mean ing
 as the term ‘preparation ’ previ­
ously used in  
Community 
legislation.
(22) For reason s of effective mark et surveillance, the competen t 
authorities 
should be 
notified 
of certain 
information 
about 
the 
cosmetic product placed on  
the market.
(23) In order to allow for rapid an d appropriate medical treat­
ment 
in 
the event 
of difficulties, the n ecessary 
information 
about 
the product formulation  
should be 
submitted 
to poi­
son control
 centres
 and
 assimilated en tities,
 where such 
centres 
have been 
established 
by 
Member 
States to that 
end.
(24) In order to k eep administrative burdens to a minimum, the 
notified
 information
 for competen t
 authorities, poison 
control 
centres 
and 
assimilated en tities 
should be 
submit­
ted
 centrally
 for the Commun ity
 by
 way of an electron ic
 
interface.
(25) In order to en sure a smooth tran sition to the n ew elec­
tronic 
interface, 
economic 
operators should b e 
allowed to 
notify
 the information
 required in accordan ce
 with this 
Regulation 
before 
its date of application .
(26) The general principle of the respon sibility of the man ufac­
turer 
or importer for the safety of the product should b e 
supported 
by 
restriction s 
of some sub stances 
in 
Annexes 
II 
and
 III.
 Moreover, sub stances
 which are in te
nde
d to be
 
used as coloran ts, 
preservatives an d 
UV-filters should b e 
listed 
in 
the Annexes 
IV, 
V and 
VI 
respectively in  
order to 
be 
allowed for these uses.N E 0 6 / 2 4 3 LOfficial Journ alof the EuropeanUnion L 342/61
(27) To avoid amb iguities, it should b e clarified that the list of 
allowed
 colorants
 contained
 in Annex
 IV inc
ludes only
 
substances 
which colour throug h 
absorption 
and 
reflection 
and 
not 
substances 
which colour throug h 
photolumin es­
cence, 
interference, 
or chemical reaction .
(28) To address safety con cerns raised, An nex IV, which is cur­
rently 
restricted to sk in 
colorants, 
should also in clude 
hair 
colorants 
once 
the risk 
assessmen t 
of these sub stances 
by 
the
 Scientific
 Committee for Con sumer
 Safety (SCCS) set 
up by
 Commission Decision 2008/721/E C
 of 5 Septem­
ber 
2008 settin g 
up an 
advisory structure of Scien tific 
Committees
 and
 experts in the field of con sumer
 safety, 
public
 health an d
 the environment
(1) OJ L 241, 10.9.2008, p. 21. (1) has been finalised. 
To 
this end, 
the Commission  
should have the possibility to 
include
 hair coloran ts
 in the scope of that An nex
 by
 the 
comitolog y 
procedure.
(29) The use of n anomaterials  in cosmetic products may 
increase
 with the further developmen t
 of technology.
 In
 
order to en sure 
a high 
level of con sumer 
protection , 
free 
movemen t 
of goods 
and 
legal 
certainty 
for manufacturers, 
it 
is necessary 
to develop a un iform 
definition 
for nanoma­
terials
 at international
 level. The Commun ity
 should 
endeavour 
to reach an  
agreement 
on 
a definition 
in 
appro­
priate international 
fora. Should such an  
agreement 
be 
reached, 
the definition 
of nanomaterials 
in 
this Regulation 
should 
be 
adapted accordin gly.
(30) At presen t, there is in adequate information  on the risk s 
associated
 with nanomaterials.
 In
 order to b etter
 assess 
their safety the SCCS should provide g uidance 
in 
coopera­
tion 
with relevan t 
bodies 
on 
test methodolog ies 
which tak e 
into 
account 
specific characteristics of n anomaterials.
(31) The Commission  should reg ularly review the provision s on 
nanomaterials 
in 
the light 
of scientific 
progress.
(32) Given the hazardous properties of sub stances classified as 
carcinogenic, 
mutagenic 
or toxic for reproduction  
(CMR), 
category
  1A, 1B an d
  2, pursuan t
 to Regulation
 (EC)
 
No 1272/2008 of the E uropean 
Parliamen t 
and 
of the 
Council 
of 16 Decemb er 
2008 on 
classification , 
labelling 
and 
packaging 
of substances 
and 
mixtures
(2) OJ L 353, 31.12.2008, p. 1. (2), their use in  
cosmetic
 products should b e
 prohibited.
 However, as a 
hazardous property of a sub stance
 does not
 necessarily
 
always en tail 
a risk, 
there should b e 
a possibility 
to allow 
the use of sub stances 
classified as CMR 2 sub stances 
where, 
in view of exposure an d
 concentration,
 they have b een
 
found 
safe for use in  
cosmetic products b y 
the SCCS an d 
are 
regulated 
by 
the Commission  
in 
the Annexes 
to this 
Regulation. 
With regard 
to substances 
which are classified as CMR 1A or 1B sub stances, 
there should b e 
a possibility, 
in 
the exception al 
case that these sub stances 
comply with 
food safety requiremen ts, 
inter 
alia as a result of their n atu­
rally
 occurring
 in food, an d
 that no
 suitable
 alternative
 
substances 
exist, to use such sub stances 
in 
cosmetic prod­
ucts on 
the condition 
that such use has b een 
found 
safe by 
the 
SCCS. Where such con ditions 
are met, the Commission  
should 
amend 
the relevan t 
Annexes 
to this Reg ulation 
within
 15 months
 of classification of sub stances
 as CMR 
1A or 1B sub stances 
under 
Regulation 
(EC) 
No 1272/2008. 
Such substances
 should b e
 continuously
 reviewed b y
 the 
SCCS.
(33) A safety assessmen t of substances, particularly those clas­
sified 
as CMR 1A or 1B sub stances, 
should con sider 
the 
overall exposure to such sub stances
 stemmin g
 from all 
sources. At the same time, for those in volved 
in 
producing 
safety 
assessmen ts, 
it is essen tial 
that there b e 
a harmon ­
ised 
approach to the developmen t 
and 
use of such overall 
exposure estimates. I n
 consequence,
 the Commission ,
 in 
close cooperation  
with the SCCS, the E uropean 
Chemicals 
Agency
 (ECHA),
 the European
 Food Safety Authority 
(EFSA) 
and 
other relevan t 
stakeholders, 
should, as a matter 
of urgency,
 carry out a review an d
 develop g uidance
 
regarding 
the production  
and 
use of overall exposure esti­
mates for these sub stances.
(34) The assessmen t by the SCCS of the use of sub stances clas­
sified 
as CMR 1A an d 
1B in 
cosmetic products should also 
take 
into 
account 
the exposure to those sub stances 
of vul­
nerable
 population g roups,
 such as children un der
 three 
years of ag e, 
elderly people, preg nant 
and 
breast-feeding 
women
 and
 persons
 with compromised immune 
responses.
(35) The SCCS should g ive opinions where appropriate on  the 
safety 
of use of n anomaterials 
in 
cosmetic products. These 
opinions 
should be 
based 
on 
full information 
being 
made 
available 
by 
the respon sible 
person.
(36) Action by the Commission  and Member States relatin g to 
the
 protection of human health should be b as
ed on the 
precaution ary 
principle.
(37) In order to en sure product safety, prohibited substances 
should
 be
 acceptable
 at trace levels on ly
 if they are tech­
nologically
 inevitable
 with correct man ufacturing
 pro­
cesses and 
provided that the product is safe.
(38) The Protocol on  protection  and welfare of an imals annexed 
to 
the Treaty provides that the Commun ity 
and 
the Mem­
ber 
States are to pay full reg ard 
to the welfare requiremen ts 
of 
animals 
in 
the implemen tation 
of Commun ity 
policies, 
in 
particular with reg ard 
to the internal 
market.N E 9 0 0 2 . 2 1 . 2 2Official Journ alof the EuropeanUnion 22.12.2009
(39) Council Directive 86/609/E EC of 24  November 1986 on 
the 
approximation  
of laws, reg ulations 
and 
administrative 
provisions 
of the Memb er 
States reg arding 
the protection  
of 
animals 
used for experimen tal 
and 
other scien tific 
pur­
poses
(1) OJ L 358, 18.12.1986, p. 1. (1) established common rules for the use of an imals 
for 
experimen tal 
purposes within  
the Commun ity 
and 
laid 
down 
the conditions 
under 
which such experimen ts 
must 
be 
carried out in  
the territory of the Memb er 
States. In 
par­
ticular, Article  7 of that Directive requires that an imal 
experimen ts 
be 
replaced b y 
alternative 
methods, where 
such methods exist an d 
are scientifically 
satisfactory.
(40) The safety of cosmetic products an d their ingredients may 
be 
ensured 
through 
the use of altern ative 
methods which 
are not 
necessarily 
applicable 
to all uses of chemical in gre­
dients.
 Therefore, the use of such methods b y
 the whole 
cosmetic in dustry 
should be 
promoted an d 
their adoption  
at 
Community 
level ensured, 
where such methods offer an  
equivalent 
level of protection  
to consumers.
(41) The safety of fin ished cosmetic products can already b e 
ensured
 on the b asis
 of knowledge
 of the safety of the 
ingredients
 that they con tain.
 Provision s
 prohibiting
 ani
­
mal testin g 
of finished 
cosmetic products should therefore 
be 
laid down . 
The application , 
in 
particular b y 
small and 
medium-sized 
enterprises, 
of both 
test methods an d 
assess­
ment 
procedures for relevan t 
available 
data, including 
the 
use of read-across an d
 weight-of-evidence
 approaches, 
which do n ot 
involve 
the use of an imals 
for assessin g 
the 
safety of fin ished 
cosmetic products could b e 
facilitated b y 
Commission  
guidelines.
(42) It will gradually become possible to ensure the safety of 
ingredients 
used in 
cosmetic products b y 
using 
non-animal 
alternative
 methods validated at Commun ity
 level, or 
approved as b eing 
scientifically 
validated, b y 
the European 
Centre 
for the Validation  
of Alternative 
Methods (E CVAM) 
and 
with due reg ard 
to the developmen t 
of validation  
within
 the Organisation
 for Economic
 Cooperation an d
 
Developmen t
 (OECD).
 After con sulting
 the SCCS as 
regards 
the applicab ility 
of the validated altern ative 
meth­
ods to the field of cosmetic products, the Commission  
should
 immediately pub lish
 the validated or approved 
methods recog nised
 as being
 applicable
 to such in gredi
­
ents. 
In 
order to achieve the hig hest 
possible 
degree 
of ani­
mal
 protection ,
 a deadlin e
 should b e
 set for the 
introduction 
of a definitive 
prohibition.
(43) The Commission estab lished timetables of deadlin es up 
to
 11 March 2009  for prohib iting
 the mark eting
 of cos­
metic products, the fin al 
formulation , 
ingredients 
or com­
binations
 of ingredients
 which have b een
 tested on 
animals, 
and 
for prohib iting 
each test curren tly 
carried out 
using
 animals.
 In
 view, however, of tests con cerning
 
repeated-dose toxicity, reproductive toxicity an d 
toxicoki­
netics, 
it is appropriate for the fin al 
deadline 
for prohib it­
ing
 the mark eting
 of cosmetic products for which those tests are used to b e 11 
March 2013. On  
the basis 
of annual 
reports, 
the Commission  
should be 
authorised to adapt the 
timetables
 within the ab ovementioned
 maximum time 
limit.
(44) Better coordin ation of resources at Commun ity level will 
contribute 
to increasing 
the scientific 
knowledge 
indis­
pensable 
for the developmen t 
of alternative 
methods. I t 
is 
essential,
 for this purpose, that the Commun ity
 continue
 
and 
increase 
its efforts an d 
take 
the measures n ecessary 
for 
the promotion of research an d
 the development of n ew
 
non-animal
 alternative
 methods, in particular within its 
Framework  
Programmes 
for research.
(45) The recog nition by third coun tries of alternative methods 
developed
 in the Commun ity
 should b e
 encouraged.
 In
 
order to achieve this ob jective,
 the Commission an d
 the 
Member 
States should tak e 
all appropriate steps to facili­
tate acceptan ce 
of such methods b y 
the OECD. 
The Com­
mission should also en deavour,
 within the framework of 
European 
Community 
cooperation  
agreements, 
to obtain 
recognition 
of the results of safety tests carried out in  
the 
Community 
using 
alternative 
methods so as to en sure 
that 
the export of cosmetic products for which such methods 
have been
 used is n ot
 hindered
 and
 to preven t
 or avoid 
third coun tries 
requiring 
the repetition  
of such tests usin g 
animals.
(46) Transparency is needed regarding the ingredients used in 
cosmetic 
products. Such tran sparency 
should be 
achieved 
by 
indication 
of the ingredients 
used in 
a cosmetic prod­
uct on 
its packaging. 
Where for practical reason s 
it is 
impossible
 to indicate
 the ingredients
 on the pack aging
, 
such information 
should be 
enclosed 
so that the con sumer 
has 
access to this in formation.
(47) A glossary of common  ingredient names should be com­
piled 
by 
the Commission  
to ensure 
uniform 
labelling 
and 
to
 facilitate iden tification
 of cosmetics in gr
edients
. This 
glossary 
should not 
be 
intended 
to constitute 
a limitative 
list of sub stances 
used in 
cosmetic products.
(48) In order to in form consumers, cosmetic products should 
bear 
precise an d 
easily understandable 
indications 
con­
cerning 
their durab ility 
for use. Given  
that consumers 
should
 be
 informed
 of the date un til
 which the cosmetic 
product will con tinue
 to fulfil its in itial
 function
 and
 
remain 
safe, it is importan t 
to know 
the date of min imum 
durability, 
i.e. the date b y 
which it is b est 
to use the prod­
uct. Where the min imum
 durability
 is more than 30 
months, 
the consumer 
should be 
informed 
of the period of 
time after open ing 
that the cosmetic product may b e 
used 
without an y 
harm to the con sumer. 
However, this require­
ment 
should not 
apply where the con cept 
of the durab ility 
after
 opening
 is not
 relevant,
 that is to say for sin gle-use
 
products, products n ot 
at risk 
of deterioration  
or products 
which do n ot 
open.N E 2 6 / 2 4 3 LOfficial Journ alof the EuropeanUnion L 342/63
(49) A number of substances have been identified by the SCCS 
as 
likely 
to cause allerg ic 
reactions 
and 
it will be 
necessary 
to 
restrict their use an d/or 
impose certain  
conditions 
con­
cerning
 them. In
 order to en sure
 that con sumers
 are 
adequately in formed,
 the presen ce
 of these sub stances
 
should be 
mentioned 
in 
the list of in gredients 
and 
consum­
ers’
 attention
 should b e
 drawn to the presence of these 
ingredients. 
This information 
should improve the diag no­
sis
 of contact
 allergies
 among
 consumers
 and
 should 
enable 
them to avoid the use of cosmetic products which 
they do n ot 
tolerate. For sub stances 
which are lik ely 
to 
cause allerg y 
to a significant 
part of the population , 
other 
restrictive measures such as a b an 
or a restriction  
of con­
centration 
should be 
considered.
(50) In the safety assessmen t of a cosmetic product it should b e 
possible
 to take
 into
 account
 results of risk assessmen ts
 
that have b een 
carried out in  
other relevan t 
areas. The use 
of such data should b e 
duly substantiated 
and 
justified.
(51) The consumer should be protected from misleadin g claims 
concerning
 efficacy an d
 other characteristics of cosmetic 
products. I n 
particular Directive 2005/29/E C 
of the Euro­
pean 
Parliamen t 
and 
of the Coun cil 
of 11 May 2005 con ­
cerning 
unfair 
business-to-consumer 
commercial practices 
in the internal
 market
(1) OJ L 149, 11.6.2005, p. 22. (1) is applicab le. Furthermore, the 
Commission , 
in 
cooperation  
with Memb er 
States, should 
define
 common criteria in relation to specific claims for 
cosmetic products.
(52) It should be possible to claim on  a cosmetic product that 
no 
animal 
testing 
was carried out in  
relation 
to its devel­
opment. 
The Commission , 
in 
consultation 
with the Mem­
ber
 States, has developed g uidelines
 to ensure
 that 
common 
criteria are applied in  
the use of claims an d 
that 
an 
aligned 
understanding 
of the claims is reached, an d 
in 
particular 
that such claims do n ot 
mislead the con sumer. 
In
 developin g
 such guidelines,
 the Commission has also 
taken
 into
 account
 the views of the man y
 small an d
 
medium-sized en terprises 
which mak e 
up the majority of 
the ‘non-animal
 testing
’ producers, relevan t
 non-
governmental
 organisations,
 and
 the need
 for consumers
 
to be 
able 
to make 
practical distin ctions 
between 
products 
on 
the basis 
of animal 
testing 
criteria.
(53) In addition to the labelled information, consumers should 
be 
given 
the possib ility 
to request certain  
product-related 
information 
from the respon sible 
person 
in 
order to mak e 
informed 
product choices.
(54) Effective market surveillance is necessary in order to en sure 
that 
the provision s 
of this Reg ulation 
are respected. To this 
end, 
serious un desirable 
effects should b e 
notified 
and 
competen t 
authorities should have a possib ility 
to request 
from the respon sible
 person a list of cosmetic products containing 
substances 
which have raised serious doub ts 
in 
terms 
of safety.
(55) This Regulation is without prejudice to the possib ility for 
Member 
States to reg ulate, 
in 
compliance 
with Commun ity 
law, 
the notification 
by 
health profession als 
or consumers 
of 
serious un desirable 
effects to the competen t 
authorities 
of Member 
States.
(56) This Regulation is without prejudice to the possib ility for 
Member 
States to reg ulate, 
in 
compliance 
with Commun ity 
law, 
the establishment 
of economic 
operators in  
the area 
of cosmetic products.
(57) In case of non-compliance with this Reg ulation, a clear and 
efficient 
procedure for the withdrawal an d 
recall of prod­
ucts may b e 
necessary. 
This procedure should, where pos­
sible, 
build 
upon 
existing 
Community 
rules for un safe 
goods.
(58) In order to address cosmetic products which, despite com­
plying 
with the provision s 
of this Reg ulation, 
might 
endan­
ger
 human health, a safeg uard
 procedure should b e
 
introduced.
(59) The Commission should provide in dications for the un i­
form 
interpretation 
and 
application  
of the con cept 
of seri­
ous risk s
 in order to facilitate the con sistent
 
implemen tation 
of this Reg ulation.
(60) In order to comply with prin ciples of good administrative 
practices,
 any
 decision b y
 a competen t
 authority in the 
framework of mark et
 surveillan ce
 should b e
 duly 
substantiated.
(61) In order to en sure effective in -market control, a high 
degree 
of administrative 
cooperation  
amongst 
the compe­
tent 
authorities is n ecessary. 
This concerns 
in 
particular 
mutual assistan ce
 in the verification of product in forma
­
tion 
files located in  
another 
Member 
State.
(62) The Commission  should be assisted by the SCCS, an  inde­
pendent 
risk 
assessmen t 
body.
(63) The measures n ecessary for the implemen tation of this 
Regulation 
should be 
adopted in  
accordance 
with Coun cil 
Decision 
1999/468/E C 
of 28 June 
1999 layin g 
down 
the 
procedures for the exercise of implemen ting 
powers con ­
ferred 
on 
the Commission
(2) OJ L 184, 17.7.1999, p. 23. (2).
(64) In particular, power should b e conferred on the Commis­
sion 
to adapt the An nexes 
to this Reg ulation 
to technical 
progress. 
Since 
those measures are of g eneral 
scope and 
are 
designed 
to amend 
non-essential 
elements 
of this Reg ula­
tion 
they must b e 
adopted in  
accordance 
with the reg ula­
tory 
procedure with scrutin y 
provided for in  
Article 5a of 
Decision 
1999/468/E C.N E 9 0 0 2 . 2 1 . 2 2Official Journ alof the EuropeanUnion 22.12.2009
(65) When, on imperative g rounds of urgency, the normal time-
limits 
for the reg ulatory 
procedure with scrutin y 
cannot 
be 
complied
 with, the Commission should b e
 able
 to apply 
the urgency 
procedure provided for in  
Article 5a(6) of 
Decision 1999/468/E C
 for the adoption of certain mea­
sures relatin g 
to CMRs, n anomaterials 
and 
potential 
risks 
to 
human 
health.
(66) Member States should lay down provision s on penalties 
applicable 
to infringements 
of the provision s 
of this Reg u­
lation 
and 
ensure 
that they are implemen ted. 
Those pen al­
ties 
should be 
effective, proportion ate 
and 
dissuasive.
(67) Economic operators as well as Memb er States and the 
Commission  
need 
sufficient 
time to adapt to the chan ges 
introduced 
by 
this Regulation. 
Therefore it is appropriate 
to provide for a sufficien t 
transitional 
period for that adap­
tation.
 However, in order to en sure
 a smooth tran sition,
 
economic 
operators should b e 
allowed to place on  
the 
market 
cosmetic products which comply with this Reg u­
lation 
before 
the expiry of that tran sitional 
period.
(68) In order to en hance the safety of cosmetic products an d 
strengthen
 the mark et
 surveillan ce,
 cosmetic products 
placed on  
the market 
after the date of application  
of this 
Regulation
 should comply with its ob ligations
 regarding
 
safety assessmen t, 
the product in formation 
file and 
notifi­
cation,
 even if similar ob ligations
 have already b een
 ful­
filled under 
Directive 76/768/E EC.
(69) Directive 76/768/E EC should be repealed. However, in  
order 
to ensure 
appropriate medical treatmen t 
in 
the event 
of 
difficulties an d 
to ensure 
market 
surveillan ce, 
the infor­
mation 
received pursuan t 
to Article 7(3) an d 
Article 7a(4) 
of Directive 76/768/E EC 
concerning 
cosmetic products 
should be 
kept 
by 
the competen t 
authorities for a certain  
period 
of time an d 
the information 
kept 
by 
the respon sible 
person 
should remain  
available 
for the same period of 
time.
(70) This Regulation should be without prejudice to the ob liga­
tions 
of the Memb er 
States relatin g 
to the time-limits for 
transposition 
into 
national 
law of the Directives set out in  
Part 
B of Annex 
IX.
(71) Since the objective of this Reg ulation, namely the achieve­
ment 
of the internal 
market 
and 
a high 
level of protection  
of
 human health throug h
 the complian ce
 of cosmetic 
products with the requiremen ts 
laid down  
in 
this Regula­
tion, 
cannot 
be 
sufficiently 
achieved b y 
the Memb er 
States 
and 
can 
therefore, b y 
reason 
of the scale of the action , 
be 
better 
achieved at Commun ity 
level, the Commun ity 
may 
adopt measures, in  
accordance 
with the prin ciple 
of sub­
sidiarity, 
as set out in  
Article 5 of the Treaty. I n 
accordance 
with
 the principle
 of proportion ality,
 as set out in that 
Article, this Reg ulation 
does not 
go 
beyond 
what is neces­
sary 
in 
order to achieve that ob jective,
HAVE ADOPTED THIS REGULATION:CHAPTER 
I
SCOPE, D EFINITIONS
Article 1
Scope and objective
This Regulation 
establishes 
rules to be 
complied with b y 
any 
cos­
metic product made availab le 
on 
the market, 
in 
order to en sure 
the 
functioning 
of the internal 
market 
and 
a high 
level of protec­
tion 
of human  
health.
Article 2
Definitions
1.
 For the purposes of this Reg ulation,
 the followin g
 defini
­
tions 
shall apply: 
(a) ‘cosmetic product’ mean s 
any 
substance 
or mixture in tended 
to 
be 
placed in 
contact 
with the extern al 
parts of the human  
body 
(epidermis, hair system, n ails, 
lips and 
external 
genital 
organs) 
or with the teeth an d 
the mucous memb ranes 
of the 
oral cavity with a view exclusively or main ly 
to cleaning 
them, 
perfuming 
them, chan ging 
their appearan ce, 
protect­
ing 
them, keeping 
them in 
good 
condition 
or correctin g 
body 
odours;
(b) ‘
substance
’ means 
a chemical elemen t 
and 
its compoun ds 
in 
the 
natural 
state or ob tained 
by 
any 
manufacturing 
process, 
including 
any 
additive n ecessary 
to preserve its stab ility 
and 
any
 impurity derivin g
 from the process used b ut
 excluding
 
any
 solvent
 which may b e
 separated without affectin g
 the 
stability 
of the sub stance 
or changing 
its composition ;
(c)
 ‘mixture’ means
 a mixture or solution composed of two or 
more substances;
(d) ‘
manufacturer
’ means 
any 
natural 
or legal 
person 
who manu­
factures 
a cosmetic product or has such a product desig ned 
or 
manufactured, 
and 
markets 
that cosmetic product un der 
his 
name 
or trademark ;
(e) ‘
distributor
’ means 
any 
natural 
or legal 
person 
in 
the supply 
chain,
 other than the man ufacturer
 or the importer, who 
makes
 a cosmetic product availab le
 on the Commun ity
 
market;
(f) ‘
end 
user’ mean s 
either a con sumer 
or profession al 
using 
the 
cosmetic product;
(g) ‘
making 
available 
on 
the market
’ means 
any 
supply of a cos­
metic product for distrib ution,
 consumption
 or use on the 
Community
 market
 in the course of a commercial activity, 
whether in  
return 
for paymen t 
or free of charg e;
(h) ‘
placing 
on 
the market
’ means 
the first mak ing 
available 
of a 
cosmetic product on  
the Commun ity 
market;N E 4 6 / 2 4 3 LOfficial Journ alof the EuropeanUnion L 342/65
(i) ‘importer’ mean s  any  natural  or legal  person established 
within 
the Commun ity, 
who places a cosmetic product from 
a third coun try 
on 
the Commun ity 
market;
(j)
 ‘harmonised
 standard
’ means
 a standard
 adopted b y
 one
 of 
the European 
standardisation 
bodies 
listed in 
Annex 
I 
to 
Directive 98/34/E C 
of the European 
Parliamen t 
and 
of the 
Council 
of 22 June 
1998 layin g 
down 
a procedure for the 
provision of in formation
 in the field of techn ical
 standards
 
and 
regulations 
and 
of rules on  
information 
society ser­
vices
(1) OJ L 204, 21.7.1998, p. 37. (1) on the basis of a request made b y the Commission  
in 
accordance 
with Article 6 of that Directive;
(k) ‘
nanomaterial
’ means 
an 
insoluble 
or biopersistant 
and inten­
tionally 
manufactured 
material with on e 
or more extern al 
dimensions,
 or an in ternal
 structure, on the scale from 1 
to 100 nm;
(l) ‘
preservatives’ mean s 
substances 
which are exclusively or 
mainly
 intended
 to inhibit
 the developmen t
 of micro-
organisms 
in 
the cosmetic product;
(m) ‘colorants
’ means 
substances 
which are exclusively or main ly 
intended 
to colour the cosmetic product, the b ody 
as a whole 
or certain 
parts thereof, b y 
absorption 
or reflection  
of visible 
light; 
in 
addition, 
precursors of oxidative hair coloran ts 
shall 
be 
deemed coloran ts;
(n) ‘
UV-filters’ mean s 
substances 
which are exclusively or mainly 
intended 
to protect the sk in 
against 
certain 
UV radiation  
by 
absorbing, 
reflecting 
or scatterin g 
UV radiation ;
(o) ‘
undesirable 
effect’ mean s 
an 
adverse reaction  
for human
health attrib utable
 to the normal
 or reason a
bly foreseeab le
use 
of a cosmetic product;
(p) ‘serious un desirable 
effect’ mean s 
an 
undesirable 
effect which
results in 
temporary or perman ent 
functional 
incapacity, 
dis­
ability, 
hospitalisation , 
congenital 
anomalies 
or an 
immedi­
ate vital risk  
or death;
(q) ‘withdrawal’ mean s 
any 
measure aimed at preven ting 
the
making 
available 
on 
the market 
of a cosmetic product in  
the
supply chain ;
(r) ‘
recall’ mean s 
any 
measure aimed at achievin g 
the return  
of a
cosmetic product that has already b een 
made availab le 
to the
end 
user;
(s) ‘frame formulation ’ means 
a formulation  
which lists the cat­
egory 
or function 
of ingredients 
and 
their maximum concen­
tration 
in 
the cosmetic product or g ives 
relevant 
quantitative
and 
qualitative in formation 
whenever 
a cosmetic product is
not 
covered or on ly 
partially covered b y 
such a formulation .
The 
Commission  
shall provide in dications 
for the estab lish­
ment 
of the frame formulation  
and 
adapt them reg ularly 
to
technical 
and 
scientific 
progress.2. For 
the purposes of poin t 
(a) of parag raph 
1, a substance 
or
mixture in tended
 to be
 ingested,
 inhaled,
 injected
 or implan ted
into 
the human  
body 
shall not 
be 
considered 
to be 
a cosmetic
product.
3. In
 view of the various defin itions
 of nanomaterials
 pub­
lished by
 different
 bodies
 and
 the constant
 technical
 and
 scien­
tific developmen ts
 in the field of n anotechnologies,
 the
Commission  
shall adjust an d 
adapt poin t 
(k) 
of paragraph 
1 to
technical 
and 
scientific 
progress 
and 
to definitions 
subsequently
agreed  at international  level. That measure, desig ned  to amend
non-essential
 elements
 of this Reg ulation,
 shall be
 adopted in
accordance 
with the reg ulatory 
procedure with scrutin y 
referred
to in 
Article 32(3).
CHAPTER II
SAFETY, 
RESPONSIBILITY, F REE 
MOVEMENT
Article 3
Safety
A cosmetic product made availab le 
on 
the market
 shall be 
safe for
human 
health when  
used under 
normal 
or reasonably 
foreseeable
conditions 
of use, tak ing 
account, 
in 
particular, of the followin g:
(a)
 presentation
 including
 conformity
 with Directive
87/357/EEC;
(b) labelling;
(c) instructions 
for use an d 
disposal;
(d) any 
other indication 
or information 
provided b y 
the respon ­
sible 
person 
defined 
in 
Article 4.
The provision of warn ings
 shall not
 exempt person s
 defined
 in
Articles 2 an d 
4 from complian ce 
with the other requiremen ts
laid 
down 
in 
this Regulation.
Article 
4
Responsible person
1. Only 
cosmetic products for which a leg al 
or natural 
person
is designated 
within 
the Commun ity 
as ‘responsible 
person’ shall
be 
placed on  
the market.
2. For 
each cosmetic product placed on  
the market, 
the respon ­
sible 
person 
shall ensure 
compliance 
with the relevant ob li
gations
set 
out in 
this Regulation.
3. For 
a cosmetic product man ufactured 
within 
the Commu­
nity, 
and 
not 
subsequently 
exported an d 
imported b ack 
into 
the
Community, 
the manufacturer 
established 
within 
the Commun ity
shall 
be 
the respon sible 
person. N E 9 0 0 2 . 2 1 . 2 2Official Journ alof the EuropeanUnion 22.12.2009
The manufacturer may desig nate, by written man date, a person
established 
within 
the Commun ity 
as the respon sible 
person 
who
shall accept in  
writing. 
4.
 Where, for a cosmetic product man ufactured
 within the
Community, 
and 
not 
subsequently 
exported an d 
imported b ack
into 
the Commun ity, 
the manufacturer 
is established 
outside the
Community,
 he shall desig nate,
 by
 written man date,
 a person
established 
within 
the Commun ity 
as the respon sible 
person 
who
shall accept in  
writing.
5. For 
an 
imported cosmetic product, each importer shall b e
the 
responsible 
person 
for the specific cosmetic product he places
on 
the market. 
The 
importer may, b y 
written 
mandate, 
designate 
a person 
estab­
lished 
within 
the Commun ity 
as the respon sible 
person 
who shall
accept in 
writing. 
6.
 The distrib utor
 shall be
 the respon sible
 person where he
places a cosmetic product on  
the market 
under
 his name 
or trade­
mark 
or modifies a product already placed on  
the market 
in 
such
a way that complian ce 
with the applicab le 
requiremen ts 
may be
affected. 
The
 translation
 of information
 relating
 to a cosmetic product
already placed on  
the market 
shall not 
be 
considered 
as a modi­
fication 
of that product of such a n ature 
that complian ce 
with the
applicable 
requiremen ts 
of this Reg ulation 
may be 
affected. 
Article 5
Obligations of responsible persons
1. Responsible
 persons
 shall en sure
 complian ce
 with
Articles 3, 8, 10, 11, 12, 13, 14, 15, 16, 17, 18, Article 19(1),(2)
and 
(5), as well as Articles 20, 21, 23 an d 
24.
2. Responsible 
persons 
who consider 
or have reason  
to believe
that 
a cosmetic product which they have placed on  
the market 
is
not 
in 
conformity 
with this Reg ulation 
shall immediately tak e 
the
corrective measures n ecessary 
to bring 
that product in to 
confor­
mity, 
withdraw it or recall it, as appropriate. 
Furthermore, where the cosmetic product presen ts
 a risk to
human 
health, respon sible 
persons 
shall immediately in form 
the
competen t
 national
 authorities of the Memb er
 States in which
they made the product availab le 
and 
of the Memb er 
State in 
which
the product in formation 
file is readily accessib le, 
giving 
details, in
particular, of the n on-compliance 
and 
of the corrective measures
taken. 
3. Responsible 
persons 
shall cooperate with these authorities,
at the request of the latter, on an y
 action to elimin ate
 the risks
posed 
by 
cosmetic products which they have made availab le 
on
the market.
 In
 particular, respon sible
 persons
 shall, further to a
reasoned 
request from a competen t 
national 
authority, provide itwith all the in formation and documentation necessary to demon ­
strate 
the conformity 
of specific aspects of the product, in  
a lan­
guage 
which can  
be 
easily understood 
by 
that authority.
Article 6
Obligations of distribu tors
1.
 In
 the context
 of their activities, when mak ing
 a cosmetic
product availab le
 on the mark et,
 distribu
tors shall act with due
care in 
relation 
to applicab le 
requiremen ts.
2. Before 
making 
a cosmetic product availab le 
on 
the market
distributors 
shall verify that: 
—the labelling 
information 
provided for in  
Article 19(1)(a), (e)
and 
(g) 
and 
Article 19(3) an d 
(4) is presen t,
—the 
language 
requiremen ts 
provided for in  
Article 19(5) are
fulfilled,
—the date of min imum
 durability
 specified, where applicab le
under 
Article 19(1), has n ot 
passed.
3. Where distrib utors 
consider 
or have reason  
to believe 
that: 
—a cosmetic product is n ot
 in conformity
 with the require­
ments 
laid down  
in 
this Regulation, 
they shall n ot 
make 
the
product availab le
 on the mark et
 until
 it has been
 brought
into 
conformity 
with the applicab le 
requiremen ts,
—a
 cosmetic product which they have made available on the
market 
is not 
in 
conformity 
with this Reg ulation, 
they shall
make
 sure that the corrective measures n ecessary
 to bring
that 
product in to 
conformity, 
withdraw it or recall it, as
appropriate, are tak en.
Furthermore,
 where the cosmetic product presen ts
 a risk to
human 
health, distrib utors 
shall immediately in form 
the respon ­
sible 
person 
and 
the competen t 
national 
authorities of the Mem­
ber 
States in 
which they made the product availab le, 
giving 
details,
in particular, of the n on-compliance
 and
 of the corrective mea­
sures taken.
4. Distributors 
shall ensure 
that, while a product is un der 
their
responsibility, 
storage 
or transport 
conditions 
do not 
jeopardise
its complian ce 
with the requiremen ts 
set out in 
this Regulation.
5. Distributors 
shall cooperate with competen t 
authorities, at
the request of the latter, on  
any 
action 
to eliminate 
the risks 
posed
by 
products which they have made availab le 
on 
the market. 
In
particular, 
distributors 
shall, further to a reason ed 
request from a
competen t 
national 
authority, provide it with all the in formation
and 
documentation 
necessary 
to demon strate 
the conformity 
of
the product with the requiremen ts 
listed under 
paragraph 
2, in 
a
language 
which can  
be 
easily understood 
by 
that authority.N E 6 6 / 2 4 3 LOfficial Journ alof the EuropeanUnion L 342/67
Article 7
Identification within the su pply 
chain
At the request of a competen t 
authority:
—responsible
 persons
 shall iden tify
 the distrib utors
 to whom
they supply the cosmetic product,
—the distrib utor 
shall identify 
the distrib utor 
or the respon sible
person 
from whom, an d 
the distrib utors 
to whom, the cos­
metic product was supplied.
This obligation 
shall apply for a period of three years followin g
the 
date on 
which the b atch 
of the cosmetic product was made
available 
to the distrib utor.
Article 
8
Good manu facturing 
practice
1. The manufacture 
of cosmetic products shall comply with
good 
manufacturing 
practice with a view to en suring 
the objec­
tives 
of Article 1.
2. Complian ce 
with good 
manufacturing 
practice shall b e 
pre­
sumed where the man ufacture 
is in 
accordance 
with the relevan t
harmonised
 standards,
 the referen ces
 of which have b een
 pub­
lished in 
the Official Journal of the European Union.
Article 9
Free 
movement
Member 
States shall n ot, 
for reason s 
related to the requiremen ts
laid 
down 
in 
this Regulation, 
refuse, prohib it 
or restrict the mak ­
ing 
available 
on 
the market 
of cosmetic products which comply
with the requiremen ts 
of this Reg ulation.
CHAPTER III
SAFETY 
ASSESSMENT, PROD UCT 
INFORMATION 
FILE,
NOTIFICATION
Article 10
Safety assessment
1. In 
order to demon strate 
that a cosmetic product complies
with Article 3, the respon sible 
person 
shall, prior to placin g 
a cos­
metic product on the mark et,
 ensure
 that the cosmetic product
has undergone
 a safety assessmen t
 on the basis of the relevan t
information 
and 
that a cosmetic product safety report is set up in
accordance 
with Annex 
I. 
The 
responsible 
person 
shall ensure 
that: 
(a) the intended 
use of the cosmetic product an d 
the anticipated
systemic 
exposure to in dividual 
ingredients 
in 
a final 
formu­
lation 
are taken 
into 
account 
in 
the safety assessmen t;(b)
 an appropriate weig ht-of-evidence
 approach is used in the
safety assessmen t 
for reviewin g 
data from all existin g 
sources;
(c) the cosmetic product safety report is k ept 
up to date in  
view
of addition al
 relevant
 information
 generated
 subsequent
 to
placing 
the product on  
the market.
The 
first subparagraph 
shall also apply to cosmetic products that
have been 
notified 
under 
Directive 76/768/E EC.
The 
Commission , 
in 
close cooperation  
with all stak eholders, 
shall
adopt appropriate g uidelines 
to enable 
undertakings, 
in 
particu­
lar small an d
 medium-sized en terprises,
 to comply with the
requiremen ts
 laid down in An nex
 I.
 Those guidelines
 shall be
adopted 
in 
accordance 
with the reg ulatory 
procedure referred to
in 
Article 32(2).
2. The cosmetic product safety assessmen t, 
as set out in  
Part B
of Annex
 I shall be
 carried out b y
 a person in possession of a
diploma or other eviden ce 
of formal qualification s 
awarded on
completion  
of a university 
course of theoretical an d 
practical
study in 
pharmacy, toxicolog y, 
medicine 
or a similar disciplin e, 
or
a course recog nised 
as equivalen t 
by 
a Member 
State.
3. Non-clinical
 safety studies referred to in the safety assess­
ment
 accordin g
 to parag raph
 1 and
 carried out after 30 June
1988
 for the purpose of assessin g 
the safety of a cosmetic prod­
uct shall comply with Commun ity 
legislation 
on 
the principles 
of
good 
laboratory 
practice, as applicab le 
at the time of performan ce
of 
the study, or with other in ternational 
standards 
recognised 
as
being 
equivalent 
by 
the Commission  
or the ECHA.
Article 
11
Product 
information file
1. When 
a cosmetic product is placed on  
the market, 
the
responsible
 person shall k eep
 a product in formation
 file for it.
The product in formation 
file shall b e 
kept 
for a period of ten  
years
following 
the date on  
which the last b atch 
of the cosmetic prod­
uct was placed on  
the market.
2.
 The product in formation
 file shall con tain
 the followin g
information 
and 
data which shall b e 
updated as n ecessary: 
(a) a 
description  
of the cosmetic product which en ables 
the
product in formation
 file to be
 clearly attributed to the cos­
metic product;
(b) the 
cosmetic product safety report referred to in  
Article 10(1);
(c) a description  
of the method of man ufacturing 
and 
a state­
ment
 on complian ce
 with good
 manufacturing
 practice
referred to in  
Article 8;N E 9 0 0 2 . 2 1 . 2 2Official Journ alof the EuropeanUnion 22.12.2009
(d) where justified b y  the nature  or the effect of the cosmetic
product, proof of the effect claimed for the cosmetic product;
(e) data on 
any 
animal 
testing 
performed b y 
the manufacturer,
his 
agents 
or suppliers, relatin g 
to the developmen t 
or safety
assessmen t 
of the cosmetic product or its in gredients, 
includ­
ing
 any
 animal
 testing
 performed to meet the leg islative
 or
regulatory 
requiremen ts 
of third coun tries.
3. The 
responsible 
person 
shall make 
the product in formation
file 
readily accessib le 
in 
electronic 
or other format at his address
indicated 
on 
the label 
to the competen t 
authority of the Memb er
State 
in 
which the file is k ept. 
The 
information 
contained 
in 
the product in formation 
file shall
be 
available 
in 
a language 
which can  
be 
easily understood 
by 
the
competen t 
authorities of the Memb er 
State. 
4. The requiremen ts
 provided in parag raphs
 1 to 3 of this
Article shall also apply to cosmetic products that have b een 
noti­
fied 
under 
Directive 76/768/E EC.
Article 
12
Sampling and analysis
1. Sampling
 and
 analysis
 of cosmetic products shall b e
 per­
formed in  
a reliable 
and 
reproducib le 
manner.
2.
 In
 the absence
 of any
 applicable
 Commun ity
 legislation,
reliability
 and
 reproducib ility
 shall be
 presumed if the method
used is in 
accordance 
with the relevan t 
harmonised 
standards, 
the
references 
of which have b een 
published 
in 
the Official Journal of
the European Union.
Article 13
Notification
1. Prior to placin g 
the cosmetic product on  
the market 
the
responsible 
person 
shall submit, 
by 
electronic 
means, 
the follow­
ing 
information 
to the Commission : 
(a) the 
category 
of cosmetic product an d 
its name 
or names,
enabling 
its specific iden tification;
(b)
 the name
 and
 address of the respon sible
 person where the
product in formation 
file is made readily accessib le;
(c) the 
country 
of origin 
in 
the case of import;
(d) the Memb er 
State in 
which the cosmetic product is to b e
placed 
on 
the market;
(e) the 
contact 
details of a physical person  
to contact 
in 
the case
of necessity;(f) the presence of substances in the form of n anomaterials and:
(i) their 
identification 
including 
the chemical n ame 
(IUPAC)
and 
other descriptors as specified in  
point 
2 of the Pre­
amble 
to Annexes 
II 
to VI 
to this Reg ulation;
(ii) the 
reasonably 
foreseeable 
exposure con ditions;
(g)
 the name
 and
 the Chemicals Ab stracts
 Service (CAS) or E C
number
 of substances
 classified as carcin ogenic,
 mutagenic
or 
toxic for reproduction  
(CMR), of categ ory 
1A or 1B, un der
Part 
3 of Annex 
VI 
to Regulation 
(EC) 
No 1272/2008;
(h) the frame formulation  
allowing 
for prompt an d 
appropriate
medical treatmen t 
in 
the event 
of difficulties.
The first sub paragraph 
shall also apply to cosmetic products n oti­
fied 
under 
Directive 76/768/E EC.
2.
 When the cosmetic product is placed on the mark et,
 the
responsible
 person shall n otify
 to the Commission the orig inal
labelling, 
and, 
where reason ably 
legible, 
a photograph 
of the cor­
responding 
packaging.
3. As 
from 11 July 2013, a distrib utor 
who makes 
available 
in
a Member 
State a cosmetic product already placed on  
the market
in 
another 
Member 
State and 
translates, 
on 
his own 
initiative, 
any
element 
of the lab elling 
of that product in  
order to comply with
national
 law, shall sub mit,
 by
 electronic
 means,
 the followin g
information 
to the Commission :
(a) the 
category 
of cosmetic product, its n ame 
in 
the Memb er
State 
of dispatch an d 
its name 
in 
the Memb er 
State in 
which
it is made availab le, 
enabling 
its specific iden tification;
(b) the 
Member 
State in 
which the cosmetic product is made
available;
(c) his 
name 
and 
address;
(d) the name
 and
 address of the respon sible
 person where the
product in formation 
file is made readily accessib le..
4. Where 
a cosmetic product has b een 
placed on  
the market
before
 11 July 2013  but
 is no
 longer
 placed on the mark et
 as
from that date, an d
 a distributor
 introduces
 that product in a
Member 
State after that date, that distrib utor 
shall commun icate
the 
following 
to the respon sible 
person:
(a) the 
category 
of cosmetic product, its n ame 
in 
the Memb er
State 
of dispatch an d 
its name 
in 
the Memb er 
State in 
which
it is made availab le, 
enabling 
its specific iden tification;
(b) the 
Member 
State in 
which the cosmetic product is made
available;N E 8 6 / 2 4 3 LOfficial Journ alof the EuropeanUnion L 342/69
(c) his name and address.
On 
the basis 
of that commun ication, 
the respon sible 
person 
shall
submit 
to the Commission , 
by 
electronic 
means, 
the information
referred 
to in 
paragraph 
1 of this Article, where n otifications
according
 to Article  7(3) an d
 Article  7a (4) of Directive
76/768/EEC
 have not
 been
 carried out in the Memb er
 State in
which the cosmetic product is made availab le.
5. The 
Commission  
shall, without delay, mak e
 the information
referred to in  
points 
(a) to (g) 
of paragraph 
1, and 
in 
paragraphs 
2
and 
3 available 
electronically 
to all competen t 
authorities. 
That information 
may be 
used by 
competen t 
authorities on ly 
for
the purposes of mark et 
surveillan ce, 
market 
analysis, 
evaluation
and 
consumer 
information 
in 
the context 
of Articles  25, 26
and 
27. 
6. The Commission  
shall, without delay, mak e
 the information
referred to in  
paragraphs 
1, 2 and 
3 available 
electronically 
to poi­
son 
centres 
or similar b odies, 
where such cen tres 
or bodies 
have
been 
established 
by 
Member 
States. 
That information 
may be 
used by 
those bodies 
only 
for the pur­
poses of medical treatmen t. 
7. Where 
any 
of the information 
set out in  
paragraphs 
1, 3
and 
4 changes, 
the respon sible 
person 
or the distrib utor 
shall pro­
vide an 
update without delay.
8. The Commission may, tak ing
 into
 account
 technical
 and
scientific
 progress
 and
 specific n eeds
 related to market surveil­
lance, 
amend 
paragraphs 
1 to 7 by 
adding 
requiremen ts. 
Those 
measures, desig ned 
to amend 
non-essential 
elements 
of this
Regulation,
 shall be
 adopted in accordan ce
 with the reg ulatory
procedure 
with scrutin y 
referred to in  
Article 32(3). 
CHAPTER IV
RESTRICTIONS 
FOR 
CERTAIN SUBSTANCES
Article 14
Restrictions for su bstances 
listed in the Annexes
1. Without prejudice to Article 3, cosmetic products shall n ot
contain 
any 
of the followin g: 
(a) prohibited 
substances
—prohibited 
substances 
listed in 
Annex 
II;
(b) restricted 
substances
—restricted 
substances 
which are n ot 
used in 
accordance 
with 
the restriction s 
laid down  
in 
Annex 
III;(c) colorants
(i) colorants 
other than  
those listed in  
Annex 
IV 
and 
colo­
rants 
which are listed there b ut 
not 
used in 
accordance 
with 
the conditions 
laid down  
in 
that Annex, 
except for 
hair colourin g 
products referred to in  
paragraph 
2;
(ii) without prejudice to poin ts 
(b), 
(d)(i) and 
(e)(i), sub ­
stances 
which are listed in  
Annex 
IV 
but 
which are n ot 
intended 
to be 
used as coloran ts, 
and 
which are n ot 
used 
in 
accordance 
with the con ditions 
laid down  
in 
that 
Annex;
(d) preservatives
(i) preservatives 
other than  
those listed in  
Annex 
V and 
pre­
servatives which are listed there b ut 
not 
used in 
accor­
dance 
with the con ditions 
laid down  
in 
that Annex;
(ii) without 
prejudice to poin ts 
(b), 
(c)(i) and 
(e)(i), sub ­
stances 
listed in 
Annex 
V but 
which are n ot 
intended 
to 
be 
used as preservatives, an d 
which are n ot 
used in 
accordance 
with the con ditions 
laid down  
in that An ne
x;
(e) UV-filters(i) UV-filters other than those listed in An
nex
  VI and
 
UV-filters which are listed there b ut 
not 
used in 
accor­
dance 
with the con ditions 
laid down  
in 
that Annex;
(ii) without 
prejudice to poin ts 
(b), 
(c)(i) and 
(d)(i), sub ­
stances 
listed in 
Annex 
VI 
but 
which are n ot 
intended 
to 
be
 used as UV-filters an d
 which are n ot
 used in accor­
dance 
with the con ditions 
laid down  
in 
that Annex.
2. Subject 
to a decision  
of the Commission  
to extend 
the scope 
of Annex 
IV 
to hair colourin g 
products, such products shall n ot 
contain
 colorants
 intended
 to colour the hair, other than those 
listed in 
Annex 
IV 
and 
colorants 
intended 
to colour the hair which 
are listed there b ut 
not 
used in 
accordance 
with the con ditions 
laid 
down 
in 
that Annex. 
The 
decision 
of the Commission  
referred to in  
the first sub para­
graph, designed to amend non-essential elements of this Reg ula­
tion, shall be adopted in  accordance with the reg ulatory procedure 
with scrutin y 
referred to in  
Article 32(3). 
Article 15
Substances 
classified as CMR su bstances
1.
 The use in cosmetic products of sub stances
 classified as 
CMR substances, 
of category 
2, under 
Part 3 of An nex 
VI 
to Regu­
lation
 (EC)
 No 1272/2008 shall b e
 prohibited.
 However, a sub­
stance 
classified in  
category 
2 may be 
used in 
cosmetic products 
where the sub stance 
has been 
evaluated b y 
the SCCS an d 
found 
safe 
for use in 
cosmetic products. To these en ds 
the Commission  
shall 
adopt the n ecessary 
measures in  
accordance 
with the reg u­
latory 
procedure with scrutin y 
referred to in  
Article 32(3) of this 
Regulation.N E 9 0 0 2 . 2 1 . 2 2Official Journ alof the EuropeanUnion 22.12.2009
2. The use in cosmetic products of sub stances  classified as 
CMR substances, 
of category 
1A or 1B un der 
Part 3 of An nex 
VI 
to 
Regulation 
(EC) 
No 1272/2008 shall b e 
prohibited. 
However, 
such substances 
may be 
used in 
cosmetic products b y 
way 
of exception  
where, sub sequent 
to their classification  
as CMR 
substances
 of category
 1A or 1B un der
 Part 3 of An nex
 VI to 
Regulation
 (EC)
 No 1272/2008, all of the followin g
 conditions
 
are fulfilled: 
(a) they comply with the food safety requiremen ts 
as defined 
in 
Regulation
 (EC)
 No 178/2002 of the E uropean
 Parliamen t
 
and 
of the Coun cil 
of 28 January 
2002 layin g 
down 
the gen­
eral 
principles 
and 
requiremen ts 
of food law, estab lishing 
the 
European 
Food Safety Authority an d 
laying 
down 
procedures 
in 
matters of food safety
(1) OJ L 31, 1.2.2002, p. 1. (1);
(b) there 
are no 
suitable 
alternative 
substances 
available, 
as docu­
mented 
in 
an 
analysis 
of alternatives;
(c) the 
application  
is made for a particular use of the product 
category 
with a known 
exposure; an d
(d) they 
have been 
evaluated an d 
found 
safe by 
the SCCS for use 
in cosmetic products, in particular in view of exposure to 
these products an d 
taking 
into 
consideration 
the overall 
exposure from other sources, tak ing 
particular accoun t 
of 
vulnerable 
population  
groups.
Specific 
labelling 
in 
order to avoid misuse of the cosmetic prod­
uct shall b e 
provided in  
accordance 
with Article 3 of this Reg u­
lation, 
taking 
into 
account 
possible 
risks 
linked 
to the presen ce 
of 
hazardous sub stances 
and 
the routes of exposure.
In 
order to implemen t 
this parag raph, 
the Commission  
shall 
amend 
the Annexes 
to this Reg ulation 
in 
accordance 
with the 
regulatory 
procedure with scrutin y 
referred to in  
Article 32(3) of 
this Regulation
 within 15 mon ths
 of the in clusion
 of the sub­
stances 
concerned 
in 
Part 3 of An nex 
VI 
to Regulation 
(EC) 
No 
1272/2008.
On 
imperative g rounds 
of urgency, 
the Commission  
may use the 
urgency 
procedure referred to in  
Article 32(4) of this Reg ulation.
The
 Commission shall man date
 the SCCS to re-evaluate those 
substances 
as soon 
as safety con cerns 
arise, and 
at the latest five 
years after their in clusion 
in 
Annexes 
III 
to VI 
to this Reg ulation, 
and 
at least every sub sequent 
five years.
3. By 11  January 
2012, the Commission  
shall ensure 
that 
appropriate g uidance 
is developed with the aim of en a
bl
ing a har­
monised 
approach to the developmen t 
and 
use of overall expo­
sure estimates in  
assessing 
the safe use of CMR sub stances. 
This 
guidance
 shall be
 developed in con sultation
 with the SCCS, the ECHA, 
the EFSA 
and 
other relevan t 
stakeholders, 
drawing, 
as 
appropriate, on  
relevant 
best 
practice.
4. When Commun ity
 or internationally
 agreed
 criteria for 
identifying
 substances
 with endocrine-disrupting
 properties are 
available,
 or at the latest on 11 January
 2015, the Commission 
shall review this Reg ulation
 with reg ard
 to substances
 with 
endocrine-disrupting 
properties.
Article 16
Nanomaterials
1. For every cosmetic product that con tains 
nanomaterials, 
a 
high level of protection  of human  health shall b e ensured.
2. The 
provisions 
of this Article do n ot 
apply to n anomateri­
als 
used as coloran ts, 
UV-filters or preservatives reg ulated 
under 
Article 
14, unless 
expressly specified.
3. In 
addition 
to the notification 
under 
Article 13, cosmetic 
products con taining 
nanomaterials 
shall be 
notified 
to the Com­
mission 
by 
the respon sible 
person 
by 
electronic 
means 
six months 
prior 
to being 
placed on  
the market, 
except where they have 
already been 
placed on  
the market 
by 
the same respon sible 
per­
son 
before 11 
January 
2013.
In
 the latter case, cosmetic products con taining
 nanomaterials
 
placed on  
the market 
shall be 
notified 
to the Commission  
by 
the 
responsible 
person 
between 11 
January 
2013 and 11 
July 2013 
by 
electronic 
means, 
in 
addition 
to the notification 
in 
Article 13.
The first an d 
the secon d 
subparagraphs 
shall not 
apply to cos­
metic products con taining 
nanomaterials 
that are in  
conformity 
with 
the requiremen ts 
set out in 
Annex 
III.
The 
information 
notified 
to the Commission  
shall contain 
at least 
the followin g:
(a) the 
identification 
of the nanomaterial 
including 
its chemical 
name 
(IUPAC) 
and 
other descriptors as specified in  
point 
2 
of the Preamb le 
to Annexes 
II 
to VI;
(b)
 the specification of the n anomaterial
 including
 size of par­
ticles, physical an d 
chemical properties;
(c) an 
estimate of the quan tity 
of nanomaterial 
contained 
in 
cos­
metic products in tended 
to be 
placed on  
the market 
per year;
(d) the toxicolog ical 
profile of the n anomaterial;
(e) the 
safety data of the n anomaterial 
relating 
to the categ ory 
of 
cosmetic product, as used in  
such products;
(f) the reason ably 
foreseeable 
exposure con ditions.N E 0 7 / 2 4 3 LOfficial Journ alof the EuropeanUnion L 342/71
The respon sible person may desig nate another legal or natural 
person 
by 
written 
mandate 
for the notification 
of nanomaterials 
and 
shall inform 
the Commission  
thereof.
The Commission shall provide a referen ce
 number
 for the sub­
mission of the toxicolog ical
 profile, which may sub stitute
 the 
information 
to be 
notified 
under 
point 
(d).
4. In
 the event
 that the Commission has con cerns
 regarding
 
the safety of a n anomaterial, 
the Commission shall, without delay, 
request the SCCS to g ive 
its opinion 
on 
the safety of such n ano­
material
 for use in the relevan t
 categorie
s of cosmetic products 
and 
on 
the reason ably 
foreseeable 
exposure conditions. The Com­
mission 
shall make 
this information 
public. 
The SCCS shall deliver 
its opinion 
within 
six months 
of the Commission ’s 
request. Where 
the SCCS fin ds
 that any
 necessary
 data is lack ing,
 the Commis­
sion 
shall request the respon sible 
person 
to provide such data 
within an explicitly stated reason able
 time, which shall n ot
 be
 
extended. 
The SCCS shall deliver its fin al 
opinion 
within 
six 
months 
of submission 
of addition al 
data. The opin ion 
of the SCCS 
shall be 
made pub licly 
available.
5. The 
Commission  
may, at an y 
time, invoke 
the procedure in  
paragraph 
4 where it has an y 
safety con cerns, 
for example due to 
new 
information 
supplied b y 
a third party.
6. Taking
 into
 account
 the opin ion
 of the SCCS, and where 
there is a poten tial 
risk 
to human  
health, including 
when 
there is 
insufficient 
data, the Commission  
may amen d 
Annexes 
II 
and 
III.
7.
 The Commission may, tak ing
 into
 account
 technical
 and
 
scientific 
progress, 
amend 
paragraph 
3 by 
adding 
requiremen ts.
8. The 
measures, referred to in  
paragraphs 
6 and 
7, designed 
to 
amend 
non-essential 
elements 
of this Reg ulation, 
shall be 
adopted 
in 
accordance 
with the reg ulatory 
procedure with scru­
tiny 
referred to in  
Article 32(3).
9. On imperative g rounds
 of urgency
 the Commission may 
use the procedure referred to in  
Article 32(4).
10. The followin g 
information 
shall be 
made availab le 
by 
the 
Commission : 
(a) By 11 
January 
2014, the Commission  
shall mak e 
available 
a 
catalogue 
of all nanomaterials 
used in 
cosmetic products 
placed on  
the market, 
including 
those used as coloran ts, 
UV-filters 
and 
preservatives in  
a separate section , 
indicating 
the 
categories 
of cosmetic products an d 
the reason ably 
fore­
seeable 
exposure con ditions. 
This catalog ue 
shall be 
regularly 
updated 
thereafter an d 
be 
made pub licly 
available.
(b)
 The Commission shall sub mit
 to the European
 Parliamen t
 
and 
the Coun cil 
an 
annual 
status report, which will g ive 
information 
on 
developmen ts 
in 
the use of n anomaterials 
in cosmetic  products within the Commun ity,  including  those 
used as coloran ts, 
UV-filters an d 
preservatives in  
a separate 
section. 
The first report shall b e 
presented 
by 11 
July 2014 
The report update shall summarise, in  
particular, the n ew 
nanomaterials
 in new
 categories
 of cosmetic products, the 
number
 of notifications,
 the prog ress
 made in developin g
 
nano-specific
 assessmen t
 methods an d
 safety assessmen t
 
guides,
 and
 information
 on international
 cooperation 
programmes.
11.
 The Commission shall reg ularly
 review the provision s
 of 
this Regulation 
concerning 
nanomaterials 
in 
the light 
of scientific 
progress 
and 
shall, where n ecessary, 
propose suitab le 
amend­
ments 
to those provision s. 
The 
first review shall b e 
undertaken 
by 11 
July 2018.
Article 17
Traces of prohibited su bstances
The
 non-intended
 presence
 of a small quan tity
 of a prohib ited
 
substance,
 stemmin g
 from impurities of n atural
 or synthetic
 
ingredients, 
the manufacturing 
process, storag e, 
migration 
from 
packaging, 
which is techn ically 
unavoidable 
in 
good 
manufactur­
ing 
practice, shall b e 
permitted provided that such presen ce 
is in 
conformity 
with Article 3.
CHAPTER V
ANIMAL 
TESTING
Article 18
Animal testing
1. Without prejudice to the g eneral 
obligations 
deriving 
from 
Article 3, the followin g 
shall be 
prohibited: 
(a) the 
placing 
on 
the market 
of cosmetic products where the 
final 
formulation , 
in 
order to meet the requiremen ts 
of this 
Regulation,
 has been
 the subject
 of animal
 testing
 using
 a 
method other than  
an 
alternative 
method after such altern a­
tive 
method has b een 
validated an d 
adopted at Commun ity 
level 
with due reg ard 
to the developmen t 
of validation  
within 
the 
OECD;
(b)
 the placin g
 on the mark et
 of cosmetic products containin g
 
ingredients 
or combinations 
of ingredients 
which, in 
order to 
meet the requiremen ts 
of this Reg ulation, 
have been 
the sub­
ject 
of animal 
testing 
using 
a method other than  
an 
alterna­
tive 
method after such altern ative 
method has b een 
validated 
and 
adopted at Commun ity 
level with due reg ard 
to the 
developmen t 
of validation  
within 
the OECD;
(c) the 
performan ce 
within 
the Commun ity 
of animal 
testing 
of 
finished 
cosmetic products in  
order to meet the requiremen ts 
of 
this Regulation;N E 9 0 0 2 . 2 1 . 2 2Official Journ alof the EuropeanUnion 22.12.2009
(d) the performan ce within the Commun ity of animal testing of 
ingredients 
or combinations 
of ingredients 
in 
order to meet 
the requiremen ts 
of this Reg ulation, 
after the date on  
which 
such tests are required to b e
 replaced b y
 one
 or more vali­
dated altern ative
 methods listed in Commission Reg ulation
 
(EC) 
No 440/2008 of 30 May 2008 layin g 
down 
test meth­
ods pursuan t 
to Regulation 
(EC) 
No 1907/2006 of the E uro­
pean 
Parliamen t 
and 
of the Coun cil 
on 
the Registration, 
Evaluation,
 Authorisation an d
 Restriction of Chemicals 
(REACH)
(1) OJ L 142, 31.5.2008, p. 1. (1) or in Annex VIII to this Reg ulation.
2. The 
Commission , 
after consulting 
the SCCS an d 
the Euro­
pean 
Centre 
for the Validation  
of Alternative 
Methods (E CVAM) 
and 
with due reg ard 
to the developmen t 
of validation  
within 
the 
OECD, 
has established 
timetables 
for the implemen tation 
of the 
provisions 
under 
points 
(a), (b) 
and 
(d) of parag raph 
1, including 
deadlines 
for the phasin g-out 
of the various tests. The timetab les 
were 
made availab le 
to the pub lic 
on 1 
October 
2004 and 
sent 
to 
the European 
Parliamen t 
and 
the Council. 
The period for imple­
mentation 
was limited to  11 March 2009 in  
relation 
to points 
(a), 
(b) 
and 
(d) of parag raph 
1.
In 
relation 
to the tests con cerning 
repeated-dose toxicity, repro­
ductive toxicity an d 
toxicokinetics, 
for which there are n o 
alter­
natives 
yet under 
consideration, 
the period for implemen tation 
of 
paragraph 
1(a) and 
(b) 
shall be 
limited to  11 March 2013.
The Commission  
shall study possib le 
technical difficulties in  
com­
plying
 with the b an
 in relation to tests, in particular those con­
cerning
 repeated-dose toxicity, reproductive toxicity an d
 
toxicokinetics, 
for which there are n o 
alternatives 
yet under 
con­
sideration . 
Information 
about 
the provision al 
and 
final 
results of 
these studies forms part of the yearly reports presen ted 
pursuant 
to 
Article 35.
On 
the basis 
of these an nual 
reports, the timetab les 
established 
as 
referred to in the first sub paragraph,
 could b e
 adapted up 
to 11 March 2009 in  
relation 
to the first sub paragraph 
and 
may 
be 
adapted up to  11 March 2013 in  
relation 
to the secon d 
sub­
paragraph 
and 
after consultation 
of the entities 
referred to in  
the 
first subparagraph.
The
 Commission shall study prog ress
 and
 compliance with the 
deadlines
 as well as possib le
 technical
 difficulties in complyin g
 
with the b an. 
Information 
about 
the provision al 
and 
final 
results 
of the Commission  
studies forms part of the yearly reports pre­
sented 
pursuant 
to Article 35. I f 
these studies con clude, 
at the lat­
est two years prior to the en d 
of the maximum period referred to 
in the secon d
 subparagraph,
 that for techn i
cal reason s
 one
 or 
more tests referred to in  
that subparagraph 
will not 
be 
developed 
and 
validated b efore 
the expiry of the period referred to therein  
it 
shall inform 
the European 
Parliamen t 
and 
the Council 
and 
shall 
put forward a leg islative 
proposal in  
accordance 
with Article 251 
of the Treaty.
In 
exception al 
circumstan ces, 
where serious con cerns 
arise as 
regards
 the safety of an existin g
 cosmetic in gredient,
 a Member
 
State may request the Commission to g rant
 a derogation
 from paragraph 
1. The request shall con tain 
an 
evaluation  
of the situ­
ation 
and 
indicate 
the measures n ecessary. 
On 
this basis, 
the 
Commission  
may, after con sulting 
the SCCS an d 
by 
means 
of a 
reasoned
 decision,
 authorise the derog ation.
 That authorisation 
shall lay down  
the conditions 
associated with this derog ation 
in 
terms 
of specific ob jectives, 
duration 
and 
reporting 
of the results.
A derogation 
shall be 
granted 
only 
where:
(a) the ingredient 
is in 
wide use an d 
cannot 
be 
replaced b y 
another 
ingredient 
capable 
of performin g 
a similar fun ction;
(b) the 
specific human  
health prob lem 
is substantiated 
and 
the 
need 
to conduct 
animal 
tests is justified an d 
is supported b y 
a 
detailed research protocol proposed as the b asis 
for the 
evaluation .
The 
decision 
on 
the authorisation , 
the conditions 
associated with 
it and 
the final 
result achieved shall b e 
part of the an nual 
report 
presented 
by 
the Commission  
in 
accordance 
with Article 35.
The measures referred to in  
the sixth sub paragraph, 
designed 
to 
amend 
non-essential 
elements 
of this Reg ulation, 
shall be 
adopted 
in accordan ce
 with the reg ulatory
 procedure with scrutin y
 
referred to in  
Article 32(3).
3. For the purposes of this Article an d 
Article 20: 
(a) ‘finished 
cosmetic product’ mean s 
the cosmetic product in  
its 
final
 formulation ,
 as placed on the mark et
 and
 made avail­
able 
to the end 
user, or its prototype;
(b) ‘
prototype’ mean s 
a first model or desig n 
that has n ot 
been 
produced 
in 
batches, 
and 
from which the fin ished 
cosmetic 
product is copied or fin ally 
developed.
CHAPTER VI
CONSUMER 
INFORMATION
Article 19
Labelling
1. Without prejudice to other provision s
 in this Article, cos­
metic products shall b e 
made availab le 
on 
the market 
only 
where 
the container
 and
 packaging
 of cosmetic products b ear
 the fol­
lowing 
information 
in 
indelible, 
easily legible 
and
 visible letterin g: 
(a) the 
name 
or registered 
name 
and 
the address of the respon ­
sible 
person. 
Such information 
may be 
abbreviated 
in 
so far 
as the abbreviation 
makes 
it possible 
to identify 
that person  
and
 his address. I f
 several addresses are in dicated,
 the one
 
where the respon sible 
person 
makes 
readily availab le 
the 
product in formation 
file shall b e 
highlighted. 
The country 
of 
origin 
shall be 
specified for imported cosmetic products;N E 2 7 / 2 4 3 LOfficial Journ alof the EuropeanUnion L 342/73
(b) the n ominal content at the time of pack aging, given by 
weight
 or by
 volume, except in the case of pack aging
 con­
taining 
less than 
five grams 
or five millilitres, free samples 
and 
single-application 
packs; 
for pre-pack ages 
normally 
sold 
as a number 
of items, for which details of weig ht 
or volume 
are not
 significant,
 the content
 need
 not be given
 provided 
the number
 of items appears on the pack aging.
 This infor
­
mation 
need 
not 
be 
given 
if the number 
of items is easy to 
see from the outside or if the product is n ormally 
only 
sold 
individually;
(c) the 
date until 
which the cosmetic product, stored un der 
appropriate 
conditions, 
will continue 
to fulfil its in itial 
func­
tion
 and,
 in particular, will remain in con formity
 with 
Article 3 (‘date of min imum 
durability
’).
The date itself or details of where it appears on  
the packag­
ing 
shall be 
preceded b y 
the symbol 
shown 
in 
point 
3 of 
Annex 
VII 
or the words: ‘best 
used before 
the end 
of’.
The date of min imum
 durability
 shall be clearly expressed 
and
 shall con sist
 of either the mon th
 and year or the day, 
month 
and 
year, in 
that order. I f 
necessary, 
this information 
shall
 be
 supplemen ted
 by
 an indication
 of the con ditions
 
which must b e 
satisfied to g uarantee 
the stated durab ility.
Indication
 of the date of min imum
 durability
 shall not
 be
 
mandatory 
for cosmetic products with a min imum 
durabil­
ity 
of more than  
30 months. 
For such products, there shall 
be 
an 
indication 
of the period of time after open ing 
for which 
the product is safe an d 
can 
be 
used without an y 
harm to the 
consumer. 
This information 
shall be 
indicated, 
except where 
the concept 
of durability 
after open ing 
is not 
relevant, 
by 
the 
symbol 
shown 
in 
point 
2 of Annex 
VII 
followed b y 
the period 
(in 
months 
and/or 
years);
(d) particular precaution s 
to be 
observed 
in 
use, and 
at least 
those listed in  
Annexes 
III 
to VI 
and 
any 
special precaution ­
ary 
information 
on 
cosmetic products for profession al 
use;
(e) the batch 
number 
of manufacture 
or the referen ce 
for iden­
tifying
 the cosmetic product. Where this is impossib le
 for 
practical reason s
 because
 the cosmetic products are too 
small, such in formation 
need 
appear on ly 
on 
the packaging;
(f) the 
function 
of the cosmetic product, un less 
it is clear from 
its presentation;
(g) a 
list of ingredients. 
This information 
may be in dicated 
on 
the 
packaging 
alone. 
The list shall b e 
preceded b y 
the term
‘ingredients
’.For the purpose of this Article, an  ingredient means any sub­
stance 
or mixture in tentionally 
used in 
the cosmetic product 
during 
the process of man ufacturing. 
The followin g 
shall not, 
however, 
be 
regarded 
as ingredients:
(i) impurities 
in 
the raw materials used;
(ii) subsidiary
 technical
 materials used in the mixture b ut
 
not 
present 
in 
the final 
product.
Perfume an d 
aromatic composition s 
and 
their raw materials 
shall be 
referred to b y 
the terms ‘parfum’ or ‘aroma’. More­
over, the presen ce 
of substances, 
the mention 
of which is 
required un der 
the column  ‘
Other’ in 
Annex 
III, 
shall be 
indi­
cated 
in 
the list of in gredients 
in 
addition 
to the terms par­
fum or aroma.
The list of in gredients 
shall be 
established 
in 
descending 
order 
of weight 
of the ingredients 
at the time they are added to the 
cosmetic product. I ngredients 
in 
concentrations 
of less than  
1 
% may be 
listed in 
any 
order after those in  
concentrations 
of 
more than  
1 %.
All ingredients 
present 
in 
the form of n anomaterials 
shall be 
clearly 
indicated 
in 
the list of in gredients. 
The names 
of such 
ingredients 
shall be 
followed b y 
the word ‘nano
’ in 
brackets.
Colorants
 other than coloran ts
 intended
 to colour the hair 
may be 
listed in 
any 
order after the other cosmetic in gredi­
ents.
 For decorative cosmetic products mark eted
 in several 
colour shades, all coloran ts 
other than  
colorants 
intended 
to 
colour the hair used in  
the range 
may be 
listed, provided that 
the words ‘may contain
’ or the symb ol ‘
+/-’ are added. The CI  
(Colour 
Index) 
nomenclature 
shall be 
used, where applicab le.
2. Where 
it is impossib le 
for practical reason s 
to label 
the 
information
 mentioned
 in points
 (d) and
 (g)
 of paragraph
 1 as 
provided, the followin g 
applies: 
—the information
 shall be
 mentioned
 on an en closed
 or 
attached leaflet, lab el, 
tape, tag 
or card; 
—unless 
impracticab le, 
this information 
shall be 
referred to b y 
abbreviated
 information
 or the symb ol
 gi
ven in poin t
 1 of 
Annex 
VII, 
which must appear on  
the container 
or packag­
ing 
for the information 
referred in  
point 
(d) of parag raph 
1 
and 
on 
packaging 
for the information 
referred in  
point 
(g) 
of 
paragraph 
1.
3. In
 the case of soap, b ath
 balls
 and
 other small products 
where it is impossib le
 for practical reason s
 for the in formation
 
referred to in  
point 
(g) 
of paragraph 
1 to appear on  
a label, 
tag, 
tape 
or card or in  
an 
enclosed 
leaflet, this in formation 
shall appear 
on 
a notice 
in 
immediate proximity to the con tainer 
in 
which the 
cosmetic product is exposed for sale.N E 9 0 0 2 . 2 1 . 2 2Official Journ alof the EuropeanUnion 22.12.2009
4. For cosmetic products that are n ot pre-packaged, are pack­
aged 
at the poin t 
of sale at the purchaser’s request, or are pre-
packaged 
for immediate sale, Memb er 
States shall adopt detailed 
rules for in dication 
of the information 
referred to in  
paragraph 
1.
5. The language
 of the in formation
 mentioned
 in points
 (b),
 
(c), (d) an d
 (f) of parag raph
 1 and
 in paragraphs
 (2), (3) an d
 (4) 
shall be 
determined 
by 
the law of the Memb er 
States in 
which the 
product is made availab le 
to the end 
user.
6. The information 
mentioned 
in 
point 
(g) 
of paragraph 1 shall 
be 
expressed b y 
using 
the common  
ingredient 
name 
set out in 
the 
glossary 
provided for in  
Article 33. I n 
the absence 
of a common  
ingredient 
name, 
a term as con tained 
in 
a generally 
accepted 
nomenclature 
shall be 
used.
Article 20
Product 
claims
1. In 
the labelling, 
making 
available 
on 
the market 
and 
adver­
tising 
of cosmetic products, text, n ames, 
trade mark s, 
pictures an d 
figurative 
or other sig ns 
shall not 
be 
used to imply that these 
products have characteristics or fun ctions 
which they do n ot 
have.
2. The Commission  
shall, in 
cooperation  
with Memb er 
States, 
establish
 an action plan reg arding
 claims used an d
 fix priorities 
for determin ing 
common 
criteria justifyin g 
the use of a claim. 
After consulting 
the SCCS or other relevan t 
authorities, the Com­
mission 
shall adopt a list of common  
criteria for claims which 
may be 
used in 
respect of cosmetic products, in  
accordance 
with 
the regulatory 
procedure with scrutin y 
referred to in  
Article 32(3) 
of this Reg ulation, 
taking 
into 
account 
the provision s 
of Directive 
2005/29/E C. 
By 11 
July 2016, the Commission  
shall submit 
to the European 
Parliamen t 
and 
the Council 
a report reg arding 
the use of claims 
on 
the basis 
of the common  
criteria adopted un der 
the secon d 
subparagraph. 
If 
the report con cludes 
that claims used in  
respect 
of cosmetic products are n ot 
in 
conformity 
with the common  
cri­
teria, the Commission  
shall take 
appropriate measures to en sure 
compliance 
in 
cooperation  
with the Memb er 
States.
3. The respon sible 
person 
may refer, on  
the product pack ag­
ing 
or in 
any 
document, 
notice, 
label, 
ring 
or collar accompan y­
ing 
or referrin g 
to the cosmetic product, to the fact that n o 
animal 
tests 
have been 
carried out on ly 
if the man ufacturer 
and 
his sup­
pliers have n ot 
carried out or commission ed 
any 
animal 
tests on 
the
 finished
 cosmetic product, or its prototype, or an y
 of the 
ingredients 
contained 
in 
it, or used an y 
ingredients 
that have b een 
tested
 on animals
 by
 others for the purpose of developin g
 new
 
cosmetic products.Article 21
Access to information for the pu blic
Without 
prejudice to the protection , 
in 
particular, of commercial 
secrecy an d 
of intellectual 
property rig hts, 
the respon sible 
person 
shall 
ensure 
that the qualitative an d 
quantitative 
composition  
of 
the cosmetic product an d,
 in the case of perfume an d
 aromatic 
composition s,
 the name
 and
 code number
 of the composition 
and 
the identity 
of the supplier, as well as existin g 
data on 
unde­
sirable 
effects and 
serious un desirable 
effects resultin g 
from use of 
the cosmetic product are made easily accessib le 
to the pub lic 
by 
any 
appropriate mean s.
The
 quantitative
 information
 regarding
 composition of the cos­
metic product required to b e
 made pub licly
 accessible
 shall be
 
limited to hazardous sub stances 
in 
accordance 
with Article 3 of 
Regulation 
(EC) 
No 1272/2008.
CHAPTER VII
MARKET 
SURVEILLANCE
Article 22
In-market 
control
Member 
States shall mon itor 
compliance 
with this Reg ulation 
via 
in-market 
controls 
of the cosmetic products made availab le 
on 
the
 market.
 They shall perform appropriate check s
 of cosmetic 
products an d 
checks 
on 
the economic 
operators on  
an 
adequate 
scale, throug h 
the product in formation 
file and, 
where appropri­
ate, physical an d 
laboratory 
checks 
on 
the basis 
of adequate 
samples.
Member 
States shall also mon itor 
compliance 
with the prin ciples 
of 
good 
manufacturing 
practices.
Member 
States shall en trust 
to market 
surveillan ce 
authorities the 
necessary
 powers, resources an d
 knowledge
 in order for those 
authorities to properly perform their task s.
Member 
States shall periodically review an d 
assess the fun ction­
ing 
of their surveillan ce 
activities. Such reviews an d 
assessmen ts 
shall 
be 
carried out at least every four years an d 
the results thereof 
shall be 
communicated 
to the other Memb er 
States and 
the Com­
mission 
and 
be 
made availab le 
to the pub lic, 
by 
way of electron ic 
communication 
and, 
where appropriate, b y 
other mean s.
Article 
23
Communication 
of seriou s 
undesirable 
effects
1. In
 the event
 of serious un desirable
 effects, the respon sible
 
person 
and 
distributors 
shall without delay n otify 
the followin g 
to 
the competen t 
authority of the Memb er 
State where the serious 
undesirable 
effect occurred: 
(a) all serious un desirable
 effects which are k nown
 to him or 
which may reason ably 
be 
expected to b e 
known 
to him;N E 4 7 / 2 4 3 LOfficial Journ alof the EuropeanUnion L 342/75
(b) the  n ame  of the cosmetic product con cerned,  enabling  its 
specific iden tification;
(c) the 
corrective measures tak en 
by 
him, if an y.
2.
 Where the respon sible
 person reports serious un desirable
 
effects to the competen t 
authority of the Memb er 
State where the 
effect occurred, that competen t 
authority shall immediately tran s
­
mit the in formation 
referred to in  
paragraph 
1 to the competen t 
authorities 
of the other Memb er 
States.
3. Where distrib utors 
report serious un desirable 
effects to the 
competen t
 authority of the Memb er
 State where the effect 
occurred, that competen t 
authority shall immediately tran smit 
the 
information 
referred to in  
paragraph 
1 to the competen t 
authori­
ties of the other Memb er 
States and 
to the respon sible 
person.
4.
 Where en d
 users or health profession als
 report serious 
undesirable
 effects to the competen t
 authority of the Memb er
 
State where the effect occurred, that competen t
 authority shall 
immediately tran smit 
the information 
on 
the cosmetic product 
concerned 
to the competen t 
authorities of the other Memb er 
States 
and 
to the respon sible 
person.
5. Competen t 
authorities may use the in formation 
referred to 
in 
this Article for the purposes of in -market 
surveillan ce, 
market 
analysis, 
evaluation  
and 
consumer 
information 
in 
the context 
of 
Articles 25, 26 an d 
27.
Article 24
Information on su bstances
In 
the event 
of serious doub t 
regarding 
the safety of an y 
substance 
contained
 in cosmetic products, the competen t
 authority of a 
Member 
State in 
which a product con taining 
such a sub stance 
is 
made availab le 
on 
the market 
may by 
reasoned 
request require the 
responsible
 person to sub mit
 a list of all cosmetic products for 
which he is respon sible 
and 
which con tain 
this substance. 
The list 
shall indicate 
the concentration 
of this sub stance 
in 
the cosmetic 
products.
Competen t 
authorities may use the in formation 
referred to in  
this 
Article for the purposes of in -market 
surveillan ce, 
market 
analy­
sis,
 evaluation an d
 consumer
 information
 in the con text
 of 
Articles 25, 26 an d 
27.
CHAPTER VIII
NON-COMPLIANCE, 
SAFEGUARD 
CLAUSE
Article 25
Non-compliance 
by the responsible person
1. Without prejudice to parag raph
 4, competen t
 authorities 
shall require the respon sible 
person 
to take 
all appropriate mea­
sures, including 
corrective action s 
bringing 
the cosmetic product into 
conformity, 
the withdrawal of the product from the mark et 
or 
its recall, within  
an 
expressly men tioned 
time limit, commen ­
surate 
with the n ature 
of the risk , 
where there is n on-compliance 
with 
any 
of the followin g: 
(a) the 
good 
manufacturing 
practice referred to in  
Article 8;
(b) the 
safety assessmen t 
referred to in  
Article 10;
(c) the requiremen ts 
for the product in formation 
file referred to 
in 
Article 11;
(d) the provision s
 on samplin g
 and
 analysis
 referred to in 
Article 12;
(e) the notification
 requiremen ts
 referred to in Articles  13 
and 
16;
(f) the restriction s 
for substances 
referred to in  
Articles 14, 15 
and 
17;
(g) the 
animal 
testing 
requiremen ts 
referred to in  
Article 18;
(h) the labelling 
requiremen ts 
referred to in  
Article 19(1), (2), (5) 
and 
(6);
(i) the requiremen ts
 related to product claims set out in 
Article 20;
(j) the access to in formation
 for the pub lic
 referred to in 
Article 21;
(k) the 
communication 
of serious un desirable 
effects referred to 
in 
Article 23;
(l) the information
 requiremen ts
 on substances
 referred to in 
Article 24.
2. Where applicab le,
 a competen t
 authority shall in form
 the 
competen t
 authority of the Memb er
 State in which the respon­
sible 
person 
is established 
of the measures which it has required 
the respon sible 
person 
to take.
3.
 The respon sible
 person shall en sure
 that the measures 
referred to in  
paragraph 
1 are taken 
in 
respect of all the products 
concerned
 which are made availab le
 on the mark et
 throughout
 
the Commun ity.
4. In 
the case of serious risk s 
to human  
health, where the com­
petent 
authority con siders 
that the non-compliance 
is not 
limited 
to the territory of the Memb er 
State in 
which the cosmetic prod­
uct is made availab le 
on 
the market, 
it shall inform 
the Commis­
sion 
and 
the competen t 
authorities of the other Memb er 
States of 
the measures which it has required the respon sible 
person 
to take.
5. The competen t authority shall tak e all appropriate measures 
to prohibit 
or restrict the mak ing 
available 
on 
the market 
of the 
cosmetic product or to withdraw the product from the mark et 
or 
to recall it in  
the followin g 
cases: 
(a) where an 
immediate action  
is necessary 
in 
the event 
of seri­
ous risk 
to human  
health; orN E 9 0 0 2 . 2 1 . 2 2Official Journ alof the EuropeanUnion 22.12.2009
(b) where  the respon sible  person does n ot  take  all appropriate 
measures within  
the time limit referred to in  
paragraph 
1.
In 
the event 
of serious risk s 
to human  
health, that competen t 
authority
 shall inform
 the Commission an d
 the competen t
 
authorities of the other Memb er 
States, without delay, of the mea­
sures taken.
6.
 In
 the absence
 of a serious risk to human health, in the 
event 
that the respon sible 
person 
does not 
take 
all appropriate 
measures, the competen t 
authority shall without delay in form 
the 
competen t
 authority of the Memb er
 State in which the respon­
sible 
person 
is established 
of the measures tak en.
7. For 
the purposes of parag raphs 
4 and 
5 of this Article, the 
information
 exchange
 system provided for in Article 12(1) of 
Directive 2001/95/E C 
of the European 
Parliamen t 
and 
of the 
Council 
of 3 Decemb er 
2001 on 
general 
product safety
(1) OJ L 11, 15.1.2002, p. 4. (1) shall 
be 
used.
Article 12(2), (3) an d 
(4) of Directive 2001/95/E C 
and 
Article 23 
of Regulation 
(EC) 
No 765/2008 of the E uropean 
Parliamen t 
and 
of 
the Council 
of 9 July 2008 settin g 
out the requiremen ts 
for 
accreditation  
and 
market 
surveillan ce 
relating 
to the mark eting 
of 
products
(2) OJ L 218, 13.8.2008, p. 30. (2) shall also apply.
Article 26
Non-compliance 
by distribu tors
Competen t 
authorities shall require distrib utors 
to take 
all appro­
priate measures, in cluding
 corrective action s
 bringing
 the cos­
metic product in to 
conformity, 
the withdrawal of the product 
from the mark et 
or its recall, within  
a given 
reasonable 
time limit, 
commensurate 
with the n ature 
of the risk , 
where there is n on-
compliance 
with obligations 
laid down  
in 
Article 6.
Article 27
Safeguard 
clause
1.
 In
 the case of products meetin g
 the requirements listed in 
Article 25(1), where a competen t 
authority ascertain s, 
or has rea­
sonable 
grounds 
for concern, 
that a cosmetic product or products 
made availab le 
on 
the market 
present 
or could presen t 
a serious 
risk 
to human  
health, it shall tak e 
all appropriate provision al 
mea­
sures in 
order to en sure 
that the product or products con cerned 
are 
withdrawn , 
recalled or their availab ility 
is otherwise restricted.
2. The competen t 
authority shall immediately commun icate 
to 
the Commission  
and 
the competen t 
authorities of the other Mem­
ber 
States the measures tak en 
and 
any 
supportin g 
data. For the purposes of the first sub paragraph,
 the information
 
exchange
 system provided for in Article  12(1) of Directive 
2001/95/E C 
shall be 
used. 
Article 12(2), (3) an d 
(4) of Directive 2001/95/E C 
shall apply. 
3. The Commission shall determin e,
 as soon as possib le,
 
whether the provision al 
measures referred to in  
paragraph 
1 are 
justified or n ot. 
For that purpose it shall, when ever 
possible, 
con­
sult 
the interested 
parties, the Memb er 
States and 
the SCCS.
4. Where the provision al 
measures are justified, Article 31(1) 
shall apply.
5. Where the provision al 
measures are n ot 
justified the Com­
mission 
shall inform 
the Memb er 
States thereof an d 
the compe­
tent 
authority con cerned 
shall repeal the provision al 
measures in  
question.
Article 
28
Good administrative practices
1. Any
 decision tak en
 pursuant
 to Articles 25 an d
 27 shall 
state the exact g rounds 
on 
which it is b ased. 
It 
shall be 
notified 
by 
the competen t authority without delay to the respon sible person, 
who 
shall at the same time b e 
informed 
of the remedies availab le 
to 
him under 
the law of the Memb er 
State concerned 
and 
of the 
time limits to which remedies are sub ject.
2. Except 
in 
the case where immediate action  
is necessary 
for 
reasons
 of serious risk to human health, the respon sible
 person 
shall have the opportun ity
 to put forward his viewpoin t
 before
 
any 
decision 
is taken.
3.
 Where applicab le,
 the provision s
 mentioned
 in para­
graphs 
1 and 
2 shall apply with reg ard 
to the distrib utor 
for any 
decisions 
taken 
pursuant 
to Articles 26 an d 
27.
CHAPTER IX
ADMINISTRATIVE 
COOPERATION
Article 29
Cooperation between competent au thorities
1. The 
competen t 
authorities of the Memb er 
States shall coop­
erate with each other an d 
with the Commission  
to ensure 
the 
proper application an d
 due enforcement
 of this Reg ulation
 and
 
shall transmit 
to each other all in formation 
necessary 
with a view 
to applyin g 
this Regulation 
uniformly.
2.
 The Commission shall provide for the org anisation
 of an 
exchange 
of experien ce 
between 
the competen t 
authorities in  
order 
to coordin ate 
the uniform 
application  
of this Reg ulation.
3.
 Cooperation may b e
 part of in itiatives
 developed at in ter
­
national 
level.N E 6 7 / 2 4 3 LOfficial Journ alof the EuropeanUnion L 342/77
Article 30
Cooperation regarding verification of produ ct 
information 
files
The competen t 
authority of an y 
Member 
State where the cosmetic 
product is made availab le 
may request the competen t 
authority of 
the Memb er
 State where the product information file is made 
readily accessib le 
to verify whether the product in formation 
file 
satisfies the requiremen ts 
referred to in  
Article 11(2) an d 
whether 
the information 
set out therein  
provides eviden ce 
of the safety of 
the cosmetic product.
The requestin g
 competen t
 authority shall provide a motivation 
for the request.Upon
 
that request, the competen t 
authority requested shall, with­
out undue 
delay and 
taking 
into 
account 
the degree 
of urgency, 
carry 
out the verification  
and 
shall inform 
the requestin g 
compe­
tent 
authority of its fin dings.
CHAPTER X
IMPLEMENTING 
MEASURES, F INAL 
PROVISIONS
Article 31
Amendment of the Annexes
1. Where there is a poten tial
 risk to human health, arisin g
 
from the use of sub stances 
in 
cosmetic products, which n eeds 
to 
be 
addressed on  
a Commun ity-wide 
basis, 
the Commission  
may, 
after consulting 
the SCCS, amen d 
Annexes 
II 
to VI 
accordingly. 
Those 
measures, desig ned 
to amend 
non-essential 
elements 
of this 
Regulation,
 shall be
 adopted in accordan ce
 with the reg ulatory
 
procedure with scrutin y 
referred to in  
Article 32(3). 
On 
imperative g rounds 
of urgency, 
the Commission  
may use the 
urgency 
procedure referred to in  
Article 32(4). 
2. The Commission may, after con sulting
 the SCCS, amen d
 
Annexes 
III 
to VI 
and 
VIII 
for the purposes of adaptin g 
them to 
technical 
and 
scientific 
progress. 
Those 
measures, desig ned 
to amend 
non-essential 
elements 
of this 
Regulation,
 shall be
 adopted in accordan ce
 with the reg ulatory
 
procedure with scrutin y 
referred to in  
Article 32(3). 
3. Where it appears n ecessary, 
in 
order to en sure 
the safety of 
cosmetic products placed on the mark et,
 the Commission may, 
after consulting 
the SCCS, amen d 
Annex 
I. 
Those 
measures, desig ned 
to amend 
non-essential 
elements 
of this 
Regulation,
 shall be
 adopted in accordan ce
 with the reg ulatory
 
procedure with scrutin y 
referred to in  
Article 32(3). 
Article 32
Committee procedu re
1. The 
Commission  
shall be 
assisted by 
the Standing 
Commit­
tee on 
Cosmetic Products.2. Where referen ce 
is made to this parag raph, 
Articles 5 an d 
7 
of Decision  
1999/468/E C 
shall apply, havin g 
regard 
to the pro­
visions 
of Article 8 thereof. 
The period laid down  
in 
Article 5(6) of Decision  
1999/468/E C 
shall 
be 
set at three mon ths. 
3. Where 
reference 
is made to this parag raph, 
Article 5a(1) 
to (4) and 
Article 7 of Decision  
1999/468/E C 
shall apply, havin g 
regard 
to the provision s 
of Article 8 thereof.
4. Where referen ce 
is made to this parag raph
, Article 5a(1), (2), 
(4) and
 (6) and
 Article 7 of Decision 1999/468/E C
 shall apply 
having 
regard 
to the provision s 
of Article 8 thereof.
Article 33
Glossary of common ingredient names
The Commission  
shall compile an d 
update a g lossary 
of common  
ingredient 
names. 
To this en d, 
the Commission  
shall take 
account 
of 
internationally 
recognised 
nomenclatures 
including 
the Inter­
national 
Nomenclature 
of Cosmetic I ngredients 
(INCI). 
That glos­
sary 
shall not 
constitute 
a list of the sub stances 
authorised for use 
in 
cosmetic products.
The common  ingredient name shall be applied for the purpose of 
labelling
 cosmetic products placed on the mark et
 at the latest 
twelve mon ths 
after publication 
of the glossary 
in 
the Official Jour­
nal of the European Union.
Article 34
Competent au thorities, 
poison control centres or 
assimilated entities
1. Member 
States shall desig nate 
their national 
competen t 
authorities.
2. Member 
States shall commun icate 
the details of authorities 
referred to in  
paragraph 
1 and 
of the poison  
centres 
and 
similar 
bodies 
referred to in  
Article 13(6) to the Commission . 
They shall 
communicate 
an 
update of these details as n ecessary.
3. The 
Commission  
shall compile an d 
update a list of the 
authorities an d 
bodies 
referred to in  
paragraph 
2 and 
make 
it 
available 
to the pub lic.
Article 
35
Annual 
report on animal testing
Every 
year the Commission  
shall presen t 
a report to the E uropean 
Parliamen t 
and 
the Council 
on:
(1)
 progress
 made in the developmen t,
 validation an d
 legal
 
acceptance 
of alternative 
methods. The report shall con tain 
precise 
data on 
the number 
and 
type of experimen ts 
relating 
to
 cosmetic products carried out on an im
als. The Memb er
 
States shall b e 
obliged 
to collect that in formation 
in 
addition 
to 
collecting 
statistics as laid down  
by 
Directive 86/609/E EC. 
The 
Commission  
shall in 
particular en sure 
the developmen t, 
validation
 and
 legal
 acceptan ce
 of altern a
tive test methods 
which do n ot 
use live an imals;N E 9 0 0 2 . 2 1 . 2 2L 342/78 EN Official Journ alof the EuropeanUnion 22.12.2009
(2) progress made by the Commission  in its efforts to ob tain 
acceptance 
by 
the OECD 
of alternative 
methods validated at 
Community
 level and
 recognition
 by
 third coun tries
 of the 
results of the safety tests carried out in  
the Commun ity 
using 
alternative 
methods, in  
particular within  
the framework  
of 
cooperation  
agreements 
between 
the Commun ity 
and 
these 
countries;
(3) the 
manner 
in 
which the specific n eeds 
of small an d 
medium-
sized enterprises 
have been 
taken 
into 
account.
Article 
36
Formal 
objection against harmonised standards
1. When 
a Member 
State or the Commission  
considers 
that a 
harmonised 
standard 
does not 
entirely 
satisfy the requiremen ts 
set 
out in 
the relevan t 
provisions 
of this Reg ulation, 
the Commission  
or 
the Memb er 
State concerned 
shall bring 
the matter b efore 
the 
Committee set up b y 
Article 5 of Directive 98/34/E C, 
giving 
its 
arguments. 
The Committee shall deliver its opin ion 
without delay.
2. In
 the light
 of the Committee’s opin ion,
 the Commission 
shall decide to pub lish, 
not 
to publish, 
to publish 
with restriction , 
to 
maintain, 
to maintain 
with restriction  
or to withdraw the ref­
erences 
to the harmon ised 
standard 
concerned 
in 
the Official Jour­
nal of the European Union.
3. The Commission shall in form
 the Memb er
 States an d
 the 
European
 standardisation
 body
 concerned.
 It
 shall, if n ecessary,
 
request the revision  
of the harmon ised 
standards 
concerned.
Article 
37
Penalties
Member 
States shall lay down  
the provision s 
on 
penalties 
appli­
cable 
for infringement 
of the provision s 
of this Reg ulation 
and 
shall
 take
 all measures n ecessary
 to ensu
re that they are imple­
mented. 
The penalties 
provided for must b e 
effective, proportion ­
ate
 and
 dissuasive. The Memb er
 States shall n otify
 those 
provisions 
to the Commission  
by 11 
July 2013 an d 
shall notify 
it 
without delay of an y 
subsequent 
amendment 
affecting 
them.Article 38
Repeal
Directive 76/768/E EC 
is repealed with effect from 11 July 2013, 
with the exception  
of Article 4b  
which is repealed with effect 
from 1 Decemb er 
2010.
References 
to the repealed Directive shall b e 
understood 
as refer­
ences 
to this Reg ulation.
This
 Regulation
 shall be
 without prejudice to the ob ligations
 of 
the Memb er
 States relatin g
 to the time-limits for tran sposition
 
into 
national 
law of the Directives set out in  
Part B of An nex 
IX.
However, 
the competen t 
authorities shall con tinue 
to keep 
avail­
able
 the information
 received pursuan t
 to Article  7(3) an d
 
Article 7a(4) of Directive 76/768/E EC
 and
 responsible
 persons
 
shall continue 
to keep 
readily accessib le 
the inf
ormation collected 
pursuant 
to Article 7a of that Directive un til 11 
July 2020.
Article 39
Transitional provisions
By way of derog ation 
from Directive 76/768/E EC, 
cosmetic prod­
ucts which comply with this Reg ulation
 may be placed on the 
market 
before 11 
July 2013.
As from 11 January 
2012, by 
way of derog ation 
from Directive 
76/768/E EC,
 notification
 carried out in accordan ce
 with 
Article 13 of this Reg ulation 
shall be 
considered 
to comply with 
Article 7(3) an d 
Article 7a(4) of that Directive.
Article 40
Entry into force and date of application
1. This Regulation 
shall enter 
into 
force on 
the [twentieth 
day 
after its pub lication 
in 
the Official Journal of the European Union
2. It 
shall apply from 11 July 2013, with the exception  
of:
—Article 15(1) an d 
(2) which shall apply from 1 Decemb er 
2010
, as well as Articles 14, 31 an d 
32 to the exten t 
that 
they are n ecessary 
to apply Article 15(1) an d 
(2); and
 
—Article 16(3) secon d
 subparagraph,
 which shall apply from
11 January 
2013.
This Regulation 
shall be 
binding 
in 
its entirety 
and 
directly applicab le 
in 
all Member 
States.
Done 
at Brussels, 30 Novemb er 
2009.
For the European Parliament
The President
J. BUZEKFor the Council
The President
B. ASKOfficial Journ alof the EuropeanUnion L 342/79
ANNEX I
COSMETIC PROD UCT 
SAFETY 
REPORT
The cosmetic product safety report shall, as a min imum, 
contain 
the followin g:
PART 
A – Cosmetic product safety in formation
1.
 Quantitative 
and qualitative 
composition of the cosmetic produ ct
The 
qualitative an d 
quantitative 
composition  
of the cosmetic product, includin g 
chemical iden tity 
of the sub stances 
(incl. 
chemical n ame, 
INCI, 
CAS, EINECS/ELINCS, 
where possib le) 
and 
their intended 
function. 
In 
the case of perfume 
and 
aromatic composition s, 
description  
of the name 
and 
code number 
of the composition  
and 
the identity 
of the 
supplier.
2. Physical/chemical characteristics and stability of the cosmetic produ c
t
The physical an d 
chemical characteristics of the sub stances 
or mixtures, as well as the cosmetic product.
The stability 
of the cosmetics product un der 
reasonably 
foreseeable 
storage 
conditions.
3.
 Microbiological qu ality
The 
microbiological 
specification s 
of the sub stance 
or mixture an d 
the cosmetic product. Particular atten tion 
shall be 
paid 
to cosmetics used aroun d 
the eyes, on  
mucous memb ranes 
in 
general, 
on 
damaged 
skin, 
on 
children 
under 
three 
years of ag e, 
on 
elderly people an d 
persons 
showing 
compromised immun e 
responses.
Results 
of preservation  
challenge 
test.
4. Impurities, 
traces, information abou t 
the packaging material
The purity of the sub stances 
and 
mixtures.
In 
the case of traces of prohib ited 
substances, 
evidence 
for their techn ic
al unavoidability.
The 
relevant 
characteristics of pack aging 
material, in  
particular purity an d 
stability.
5.
 Normal and reasonably foreseeable u se
The 
normal 
and 
reasonably 
foreseeable 
use of the product. The reason ing 
shall be 
justified in  
particular in  
the light 
of 
warnings 
and 
other explan ations 
in 
the product lab elling.
6.
 Exposure 
to the cosmetic produ ct
Data 
on 
the exposure to cosmetic product tak ing 
into 
consideration 
the findin gs 
under 
Section 
5 in 
relation 
to
1) The site(s) of application ;
2) The 
surface area(s) of application ;
3) The 
amount 
of product applied;
4) The duration  
and 
frequency 
of use;
5) The normal 
and 
reasonably 
foreseeable 
exposure route(s);
6) The targeted
 (or exposed) population (s).
 Potential
 exposure of a specific population shall also b e
 taken
 into
 
account.N E 9 0 0 2 . 2 1 . 2 2Official Journ alof the EuropeanUnion 22.12.2009
The calculation  of the exposure shall also tak e into consideration the toxicolog ical effects to b e considered (e.g. expo­
sure 
might 
need 
to be 
calculated per un it 
area of sk in 
or per unit 
of body 
weight). The possib ility 
of secondary 
expo­
sure by 
routes other than  
those resultin g 
from direct application  
should also b e 
considered 
(e.g. 
non-
intended 
inh
alation 
of 
sprays, non-intended 
ingestion 
of lip products, etc.).
Particular con sideration 
shall be 
given 
to any 
possible 
impacts on  
exposure due to particle sizes.
7. Exposure 
to the substances
Data 
on 
the exposure to the sub stances 
contained 
in 
the cosmetic product for the relevan t 
toxicological 
endpoints 
tak­
ing 
into 
account 
the information 
under 
Section 
6.
8. Toxicological profile of the su bstances
Without 
prejudice to Article 18, the toxicolog ical 
profile of sub stance 
contained 
in 
the cosmetic product for all rel­
evant 
toxicological 
endpoints. 
A particular focus on  
local toxicity evaluation  
(skin 
and 
eye irritation ), 
skin 
sensitisa­
tion, 
and 
in 
the case of UV ab sorption 
photo-induced 
toxicity shall b e 
made.
All significant 
toxicological 
routes of ab sorption 
shall be 
considered 
as well as the systemic effects an d 
margin 
of safety 
(MoS) based 
on 
a no 
observed 
adverse effects level (NOAE L) 
shall be 
calculated. The ab sence 
of these con siderations 
shall 
be 
duly justified.
Particular con sideration 
shall be 
given 
to any 
possible 
impacts on  
the toxicolog ical 
profile due to
—particle sizes, in cluding 
nanomaterials,
 
—impurities of the sub stances 
and 
raw material used, an d
 
—interaction 
of substances.
Any 
read-across shall b e 
duly substantiated 
and 
justified.
The source of in formation 
shall be 
clearly iden tified.
9.
 Undesirable effects and seriou s 
undesirable 
effects
All availab le 
data on 
the undesirable 
effects and 
serious un desirable 
effects to the cosmetic product or, where relevan t, 
other 
cosmetic products. This in cludes 
statistical data.
10. Information on the cosmetic produ ct
Other 
relevant 
information, 
e.g. 
existing 
studies from human  
volunteers 
or the duly con firmed 
and 
substantiated 
find­
ings 
of risk 
assessmen ts 
carried out in  
other relevan t 
areas.
PART B –  Cosmetic product safety assessmen t
1.
 Assessment conclu sion
Statement 
on 
the safety of the cosmetic product in  
relation 
to Article 3.
2. Labelled warnings and instru ctions 
of use
Statement 
on 
the need 
to label 
any 
particular warn ings 
and 
instructions 
of use in 
accordance 
with Article 19(1)(d).
3. Reasoning
Explanation 
of the scien tific 
reasoning 
leading 
to the assessmen t 
conclu
sion 
set out un der 
Section 
1 and 
the statemen t 
set 
out under 
Section 
2. This explan ation 
shall be 
based 
on 
the descriptions set out un der 
Part A. Where relevan t, 
mar­
gins 
of safety shall b e 
assessed an d 
discussed.N E 0 8 / 2 4 3 L22.12.2009 EN Official Journ alof the EuropeanUnion L 342/81
There shall b e inter alia a specific assessmen t for cosmetic products in tended for use on  children under the age of three 
and 
for cosmetic products in tended 
exclusively for use in  
external 
intima
te hygiene.
Possible 
interactions 
of the sub stances 
contained 
in 
the cosmetic product shall b e 
assessed.
The consideration 
and 
non-consideration 
of the differen t 
toxicological 
profiles shall b e 
duly justified.
Impacts 
of the stab ility 
on 
the safety of the cosmetic product shall b e 
duly considered.
4.
 Assessor’s credentials and approval of part B
Name and 
address of the safety assessor.
Proof of qualification  
of safety assessor.
Date and 
signature 
of safety assessor.L 342/82 EN Official Journ alof the EuropeanUnion 22.12.2009
Preamble to Annexes II to VI
(1) For the purposes of the An nexes 
II 
to VI:
(a) ‘
Rinse-off 
product’ mean s 
a cosmetic product which is in tended 
to be 
removed after application  
on 
the skin, 
the
hair or the mucous memb ranes;
(b) ‘
Leave-on 
product’ mean s 
a cosmetic product which is in tended 
to stay in 
prolonged 
contact 
with the sk in, 
the
hair or the mucous memb ranes;
(c) ‘
Hair product’ mean s 
a cosmetic product which is in tended 
to be 
applied on  
the hair of head or face, except eye
lashes;
(d) ‘Skin 
product’ mean s 
a cosmetic product which is in tended 
to be 
applied on  
the skin;
(e) ‘
Lip product’ mean s 
a cosmetic product which is in tended 
to be 
applied on  
the lips;
(f) ‘Face product’ mean s 
a cosmetic product which is in tended 
to be 
applied on  
the skin 
of the face;
(g) ‘
Nail product’ mean s 
a cosmetic product which is in tended 
to be 
applied on  
nails;
(h) ‘
Oral product’ mean s 
a cosmetic product which is in tended 
to be 
applied on  
teeth or the mucous memb ranes 
of
the oral cavity;
(i) ‘Product applied on  
mucous memb ranes
’ means 
a cosmetic product which is in tended 
to be 
applied on  
the mucous
membranes
—of 
the oral cavity,
—on 
the rim of the eyes,
—or of the extern al 
genital 
organs;
(j) ‘
Eye 
product’ mean s 
a cosmetic product which is in tended 
to be 
applied in  
the vicinity 
of the eyes;
(k) ‘
Profession al 
use’ mean s 
the application  
and 
use of cosmetic products b y 
persons 
in 
the exercise of their profes­
sional 
activity.
(2) In 
order to facilitate sub stance 
identification, 
the followin g 
descriptors are used:
—The Non-proprietary 
Names (INN) 
for pharmaceutical products, WHO, Gen e
va, August 
1975;
—The Chemical Ab stracts 
Service numbers 
(CAS);
—The EC 
number 
which correspon d 
to either the E uropean 
Inventory 
of Existi
ng 
Commercial chemical Sub stances
(EINECS)
 numbers
 or the European
 List of Notified Chemical Sub stances
 (ELINCS)
 numbers
 or the reg istration
number 
given 
under 
Regulation 
(EC) 
No 1907/2006;
—The XAN which is the n ame 
approved b y 
specific coun try 
(X), e.g. 
USAN which correspon d 
to the Un ited 
State
approved n ame;
—The 
name 
in 
the glossary 
of common  
ingredient 
names 
referred to in  
Article 33 of this Reg ulation.
(3) Substances 
listed in 
Annexes 
III 
to VI 
do not 
cover nanomaterials, 
except where specifically men tioned.Official Journ alof the EuropeanUnion L 342/83
ANNEX II
LIST OF 
SUBSTANCES PROHIBITED  
IN COSMETIC PROD UCTS
Reference 
numberSubstance identification
Chemical
 name/INN CAS
 number EC
 number
a
b c d
1 N-(5-Chlorob enzoxazol-2-yl)acetamide 35783-57-4
2
(2-Acetoxyethyl)trimethylammon ium 
hydroxide (Acetylcholin e) 
and 
its 
salts51-84-3 200-128-9
3 Deanol 
aceglumate 
(INN) 3342-61-8 222-085-5
4 Spironolactone 
(INN) 52-01-7 200-133-6
5 [4-(4-Hydroxy-3-iodophen oxy)-3,5-diiodophenyl]acetic 
acid (Tiratricol 
(INN)) 
and 
its salts51-24-1 200-086-1
6 Methotrexate (I NN) 59-05-2 200-413-8
7 Aminocaproic 
acid (INN) 
and 
its salts 60-32-2 200-469-3
8 Cinchophen 
(INN), 
its salts, derivatives an d 
salts of these derivatives 132-60-5 205-067-1
9 Thyropropic acid (I NN) 
and 
its salts 51-26-3
10 Trichloroacetic acid 76-03-9 200-927-2
11 Aconitum napellus L. (leaves, roots an d 
galenical 
preparation s) 84603-50-9 283-252-6
12 Aconitine 
(principal 
alkaloid 
of Aconitum napellus L.) an d 
its salts 302-27-2 206-121-7
13 Adonis vernalis L. an d 
its preparation s 84649-73-0 283-458-6
14 Epinephrine 
(INN) 51-43-4 200-098-7
15 Rauwolfia 
serpentina L., alk aloids 
and 
their salts 90106-13-1 290-234-1
16 Alkyne 
alcohols, their esters, ethers an d 
salts
17 Isoprenaline 
(INN) 7683-59-2 231-687-7
18 Allyl 
isothiocyan ate 57-06-7 200-309-2
19 Alloclamide 
(INN) 
and 
its salts 5486-77-1
20 Nalorphin e 
(INN), 
its salts an d 
ethers 62-67-9 200-546-1
21 Sympathicomimetic amin es 
acting 
on 
the central 
nervous 
system: an y 
substance 
contained 
in 
the first list of medicamen ts 
which are sub ject 
to 
medical prescription  
and 
are referred to in  
resolution  
AP (69) 2 of 
the Council 
of Europe300-62-9 206-096-2
22 Aniline, 
its salts an d 
its halogenated 
and 
sulphonated 
derivatives 62-53-3 200-539-3
23 Betoxycain e 
(INN) 
and 
its salts 3818-62-0
24 Zoxazolamin e 
(INN) 61-80-3 200-519-4
25 Procainamide 
(INN), 
its salts an d 
derivatives 51-06-9 200-078-8
26 Benzidine 92-87-5 202-199-1
27 Tuaminoheptane 
(INN), 
its isomers an d 
salts 123-82-0 204-655-5
28 Octodrine 
(INN) 
and 
its salts 543-82-8 208-851-1
29 2-Amino-1,2-bis(4-methoxyphenyl)ethanol 
and 
its salts 530-34-7
30 1,3-Dimethylpen tylamine 
and 
its salts 105-41-9 203-296-1
31 4-Aminosalicylic 
acid and 
its salts 65-49-6 200-613-5
32 Toluidines, 
their isomers, salts an d 
halogenated 
and 
sulphonated 
derivatives26915-12-8 248-105-2N E 9 0 0 2 . 2 1 . 2 2Official Journ alof the EuropeanUnion 22.12.2009
33 Xylidines, their isomers, salts an d halogenated and sulphonated 
derivatives1300-73-8 215-091-4
34 Imperatorin 
(9-(3-methylb ut-2-enyloxy)furo[3,2-g]chromen-7-one
)482-44-0 207-581-1
35 Ammi majus L. an d 
its galenical 
preparation s 90320-46-0 291-072-4
36 2,3-Dichloro-2-methylb utane 507-45-9
37 Substances 
with androgenic 
effect
38 Anthracene 
oil 120-12-7 204-371-1
39 Antibiotics
40 Antimony 
and 
its compoun ds 7440-36-0 231-146-5
41 Apocynum 
cannabinum L. an d 
its preparation s 84603-51-0 283-253-1
42 Apomorphin e 
((R) 
5,6,6a,7-tetrahydro-6-methyl-4 H-dibenzo[de,g]quinoline-10,11-diol) 
and 
its salts58-00-4 200-360-0
43 Arsenic 
and 
its compoun ds 7440-38-2 231-148-6
44 Atropa 
belladonna L. an d 
its preparation s 8007-93-0 232-365-9
45 Atropine, 
its salts an d 
derivatives 51-55-8 200-104-8
46 Barium salts, with the exception  
of barium 
sulphide un der 
the 
conditions 
laid down  
in 
Annex 
III, 
and 
of barium 
sulfate, lak es, 
salts 
and 
pigments 
prepared from colourin g 
agents 
when 
listed in 
Annex 
IV
47 Benzene 71-43-2 200-753-7
48 Benzimidazol-2(3
H)-one 615-16-7 210-412-4
49 Benzazepines 
and 
benzodiazepines 12794-10-4
50 1-Dimethylamin omethyl-1-methylpropyl 
benzoate 
(amylocain e) 
and 
its 
salts644-26-8 211-411-1
51 2,2,6-Trimethyl-4-piperidyl b enzoate 
(eucaine) 
and 
its salts 500-34-5
52 Isocarboxazid 
(INN) 59-63-2 200-438-4
53 Bendroflumethiazide 
(INN) 
and 
its derivatives 73-48-3 200-800-1
54 Beryllium an d 
its compoun ds 7440-41-7 231-150-7
55 Bromine, 
elemental 7726-95-6 231-778-1
56 Bretylium 
tosilate (INN) 61-75-6 200-516-8
57 Carbromal 
(INN) 77-65-6 201-046-6
58 Bromisoval 
(INN) 496-67-3 207-825-7
59 Bromphen iramine 
(INN) 
and 
its salts 86-22-6 201-657-8
60 Benzilonium 
bromide 
(INN) 1050-48-2 213-885-5
61 Tetrylammon ium 
bromide 
(INN) 71-91-0 200-769-4
62 Brucine 357-57-3 206-614-7
63 Tetracaine 
(INN) 
and 
its salts 94-24-6 202-316-6
64 Mofebutazone 
(INN) 2210-63-1 218-641-1
65 Tolbutamide 
(INN) 64-77-7 200-594-3
66 Carbutamide 
(INN) 339-43-5 206-424-4
67 Phenylbutazone 
(INN) 50-33-9 200-029-0
68 Cadmium 
and 
its compoun ds 7440-43-9 231-152-8
69 Cantharides,
 Cantharis vesicatoria 92457-17-5 296-298-7
70 Cantharidine 56-25-7 200-263-3N E 4 8 / 2 4 3 L
d c b ar e b m u n C E r e b m u n S A C N N I / e m a n l a c i m e h Cn o i t a c i f i t n e d i e c n a t s b u S
r e b m u ne c n e r e f e ROfficial Journ alof the EuropeanUnion L 342/85
71 Phenprobamate (INN) 673-31-4 211-606-1
72 Nitroderivatives 
of carbazole
73 Carbon 
disulphide 75-15-0 200-843-6
74 Catalase 9001-05-2 232-577-1
75 Cephaelin e 
and 
its salts 483-17-0 207-591-6
76 Chenopodium ambrosioides L. (essen tial 
oil) 8006-99-3
77 2,2,2-Trichloroethan e-1,1-diol 302-17-0 206-117-5
78 Chlorine 7782-50-5 231-959-5
79 Chlorpropamide 
(INN) 94-20-2 202-314-5
80 Moved 
or deleted
81 4-Phenylazophenylene-1,3-diamine 
citrate hydrochloride (chrysoidin e 
citrate 
hydrochloride)5909-04-6
82 Chlorzoxazon e 
(INN) 95-25-0 202-403-9
83 2-Chloro-6-methylpyrimidin -4-yldimethylamine 
(crimidine-ISO) 53
5-89-7 208-622-6
84 Chlorprothixen e 
(INN) 
and 
its salts 113-59-7 204-032-8
85 Clofenamide 
(INN) 671-95-4 211-588-5
86 N,N
-bis(2-chloroethyl)methylamine
 N-oxide an d 
its salts 126-85-2
87 Chlormethin e 
(INN) 
and 
its salts 51-75-2 200-120-5
88 Cyclophosphamide (I NN) 
and 
its salts 50-18-0 200-015-4
89 Mannomustine 
(INN) 
and 
its salts 576-68-1 209-404-3
90 Butanilicaine 
(INN) 
and 
its salts 3785-21-5
91 Chlormezan one 
(INN) 80-77-3 201-307-4
92 Triparanol 
(INN) 78-41-1 201-115-0
93 2-[2(4-Chlorophen yl)-2-phenylacetyl]indane-1,3-dione 
(chlorophacin one-ISO)3691-35-8 223-003-0
94 Chlorphen oxamine 
(INN) 77-38-3
95 Phenaglycodol 
(INN) 79-93-6 201-235-3
96 Chloroethan e 75-00-3 200-830-5
97 Chromium; 
chromic acid an d 
its salts 7440-47-3 231-157-5
98 Claviceps purpurea Tul., its alk aloids 
and 
galenical 
preparation s 84775-56-4 283-885-8
99 Conium 
maculatum L. (fruit, powder, g alenical 
preparation s) 85116-75-2 285-527-6
100 Glycyclamide 
(INN) 664-95-9 211-557-6
101 Cobalt 
benzenesulphonate 23384-69-2
102 Colchicine, 
its salts an d 
derivatives 64-86-8 200-598-5
103 Colchicoside an d 
its derivatives 477-29-2 207-513-0
104 Colchicum autumnale L. an d 
its galenical 
preparation s 84696-03-7 283-623-2
105 Convallatoxin 508-75-8 208-086-3
106 Anamirta 
cocculus L. (fruit)
107 Croton tiglium L. (oil) 8001-28-3
108 1-Butyl-3-(N-croton oylsulphanilyl)urea 52964-42-8N E 9 0 0 2 . 2 1 . 2 2
d c b ar e b m u n C E r e b m u n S A C N N I / e m a n l a c i m e h Cn o i t a c i f i t n e d i e c n a t s b u S
r e b m u ne c n e r e f e ROfficial Journ alof the EuropeanUnion 22.12.2009
109 Curare an d curarine 8063-06-7/ 
22260-42-0232-511-1/ 244-880-6
110 Syn
thetic 
curarizants
111 Hydrogen 
cyanide 
and 
its salts 74-90-8 200-821-6
112 Feclemine 
(INN); 
2-(alpha-Cyclohexylb enzyl)-N,N,N’,N’-tetraethyl-1,3-propanediam
ine3590-16-7
113 Cyclomen ol 
(INN) 
and 
its salts 5591-47-9 227-002-6
114 Sodium hexacyclon ate 
(INN) 7009-49-6
115 Hexapropymate 
(INN) 358-52-1 206-618-9
116 Moved 
or deleted
117 O,O’-Diacetyl-N-allyl-N-n ormorphine 2748-74-5
118 Pipazetate 
(INN) 
and 
its salts 2167-85-3 218-508-8
119 5-(α,β-Dib romophenethyl)-5-methylhydantoin 511-75-1 208-133-8
120 N,N
’-Pentamethylenebis(trimethylammonium) 
salts, e. g. 
pentamethonium 
bromide 
(INN)541-20-8 208-771-7
121 N,N
’-[(Methylimin o)diethylene]bis(ethyldimethylammonium) 
salts, e. g. 
azamethon ium 
bromide 
(INN)306-53-6 206-186-1
122 Cyclarbamate 
(INN) 5779-54-4 227-302-7
123 Clofenotane 
(INN); 
DDT (ISO) 50-29-3 200-024-3
124 N,N
’-Hexamethylen ebis(trimethylammonium) 
salts, e. g. 
hexamethon ium 
bromide 
(INN)55-97-0 200-249-7
125 Dichloroethan es 
(ethylene 
chlorides) e.g . 
1,2-Dichloroethan e 107-
06-2 203-458-1
126 Dichloroethylen es 
(acetylene 
chlorides) e.g . 
Vinylidene 
chloride 
(1,1-Dichloroethylen e)75-35-4 200-864-0
127 Lysergide 
(INN) 
(LSD) and 
its salts 50-37-3 200-033-2
128 2-Diethylamin oethyl 
3-hydroxy-4-phen ylbenzoate 
and 
its salts 3572-52-9 222-686-2
129 Cinchocaine 
(INN) 
and 
its salts 85-79-0 201-632-1
130 3-Diethylamin opropyl 
cinnamate 538-66-9
131 O,O
’-Diethyl-O-4-n itrophenyl 
phosphorothioate (Parathion  
- ISO) 56-38-2 200-271-7
132 [Oxalylbis(iminoethylene)]bis[( o
-chlorobenzyl)diethylammonium] 
salts, 
e. g. 
ambenonium 
chloride (I NN)115-79-7 204-107-5
133 Methyprylon  
(INN) 
and 
its salts 125-64-4 204-745-4
134 Digitaline 
and 
all heterosides of Digitalis purpurea L. 752-61-4 212-036-6
135 7-[2-Hydroxy-3-(2-hydroxyethyl- N-methylamin o)propyl]theophylline 
(xanthinol)2530-97-4
136 Dioxethedrin  
(INN) 
and 
its salts 497-75-6 207-849-8
137 Piprocurarium iodide (I NN) 3562-55-8 222-627-0
138 Propyphen azone 
(INN) 479-92-5 207-539-2
139 Tetrabenazine 
(INN) 
and 
its salts 58-46-8 200-383-6
140 Captodiame (I NN) 486-17-9 207-629-1
141 Mefeclorazin e 
(INN) 
and 
its salts 1243-33-0
142 Dimethylamin e 124-40-3 204-697-4
143 1,1-Bis(dimethylamin omethyl)propyl 
benzoate 
(amydricain e, 
alypine) 
and 
its salts963-07-5 213-512-6
144 Methapyrilen e 
(INN) 
and 
its salts 91-80-5 202-099-8N E 6 8 / 2 4 3 L
d c b ar e b m u n C E r e b m u n S A C N N I / e m a n l a c i m e h Cn o i t a c i f i t n e d i e c n a t s b u S
r e b m u ne c n e r e f e ROfficial Journ alof the EuropeanUnion L 342/87
145 Metamfepramon e (INN) and its salts 15351-09-4 239-384-1
146 Amitriptylin e 
(INN) 
and 
its salts 50-48-6 200-041-6
147 Metformin  
(INN) 
and 
its salts 657-24-9 211-517-8
148 Isosorbide 
dinitrate 
(INN) 87-33-2 201-740-9
149 Malononitrile 109-77-3 203-703-2
150 Succinonitrile 110-61-2 203-783-9
151 Dinitrophenol 
isomers 51-28-5/ 
329-71-5/ 
573-56-8/ 25550-58-7200-087-7/ 206-348-1/ 209-357-9/ 247-096-2
152 I
nproquone 
(INN) 436-40-8
153 Dimevamide 
(INN) 
and 
its salts 60-46-8 200-479-8
154 Diphenylpyraline 
(INN) 
and 
its salts 147-20-6 205-686-7
155 Sulfinpyrazone 
(INN) 57-96-5 200-357-4
156 N
-(3-Carbamoyl-3,3-diphenylpropyl)- N,N
-diisopropylmethyl-
ammonium 
salts, e. g. 
isopropamide iodide (I NN)71-81-8 200-766-8
157 Benactyzine 
(INN) 302-40-9 206-123-8
158 Benzatropine 
(INN) 
and 
its salts 86-13-5
159 Cyclizine 
(INN) 
and 
its salts 82-92-8 201-445-5
160 5,5-Diphen yl-4-imidazolidone 
(Doxenitoin 
(INN)) 3254-93-1 221-85
1-6
161 Probenecid 
(INN) 57-66-9 200-344-3
162 Disulfiram 
(INN); 
thiram (INN) 97-77-8/ 
137-26-8202-607-8/ 205-286-2
163 E
metine, 
its salts an d 
derivatives 483-18-1 207-592-1
164 Ephedrine 
and 
its salts 299-42-3 206-080-5
165 Oxanamide 
(INN) 
and 
its derivatives 126-93-2
166 Eserine 
or physostig mine 
and 
its salts 57-47-6 200-332-8
167 Esters 
of 4-amin obenzoic 
acid, with the free amin o 
group, 
with the 
exception  
of that given 
in 
Annex 
VI
168 Choline 
salts and 
their esters, e. g . 
choline 
chloride (I NN) 67-48-1 20
0-655-4
169 Caramiphen  
(INN) 
and 
its salts 77-22-5 201-013-6
170 Diethyl 4-n itrophenyl 
phosphate (Paraoxon  
- ISO) 311-45-5 206-221-0
171 Metethoheptazin e 
(INN) 
and 
its salts 509-84-2
172 Oxpheneridine 
(INN) 
and 
its salts 546-32-7
173 Ethoheptazine 
(INN) 
and 
its salts 77-15-6 201-007-3
174 Metheptazin e 
(INN) 
and 
its salts 469-78-3
175 Methylphen idate 
(INN) 
and 
its salts 113-45-1 204-028-6
176 Doxylamin e 
(INN) 
and 
its salts 469-21-6 207-414-2
177 Tolboxane 
(INN) 2430-46-8
178 4-Benzyloxyphenol 
and 
4-ethoxyphen ol 103-16-2/ 
622-62-8203-083-3/ 210-748-1
179 Parethoxycain
e 
(INN) 
and 
its salts 94-23-5 205-246-4
180 Fenozolone 
(INN) 15302-16-6 239-339-6
181 Glutethimide (I NN) 
and 
its salts 77-21-4 201-012-0N E 9 0 0 2 . 2 1 . 2 2
d c b ar e b m u n C E r e b m u n S A C N N I / e m a n l a c i m e h Cn o i t a c i f i t n e d i e c n a t s b u S
r e b m u ne c n e r e f e ROfficial Journ alof the EuropeanUnion 22.12.2009
182 Ethylene oxide 75-21-8 200-849-9
183 Bemegride 
(INN) 
and 
its salts 64-65-3 200-588-0
184 Valnoctamide 
(INN) 4171-13-5 224-033-7
185 Haloperidol 
(INN) 52-86-8 200-155-6
186 Paramethason e 
(INN) 53-33-8 200-169-2
187 Fluanisone 
(INN) 1480-19-9 216-038-8
188 Trifluperidol 
(INN) 749-13-3
189 Fluoreson e 
(INN) 2924-67-6 220-889-0
190 Fluorouracil 
(INN) 51-21-8 200-085-6
191 Hydrofluoric 
acid, its n ormal 
salts, its complexes an d 
hydrofluorides 
with the exception  
of those g iven 
in 
Annex 
III7664-39-3 231-634-8
192 Furfuryltrimethylammon ium 
salts, e. g. 
furtrethon ium 
iodide (INN) 5
41-64-0 208-789-5
193 Galantamine 
(INN) 357-70-0
194 Progestogens
195 1,2,3,4,5,6-Hexachlorocyclohexan e 
(BHC-ISO) 58-89-9 200-401-2
196 (1
R,4S,5R,8S)-1,2,3,4,10,10-Hexachloro-6,7-epoxy-1,4,4a,5,6,7,8, 
8a-octahydro-1,4:5,8-dimethan o-naphthalene 
(endrin-ISO)72-20-8 200-775-7
197 Hexachloroethan e 67-72-1 200-666-4
198 (1
R,4S,5R,8S)-1,2,3,4,10,10-Hexachloro-1,4,4a,5,8,8a-hexahydro-1, 
4:5,8-dimethan onaphthalene 
(isodrin-ISO)465-73-6 207-366-2
199 Hydrastin e, 
hydrastinine 
and 
their salts 118-08-1/ 
6592-85-4204-233-0/ 
229-533-9
200 Hydrazides an d 
their salts e.g . 
Isoniazid 
(INN) 54-85-3 200-214-6
201 Hydrazine, 
its derivatives an d 
their salts 302-01-2 206-114-9
202 Octamoxin  
(INN) 
and 
its salts 4684-87-1
203 Warfarin 
(INN) 
and 
its salts 81-81-2 201-377-6
204 Ethyl 
bis(4-hydroxy-2-oxo-1-benzopyran-3-yl)acetate 
and 
salts of the 
acid548-00-5 208-940-5
205 Methocarb amol 
(INN) 532-03-6 208-524-3
206 Propatyln itrate 
(INN) 2921-92-8 220-866-5
207 4,4’-Dihydroxy-3,3’-(3-methylthiopropyliden e) 
dicoumarin
208 Fenadiazole 
(INN) 1008-65-7
209 Nitroxolin e 
(INN) 
and 
its salts 4008-48-4 223-662-4
210 Hyoscyamin e, 
its salts an d 
derivatives 101-31-5 202-933-0
211 Hyoscyamus niger L. (leaves, seeds, powder an d 
galenical 
preparation s)84603-65-6 283-26
5-7
212 Pemoline 
(INN) 
and 
its salts 2152-34-3 218-438-8
213 Iodine 7553-56-2 231-442-4
214 Decamethylen ebis(trimethylammonium) 
salts, e. g. 
decamethon ium 
bromide 
(INN)541-22-0 208-772-2
215 Ipecacuanha 
(Cephaelis ipecacuanha Brot. an d 
related species) (roots, 
powder an d 
galenical 
preparation s)8012-96-2 232-385-8
216 (2-Isopropylpent4-enoyl)urea 
(apronalide) 528-92-7 208-443-3
217 α-Santonin 
[(3S,5a
R,9bS)-3,3a,4,5,5a,9b -hexahydro-3,5a,9-trimethylnaphto 
[1,2-b] 
furan-2,8-dione]481-06-1 207-560-7
218 Lobelia inflata L. an d 
its galenical 
preparation s 84696-23-1 283-642-6N E 8 8 / 2 4 3 L
d c b ar e b m u n C E r e b m u n S A C N N I / e m a n l a c i m e h Cn o i t a c i f i t n e d i e c n a t s b u S
r e b m u ne c n e r e f e ROfficial Journ alof the EuropeanUnion L 342/89
219 Lobeline (INN) and its salts 90-69-7 202-012-3
220 Barbiturates
221 Mercury 
and 
its compoun ds, 
except those special cases in cluded 
in 
Annex 
V7439-97-6 231-106-7
222 3,4,5-Trimethoxyphen ethylamine 
(Mescaline) 
and 
its salts 54-04-6 200-190-7
223 Metaldehyde 9002-91-9
224 2-(4-Allyl-2-methoxyphen oxy)-N,N
-diethylacetamide an d 
its salts 305-13-5
225 Coumetarol (I NN) 4366-18-1 224-455-1
226 Dextromethorphan  
(INN) 
and 
its salts 125-71-3 204-752-2
227 2-Methylheptylamin e 
and 
its salts 540-43-2
228 Isometheptene 
(INN) 
and 
its salts 503-01-5 207-959-6
229 Mecamylamin e 
(INN) 60-40-2 200-476-1
230 Guaifenesin 
(INN) 93-14-1 202-222-5
231 Dicoumarol 
(INN) 66-76-2 200-632-9
232 Phenmetrazine 
(INN), 
its derivatives an d 
salts 134-49-6 205-143-4
233 Thiamazole (I NN) 60-56-0 200-482-4
234 3,4-Dihydro-2-methoxy-2-methyl-4-phen yl-2H,5H
-pyrano 
[3,2-c]-[1] 
benzopyran-5-one 
(cyclocoumarol)518-20-7 208-248-3
235 Carisoprodol (I NN) 78-44-4 201-118-7
236 Meprobamate 
(INN) 57-53-4 200-337-5
237 Tefazoline 
(INN) 
and 
its salts 1082-56-0
238 Arecoline 63-75-2 200-565-5
239 Poldine 
metilsulfate (I NN) 545-80-2 208-894-6
240 Hydroxyzin e 
(INN) 68-88-2 200-693-1
241 2-Naphthol 135-19-3 205-182-7
242 1-and 
2-Naphthylamin es 
and 
their salts 134-32-7/ 
91-59-8205-138-7/ 
202-080-4
243 3-(1-Naphthyl)-4-hydroxycoumarin 39923-41-6
244 Naphazolin e 
(INN) 
and 
its salts 835-31-4 212-641-5
245 Neostigmine 
and 
its salts e. g . 
neostigmine 
bromide 
(INN) 114-80-7 204
-054-8
246 Nicotine 
and 
its salts 54-11-5 200-193-3
247 Amyl nitrites 110-46-3 203-770-8
248 Inorganic 
nitrites, 
with the exception  
of sodium n itrite 14797-65-0
249 Nitrobenzene 98-95-3 202-716-0
250 Nitrocresols 
and 
their alkali 
metal salts 12167-20-3
251 Nitrofuran toin 
(INN) 67-20-9 200-646-5
252 Furazolidon e 
(INN) 67-45-8 200-653-3
253 Nitroglycerin; 
Propane-1,2,3-triyl 
trinitrate 55-63-0 200-240-8
254 Acenocoumarol 
(INN) 152-72-7 205-807-3
255 Alkali 
pentacyanonitrosylferrate 
(2-) e.g. 14402-89-2/ 
13755-38-9238-373-9 
/ -
256 Nitrostilbenes, 
their homolog ues 
and 
their derivatives
257 Noradrenaline 
and 
its salts 51-41-2 200-096-6N E 9 0 0 2 . 2 1 . 2 2
d c b ar e b m u n C E r e b m u n S A C N N I / e m a n l a c i m e h Cn o i t a c i f i t n e d i e c n a t s b u S
r e b m u ne c n e r e f e ROfficial Journ alof the EuropeanUnion 22.12.2009
258 Noscapine (INN) and its salts 128-62-1 204-899-2
259 Guanethidine 
(INN) 
and 
its salts 55-65-2 200-241-3
260 Oestrogens
261 Oleandrin 465-16-7 207-361-5
262 Chlortalidon e 
(INN) 77-36-1 201-022-5
263 Pelletierin e 
and 
its salts 2858-66-4/ 
4396-01-4220-673-6/ 224-523-0
264 Pen
tachloroethane 76-01-7 200-925-1
265 Pentaerithrityl 
tetranitrate 
(INN) 78-11-5 201-084-3
266 Petrichloral 
(INN) 78-12-6
267 Octamylamin e 
(INN) 
and 
its salts 502-59-0 207-947-0
268 Picric acid 88-89-1 201-865-9
269 Phenacemide 
(INN) 63-98-9 200-570-2
270 Difencloxazine 
(INN) 5617-26-5
271 2-Phenylindan-1,3-dione 
(phenindione 
(INN)) 83-12-5 201-454-4
272 Ethylphenacemide 
(pheneturide 
(INN)) 90-49-3 201-998-2
273 Phenprocoumon 
(INN) 435-97-2 207-108-9
274 Fenyramidol 
(INN) 553-69-5 209-044-7
275 Triamteren e 
(INN) 
and 
its salts 396-01-0 206-904-3
276 Tetraethyl pyrophosphate (TE PP 
- ISO) 107-49-3 203-495-3
277 Tritolyl 
phosphate 1330-78-5 215-548-8
278 Psilocybine 
(INN) 520-52-5 208-294-4
279 Phosphorus 
and 
metal phosphides 7723-14-0 231-768-7
280 Thalidomide (I NN) 
and 
its salts 50-35-1 200-031-1
281 Physostigma venenosum Balf. 89958-15-6 289-638-0
282 Picrotoxin 124-87-8 204-716-6
283 Pilocarpin e 
and 
its salts 92-13-7 202-128-4
284 α-Piperidin -2-ylbenzyl 
acetate, laevorotatory threoform 
(levofacetoperan e 
(INN)) 
and 
its salts24558-01-8
285 Pipradrol (I NN) 
and 
its salts 467-60-7 207-394-5
286 Azacyclon ol 
(INN) 
and 
its salts 115-46-8 204-092-5
287 Bietamiverin e 
(INN) 479-81-2 207-538-7
288 Butopiprin e 
(INN) 
and 
its salts 55837-15-5 259-848-7
289 Lead and 
its compoun ds 7439-92-1 231-100-4
290 Coniine 458-88-8 207-282-6
291 Prunus 
laurocerasus L. (‘cherry laurel water’) 89997-54-6 289-689-9
292 Metyrapon e 
(INN) 54-36-4 200-206-2
293 Radioactive 
substances, 
as defined 
by 
Directive 96/29/E uratom
 (1) 
laying 
down 
basic 
safety stan dards 
for the protection  
of the health of 
workers 
and 
the general 
public 
against 
the dangers 
arising 
from 
ionising 
radiation
294 Juniperus sabina L. (leaves, essen tial 
oil and 
galenical 
preparation s) 90046-04-1 289-97
1-1N E 0 9 / 2 4 3 L
d c b ar e b m u n C E r e b m u n S A C N N I / e m a n l a c i m e h Cn o i t a c i f i t n e d i e c n a t s b u S
r e b m u ne c n e r e f e ROfficial Journ alof the EuropeanUnion L 342/91
295 Hyoscine, its salts an d derivatives 51-34-3 200-090-3
296 Gold salts
297 Selenium 
and 
its compoun ds 
with the exception  
of selenium 
disulphide 
under 
the conditions 
set out un der 
reference 
No 49 in 
Annex 
III7782-49-2 231-957-4
298 Solanum 
nigrum L. an d 
its galenical 
preparation s 84929-77-1 284-555-6
299 Sparteine 
(INN) 
and 
its salts 90-39-1 201-988-8
300 Glucocorticoids (Corticosteroids)
301 Datura stramonium L. an d 
its galenical 
preparation s 84696-08-2 283-627-4
302 Strophantines, 
their aglucones 
and 
their respective derivatives 11005-63-3 234-239-9
303 Strophantus species an d 
their galenical 
preparation s
304 Strychnine 
and 
its salts 57-24-9 200-319-7
305 Strychnos species an d 
their galenical 
preparation s
306 Narcotics, 
natural 
and 
synthetic: 
All substances 
listed in 
Tables 
I 
and  I I  
of the sin gle 
Convention 
on 
narcotic 
drugs 
signed 
in 
New York  
on
30 March 1961
307 Sulphonamides 
(sulphanilamide 
and 
its derivatives ob tained 
by 
substitution 
of one 
or more H-atoms of the -NH2 groups) and their 
salts
308 Sultiame (I NN) 61-56-3 200-511-0
309 Neodymium 
and 
its salts 7440-00-8 231-109-3
310 Thiotepa (I NN) 52-24-4 200-135-7
311 Pilocarpus 
jaborandi Holmes an d 
its galenical 
preparation s 84696-42-4 283-649-4
312 Tellurium 
and 
its compoun ds 13494-80-9 236-813-4
313 Xylometazolin e 
(INN) 
and 
its salts 526-36-3 208-390-6
314 Tetrachloroethylen e 127-18-4 204-825-9
315 Carbon 
tetrachloride 56-23-5 200-262-8
316 Hexaethyl tetraphosphate 757-58-4 212-057-0
317 Thallium an d 
its compoun ds 7440-28-0 231-138-1
318 Thevetia 
neriifolia Juss., g lycoside 
extract 90147-54-9 290-446-4
319 Ethionamide 
(INN) 536-33-4 208-628-9
320 Phenothiazine 
(INN) 
and 
its compoun ds 92-84-2 202-196-5
321 Thiourea 
and 
its derivatives, with the exception  
of the one 
listed in 
Annex 
III62-56-6 200-543-5
322 Mephenesin 
(INN) 
and 
its esters 59-47-2 200-427-4
323 Vaccines, 
toxins 
or serums defin ed 
as immun ological 
medicinal 
products 
pursuant 
to Article 1(4) of Directive 2001/83/E C
324 Tranylcypromine 
(INN) 
and 
its salts 155-09-9 205-841-9
325 Trichloron itromethane 
(chloropicrin e) 76-06-2 200-930-9
326 2,2,2-Trib romoethanol 
(tribromoethyl 
alcohol) 75-80-9 200-903-1
327 Trichlormethin e 
(INN) 
and 
its salts 817-09-4 212-442-3
328 Tretamine 
(INN) 51-18-3 200-083-5
329 Gallamine 
triethiodide (I NN) 65-29-2 200-605-1
330 Urginea 
scilla Stein h. 
and 
its galenical 
preparation s 84650-62-4 283-520-2
331 Veratrine, 
its salts an d 
galenical 
preparation s 8051-02-3 613-062-00-4
332 Schoenocaulon officinale Lin d 
(seeds and 
galenical 
preparation s) 84604-18-2 283-296-6N E 9 0 0 2 . 2 1 . 2 2
d c b ar e b m u n C E r e b m u n S A C N N I / e m a n l a c i m e h Cn o i t a c i f i t n e d i e c n a t s b u S
r e b m u ne c n e r e f e ROfficial Journ alof the EuropeanUnion 22.12.2009
333 Veratrum spp. an d their preparation s 90131-91-2 290-407-1
334 Vinyl 
chloride mon omer 75-01-4 200-831-0
335 Ergocalciferol 
(INN) 
and 
cholecalciferol (vitamin s 
D2 and D3) 50-14-6/ 
67-97-0200-014-9/ 200-673-2
336 Salts of O-alk
yldithiocarbonic 
acids (xan thates)
337 Yohimbine 
and 
its salts 146-48-5 205-672-0
338 Dimethyl sulfoxide (I NN) 67-68-5 200-664-3
339 Diphenhydramine 
(INN) 
and 
its salts 58-73-1 200-396-7
340 4-tert-Butylphen ol 98-54-4 202-679-0
341 4-tert-Butylpyrocatechol 98-29-3 202-653-9
342 Dihydrotachysterol 
(INN) 67-96-9 200-672-7
343 Dioxane 123-91-1 204-661-8
344 Morpholin e 
and 
its salts 110-91-8 203-815-1
345. Pyrethrum album L. an d 
its galenical 
preparation s
346 2-[4-Methoxyb enzyl-
N-(2-pyridyl)amin o]ethyldimethylamine 
maleate 
(Mepyramin e 
maleate; pyrilamin e 
maleate)59-33-6 200-422-7
347 Tripelennamine 
(INN) 91-81-6 202-100-1
348 Tetrachlorosalicylan ilides 7426-07-5
349 Dichlorosalicylan ilides 1147-98-4
350 Tetrabromosalicylanilides
351 Dibromosalicylanilides
352 Bithionol 
(INN) 97-18-7 202-565-0
353 Thiuram 
monosulphides 97-74-5 202-605-7
354 Moved 
or deleted
355 Dimethylformamide (N,N-Dimethylformamide) 68-12-2 200-679-5
356 4-Phenylbut-3-en-2-one 
(Benzylidene 
acetone) 122-57-6 204-555-1
357 Benzoates 
of 4-hydroxy-3-methoxycin namyl 
alcohol (con iferyl 
alcohol) 
except for n ormal 
content 
in 
natural 
essences 
used
358 Furocoumarin es 
(e. g. 
trioxysalen  
(INN), 
8-methoxypsoralen , 
5-methoxypsoralen ) 
except for n ormal 
content 
in 
natural 
essences 
used.
In 
sun 
protection  
and 
in 
bronzing 
products, furocoumarin es 
shall be 
below 
1 mg/kg3902-71-4/ 
298-81-7/ 484-20-8223-459-0/ 206-066-9/ 207-604-5
359 Oil 
from the seeds of Laurus nobilis L. 84603-73-6 283-272-5
360 Safrole except for n ormal 
content 
in 
the natural 
essences 
used and 
provided 
the concentration 
does not 
exceed:
100 ppm in  
the finished 
product, 50 ppm in  
products for den tal 
and 
oral 
hygiene, 
and 
provided that Safrole is n ot 
present 
in 
toothpastes 
intended 
specifically for children94-59-7 202-345-4
361 5,5’-Di-isopropyl-2,2’-dimethylb iphenyl-4,4’-diyl 
dihypoiodite (thymol 
iodide)552-22-7 209-007-5
362 3’-Ethyl-5’,6’,7’,8’-tetrahydro-5’,5’,8’,8’-tetramethyl-2’-a
cetonaphthone 
or 
7-acetyl-6-ethyl-1,1,4,4-tetramethyl-1,2,3,4-tetrahydron aphta
len 
(AETT; 
Versalide)88-29-9 201-817-7
363 o-Phenylenediamine 
and 
its salts 95-54-5 202-430-6N E 2 9 / 2 4 3 L
d c b ar e b m u n C E r e b m u n S A C N N I / e m a n l a c i m e h Cn o i t a c i f i t n e d i e c n a t s b u S
r e b m u ne c n e r e f e ROfficial Journ alof the EuropeanUnion L 342/93
364 4-Methyl-m-phen ylenediamine (Toluene-2,4-diamine) and its salts 95-80-7 202-453-1
365 Aristolochic acid an d 
its salts; Aristolochia spp. an d 
their preparation s475-80-9/ 
313-67-7/ 
15918-62-4202-499-6/ 206-238-3/-
366 Chloroform 67-66-3 200-663-8
367 2,3,7,8-Tetrachlorodib
enzo-p-dioxin 
(TCDD) 1746-01-6 217-122-7
368 2,6-Dimethyl-1,3-dioxan -4-yl 
acetate (Dimethoxan e) 828-00-2 212-
579-9
369 Pyrithione 
sodium (I NNM)
 (2) 3811-73-2 223-296-5
370 N-(Trichloromethylthio)-4-cyclohexen e-1,2-dicarboximide 
(Captan 
-
ISO)133-06-2 205-087-0
371 2,2’-Dihydroxy-3,3’,5,5’,6,6’-hexachlorodiphen ylmethane 
(Hexachlorophen e 
(INN))70-30-4 200-733-8
372 6-(Piperidin yl)-2,4-pyrimidinediamine 
3-oxide (Min oxidil 
(INN)) 
and 
its 
salts38304-91-5 253-874-2
373 3,4’,5-Trib romosalicylanilide 
(Tribromsalan 
(INN)) 87-10-5 201-7
23-6
374 Phytolacca spp. an d 
their preparation s 65497-07-6/ 
60820-94-2
375 Tretinoin 
(INN) 
(retinoic 
acid and 
its salts) 302-79-4 206-129-0
376 1-Methoxy-2,4-diamin obenzene 
(2,4-diamin oanisole 
- CI 
76050) an d 
its 
salts615-05-4 210-406-1
377 1-Methoxy-2,5-diamin obenzene 
(2,5-diamin oanisole) 
and 
its salts 5307-02-8 226-161-9
378 Colouring 
agent 
CI 
12140 3118-97-6 221-490-4
379 Colouring 
agent 
CI 
26105 (Solven t 
Red 24) 85-83-6 201-635-8
380 Colouring 
agent 
CI 
42555 (Basic Violet 3)
Colouring 
agent 
CI 
42555:1
Colouring 
agent 
CI 
42555:2548-62-9
467-63-0208-953-6207-396-6
381 Amyl 4-dimethylamin
obenzoate, 
mixed isomers (Padimate A (I NN)) 1477
9-78-3 238-849-6
383 2-Amino-4-nitrophenol 99-57-0 202-767-9
384 2-Amino-5-nitrophenol 121-88-0 204-503-8
385 11-α-Hydroxypreg n-4-ene-3,20-dione 
and 
its esters 80-75-1 201-306-9
386 Colouring 
agent 
CI 
42640 ([4-[[4-(Dimethylamin o)phenyl][4-[ethyl
(3-
sulphonatobenzyl)amino]phenyl]methylene]cyclohexa-2,5-dien-1-
ylidene](ethyl)(3-sulphonatobenzyl)ammonium, 
sodium salt)1694-09-3 216-901-9
387 Colouring 
agent 
CI 
13065 587-98-4 209-608-2
388 Colouring 
agent 
CI 
42535 (Basic Violet 1) 8004-87-3
389 Colouring 
agent 
CI 
61554 (Solven t 
Blue 35) 17354-14-2 241-379-4
390 Anti-androgens 
of steroidal structure
391 Zirconium 
and 
its compoun ds, 
with the exception  
of the sub stances 
listed 
under 
reference 
number 
50 in 
Annex 
III, 
and 
the zircon ium 
lakes, 
pigments 
or salts of the colourin g 
agents 
when 
listed in 
Annex 
IV7440-67-7 231-176-9
392 Moved 
or deleted
393 Acetonitrile 75-05-8 200-835-2
394 Tetrahydrozolin e 
(Tetryzolin e 
(INN)) 
and 
its salts 84-22-0 201-522-3N E 9 0 0 2 . 2 1 . 2 2
d c b ar e b m u n C E r e b m u n S A C N N I / e m a n l a c i m e h Cn o i t a c i f i t n e d i e c n a t s b u S
r e b m u ne c n e r e f e ROfficial Journ alof the EuropeanUnion 22.12.2009
395 Hydroxy-8-quin oline and its sulphate, except for the uses provided for 
in 
No 51 in 
Annex 
III148-24-3/ 
134-31-6205-711-1/ 205-137-1
396 Dithio-2,2-b
ispyridine-dioxide 
1,1’ (additive with trihydrated 
magnesium 
sulphate) - (pyrithion e 
disulphide + mag nesium 
sulphate)43143-11-9 256-115-3
397 Colouring 
agent 
CI 
12075 (Pig ment 
Orange 
5) and 
its lakes, 
pigments 
and 
salts3468-63-1 222-429-4
398 Colouring 
agent 
CI 
45170 an d 
CI 
45170:1 (Basic Violet 10) 81-88-9/ 
509-34-2201-383-9/ 208-096-8
399 Lidocain
e 
(INN) 137-58-6 205-302-8
400 1,2-Epoxybutane 106-88-7 203-438-2
401 Colouring 
agent 
CI 
15585 5160-02-1/ 
2092-56-0225-935-3/ 218-248-5
402 Stron
tium 
lactate 29870-99-3 249-915-9
403 Strontium 
nitrate 10042-76-9 233-131-9
404 Strontium 
polycarboxylate
405 Pramocain e 
(INN) 140-65-8 205-425-7
406 4-Ethoxy-m-phenylenediamine 
and 
its salts 5862-77-1
407 2,4-Diamin ophenylethanol 
and 
its salts 14572-93-1
408 Pyrocatechol (Catechol) 120-80-9 204-427-5
409 Pyrogallol 87-66-1 201-762-9
410 Nitrosamin es 
e.g. 
Dimethyln itrosoamine; 
Nitrosodipropylamin e; 
2,2’-Nitrosoimin o)bisethanol62-75-9/ 621-64-7/ 1116-54-7200-549-8/ 210-698-0/ 214-237-4
411 Secon
dary 
alkyl- 
and 
alkanolamines 
and 
their salts
412 4-Amino-2-nitrophenol 119-34-6 204-316-1
413 2-Methyl-m-phen ylenediamine 
(Toluene-2,6-diamine) 823-40-5 212-
513-9
414 4-tert.-Butyl-3-methoxy-2,6-din itrotoluene 
(Musk 
Ambrette) 83-66-9 201-49
3-7
415 Moved or deleted
416 Cells, tissues or products of human  
origin
417 3,3-Bis(4-hydroxyphen yl)phthalide 
(Phenolphthalein 
(INN)) 77-09
-8 201-004-7
418 3-Imidazol-4-ylacrylic 
acid (Urocan ic 
acid) and 
its ethyl ester 104-98-3/ 
27538-35-8203-258-4/ 248-515-1
419 Categ
ory 
1 material an d 
Category 
2 material as defin ed 
in 
Articles 4 
and 
5 respectively of Reg ulation 
(EC) 
No 1774/2002 of the E uropean 
Parliamen t 
and 
of the Coun cil
 (3), and ingredients derived therefrom
420 Crude 
and 
refined 
coal tars 8007-45-2 232-361-7
421 1,1,3,3,5-Pen tamethyl-4,6-dinitroindane 
(Moskene) 116-66-5 204-
149-4
422 5-tert.-Butyl-1,2,3-trimethyl-4,6-din itrobenzene 
(Musk 
Tibetene) 145-39-
1 205-651-6
423 Alanroot 
oil (Inula helenium L.), when  
used as a frag rance 
ingredient 97676-35-2
424 Benzyl 
cyanide, 
when 
used as a frag rance 
ingredient 140-29-4 205-410-
5
425 Cyclamen  
alcohol, when  
used as a frag rance 
ingredient 4756-19-8 225-2
89-2
426 Diethyl maleate, when  
used as a frag rance 
ingredient 141-05-9 205-451
-9
427 3,4-Dihydrocoumarin , 
when 
used as a frag rance 
ingredient 119-84-6 20
4-354-9
428 2,4-Dihydroxy-3-methylb enzaldehyde, 
when 
used as a frag rance 
ingredient6248-20-0 228-369-5N E 4 9 / 2 4 3 L
d c b ar e b m u n C E r e b m u n S A C N N I / e m a n l a c i m e h Cn o i t a c i f i t n e d i e c n a t s b u S
r e b m u ne c n e r e f e ROfficial Journ alof the EuropeanUnion L 342/95
429 3,7-Dimethyl-2-octen -1-ol (6,7-Dihydrog eraniol), when used as a 
fragrance 
ingredient40607-48-5 254-999-5
430 4,6-Dimethyl-8-
tert-butylcoumarin, 
when 
used as a frag rance 
ingredient17874-34-9 241-827-9
431 Dimethyl 
citraconate, 
when 
used as a frag rance 
ingredient 617-54-9
432 7,11-Dimethyl-4,6,10-dodecatrien -3-one 
(Pseudomethylion one), 
when 
used 
as a fragrance 
ingredient26651-96-7 247-878-3
433 6,10-Dimethyl-3,5,9-un decatrien-2-one 
(Pseudoion one)(, 
when 
used  a s  
a fragrance 
ingredient141-10-6 205-457-1
434 Diphenylamine, 
when 
used as a frag rance 
ingredient 122-39-4 204-539-
4
435 Ethyl 
acrylate, when  
used as a frag rance 
ingredient 140-88-5 205-438-
8
436 Fig 
leaf absolute 
(Ficus carica L.), when  
used as a frag rance 
ingredient 68916-52-9
437 trans
-2-Hepten al, 
when 
used as a frag rance 
ingredient 18829-55-5 242-608-0
438 trans
-2-Hexenal 
diethyl acetal, when  
used as a frag rance 
ingredient 67746-30-
9266-989-8
439 trans-2-Hexen al 
dimethyl acetal, when  
used as a frag rance 
ingredient 18318-83
-7242-204-4
440 Hydroabietyl 
alcohol, when  
used as a frag rance 
ingredient 13393-93-6 236-476-3
441 6-Isopropyl-2-decahydronaphthalenol, 
when 
used as a frag rance 
ingredient34131-99-2 251-841-7
442 7-Methoxycoumarin , 
when 
used as a frag rance 
ingredient 531-59-9 208-
513-3
443 4-(4-Methoxyphen yl)-3-butene-2-one 
(Anisylidene 
acetone), 
when 
used 
as a fragrance 
ingredient943-88-4 213-404-9
444 1-(4-Methoxyphen yl)-1-penten-3-one 
(alpha-Methylan isylideneacetone), 
when 
used as a frag rance 
ingredient104-27-8 203-190-5
445 Methyl
 trans-2-b utenoate, 
when 
used as a frag rance 
ingredient 623-43-8 210-793-7
446 7-Methylcoumarin , 
when 
used as a frag rance 
ingredient 2445-83-2 219-
499-3
447 5-Methyl-2,3-hexan edione 
(Acetyl isovaleryl), when  
used as a frag ra
nce 
ingredient13706-86-0 237-241-8
448 2-Pentylidenecyclohexanone, 
when 
used as a frag rance 
ingredient 256
77-40-1 247-178-8
449 3,6,10-Trimethyl-3,5,9-un decatrien-2-one 
(Pseudo-Isomethyl 
ionone), 
when 
used as a frag rance 
ingredient1117-41-5 214-245-8
450 Verbena 
oil (Lippia citriodora K unth.), 
when 
used as a frag rance 
ingredient8024-12-2
451 Moved 
or deleted
452 6-(2-Chloroethyl)-6-(2-methoxyethoxy)-2,5,7,10-tetraoxa-
6-silaundecane37894-46-5 253-704-7
453 Cobalt 
dichloride 7646-79-9 231-589-4
454 Cobalt 
sulphate 10124-43-3 233-334-2
455 Nickel 
monoxide 1313-99-1 215-215-7
456 Dinickel 
trioxide 1314-06-3 215-217-8
457 Nickel 
dioxide 12035-36-8 234-823-3
458 Trinickel 
disulphide 12035-72-2 234-829-6
459 Tetracarbonylnickel 13463-39-3 236-669-2
460 Nickel 
sulphide 16812-54-7 240-841-2
461 Potassium b romate 7758-01-2 231-829-8
462 Carbon 
monoxide 630-08-0 211-128-3
463 Buta-1,3-dien e, 
see also en tries 
464-611 106-99-0 203-450-8N E 9 0 0 2 . 2 1 . 2 2
d c b ar e b m u n C E r e b m u n S A C N N I / e m a n l a c i m e h Cn o i t a c i f i t n e d i e c n a t s b u S
r e b m u ne c n e r e f e ROfficial Journ alof the EuropeanUnion 22.12.2009
464 Isobutane, if it contains ≥ 0,1 % w/w Butadien e 75-28-5 200-857-2
465 Butane, 
if it contains 
≥ 0,1 % w/w Butadien e 106-97-8 203-448-7
466 Gases 
(petroleum), C3-4, if they con tain > 0,1 % w/w Butadien e 68131-75-9 268-629-5
467 Tail 
gas 
(petroleum), catalytic crack ed 
distillate an d 
catalytic crack ed 
naphtha 
fractionation 
absorber, 
if it contains 
> 0,1 % w/w Butadien e68307-98-2 269-617-2
468 Tail 
gas 
(petroleum), catalytic polymn . 
naphtha 
fractionation 
stabi
liser, 
if it contains 
> 0,1 % w/w Butadien e68307-99-3 269-618-8
469 Tail 
gas 
(petroleum), catalytic reformed n aphtha 
fractionation 
stabiliser, 
hydrogen 
sulfide-free, if it con tains 
> 0,1 % w/w Butadien e68308-00-9 269-619-3
470 Tail 
gas 
(petroleum), crack ed 
distillate hydrotreater stripper, if it 
contains 
> 0,1 % w/w Butadien e68308-01-0 269-620-9
471 Tail 
gas 
(petroleum), g as 
oil catalytic crack ing 
absorber, 
if it conta
ins 
> 
0,1 % w/w Butadien e68308-03-2 269-623-5
472 Tail 
gas 
(petroleum), g as 
recovery plan t, 
if it contains 
> 0,1 % w/w 
Butadiene68308-04-3 269-624-0
473 Tail 
gas 
(petroleum), g as 
recovery plan t 
deethaniser, 
if it contains 
> 
0,1 % w/w Butadien e68308-05-4 269-625-6
474 Tail 
gas 
(petroleum), hydrodesulfurised distillate an d 
hydrodesulfurised 
naphtha 
fractionator, 
acid-free, if it con tains 
> 0,1 % w/w Butadien e68308-06-5 269-626-1
475 Tail 
gas 
(petroleum), hydrodesulfurised vacuum g as 
oil stripper, 
hydrogen 
sulfide-free, if it con tains 
> 0,1 % w/w Butadien e68308-07-6 269-627-7
476 Tail 
gas 
(petroleum), isomerised n aphtha 
fractionation 
stabiliser, 
if it 
contains 
> 0,1 % w/w Butadien e68308-08-7 269-628-2
477 Tail 
gas 
(petroleum), lig ht 
straight-run 
naphtha 
stabiliser, 
hydrogen 
sulfide-free, 
if it contains 
> 0,1 % w/w Butadien e68308-09-8 269-629-8
478 Tail 
gas 
(petroleum), straig ht-run 
distillate hydrodesulfurised, hydrog en 
sulfide-free, 
if it contains 
> 0,1 % w/w Butadien e68308-10-1 269-630-3
479 Tail 
gas 
(petroleum), propan e-propylene 
alkylation 
feed prep 
deethaniser, 
if it contains 
> 0,1 % w/w Butadien e68308-11-2 269-631-9
480 Tail 
gas 
(petroleum), vacuum g as 
oil hydrodesulfurised, hydrog en 
sulfide-free, 
if it contains 
> 0,1 % w/w Butadien e68308-12-3 269-632-4
481 Gases 
(petroleum), catalytic crack ed 
overheads, if they con tain 
> 0,1 % 
w/w Butadien e68409-99-4 270-071-2
482 Alkanes, 
C1-2, if they con tain > 0,1 % w/w Butadien e 68475-57-0 270-651-5
483 Alkanes, 
C2-3, if they con tain > 0,1 % w/w Butadien e 68475-58-1 270-652-0
484 Alkanes, 
C3-4, if they con tain > 0,1 % w/w Butadien e 68475-59-2 270-653-6
485 Alkanes, 
C4-5, if they con tain > 0,1 % w/w Butadien e 68475-60-5 270-654-1
486 Fuel-gases, 
if they con tain 
> 0,1 % w/w Butadien e 68476-26-6 270-667-2
487 Fuel 
gases, 
crude oil distillates, if they con tain 
> 0,1 % w/w Butadien e68476-29-9 270-670-9
488 Hydrocarb ons, 
C3-4, if they con tain > 0,1 % w/w Butadien e 68476-40-4 270-681-9
489 Hydrocarb ons, 
C4-5, if they con tain > 0,1 % w/w Butadien e 68476-42-6 270-682-4
490 Hydrocarb ons, 
C2-4,  C3-rich, if they con tain > 0,1 % w/w Butadien e68476-49-3 270-689-2N E 6 9 / 2 4 3 L
d c b ar e b m u n C E r e b m u n S A C N N I / e m a n l a c i m e h Cn o i t a c i f i t n e d i e c n a t s b u S
r e b m u ne c n e r e f e ROfficial Journ alof the EuropeanUnion L 342/97
491 Petroleum g ases, liquefied, if they con tain > 0,1 % w/w Butadien e 68476 -85-7 270-704-2
492 Petroleum g ases, 
liquefied, sweeten ed, 
if they con tain 
> 0,1 % w/w 
Butadiene68476-86-8 270-705-8
493 Gases 
(petroleum), C3-4, isobutane-rich if they con tain > 0,1 % w/w 
Butadiene68477-33-8 270-724-1
494 Distillates 
(petroleum), C3-6, piperylen e-rich, if they con tain > 0,1 % 
w/w 
Butadiene68477-35-0 270-726-2
495 Gases 
(petroleum), amin e 
system feed, if they con tain 
> 0,1 % w/w 
Butadiene68477-65-6 270-746-1
496 Gases 
(petroleum), b enzene 
unit 
hydrodesulfurised off, if they con ta
in 
> 
0,1 % w/w Butadien e68477-66-7 270-747-7
497 Gases 
(petroleum), b enzene 
unit 
recycle, hydrog en-rich, 
if they con t
ain 
> 
0,1 % w/w Butadien e68477-67-8 270-748-2
498 Gases 
(petroleum), b lend 
oil, hydrog en-nitrogen-rich, 
if they con ta
in 
> 
0,1 % w/w Butadien e68477-68-9 270-749-8
499 Gases 
(petroleum), b utane 
splitter overheads, if they con tain 
> 0,1 % 
w/w Butadien e68477-69-0 270-750-3
500 Gases 
(petroleum), C2-3, if they con tain > 0,1 % w/w Butadien e 68477-70-3 270-751-9
501 Gases 
(petroleum), catalytic-crack ed 
gas 
oil depropan iser 
bottoms, 
C4-rich acid-free, if they con tain > 0,1 % w/w Butadien e68477-71-4 270-752-4
502 Gases 
(petroleum), catalytic-crack ed 
naphtha 
debutaniser 
bottoms, 
C3-5-rich, if they con tain > 0,1 % w/w Butadien e68477-72-5 270-754-5
503 Gases 
(petroleum), catalytic crack ed 
naphtha 
depropaniser 
overhead, 
C3-rich acid-free, if they con tain > 0,1 % w/w Butadien e68477-73-6 270-755-0
504 Gases 
(petroleum), catalytic crack er, 
if they con tain 
> 0,1 % w/w 
Butadiene68477-74-7 270-756-6
505 Gases 
(petroleum), catalytic crack er, 
C1-5-rich, if they con tain > 0,1 % 
w/w 
Butadiene68477-75-8 270-757-1
506 Gases 
(petroleum), catalytic polymd. n aphtha 
stabiliser 
overhead, 
C2-4-rich, if they con tain > 0,1 % w/w Butadien e68477-76-9 270-758-7
507 Gases 
(petroleum), catalytic reformed n aphtha 
stripper overheads, if 
they contain 
> 0,1 % w/w Butadien e68477-77-0 270-759-2
508 Gases 
(petroleum), catalytic reformer, C1-4-rich, if they con tain > 0,1 % 
w/w 
Butadiene68477-79-2 270-760-8
509 Gases 
(petroleum), C6-8 catalytic reformer recycle, if they con tain 
> 
0,1 % w/w Butadien e68477-80-5 270-761-3
510 Gases 
(petroleum), C6-8 catalytic reformer, if they con tain > 0,1 % w/w 
Butadiene68477-81-6 270-762-9
511 Gases 
(petroleum), C6-8 catalytic reformer recycle, hydrog en-rich, if 
they contain 
> 0,1 % w/w Butadien e68477-82-7 270-763-4
512 Gases 
(petroleum), C3-5 olefinic-paraffinic alkylation feed, if they 
contain 
> 0,1 % w/w Butadien e68477-83-8 270-765-5
513 Gases 
(petroleum), C2-return stream, if they con tain > 0,1 % w/w 
Butadiene68477-84-9 270-766-0
514 Gases 
(petroleum), C4-rich, if they con tain > 0,1 % w/w Butadien e68477-85-0 270-767-6
515 Gases 
(petroleum), deethan iser 
overheads, if they con tain 
> 0,1 % w/w 
Butadiene68477-86-1 270-768-1
516 Gases 
(petroleum), deisob utaniser 
tower overheads, if they con tain 
> 
0,1 % w/w Butadien e68477-87-2 270-769-7
517 Gases 
(petroleum), depropan iser 
dry, propen e-rich, 
if they con tain 
> 
0,1 % w/w Butadien e68477-90-7 270-772-3N E 9 0 0 2 . 2 1 . 2 2
d c b ar e b m u n C E r e b m u n S A C N N I / e m a n l a c i m e h Cn o i t a c i f i t n e d i e c n a t s b u S
r e b m u ne c n e r e f e ROfficial Journ alof the EuropeanUnion 22.12.2009
518 Gases (petroleum), depropan iser overheads, if they con tain > 0,1 % 
w/w Butadien e68477-91-8 270-773-9
519 Gases 
(petroleum), dry sour, g as-concn. 
-unit-off, 
if they con tain 
> 
0,1 % w/w Butadien e68477-92-9 270-774-4
520 Gases 
(petroleum), g as 
concn. 
reabsorber 
distn., 
if they con tain 
> 
0,1 % w/w Butadien e68477-93-0 270-776-5
521 Gases 
(petroleum), g as 
recovery plan t 
depropaniser 
overheads, if they 
contain 
> 0,1 % w/w Butadien e68477-94-1 270-777-0
522 Gases 
(petroleum), Girb atol 
unit 
feed, if they con tain 
> 0,1 % w/w 
Butadiene68477-95-2 270-778-6
523 Gases 
(petroleum), hydrog en 
absorber 
off, if they con tain 
> 0,1 % w/w 
Butadiene68477-96-3 270-779-1
524 Gases 
(petroleum), hydrog en-rich, 
if they con tain 
> 0,1 % w/w 
Butadiene68477-97-4 270-780-7
525 Gases 
(petroleum), hydrotreater b lend 
oil recycle, 
hydrogen-nitrogen-rich, 
if they con tain 
> 0,1 % w/w Butadien e68477-98-5 270-781-2
526 Gases 
(petroleum), isomerised n aphtha 
fractionator, 
C4-rich, hydrog en 
sulfide-free, 
if they con tain 
> 0,1 % w/w Butadien e68477-99-6 270-782-8
527 Gases 
(petroleum), recycle, hydrog en-rich, 
if they con tain 
> 0,1 % w/w 
Butadiene68478-00-2 270-783-3
528 Gases 
(petroleum), reformer mak e-up, 
hydrogen-rich, 
if they con tain 
> 
0,1 % w/w Butadien e68478-01-3 270-784-9
529 Gases 
(petroleum), reformin g 
hydrotreater, if they con tain 
> 0,1 % 
w/w Butadien e68478-02-4 270-785-4
530 Gases 
(petroleum), reformin g 
hydrotreater, hydrog en-methane-rich ,
 i f  
they contain 
> 0,1 % w/w Butadien e68478-03-5 270-787-5
531 Gases 
(petroleum), reformin g 
hydrotreater mak e-up, 
hydrogen-rich, 
if 
they contain 
> 0,1 % w/w Butadien e68478-04-6 270-788-0
532 Gases 
(petroleum), thermal crack ing 
distn., 
if they con tain 
> 0,1 % 
w/w Butadien e68478-05-7 270-789-6
533 Tail 
gas 
(petroleum), catalytic crack ed 
clarified oil an d 
thermal crack ed 
vacuum 
residue fraction ation 
reflux drum, if it con tains 
> 0,1 % w/w 
Butadiene68478-21-7 270-802-5
534 Tail 
gas 
(petroleum), catalytic crack ed 
naphtha 
stabilisation 
absor
ber, 
if 
it contains 
> 0,1 % w/w Butadien e68478-22-8 270-803-0
535 Tail 
gas 
(petroleum), catalytic crack er, 
catalytic reformer an d 
hydrodesulfurised 
combined 
fractionater, 
if it contains 
> 0,1 % w/w 
Butadiene68478-24-0 270-804-6
536 Tail 
gas 
(petroleum), catalytic crack er 
refraction ation 
absorber, 
if  i t  
contains 
> 0,1 % w/w Butadien e68478-25-1 270-805-1
537 Tail 
gas 
(petroleum), catalytic reformed n aphtha 
fractionation 
stabiliser, 
if it contains 
> 0,1 % w/w Butadien e68478-26-2 270-806-7
538 Tail 
gas 
(petroleum), catalytic reformed n aphtha 
separator, if it 
contains 
> 0,1 % w/w Butadien e68478-27-3 270-807-2
539 Tail 
gas 
(petroleum), catalytic reformed n aphtha 
stabiliser, 
if it 
contains 
> 0,1 % w/w Butadien e68478-28-4 270-808-8
540 Tail 
gas 
(petroleum), crack ed 
distillate hydrotreater separator, if it 
contains 
> 0,1 % w/w Butadien e68478-29-5 270-809-3
541 Tail 
gas 
(petroleum), hydrodesulfurised straig ht-run 
naphtha 
separator, 
if it contains 
> 0,1 % w/w Butadien e68478-30-8 270-810-9N E 8 9 / 2 4 3 L
d c b ar e b m u n C E r e b m u n S A C N N I / e m a n l a c i m e h Cn o i t a c i f i t n e d i e c n a t s b u S
r e b m u ne c n e r e f e ROfficial Journ alof the EuropeanUnion L 342/99
542 Tail gas (petroleum), saturate g as plant mixed stream, C4-rich, if it 
contains 
> 0,1 % w/w Butadien e68478-32-0 270-813-5
543 Tail 
gas 
(petroleum), saturate g as 
recovery plan t, 
C1-2-rich, if it 
contains 
> 0,1 % w/w Butadien e68478-33-1 270-814-0
544 Tail 
gas 
(petroleum), vacuum residues thermal crack er, 
if it contains 
> 
0,1 % w/w Butadien e68478-34-2 270-815-6
545 Hydrocarb ons, 
C3-4-rich, petroleum distillate, if they con tain > 0,1 % 
w/w 
Butadiene68512-91-4 270-990-9
546 Gases 
(petroleum), catalytic reformed straig ht-run 
naphtha 
stabili
ser 
overheads, if they con tain 
> 0,1 % w/w Butadien e68513-14-4 270-999-8
547 Gases 
(petroleum), full-ran ge 
straight-run 
naphtha 
dehexaniser 
off,  i f  
they contain 
> 0,1 % w/w Butadien e68513-15-5 271-000-8
548 Gases 
(petroleum), hydrocrack ing 
depropaniser 
off, hydrocarb on-ri
ch, 
if they con tain 
> 0,1 % w/w Butadien e68513-16-6 271-001-3
549 Gases 
(petroleum), lig ht 
straight-run 
naphtha 
stabiliser 
off, if they 
contain 
> 0,1 % w/w Butadien e68513-17-7 271-002-9
550 Gases 
(petroleum), reformer effluen t 
high-pressure 
flash drum off, if 
they contain 
> 0,1 % w/w Butadien e68513-18-8 271-003-4
551 Gases 
(petroleum), reformer effluen t 
low-pressure flash drum off, if 
they contain 
> 0,1 % w/w Butadien e68513-19-9 271-005-5
552 Residues 
(petroleum), alk ylation 
splitter, C4-rich, if they con tain 
> 
0,1 % w/w Butadien e68513-66-6 271-010-2
553 Hydrocarb ons, 
C1-4, if they con tain > 0,1 % w/w Butadien e 68514-31-8 271-032-2
554 Hydrocarb ons, 
C1-4, sweetened, if they con tain > 0,1 % w/w Butadien e68514-36-3 271-038-5
555 Gases 
(petroleum), oil refin ery 
gas 
distn. 
off, if they con tain 
> 0,1 % 
w/w Butadien e68527-15-1 271-258-1
556 Hydrocarb ons, 
C1-3, if they con tain > 0,1 % w/w Butadien e 68527-16-2 271-259-7
557 Hydrocarb ons, 
C1-4, debutaniser fraction, if they con tain > 0,1 % w/w 
Butadiene68527-19-5 271-261-8
558 Gases 
(petroleum), b enzene 
unit 
hydrotreater depen taniser 
overheads, 
if they con tain 
> 0,1 % w/w Butadien e68602-82-4 271-623-5
559 Gases 
(petroleum), C1-5, wet, if they con tain > 0,1 % w/w Butadien e68602-83-5 271-624-0
560 Gases 
(petroleum), secon dary 
absorber 
off, fluidised catalytic crack er 
overheads 
fractionator, 
if they con tain 
> 0,1 % w/w Butadien e68602-84-6 271-625-6
561 Hydrocarb ons, 
C2-4, if they con tain > 0,1 % w/w Butadien e 68606-25-7 271-734-9
562 Hydrocarb ons, 
C3, if they con tain > 0,1 % w/w Butadien e 68606-26-8 271-735-4
563 Gases 
(petroleum), alk ylation 
feed, if they con tain 
> 0,1 % w/w 
Butadiene68606-27-9 271-737-5
564 Gases 
(petroleum), depropan iser 
bottoms 
fractionation 
off, if they 
contain 
> 0,1 % w/w Butadien e68606-34-8 271-742-2
565 Petroleum 
products, refin ery 
gases, 
if they con tain 
> 0,1 % w/w 
Butadiene68607-11-4 271-750-6
566 Gases 
(petroleum), hydrocrack ing 
low-pressure separator, if they 
contain 
> 0,1 % w/w Butadien e68783-06-2 272-182-1
567 Gases 
(petroleum), refin ery 
blend, 
if they con tain 
> 0,1 % w/w 
Butadiene68783-07-3 272-183-7
568 Gases 
(petroleum), catalytic crack ing, 
if they con tain 
> 0,1 % w/w 
Butadiene68783-64-2 272-203-4N E 9 0 0 2 . 2 1 . 2 2
d c b ar e b m u n C E r e b m u n S A C N N I / e m a n l a c i m e h Cn o i t a c i f i t n e d i e c n a t s b u S
r e b m u ne c n e r e f e ROfficial Journ alof the EuropeanUnion 22.12.2009
569 Gases (petroleum), C2-4, sweetened, if they con tain > 0,1 % w/w 
Butadiene68783-65-3 272-205-5
570 Gases 
(petroleum), refin ery, 
if they con tain 
> 0,1 % w/w Butadien e6881
4-67-5 272-338-9
571 Gases (petroleum), platformer products separator off, if they con tai
n 
> 
0,1 % w/w Butadien e68814-90-4 272-343-6
572 Gases 
(petroleum), hydrotreated sour k erosine 
depentaniser 
stabili
ser 
off, if they con tain 
> 0,1 % w/w Butadien e68911-58-0 272-775-5
573 Gases 
(petroleum), hydrotreated sour k erosine 
flash drum, if they 
contain 
> 0,1 % w/w Butadien e68911-59-1 272-776-0
574 Gases 
(petroleum), crude oil fraction ation 
off, if they con tain 
> 0,1 % 
w/w Butadien e68918-99-0 272-871-7
575 Gases 
(petroleum), dehexan iser 
off, if they con tain 
> 0,1 % w/w 
Butadiene68919-00-6 272-872-2
576 Gases 
(petroleum), distillate un ifiner 
desulfurisation  
stripper off, if they 
contain 
> 0,1 % w/w Butadien e68919-01-7 272-873-8
577 Gases 
(petroleum), fluidised catalytic crack er 
fractionation 
off if they 
contain 
> 0,1 % w/w Butadien e68919-02-8 272-874-3
578 Gases 
(petroleum), fluidised catalytic crack er 
scrubbing 
secondary 
absorber 
off, if they con tain 
> 0,1 % w/w Butadien e68919-03-9 272-875-9
579 Gases 
(petroleum), heavy distillate hydrotreater desulfurisation  
stripper 
off, if they con tain 
> 0,1 % w/w Butadien e68919-04-0 272-876-4
580 Gases 
(petroleum), lig ht 
straight 
run 
gasoline 
fractionation 
stabil
iser 
off, if they con tain 
> 0,1 % w/w Butadien e68919-05-1 272-878-5
581 Gases 
(petroleum), n aphtha 
unifiner 
desulfurisation  
stripper off, if they 
contain 
> 0,1 % w/w Butadien e68919-06-2 272-879-0
582 Gases 
(petroleum), platformer stab iliser 
off, light 
ends 
fractionat
ion, 
if 
they contain 
> 0,1 % w/w Butadien e68919-07-3 272-880-6
583 Gases 
(petroleum), preflash tower off, crude distn ., 
if they con tain 
> 
0,1 % w/w Butadien e68919-08-4 272-881-1
584 Gases 
(petroleum), straig ht-run 
naphtha 
catalytic reformin g 
off, if they 
contain 
> 0,1 % w/w Butadien e68919-09-5 272-882-7
585 Gases 
(petroleum), straig ht-run 
stabiliser 
off, if they con tain 
> 0,1 % 
w/w Butadien e68919-10-8 272-883-2
586 Gases 
(petroleum), tar stripper off, if they con tain 
> 0,1 % w/w 
Butadiene68919-11-9 272-884-8
587 Gases 
(petroleum), un ifiner 
stripper off, if they con tain 
> 0,1 % w/w 
Butadiene68919-12-0 272-885-3
588 Gases 
(petroleum), fluidised catalytic crack er 
splitter overheads, if they 
contain 
> 0,1 % w/w Butadien e68919-20-0 272-893-7
589 Gases 
(petroleum), catalytic crack ed 
naphtha 
debutaniser, 
if they 
contain 
> 0,1 % w/w Butadien e68952-76-1 273-169-3
590 Tail 
gas 
(petroleum), catalytic crack ed 
distillate an d 
naphtha 
stabi
liser, 
if it contains 
> 0,1 % w/w Butadien e68952-77-2 273-170-9
591 Tail 
gas 
(petroleum), catalytic hydrodesulfurised n aphtha 
separator, if 
it contains 
> 0,1 % w/w Butadien e68952-79-4 273-173-5
592 Tail 
gas 
(petroleum), straig ht-run 
naphtha 
hydrodesulfurised, if it 
contains 
> 0,1 % w/w Butadien e68952-80-7 273-174-0
593 Tail 
gas 
(petroleum), thermal-crack ed 
distillate, g as 
oil and 
naphth
a 
absorber, 
if it contains 
> 0,1 % w/w Butadien e68952-81-8 273-175-6N E 0 0 1 / 2 4 3 L
d c b ar e b m u n C E r e b m u n S A C N N I / e m a n l a c i m e h Cn o i t a c i f i t n e d i e c n a t s b u S
r e b m u ne c n e r e f e ROfficial Journ alof the EuropeanUnion L 342/101
594 Tail gas (petroleum), thermal crack ed hydrocarb on fractionation 
stabiliser, 
petroleum cok ing, 
if it contains 
> 0,1 % w/w Butadien e68952-82-9 273-176-1
595 Gases 
(petroleum), lig ht 
steam-crack ed, 
butadiene 
conc., 
if they 
contain 
> 0,1 % w/w Butadien e68955-28-2 273-265-5
596 Gases 
(petroleum), spon ge 
absorber 
off, fluidised catalytic crack er 
and 
gas 
oil desulfuriser overhead fraction ation, 
if they con tain 
> 0,1 % w/w 
Butadiene68955-33-9 273-269-7
597 Gases 
(petroleum), straig ht-run 
naphtha 
catalytic reformer stab ili
ser 
overhead, if they con tain 
> 0,1 % w/w Butadien e68955-34-0 273-270-2
598 Gases 
(petroleum), crude distn . 
and 
catalytic crack ing, 
if they con ta
in 
> 
0,1 % w/w Butadien e68989-88-8 273-563-5
599 Hydrocarb ons, 
C4, if they con tain > 0,1 % w/w Butadien e 87741-01-3 289-339-5
600 Alkanes, 
C1-4,  C3-rich, if they con tain > 0,1 % w/w Butadien e 90622-55-2 292-456-4
601 Gases 
(petroleum), g as 
oil diethan olamine 
scrubber 
off, if they con ta
in 
> 
0,1 % w/w Butadien e92045-15-3 295-397-2
602 Gases 
(petroleum), g as 
oil hydrodesulfurisation  
effluent, 
if they con tain 
> 
0,1 % w/w Butadien e92045-16-4 295-398-8
603 Gases 
(petroleum), g as 
oil hydrodesulfurisation  
purge, 
if they con ta
in 
> 
0,1 % w/w Butadien e92045-17-5 295-399-3
604 Gases 
(petroleum), hydrog enator 
effluent 
flash drum off, if they 
contain 
> 0,1 % w/w Butadien e92045-18-6 295-400-7
605 Gases 
(petroleum), n aphtha 
steam crack ing 
high-pressure 
residual, if 
they contain 
> 0,1 % w/w Butadien e92045-19-7 295-401-2
606 Gases 
(petroleum), residue visb reaking 
off, if they con tain 
> 0,1 % w/w 
Butadiene92045-20-0 295-402-8
607 Gases 
(petroleum), steam-crack er 
C3-rich, if they con tain > 0,1 % w/w 
Butadiene92045-22-2 295-404-9
608 Hydrocarb ons, 
C4, steam-crack er distillate, if they con tain > 0,1 % w/w 
Butadiene92045-23-3 295-405-4
609 Petroleum 
gases, 
liquefied, sweeten ed, 
C4 fraction, if they con tain 
> 
0,1 % w/w Butadien e92045-80-2 295-463-0
610 Hydrocarb ons, 
C4, 1,3-butadiene- and isobutene-free, if they con tain 
> 
0,1 % w/w Butadien e95465-89-7 306-004-1
611 Raffinates 
(petroleum), steam-crack ed 
C4 fraction cuprous ammon ium 
acetate 
extn., 
C3-5 and C3-5 unsatd., butadiene-free, if they con tain 
> 
0,1 % w/w Butadien e97722-19-5 307-769-4
612 Benzo[def]chrysene 
(benzo[a]pyrene) 50-32-8 200-028-5
613 Pitch, 
coal tar-petroleum, if it con tains 
> 0,005 % w/w b enzo[a]pyrene 68187-57-5 269-109-0
614 Distillates 
(coal-petroleum), con densed-ring 
arom., if they con tai
n 
> 
0,005 % w/w b enzo[a]pyrene68188-48-7 269-159-3
615 Moved 
or deleted
616 Moved or deleted
617 Creosote oil, acen aphthene 
fraction, 
acenaphthene-free, 
if it conta
ins 
> 
0,005 % w/w b enzo[a]pyrene90640-85-0 292-606-9
618 Pitch, 
coal tar, low-temp., if it con tains 
> 0,005 % w/w 
benzo[a]pyrene90669-57-1 292-651-4
619 Pitch, 
coal tar, low-temp., heat-treated, if it con tains 
> 0,005 % w/w 
benzo[a]pyrene90669-58-2 292-653-5N E 9 0 0 2 . 2 1 . 2 2
d c b ar e b m u n C E r e b m u n S A C N N I / e m a n l a c i m e h Cn o i t a c i f i t n e d i e c n a t s b u S
r e b m u ne c n e r e f e ROfficial Journ alof the EuropeanUnion 22.12.2009
620 Pitch, coal tar, low-temp., oxidised, if it con tains > 0,005 % w/w 
benzo[a]pyrene90669-59-3 292-654-0
621 Extract 
residues (coal), b rown, 
if they con tain 
> 0,005 % w/w 
benzo[a]pyrene91697-23-3 294-285-0
622 Paraffin 
waxes (coal), b rown-coal 
high-temp. 
tar, if they con tain 
> 
0,005 % w/w b enzo[a]pyrene92045-71-1 295-454-1
623 Paraffin 
waxes (coal), b rown-coal 
high-temp. 
tar, hydrotreated, if they 
contain 
> 0,005 % w/w b enzo[a]pyrene92045-72-2 295-455-7
624 Waste 
solids, coal-tar pitch cok ing, 
if they con tain 
> 0,005 % w/w 
benzo[a]pyrene92062-34-5 295-549-8
625 Pitch, 
coal tar, hig h-temp., 
secondary, 
if it contains 
> 0,005 % w/w 
benzo[a]pyrene94114-13-3 302-650-3
626 Residues 
(coal), liq. solven t 
extn., 
if they con tain 
> 0,005 % w/w 
benzo[a]pyrene94114-46-2 302-681-2
627 Coal 
liquids, liq. solven t 
extn. 
soln., 
if they con tain 
> 0,005 % w/w 
benzo[a]pyrene94114-47-3 302-682-8
628 Coal 
liquids, liq. solven t 
extn., 
if they con tain 
> 0,005 % w/w 
benzo[a]pyrene94114-48-4 302-683-3
629 Paraffin 
waxes (coal), b rown-coal 
high-temp. 
tar, carbon-treated, 
if 
they contain 
> 0,005 % w/w b enzo[a]pyrene97926-76-6 308-296-6
630 Paraffin 
waxes (coal), b rown-coal 
high-temp 
tar, clay-treated, if they 
contain 
> 0,005 % w/w b enzo[a]pyrene97926-77-7 308-297-1
631 Paraffin 
waxes (coal), b rown-coal 
high-temp 
tar, silicic acid-treated, if 
they contain 
> 0,005 % w/w b enzo[a]pyrene97926-78-8 308-298-7
632 Absorption 
oils, bicyclo 
arom. and 
heterocylic hydrocarb on 
fraction,  i f  
they contain 
> 0,005 % w/w b enzo[a]pyrene101316-45-4 309-851-5
633 Aromatic 
hydrocarb ons, 
C20-28, polycyclic, mixed coal-tar 
pitch-polyethylen e 
polypropylen e 
pyrolysis-derived, if they con tain 
> 
0,005 % w/w b enzo[a]pyrene101794-74-5 309-956-6
634 Aromatic 
hydrocarb ons, 
C20-28, polycyclic, mixed coal-tar 
pitch-polyethylen e 
pyrolysis-derived, if they con tain 
> 0,005 % w/w 
benzo[a]pyrene101794-75-6 309-957-1
635 Aromatic 
hydrocarb ons, 
C20-28, polycyclic, mixed coal-tar 
pitch-polystyren e 
pyrolysis-derived, if they con tain 
> 0,005 % w/w 
benzo[a]pyrene101794-76-7 309-958-7
636 Pitch, 
coal tar, hig h-temp., 
heat-treated, if it con tains 
> 0,005 % w/w 
benzo[a]pyrene121575-60-8 310-162-7
637 Dibenz[
a,h]anthracene 53-70-3 200-181-8
638 Benz[a]anthracene 56-55-3 200-280-6
639 Benzo[e]pyrene 192-97-2 205-892-7
640 Benzo[j]fluoranthene 205-82-3 205-910-3
641 Benz(e)acephenanthrylene 205-99-2 205-911-9
642 Benzo(k)fluoranthene 207-08-9 205-916-6
643 Chrysene 218-01-9 205-923-4
644 2-Bromopropan e 75-26-3 200-855-1
645 Trichloroethylen e 79-01-6 201-167-4
646 1,2-Dibromo-3-chloropropane 96-12-8 202-479-3N E 2 0 1 / 2 4 3 L
d c b ar e b m u n C E r e b m u n S A C N N I / e m a n l a c i m e h Cn o i t a c i f i t n e d i e c n a t s b u S
r e b m u ne c n e r e f e ROfficial Journ alof the EuropeanUnion L 342/103
647 2,3-Dibromopropan-1-ol 96-13-9 202-480-9
648 1,3-Dichloropropan -2-ol 96-23-1 202-491-9
649 α,α,α-Trichlorotoluen e 98-07-7 202-634-5
650 α-Chlorotoluen e 
(Benzyl 
chloride) 100-44-7 202-853-6
651 1,2-Dibromoethane 106-93-4 203-444-5
652 Hexachlorob enzene 118-74-1 204-273-9
653 Bromoethylen e 
(Vinyl 
bromide) 593-60-2 209-800-6
654 1,4-Dichlorob ut-2-ene 764-41-0 212-121-8
655 Methyloxiran e 
(Propylene 
oxide) 75-56-9 200-879-2
656 (Epoxyethyl)benzene 
(Styrene 
oxide) 96-09-3 202-476-7
657 1-Chloro-2,3-epoxypropan e 
(Epichlorohydrin) 106-89-8 203-439-8
658 R
-1-Chloro-2,3-epoxypropan e 51594-55-9 424-280-2
659 1,2-Epoxy-3-phenoxypropane 
(Phenylglycidyl 
ether) 122-60-1 204-557-2
660 2,3-Epoxypropan-1-ol 
(Glycidol) 556-52-5 209-128-3
661 R-2,3-Epoxy-1-propanol 57044-25-4 404-660-4
662 2,2′-Bioxiran e 
(1,2:3,4-Diepoxyb utane) 1464-53-5 215-979-1
663 (2RS,3RS)-3-(2-Chlorophen yl)-2-(4-fluorophenyl)-[1H-1,2,4-tr
iazol-1-yl) 
methyl]oxiran e; 
Epoxiconazole133855-98-8 406-850-2
664 Chloromethyl 
methyl ether 107-30-2 203-480-1
665 2-Methoxyethan ol 
and 
its acetate (2-Methoxyethyl acetate) 109-86-4/ 
110-49-6203-713-7/ 
203-772-9
666 2-Ethoxyethanol 
and 
its acetate (2-E thoxyethyl 
acetate) 110-80-5/ 
111-15-9203-804-1/ 203-839-2
667 Oxyb
is[chloromethane], 
bis 
(Chloromethyl) ether 542-88-1 208-832-8
668 2-Methoxypropan ol 1589-47-5 216-455-5
669 Propiolacton e 57-57-8 200-340-1
670 Dimethylcarb amoyl 
chloride 79-44-7 201-208-6
671 Urethane 
(Ethyl 
carbamate) 51-79-6 200-123-1
672 Moved 
or deleted
673 Moved or deleted
674 Methoxyacetic acid 625-45-6 210-894-6
675 Dibutyl 
phthalate 84-74-2 201-557-4
676 bis(2-Methoxyethyl) 
ether (Dimethoxydig lycol) 111-96-6 203-924-4
677 bis(2-Ethylhexyl) 
phthalate (Diethylhexyl phthalate) 117-81-7 204-211-0
678 bis(2-Methoxyethyl) 
phthalate 117-82-8 204-212-6
679 2-Methoxypropyl acetate 70657-70-4 274-724-2
680 2-Ethylhexyl[[[3,5-bis(1,1-dimethylethyl)-4-hydroxyphenyl]-
methyl]thio]acetate80387-97-9 279-452-8
681 Acrylamide, 
unless 
regulated 
elsewhere in  
this Regulation 79-06-1 201-173-7
682 Acrylonitrile 107-13-1 203-466-5
683 2-Nitropropan e 79-46-9 201-209-1N E 9 0 0 2 . 2 1 . 2 2
d c b ar e b m u n C E r e b m u n S A C N N I / e m a n l a c i m e h Cn o i t a c i f i t n e d i e c n a t s b u S
r e b m u ne c n e r e f e ROfficial Journ alof the EuropeanUnion 22.12.2009
684 Dinoseb, its salts an d esters with the exception  of those specified 
elsewhere in  
this list88-85-7 201-861-7
685 2-Nitroan isole 91-23-6 202-052-1
686 4-Nitrobiphenyl 92-93-3 202-204-7
687 2,4-Dinitrotoluene;
Dinitrotoluene, 
technical 
grade121-14-2/ 
25321-14-6204-450-0/ 246-836-1
688 Bin
apacryl 485-31-4 207-612-9
689 2-Nitronaphthalene 581-89-5 209-474-5
690 2,3-Dinitrotoluene 602-01-7 210-013-5
691 5-Nitroacen aphthene 602-87-9 210-025-0
692 2,6-Dinitrotoluene 606-20-2 210-106-0
693 3,4-Dinitrotoluene 610-39-9 210-222-1
694 3,5-Dinitrotoluene 618-85-9 210-566-2
695 2,5-Dinitrotoluene 619-15-8 210-581-4
696 Dinoterb, 
its salts an d 
esters 1420-07-1 215-813-8
697 Nitrofen 1836-75-5 217-406-0
698 Moved or deleted
699 Diazomethan e 334-88-3 206-382-7
700 1,4,5,8-Tetraamin oanthraquinone 
(Disperse Blue 1) 2475-45-8 219-603-7
701 Moved or deleted
702 1-Methyl-3-n itro-1-nitrosoguanidine 70-25-7 200-730-1
703 Moved 
or deleted
704 Moved or deleted
705 4,4′-Methylen edianiline 101-77-9 202-974-4
706 4,4′-(4-Iminocyclohexa-2,5-dienylidenemethylene) 
dianiline 
hydrochlo­
ride569-61-9 209-321-2
707 4,4′-Methylen edi-o-toluidine 838-88-0 212-658-8
708 o-Anisidine 90-04-0 201-963-1
709 3,3′-Dimethoxyb enzidine 
(ortho-Dian isidine) 
and 
its salts 119-90-4 204-355-4
710 Moved or deleted
711 o-Dianisidine 
based 
azo dyes
712 3,3′-Dichlorob enzidine 91-94-1 202-109-0
713 Benzidine 
dihydrochloride 531-85-1 208-519-6
714 [[1,1′-Biphen yl]-4,4′-diyl]diammonium 
sulphate 531-86-2 208-520-1
715 3,3′-Dichlorob enzidine 
dihydrochloride 612-83-9 210-323-0
716 Benzidine 
sulphate 21136-70-9 244-236-4
717 Benzidine 
acetate 36341-27-2 252-984-8
718 3,3′-Dichlorob enzidine 
dihydrogen 
bis(sulphate) 64969-34-2 265-2
93-1
719 3,3′-Dichlorob enzidine 
sulphate 74332-73-3 277-822-3
720 Benzidine based azo dyes
721 4,4′-Bi-o-toluidin e 
(ortho-Tolidin e) 119-93-7 204-358-0
722 4,4′-Bi-o-toluidin e 
dihydrochloride 612-82-8 210-322-5
723 [3,3′-Dimethyl[1,1′-b iphenyl]-4,4′-diyl]diammonium 
bis(hydrog
en 
sulphate)64969-36-4 265-294-7N E 4 0 1 / 2 4 3 L
d c b ar e b m u n C E r e b m u n S A C N N I / e m a n l a c i m e h Cn o i t a c i f i t n e d i e c n a t s b u S
r e b m u ne c n e r e f e R724 4,4′-Bi-o-toluidin e sulphate 74753-18-7 277-985-0
725 o-Tolidine 
based 
dyes 611-030-00-4
726 Biphenyl-4-ylamine 
(4-Aminobiphenyl) 
and 
its salts 92-67-1 202-177-1
727 Azobenzene 103-33-3 203-102-5
728 (Methyl-ONN-azoxy)methyl 
acetate 592-62-1 209-765-7
729 Cycloheximide 66-81-9 200-636-0
730 2-Methylaziridin e 75-55-8 200-878-7
731 Imidazolidine-2-thione 
(Ethylene 
thiourea) 96-45-7 202-506-9
732 Furan 110-00-9 203-727-3
733 Aziridine 151-56-4 205-793-9
734 Captafol 2425-06-1 219-363-3
735 Carbadox 6804-07-5 229-879-0
736 Flumioxazin 103361-09-7 613-166-00-X
737 Tridemorph 24602-86-6 246-347-3
738 Vinclozolin 50471-44-8 256-599-6
739 Fluazifop-b utyl 69806-50-4 274-125-6
740 Flusilazole 85509-19-9 014-017-00-6
741 1,3,5-Tris(oxiran ylmethyl)-1,3,5-triazine-2,4,6(1 H
,3H,5H)-trion e 
(TGIC)2451-62-9 219-514-3
742 Thioacetamide 62-55-5 200-541-4
743 Moved 
or deleted
744 Formamide 75-12-7 200-842-0
745 N-Methylacetamide 79-16-3 201-182-6
746 N-Methylformamide 123-39-7 204-624-6
747 N,N-Dimethylacetamide 127-19-5 204-826-4
748 Hexamethylphosphoric-triamide 680-31-9 211-653-8
749 Diethyl sulphate 64-67-5 200-589-6
750 Dimethyl sulphate 77-78-1 201-058-1
751 1,3-Propan esultone 1120-71-4 214-317-9
752 Dimethylsulphamoyl-chloride 13360-57-1 236-412-4
753 Sulfallate 95-06-7 202-388-9
754 A 
mixture of: 
4-[[bis-(4-Fluorophenyl)methylsilyl]methyl]-4 H
-1,2,4-triazole 
and 
1-[[bis-(4-fluorophenyl)methylsilyl]methyl]-1 H
-1,2,4-triazole403-250-2
755 (+/–)-Tetrahydrofurfuryl 
–(R)-2-[4-(6-chloroquin oxalin-2-yloxy)phenyloxy]propionate119738-06-6 607-373-00-4
756 6-Hydroxy-1-(3-I sopropoxypropyl)-4-methyl-2-oxo-5-[4-(phenyl
azo) 
phenylazo]-1,2-dihydro-3-pyridinecarbonitrile85136-74-9­ -
400-3
757 (6-(4-Hydroxy-3-(2-methoxyphen ylazo)-2-sulfonato-7-naphthyla
mino)-
1,3,5-triazin e-2,4-diyl)bis[(amino-1-methylethyl)ammonium] 
formate108225-03-2 402-060-7
758 Trisodium [4′-(8-acetylamin
o-3,6-disulfonato-2-naphthylazo)-4″-(6-benzoyl
amino-
3-Sulfonato-2-naphthylazo)-biphenyl-1,3′,3″,1‴-tetraolato- O
,O′,O″,O‴] 
copper(II)413-590-35 0 1 / 2 4 3 L n o i n U n a e p o r u E e h t f o l a n r u o J l a i c i f f O N E 9 0 0 2 . 2 1 . 2 2
3 0 4d c b ar e b m u n C E r e b m u n S A C N N I / e m a n l a c i m e h Cn o i t a c i f i t n e d i e c n a t s b u S
r e b m u ne c n e r e f e ROfficial Journ alof the EuropeanUnion 22.12.2009
759 A mixture of: 
N-[3-Hydroxy-2-(2-methylacryloylamin omethoxy)propoxymethyl]-
2-methylacrylamide 
and 
N
-[2,3-bis-(2-Methylacryloylaminomethoxy)propoxymethyl]-
2-methylacrylamide 
and 
methacrylamide 
and 
2-methyl-N-(2-methylacryloylamin omethoxymethyl)-acrylamide 
and
 N-(2,3-dihydroxypropoxymethyl)-2-methylacrylamide412-790-8
760 1,3,5-tris-[(2S an
d 
2R)-2,3-E poxypropyl]-1,3,5-triazine-2,4,6-(1 H
,3H,5H)-trion e 
(Teroxiron e)59653-74-6 616-091-00-0
761 Erionite 12510-42-8 650-012-00-0
762 Asbestos 12001-28-4 650-013-00-6
763 Petroleum 8002-05-9 232-298-5
764 Distillates 
(petroleum), heavy hydrocrack ed, 
if they con tain 
> 3 % w/w 
DMSO extract64741-76-0 265-077-7
765 Distillates (petroleum), solven t-refined 
heavy paraffin ic, 
if they con tain 
> 
3 % w/w DMSO extract64741-88-4 265-090-8
766 Distillates (petroleum), solven t-refined 
light 
paraffinic, 
if they con tain 
> 
3 % w/w DMSO extract64741-89-5 265-091-3
767 Residual oils (petroleum), solven t 
deasphalted, if they con tain 
> 3 % 
w/w DMSO extract64741-95-3 265-096-0
768 Distillates (petroleum), solven t-refined 
heavy naphthenic, 
if they 
contain 
> 3 % w/w DMSO extract64741-96-4 265-097-6
769 Distillates (petroleum), solven t-refined 
light 
naphthenic, 
if they con tain 
> 
3 % w/w DMSO extract64741-97-5 265-098-1
770 Residual oils (petroleum), solven t-refined, 
if they con tain 
> 3 % w/w 
DMSO extract64742-01-4 265-101-6
771 Distillates (petroleum), clay-treated heavy paraffin ic, 
if they contain  
> 
3 % w/w DMSO extract64742-36-5 265-137-2
772 Distillates (petroleum), clay-treated lig ht 
paraffinic, 
if they contain  
> 
3 % w/w DMSO extract64742-37-6 265-138-8
773 Residual oils (petroleum), clay-treated, if they con tain 
> 3 % w/w 
DMSO extract64742-41-2 265-143-5
774 Distillates (petroleum), clay-treated heavy n aphthenic, 
if they contain  
> 
3 % w/w DMSO extract64742-44-5 265-146-1
775 Distillates (petroleum), clay-treated lig ht 
naphthenic, 
if they contain  
> 
3 % w/w DMSO extract64742-45-6 265-147-7
776 Distillates (petroleum), hydrotreated heavy n aphthenic, 
if they contain  
> 
3 % w/w DMSO extract64742-52-5 265-155-0
777 Distillates (petroleum), hydrotreated lig ht 
naphthenic, 
if they contain  
> 
3 % w/w DMSO extract64742-53-6 265-156-6
778 Distillates (petroleum), hydrotreated heavy paraffin ic, 
if they contain  
> 
3 % w/w DMSO extract64742-54-7 265-157-1
779 Distillates (petroleum), hydrotreated lig ht 
paraffinic, 
if they contain  
> 
3 % w/w DMSO extract64742-55-8 265-158-7
780 Distillates (petroleum), solven t-dewaxed 
light 
paraffinic, 
if they con tain 
> 
3 % w/w DMSO extract64742-56-9 265-159-2
781 Residual oils (petroleum), hydrotreated, if they con tain 
> 3 % w/w 
DMSO extract64742-57-0 265-160-8
782 Residual oils (petroleum), solven t-dewaxed, 
if they con tain 
> 3 % w/w 
DMSO extract64742-62-7 265-166-0N E 6 0 1 / 2 4 3 L
d c b ar e b m u n C E r e b m u n S A C N N I / e m a n l a c i m e h Cn o i t a c i f i t n e d i e c n a t s b u S
r e b m u ne c n e r e f e ROfficial Journ alof the EuropeanUnion L 342/107
783 Distillates (petroleum), solven t-dewaxed heavy naphthenic, if they 
contain 
> 3 % w/w DMSO extract64742-63-8 265-167-6
784 Distillates (petroleum), solven t-dewaxed 
light 
naphthenic, 
if they 
contain 
> 3 % w/w DMSO extract64742-64-9 265-168-1
785 Distillates (petroleum), solven t-dewaxed 
heavy paraffin ic, 
if they 
contain 
> 3 % w/w DMSO extract64742-65-0 265-169-7
786 Foots oil (petroleum), if it con tains 
> 3 % w/w DMSO extract 64742-67-2 265-171-8
787 Naphthen ic 
oils (petroleum), catalytic dewaxed heavy, if they con tai
n 
> 
3 % w/w DMSO extract64742-68-3 265-172-3
788 Naphthen ic 
oils (petroleum), catalytic dewaxed lig ht, 
if they con tai
n 
> 
3 % w/w DMSO extract64742-69-4 265-173-9
789 Paraffin 
oils (petroleum), catalytic dewaxed heavy, if they con tain 
> 
3 % w/w DMSO extract64742-70-7 265-174-4
790 Paraffin 
oils (petroleum), catalytic dewaxed lig ht, 
if they con tain 
> 3  %  
w/w DMSO extract64742-71-8 265-176-5
791 Naphthen ic 
oils (petroleum), complex dewaxed heavy, if they con tain 
> 
3 % w/w DMSO extract64742-75-2 265-179-1
792 Naphthen ic 
oils (petroleum), complex dewaxed lig ht, 
if they con tain 
> 
3 % w/w DMSO extract64742-76-3 265-180-7
793 Extracts 
(petroleum), heavy n aphthenic 
distillate solven t, 
arom. Con c., 
if 
they contain 
> 3 % w/w DMSO extract68783-00-6 272-175-3
794 Extracts 
(petroleum), solven t-refined 
heavy paraffin ic 
distillate solven t, 
if 
they contain 
> 3 % w/w DMSO extract68783-04-0 272-180-0
795 Extracts 
(petroleum), heavy paraffin ic 
distillates, solven t-deasp
halted, if 
they contain 
> 3 % w/w DMSO extract68814-89-1 272-342-0
796 Lubricating 
oils (petroleum), C20-50, hydrotreated n eutral oil-based, 
high-viscosity, 
if they con tain 
> 3 % w/w DMSO extract72623-85-9 276-736-3
797 Lubricating 
oils (petroleum), C15-30, hydrotreated n eutral oil-based, if 
they 
contain 
> 3 % w/w DMSO extract72623- 86-0 276-737-9
798 Lubricating 
oils (petroleum), C20-50, hydrotreated n eutral oil-based, if 
they 
contain 
> 3 % w/w DMSO extract72623- 87-1 276-738-4
799 Lubricating 
oils, if they con tain 
> 3 % w/w DMSO extract 74869-22-0 278-012-2
800 Distillates (petroleum), complex dewaxed heavy paraffin ic, 
if they 
contain 
> 3 % w/w DMSO extract90640-91-8 292-613-7
801 Distillates (petroleum), complex dewaxed lig ht 
paraffinic, 
if they 
contain 
> 3 % w/w DMSO extract90640-92-9 292-614-2
802 Distillates (petroleum), solven t 
dewaxed heavy paraffin ic, 
clay-treated, 
if they con tain 
> 3 % w/w DMSO extract90640-94-1 292-616-3
803 Hydrocarb ons, 
C20-50, solvent dewaxed heavy paraffin ic, hydrotreated, 
if 
they contain 
> 3 % w/w DMSO extract90640-95-2 292-617-9
804 Distillates (petroleum), solven t 
dewaxed lig ht 
paraffinic, 
clay-treated, if 
they contain 
> 3 % w/w DMSO extract90640-96-3 292-618-4
805 Distillates (petroleum), solven t 
dewaxed lig ht 
paraffinic, 
hydrotreated, 
if they con tain 
> 3 % w/w DMSO extract90640-97-4 292-620-5
806 Extracts 
(petroleum), heavy n aphthenic 
distillate solven t, 
hydrotreated, 
if they con tain 
> 3 % w/w DMSO extract90641-07-9 292-631-5N E 9 0 0 2 . 2 1 . 2 2
d c b ar e b m u n C E r e b m u n S A C N N I / e m a n l a c i m e h Cn o i t a c i f i t n e d i e c n a t s b u S
r e b m u ne c n e r e f e ROfficial Journ alof the EuropeanUnion 22.12.2009
807 Extracts (petroleum), heavy paraffin ic distillate solven t, hydrotreated, if 
they contain 
> 3 % w/w DMSO extract90641-08-0 292-632-0
808 Extracts 
(petroleum), lig ht 
paraffinic 
distillate solven t, 
hydrotreated, if 
they contain 
> 3 % w/w DMSO extract90641-09-1 292-633-6
809 Residual oils (petroleum), hydrotreated solven t 
dewaxed, if they 
contain 
> 3 % w/w DMSO extract90669-74-2 292-656-1
810 Residual oils (petroleum), catalytic dewaxed, if they con tain 
> 3 % w/w 
DMSO extract91770-57-9 294-843-3
811 Distillates (petroleum), dewaxed heavy paraffin ic, 
hydrotreated, if they 
contain 
> 3 % w/w DMSO extract91995-39-0 295-300-3
812 Distillates (petroleum), dewaxed lig ht 
paraffinic, 
hydrotreated, if they 
contain 
> 3 % w/w DMSO extract91995-40-3 295-301-9
813 Distillates (petroleum), hydrocrack ed 
solvent-refined, 
dewaxed, if they 
contain 
> 3 % w/w DMSO extract91995-45-8 295-306-6
814 Distillates (petroleum), solven t-refined 
light 
naphthenic, 
hydrotreated, 
if they con tain 
> 3 % w/w DMSO extract91995-54-9 295-316-0
815 Extracts 
(petroleum), hydrotreated lig ht 
paraffinic 
distillate solven t, 
if 
they contain 
> 3 % w/w DMSO extract91995- 73-2 295-335-4
816 Extracts 
(petroleum), lig ht 
naphthenic 
distillate solven t, 
hydrodesulfurised, 
if they con tain 
> 3 % w/w DMSO extract91995-75-4 295-338-0
817 Extracts 
(petroleum), lig ht 
paraffinic 
distillate solven t, 
acid-treated, if 
they contain 
> 3 % w/w DMSO extract91995-76-5 295-339-6
818 Extracts 
(petroleum), lig ht 
paraffinic 
distillate solven t, 
hydrodesulfurised, 
if they con tain 
> 3 % w/w DMSO extract91995-77-6 295-340-1
819 Extracts 
(petroleum), lig ht 
vacuum g as 
oil solven t, 
hydrotreated, if they 
contain 
> 3 % w/w DMSO extract91995-79-8 295-342-2
820 Foots oil (petroleum), hydrotreated, if it con tains 
> 3 % w/w DMSO 
extract92045-12-0 295-394-6
821 Lubricating 
oils (petroleum), C17-35, solvent-extd., dewaxed, 
hydrotreated, 
if they con tain 
> 3 % w/w DMSO extract92045-42-6 295-423-2
822 Lubricating 
oils (petroleum), hydrocrack ed 
nonarom 
solvent-deparaffined, 
if they con tain 
> 3 % w/w DMSO extract92045-43-7 295-424-8
823 Residual oils (petroleum), hydrocrack ed 
acid-treated solven t-dewa
xed, 
if they con tain 
> 3 % w/w DMSO extract92061-86-4 295-499-7
824 Paraffin 
oils (petroleum), solven t-refined 
dewaxed heavy, if they 
contain 
> 3 % w/w DMSO extract92129-09-4 295-810-6
825 Extracts 
(petroleum), heavy paraffin ic 
distillate solven t, 
clay-treated, if 
they contain 
> 3 % w/w DMSO extract92704-08-0 296-437-1
826 Lubricating 
oils (petroleum), b ase 
oils, paraffin ic, 
if they con tain
 >  3   %  
w/w DMSO extract93572-43-1 297-474-6
827 Extracts 
(petroleum), heavy n aphthenic 
distillate solven t, 
hydrodesulfurised, 
if they con tain 
> 3 % w/w DMSO extract93763-10-1 297-827-4
828 Extracts 
(petroleum), solven t-dewaxed 
heavy paraffin ic 
distillate 
solvent, 
hydrodesulfurised, if they con tain 
> 3 % w/w DMSO extract93763-11-2 297-829-5N E 8 0 1 / 2 4 3 L
d c b ar e b m u n C E r e b m u n S A C N N I / e m a n l a c i m e h Cn o i t a c i f i t n e d i e c n a t s b u S
r e b m u ne c n e r e f e ROfficial Journ alof the EuropeanUnion L 342/109
829 Hydrocarb ons, hydrocrack ed paraffinic distn. residues, 
solvent-dewaxed, 
if they con tain 
> 3 % w/w DMSO extract93763-38-3 297-857-8
830 Foots oil (petroleum), acid-treated, if it con tains 
> 3 % w/w DMSO 
extract93924-31-3 300-225-7
831 Foots oil (petroleum), clay-treated, if it con tains 
> 3 % w/w DMSO 
extract93924-32-4 300-226-2
832 Hydrocarb ons, 
C20-50, residual oil hydrog enation vacuum distillate, if 
they 
contain 
> 3 % w/w DMSO extract93924-61-9 300-257-1
833 Distillates (petroleum), solven t-refined 
hydrotreated heavy, 
hydrogenated, 
if they con tain 
> 3 % w/w DMSO extract94733-08-1 305-588-5
834 Distillates (petroleum), solven t-refined 
hydrocrack ed 
light, 
if they 
contain 
> 3 % w/w DMSO extract94733-09-2 305-589-0
835 Lubricating 
oils (petroleum), C18-40, solvent-dewaxed hydrocrack ed 
distillate-b ased, 
if they con tain 
> 3 % w/w DMSO extract94733-15-0 305-594-8
836 Lubricating 
oils (petroleum), C18-40, solvent-dewaxed hydrogenated 
raffinate-based, 
if they con tain 
> 3 % w/w DMSO extract94733-16-1 305-595-3
837 Hydrocarb ons, 
C13-30, arom. -rich, solven t-extd. naphthenic distillate, 
if 
they contain 
> 3 % w/w DMSO extract95371-04-3 305-971-7
838 Hydrocarb ons, 
C16-32, arom. rich, solven t-extd. naphthenic distillate, if 
they 
contain 
> 3 % w/w DMSO extract95371-05-4 305-972-2
839 Hydrocarb ons, 
C37-68, dewaxed deasphalted hydrotreated vacuum 
distn. 
Residues, if they con tain 
> 3 % w/w DMSO extract95371-07-6 305-974-3
840 Hydrocarb ons, 
C37-65, hydrotreated deasphalted vacuum distn . 
Residues, 
if they con tain 
> 3 % w/w DMSO extract95371-08-7 305-975-9
841 Distillates (petroleum), hydrocrack ed 
solvent-refined 
light, 
if they 
contain 
> 3 % w/w DMSO extract97488-73-8 307-010-7
842 Distillates (petroleum), solven t-refined 
hydrogenated 
heavy, if they 
contain 
> 3 % w/w DMSO extract97488-74-9 307-011-2
843 Lubricating 
oils (petroleum), C18-27, hydrocrack ed solvent-dewaxed, if 
they 
contain 
> 3 % w/w DMSO extract97488-95-4 307-034-8
844 Hydrocarb ons, 
C17-30, hydrotreated solven t-deasphalted atm. distn . 
residue, 
distn. 
lights, 
if they con tain 
> 3 % w/w DMSO extract97675-87-1 307-661-7
845 Hydrocarb ons, 
C17-40, hydrotreated solven t-deasphalted distn. residue, 
vacuum 
distn. 
lights, 
if they con tain 
> 3 % w/w DMSO extract97722-06-0 307-755-8
846 Hydrocarb ons, 
C13-27, solvent-extd. light naphthenic, if they con tain 
> 
3 % w/w DMSO extract97722-09-3 307-758-4
847 Hydrocarb ons, 
C14-29, solvent-extd. light naphthenic, if they con tain 
> 
3 % w/w DMSO extract97722-10-6 307-760-5
848 Foots oil (petroleum), carb on-treated, 
if it contains 
> 3 % w/w DMSO 
extract97862-76-5 308-126-0
849 Foots oil (petroleum), silicic acid-treated, if it con tains 
> 3 % w/w 
DMSO extract97862-77-6 308-127-6N E 9 0 0 2 . 2 1 . 2 2
d c b ar e b m u n C E r e b m u n S A C N N I / e m a n l a c i m e h Cn o i t a c i f i t n e d i e c n a t s b u S
r e b m u ne c n e r e f e ROfficial Journ alof the EuropeanUnion 22.12.2009
850 Hydrocarb ons, C27-42, dearomatised, if they con tain > 3 % w/w DMSO 
extract97862-81-2 308-131-8
851 Hydrocarb ons, 
C17-30, hydrotreated distillates, distn . Lights, if they 
contain 
> 3 % w/w DMSO extract97862-82-3 308-132-3
852 Hydrocarb ons, 
C27-45, naphthenic vacuum distn ., if they con tain > 3 % 
w/w 
DMSO extract97862-83-4 308-133-9
853 Hydrocarb ons, 
C27-45, dearomatised, if they con tain > 3 % w/w DMSO 
extract97926-68-6 308-287-7
854 Hydrocarb ons, 
C20-58, hydrotreated, if they con tain > 3 % w/w DMSO 
extract97926-70-0 308-289-8
855 Hydrocarb ons, 
C27-42, naphthenic, if they con tain > 3 % w/w DMSO 
extract97926-71-1 308-290-3
856 Extracts 
(petroleum), lig ht 
paraffinic 
distillate solven t, 
carbon-
treated, if 
they contain 
> 3 % w/w DMSO extract100684-02-4 309-672-2
857 Extracts 
(petroleum), lig ht 
paraffinic 
distillate solven t, 
clay-treated, if 
they contain 
> 3 % w/w DMSO extract100684- 03-5 309-673-8
858 Extracts 
(petroleum), lig ht 
vacuum, g as 
oil solven t, 
carbon-treated
,  i f  
they contain 
> 3 % w/w DMSO extract100684-04-6 309-674-3
859 Extracts 
(petroleum), lig ht 
vacuum g as 
oil solven t, 
clay-treated, if they 
contain 
> 3 % w/w DMSO extract100684-05-7 309-675-9
860 Residual oils (petroleum), carb on-treated 
solvent-dewaxed, 
if they 
contain 
> 3 % w/w DMSO extract100684-37-5 309-710-8
861 Residual oils (petroleum), clay-treated solven t-dewaxed, 
if they con tain 
> 
3 % w/w DMSO extract100684-38-6 309-711-3
862 Lubricating 
oils (petroleum), C>25, solvent-extd., deasphalted, dewaxed, 
hydrogenated, 
if they con tain 
> 3 % w/w DMSO extract101316-69-2 309-874-0
863 Lubricating 
oils (petroleum), C17-32, solvent-extd., dewaxed, 
hydrogenated, 
if they con tain 
> 3 % w/w DMSO extract101316-70-5 309-875-6
864 Lubricating 
oils (petroleum), C20-35, solvent-extd., dewaxed, 
hydrogenated, 
if they con tain 
> 3 % w/w DMSO extract101316-71-6 309-876-1
865 Lubricating 
oils (petroleum), C24-50, solvent-extd., dewaxed, 
hydrogenated, 
if they con tain 
> 3 % w/w DMSO extract101316-72-7 309-877-7
866 Distillates (petroleum), sweeten ed 
middle, except if the full refin i
ng 
history 
is known 
and 
it can 
be 
shown 
that the sub stance 
from which 
it is produced is n ot 
a carcinogen64741-86-2 265-088-7
867 Gas 
oils (petroleum), solven t-refined, 
except if the full refin ing 
history 
is known 
and 
it can 
be 
shown 
that the sub stance 
from which it is 
produced is n ot 
a carcinogen64741-90-8 265-092-9
868 Distillates 
(petroleum), solven t-refined 
middle, except if the full 
refining 
history is k nown 
and 
it can 
be 
shown 
that the sub stance 
from 
which it is produced is n ot 
a carcinogen64741-91-9 265-093-4
869 Gas 
oils (petroleum), acid-treated, except if the full refin ing 
history is 
known 
and 
it can 
be 
shown 
that the sub stance 
from which it is 
produced is n ot 
a carcinogen64742-12-7 265-112-6
870 Distillates 
(petroleum), acid-treated middle, except if the full refin ing 
history 
is known 
and 
it can 
be 
shown 
that the sub stance 
from which 
it is produced is n ot 
a carcinogen64742-13-8 265-113-1
871 Distillates 
(petroleum), acid-treated lig ht, 
except if the full refin ing 
history 
is known 
and 
it can 
be 
shown 
that the sub stance 
from which 
it is produced is n ot 
a carcinogen64742-14-9 265-114-7N E 0 1 1 / 2 4 3 L
d c b ar e b m u n C E r e b m u n S A C N N I / e m a n l a c i m e h Cn o i t a c i f i t n e d i e c n a t s b u S
r e b m u ne c n e r e f e ROfficial Journ alof the EuropeanUnion L 342/111
872 Gas oils (petroleum), chemically n eutralised, except if the full refin ing 
history 
is known 
and 
it can 
be 
shown 
that the sub stance 
from which 
it is produced is n ot 
a carcinogen64742-29-6 265-129-9
873 Distillates 
(petroleum), chemically n eutralised 
middle, except if the full 
refining 
history is k nown 
and 
it can 
be 
shown 
that the sub stance 
from 
which it is produced is n ot 
a carcinogen64742-30-9 265-130-4
874 Distillates 
(petroleum), clay-treated middle, except if the full refin ing 
history 
is known 
and 
it can 
be 
shown 
that the sub stance 
from which 
it is produced is n ot 
a carcinogen64742-38-7 265-139-3
875 Distillates 
(petroleum), hydrotreated middle, except if the full refin ing 
history 
is known 
and 
it can 
be 
shown 
that the sub stance 
from which 
it is produced is n ot 
a carcinogen64742-46-7 265-148-2
876 Gas 
oils (petroleum), hydrodesulfurised, except if the full refin ing 
history 
is known 
and 
it can 
be 
shown 
that the sub stance 
from which 
it is produced is n ot 
a carcinogen64742-79-6 265-182-8
877 Distillates 
(petroleum), hydrodesulfurised middle, except if the full 
refining 
history is k nown 
and 
it can 
be 
shown 
that the sub stance 
from 
which it is produced is n ot 
a carcinogen64742-80-9 265-183-3
878 Distillates 
(petroleum), catalytic reformer fraction ator 
residue, 
high-boiling, 
except if the full refin ing 
history is k nown 
and 
it can 
be 
shown 
that the sub stance 
from which it is produced is n ot 
a 
carcinogen68477-29-2 270-719-4
879 Distillates 
(petroleum), catalytic reformer fraction ator 
residue, 
intermediate-boiling, 
except if the full refin ing 
history is k nown 
and 
it 
can 
be 
shown 
that the sub stance 
from which it is produced is n ot 
a 
carcinogen68477-30-5 270-721-5
880 Distillates 
(petroleum), catalytic reformer fraction ator 
residue, 
low-boiling, 
except if the full refin ing 
history is k nown 
and 
it can 
be 
shown 
that the sub stance 
from which it is produced is n ot 
a 
carcinogen68477-31-6 270-722-0
881 Alkanes, 
C12-26, branched and linear, except if the full refin ing history 
is 
known 
and 
it can 
be 
shown 
that the sub stance 
from which it is 
produced is n ot 
a carcinogen90622-53-0 292-454-3
882 Distillates 
(petroleum), hig hly 
refined 
middle, except if the full refin ing 
history 
is known 
and 
it can 
be 
shown 
that the sub stance 
from which 
it is produced is n ot 
a carcinogen90640-93-0 292-615-8
883 Distillates 
(petroleum), catalytic reformer, heavy arom. con c., 
except if 
the full refin ing 
history is k nown 
and 
it can 
be 
shown 
that the 
substance 
from which it is produced is n ot 
a carcinogen91995-34-5 295-294-2
884 Gas 
oils, paraffin ic, 
except if the full refin ing 
history is k nown 
and 
it 
can 
be 
shown 
that the sub stance 
from which it is produced is n ot 
a 
carcinogen93924-33-5 300-227-8
885 Naphtha 
(petroleum), solven t-refined 
hydrodesulfurised heavy, except 
if the full refin ing 
history is k nown 
and 
it can 
be 
shown 
that the 
substance 
from which it is produced is n ot 
a carcinogen97488-96-5 307-035-3
886 Hydrocarb ons, 
C16-20, hydrotreated middle distillate, distn . Lights, 
except 
if the full refin ing 
history is k nown 
and 
it can 
be 
shown 
that 
the substance 
from which it is produced is n ot 
a carcinogen97675- 85-9 307-659-6
887 Hydrocarb ons, 
C12-20, hydrotreated paraffin ic, distn. lights, except if 
the 
full refining 
history is k nown 
and 
it can 
be 
shown 
that the 
substance 
from which it is produced is n ot 
a carcinogen97675-86-0 307-660-1
888 Hydrocarb ons, 
C11-17, solvent-extd. light naphthenic, except if the full 
refining 
history is k nown 
and 
it can 
be 
shown 
that the sub stance 
from 
which it is produced is n ot 
a carcinogen97722-08-2 307-757-9N E 9 0 0 2 . 2 1 . 2 2
d c b ar e b m u n C E r e b m u n S A C N N I / e m a n l a c i m e h Cn o i t a c i f i t n e d i e c n a t s b u S
r e b m u ne c n e r e f e ROfficial Journ alof the EuropeanUnion 22.12.2009
889 Gas oils, hydrotreated, except if the full refin ing history is k nown and 
it can 
be 
shown 
that the sub stance 
from which it is produced is n ot 
a 
carcinogen97862-78-7 308-128-1
890 Distillates 
(petroleum), carb on-treated 
light 
paraffinic, 
except if the full 
refining 
history is k nown 
and 
it can 
be 
shown 
that the sub stance 
from 
which it is produced is n ot 
a carcinogen100683-97-4 309-667-5
891 Distillates 
(petroleum), in termediate 
paraffinic, 
carbon-treated
, except if 
the full refin ing 
history is k nown 
and 
it can 
be 
shown 
that the 
substance 
from which it is produced is n ot 
a carcinogen100683-98-5 309-668-0
892 Distillates 
(petroleum), in termediate 
paraffinic, 
clay-treated, except if 
the full refin ing 
history is k nown 
and 
it can 
be 
shown 
that the 
substance 
from which it is produced is n ot 
a carcinogen100683-99-6 309-669-6
893 Lubricating 
greases, 
except if the full refin ing 
history is k nown 
and 
it 
can 
be 
shown 
that the sub stance 
from which it is produced is n ot 
a 
carcinogen74869-21-9 278-011-7
894 Slack 
wax (petroleum), except if the full refin ing 
history is k nown 
and 
it 
can 
be 
shown 
that the sub stance 
from which it is produced is n ot 
a 
carcinogen64742-61-6 265-165-5
895 Slack 
wax (petroleum), acid-treated, except if the full refin ing 
history is 
known 
and 
it can 
be 
shown 
that the sub stance 
from which it is 
produced is n ot 
a carcinogen90669-77-5 292-659-8
896 Slack 
wax (petroleum), clay-treated, except if the full refin ing 
history is 
known 
and 
it can 
be 
shown 
that the sub stance 
from which it is 
produced is n ot 
a carcinogen90669-78-6 292-660-3
897 Slack 
wax (petroleum), hydrotreated, except if the full refin ing 
history 
is known 
and 
it can 
be 
shown 
that the sub stance 
from which it is 
produced is n ot 
a carcinogen92062-09-4 295-523-6
898 Slack 
wax (petroleum), low-meltin g, 
except if the full refin ing 
history 
is known 
and 
it can 
be 
shown 
that the sub stance 
from which it is 
produced is n ot 
a carcinogen92062-10-7 295-524-1
899 Slack 
wax (petroleum), low-meltin g, 
hydrotreated, except if the full 
refining 
history is k nown 
and 
it can 
be 
shown 
that the sub stance 
from 
which it is produced is n ot 
a carcinogen92062-11-8 295-525-7
900 Slack 
wax (petroleum), low-meltin g, 
carbon-treated, 
except if the full 
refining 
history is k nown 
and 
it can 
be 
shown 
that the sub stance 
from 
which it is produced is n ot 
a carcinogen97863-04-2 308-155-9
901 Slack 
wax (petroleum), low-meltin g, 
clay-treated, except if the full 
refining 
history is k nown 
and 
it can 
be 
shown 
that the sub stance 
from 
which it is produced is n ot 
a carcinogen97863-05-3 308-156-4
902 Slack 
wax (petroleum), low-meltin g, 
silicic acid-treated, except if the 
full refining 
history is k nown 
and 
it can 
be 
shown 
that the sub stance 
from 
which it is produced is n ot 
a carcinogen97863-06-4 308-158-5
903 Slack 
wax (petroleum), carb on-treated, 
except if the full refin ing 
history 
is known 
and 
it can 
be 
shown 
that the sub stance 
from which 
it is produced is n ot 
a carcinogen100684-49-9 309-723-9
904 Petrolatum, 
except if the full refin ing 
history is k nown 
and 
it can 
be 
shown 
that the sub stance 
from which it is produced is n ot 
a 
carcinogen8009-03-8 232-373-2
905 Petrolatum 
(petroleum), oxidised, except if the full refin ing 
history  i s  
known 
and 
it can 
be 
shown 
that the sub stance 
from which it is 
produced is n ot 
a carcinogen64743-01-7 265-206-7
906 Petrolatum 
(petroleum), alumin a-treated, 
except if the full refin in
g 
history 
is known 
and 
it can 
be 
shown 
that the sub stance 
from which 
it is produced is n ot 
a carcinogen85029-74-9 285-098-5N E 2 1 1 / 2 4 3 L
d c b ar e b m u n C E r e b m u n S A C N N I / e m a n l a c i m e h Cn o i t a c i f i t n e d i e c n a t s b u S
r e b m u ne c n e r e f e ROfficial Journ alof the EuropeanUnion L 342/113
907 Petrolatum (petroleum), hydrotreated, except if the full refin ing history 
is known 
and 
it can 
be 
shown 
that the sub stance 
from which it is 
produced is n ot 
a carcinogen92045-77-7 295-459-9
908 Petrolatum 
(petroleum), carb on-treated, 
except if the full refin ing 
history 
is known 
and 
it can 
be 
shown 
that the sub stance 
from which 
it is produced is n ot 
a carcinogen97862-97-0 308-149-6
909 Petrolatum 
(petroleum), silicic acid-treated, except if the full refin ing 
history 
is known 
and 
it can 
be 
shown 
that the sub stance 
from which 
it is produced is n ot 
a carcinogen97862-98-1 308-150-1
910 Petrolatum 
(petroleum), clay-treated, except if the full refin ing 
history 
is known 
and 
it can 
be 
shown 
that the sub stance 
from which it is 
produced is n ot 
a carcinogen100684-33-1 309-706-6
911 Distillates 
(petroleum), lig ht 
catalytic crack ed 64741-59-9 265-06
0-4
912 Distillates (petroleum), in termediate 
catalytic crack ed 64741-60-
2265-062-5
913 Distillates (petroleum), lig ht 
thermal crack ed 64741-82-8 265-084-
5
914 Distillates (petroleum), hydrodesulfurised lig ht 
catalytic crack e
d 68333-25-5 269-781-5
915 Distillates (petroleum), lig ht 
steam-crack ed 
naphtha 68475-80-9 27
0-662-5
916 Distillates (petroleum), crack ed 
steam-crack ed 
petroleum distillates 68477-38-3 270-727-8
917 Gas oils (petroleum), steam-crack ed 68527-18-4 271-260-2
918 Distillates 
(petroleum), hydrodesulfurised thermal crack ed 
middle 85116-53-6 285-505-6
919 Gas oils (petroleum), thermal-crack ed, 
hydrodesulfurised 92045-29-9 295-411-7
920 Residues (petroleum), hydrog enated 
steam-crack ed 
naphtha 92062-00
-5295-514-7
921 Residues (petroleum), steam-crack ed 
naphtha 
distn. 92062-04-9 295-
517-3
922 Distillates (petroleum), lig ht 
catalytic crack ed, 
thermally deg rad
ed 92201-60-0 295-991-1
923 Residues (petroleum), steam-crack ed 
heat-soaked 
naphtha 93763-85-
0297-905-8
924 Gas oils (petroleum), lig ht 
vacuum, thermal-crack ed 
hydrodesulfurised 97926-59-5 308-278-8
925 Distillates (petroleum), hydrodesulfurised middle cok er 101316-59
-0309-865-1
926 Distillates (petroleum), heavy steam-crack ed 101631-14-5 309-939-
3
927 Residues (petroleum), atm. Tower 64741-45-3 265-045-2
928 Gas oils (petroleum), heavy vacuum 64741-57-7 265-058-3
929 Distillates (petroleum), heavy catalytic crack ed 64741-61-3 265-06
3-0
930 Clarified oils (petroleum), catalytic crack ed 64741-62-4 265-064-6
931 Residues 
(petroleum), catalytic reformer fraction ator 64741-67-9 2
65-069-3
932 Residues (petroleum), hydrocrack ed 64741-75-9 265-076-1
933 Residues 
(petroleum), thermal crack ed 64741-80-6 265-081-9
934 Distillates 
(petroleum), heavy thermal crack ed 64741-81-7 265-082-
4
935 Gas oils (petroleum), hydrotreated vacuum 64742-59-2 265-162-9
936 Residues (petroleum), hydrodesulfurised atmospheric tower 64742-78-5 265-181-2
937 Gas oils (petroleum), hydrodesulfurised heavy vacuum 64742-86-5 265-189-6
938 Residues (petroleum), steam-crack ed 64742-90-1 265-193-8
939 Residues 
(petroleum), atmospheric 68333-22-2 269-777-3
940 Clarified oils (petroleum), hydrodesulfurised catalytic crack ed 68333-26-6 269-782-0
941 Distillates (petroleum), hydrodesulfurised in termediate 
catalytic crack ed68333-27-7 269-783-6
942 Distillates 
(petroleum), hydrodesulfurised heavy catalytic crack e
d 68333-28-8 269-784-1N E 9 0 0 2 . 2 1 . 2 2
d c b ar e b m u n C E r e b m u n S A C N N I / e m a n l a c i m e h Cn o i t a c i f i t n e d i e c n a t s b u S
r e b m u ne c n e r e f e ROfficial Journ alof the EuropeanUnion 22.12.2009
943 Fuel oil, residues-straig ht-run gas oils, high-sulfur 68476-32-4 27 0-674-0
944 Fuel oil, residual 68476-33-5 270-675-6
945 Residues (petroleum), catalytic reformer fraction ator 
residue distn .68478-13-7 270-792-2
946 Residues 
(petroleum), heavy cok er 
gas 
oil and 
vacuum g as 
oil 68478-17-1 270-796-4
947 Residues (petroleum), heavy cok er 
and 
light 
vacuum 68512-61-8 270-983-0
948 Residues (petroleum), lig ht 
vacuum 68512-62-9 270-984-6
949 Residues (petroleum), steam-crack ed 
light 68513-69-9 271-013-9
950 Fuel 
oil, No 6 68553-00-4 271-384-7
951 Residues (petroleum), toppin g 
plant, 
low-sulfur 68607-30-7 271-763-7
952 Gas oils (petroleum), heavy atmospheric 68783-08-4 272-184-2
953 Residues (petroleum), cok er 
scrubber, 
condensed-ring-arom. 
-contg68783-13-1 272-187-9
954 Distillates 
(petroleum), petroleum residues vacuum 68955-27-1 273-263-4
955 Residues (petroleum), steam-crack ed, 
resinous 68955-36-2 273-272-
3
956 Distillates (petroleum), in termediate 
vacuum 70592-76-6 274-683-0
957 Distillates (petroleum), lig ht 
vacuum 70592-77-7 274-684-6
958 Distillates (petroleum), vacuum 70592-78-8 274-685-1
959 Gas oils (petroleum), hydrodesulfurised cok er 
heavy vacuum 85117-03-9 285-555-9
960 Residues (petroleum), steam-crack ed, 
distillates 90669-75-3 292-657-7
961 Residues (petroleum), vacuum, lig ht 90669-76-4 292-658-2
962 Fuel 
oil, heavy, hig h-sulfur 92045-14-2 295-396-7
963 Residues 
(petroleum), catalytic crack ing 92061-97-7 295-511-0
964 Distillates 
(petroleum), in termediate 
catalytic crack ed, 
thermally 
degraded92201-59-7 295-990-6
965 Residual 
oils (petroleum) 93821-66-0 298-754-0
966 Residues, steam crack ed, 
thermally treated 98219-64-8 308-733-0
967 Distillates (petroleum), hydrodesulfurised full-ran ge 
middle 101316-57-8 309-863-0
968 Distillates (petroleum), lig ht 
paraffinic 64741-50-0 265-051-5
969 Distillates 
(petroleum), heavy paraffin ic 64741-51-1 265-052-0
970 Distillates 
(petroleum), lig ht 
naphthenic 64741-52-2 265-053-6
971 Distillates 
(petroleum), heavy n aphthenic 64741-53-3 265-054-1
972 Distillates 
(petroleum), acid-treated heavy n aphthenic 64742-18-3 265-117-3
973 Distillates 
(petroleum), acid-treated lig ht 
naphthenic 64742-19-4 265-118-9
974 Distillates 
(petroleum), acid-treated heavy paraffin ic 64742-20-7 265-119-4
975 Distillates 
(petroleum), acid-treated lig ht 
paraffinic 64742-21-8 265-121-5
976 Distillates 
(petroleum), chemically n eutralised 
heavy paraffin ic 64742-27-4 265-127-8
977 Distillates (petroleum), chemically n eutralised 
light 
paraffinic 6
4742-28-5 265-128-3
978 Distillates (petroleum), chemically n eutralised 
heavy naphthenic 6
4742-34-3 265-135-1
979 Distillates (petroleum), chemically n eutralised 
light 
naphthenic 6
4742-35-4 265-136-7
980 Extracts 
(petroleum), lig ht 
naphthenic 
distillate solven t 64742-03
-6265-102-1
981 Extracts 
(petroleum), heavy paraffin ic 
distillate solven t 64742-04
-7265-103-7N E 4 1 1 / 2 4 3 L
d c b ar e b m u n C E r e b m u n S A C N N I / e m a n l a c i m e h Cn o i t a c i f i t n e d i e c n a t s b u S
r e b m u ne c n e r e f e ROfficial Journ alof the EuropeanUnion L 342/115
982 Extracts (petroleum), lig ht paraffinic distillate solven t 64742-05 -8265-104-2
983 Extracts 
(petroleum), heavy n aphthenic 
distillate solven t 64742-11
-6265-111-0
984 Extracts 
(petroleum), lig ht 
vacuum g as 
oil solven t 91995-78-7 295-34
1-7
985 Hydrocarb ons, 
C26-55, arom. rich 97722-04-8 307-753-7
986 Disodium 
3,3′-[[1,1′-b iphenyl]-4,4′-diylbis(azo)]bis(4-aminonaphthalene-
1-sulphon ate)573-58-0 209-358-4
987 Disodium 
4-amino-3-[[4′-[(2,4-diaminophenyl)azo] 
[1,1′-biphenyl]-4-yl]azo]-5-hydroxy-6-(phenylazo)naphthalene-
2,7-disulphon ate1937-37-7 217-710-3
988 Tetrasodium 
3,3′-[[1,1′-b iphenyl]-4,4′-diylbis(azo)]bis[5-ami
no-
4-hydroxyn aphthalene-2,7-disulphonate]2602-46-2 220-012-1
989 4-o-Tolylazo-o-toluidin e 97-56-3 202-591-2
990 4-Aminoazobenzene 60-09-3 200-453-6
991 Disodium[5-[[4′-[[2,6-dihydroxy-3-[(2-hydroxy-5-sulphophen yl
) 
azo]phenyl]azo][1,1′-biphenyl]-4-yl]azo]salicylato(4-)]cuprate(
2-)16071-86-6 240-221-1
992 Resorcinol 
diglycidyl 
ether 101-90-6 202-987-5
993 1,3-Diphen ylguanidine 102-06-7 203-002-1
994 Heptachlor-epoxide 1024-57-3 213-831-0
995 4-Nitrosophen ol 104-91-6 203-251-6
996 Carbendazim 10605-21-7 234-232-0
997 Allyl 
glycidyl 
ether 106-92-3 203-442-4
998 Chloroacetaldehyde 107-20-0 203-472-8
999 Hexane 110-54-3 203-777-6
1000 2-(2-Methoxyethoxy)ethan ol 
(Diethylen e 
glycol 
monomethyl 
ether; 
DEGME)111-77-3 203-906-6
1001 (+/–)-2-(2,4-Dichlorophen yl)-3-(1H
-1,2,4-triazol-1-yl)propyl-1,1,2, 
2-tetrafluoroethylether (Tetracon azole 
- ISO)112281-77-3 407-760-6
1002 4-[4-(1,3-Dihydroxyprop-2-yl)phen ylamino]-1,8-dihydroxy-
5-nitroanthraquinone114565-66-1 406-057-1
1003 5,6,12,13-Tetrachloroan thra(2,1,9- def
:6,5,10-d’e’f’)diisoquin oline-1,3, 
8,10(2
H,9H)-tetron e115662-06-1 405-100-1
1004 tris(2-Chloroethyl) 
phosphate 115-96-8 204-118-5
1005 4′-Ethoxy-2-benzimidazoleanilide 120187-29-3 407-600-5
1006 Nickel 
dihydroxide 12054-48-7 235-008-5
1007 N,N-Dimethylan iline 121-69-7 204-493-5
1008 Simazine 122-34-9 204-535-2
1009 bis(Cyclopentadienyl)-bis(2,6-difluoro-3-(pyrrol-1-yl)-phen
yl)titanium125051-32-3 412-000-1
1010 N,N,N′,N′-Tetrag lycidyl-4,4′-diamino-3,3′-diethyldiphenylme
thane130728-76-6 410-060-3
1011 Divanadium 
pentaoxide 1314-62-1 215-239-8
1012 Pentachlorophenol 
and 
its alkali 
salts 87-86-5/ 
131-52-2/ 7778-73-6201-778-6/ 205-025-2/ 231-911-3N E 9 0 0 2 . 2 1 . 2 2
d c b ar e b m u n C E r e b m u n S A C N N I / e m a n l a c i m e h Cn o i t a c i f i t n e d i e c n a t s b u S
r e b m u ne c n e r e f e ROfficial Journ alof the EuropeanUnion 22.12.2009
1013 Phosphamidon 13171-21-6 236-116-5
1014 N-(Trichloromethylthio)phthalimide (Folpet - I SO) 133-07-3 205-088-6
1015 N-2-Naphthylan iline 135-88-6 205-223-9
1016 Ziram 137-30-4 205-288-3
1017 1-Bromo-3,4,5-trifluorob enzene 138526-69-9 418-480-9
1018 Propazine 139-40-2 205-359-9
1019 3-(4-Chlorophen yl)-1,1-dimethyluronium 
trichloroacetate; 
monuron-TCA140-41-0 006-043-00-1
1020 Isoxaflutole 141112-29-0 606-054-00-7
1021 Kresoxim-methyl 143390-89-0 607-310-00-0
1022 Chlordecon e 143-50-0 205-601-3
1023 9-Vinylcarbazole 1484-13-5 216-055-0
1024 2-Ethylhexanoic 
acid 149-57-5 205-743-6
1025 Monuron 150-68-5 205-766-1
1026 Morpholin e-4-carbonyl 
chloride 15159-40-7 239-213-0
1027 Daminozide 1596-84-5 216-485-9
1028 Alachlor 
(ISO) 15972-60-8 240-110-8
1029 UVCB 
condensation 
product of: tetrak is-hydroxymethylphosphonium 
chloride, 
urea and 
distilled hydrog enated 
C16-18 tallow alk ylamine166242-53-1 422-720-8
1030 Ioxynil 
and 
Ioxynil 
octanoate 
(ISO) 1689-83-4/ 
3861-47-0216-881-1/ 
223-375-4
1031 Bromoxyn il 
(ISO) 
(3,5-Dibromo-4-hydroxybenzonitrile) 
and 
Bromoxyn il 
heptanoate 
(ISO)1689-84-5/ 56634-95-8216-882-7/ 260-300-4
1032 2,6-Dib
romo-4-cyanophenyl 
octanoate 1689-99-2 216-885-3
1033 Moved 
or deleted
1034 5-Chloro-1,3-dihydro-2 H-indol-2-one 17630-75-0 412-200-9
1035 Benomyl 17804-35-2 241-775-7
1036 Chlorothalon il 1897-45-6 217-588-1
1037 N′-(4-Chloro-o-tolyl)-N,N-dimethylformamidin e 
monohydrochlor
ide19750-95-9 243-269-1
1038 4,4′-Methylen ebis(2-ethylaniline) 19900-65-3 243-420-1
1039 Valinamide 20108-78-5 402-840-7
1040 [(p-Tolyloxy)methyl]oxiran e 2186-24-5 218-574-8
1041 [(m-Tolyloxy)methyl]oxiran e 2186-25-6 218-575-3
1042 2,3-Epoxypropyl 
o-tolyl ether 2210-79-9 218-645-3
1043 [(Tolyloxy)methyl]oxiran e, 
cresyl glycidyl 
ether 26447-14-3 247-711-4
1044 Di-allate 2303-16-4 218-961-1
1045 Benzyl 
2,4-dibromobutanoate 23085-60-1 420-710-8
1046 Trifluoroiodomethan e 2314-97-8 219-014-5
1047 Thiophan ate-methyl 23564-05-8 245-740-7
1048 Dodecachloropen tacyclo[5.2.1.02,6.03,905,8]decane (Mirex) 2385-85-5 219-196-6
1049 Propyzamide 23950-58-5 245-951-4
1050 Butyl 
glycidyl 
ether 2426-08-6 219-376-4
1051 2,3,4-Trichlorob ut-1-ene 2431-50-7 219-397-9N E 6 1 1 / 2 4 3 L
d c b ar e b m u n C E r e b m u n S A C N N I / e m a n l a c i m e h Cn o i t a c i f i t n e d i e c n a t s b u S
r e b m u ne c n e r e f e ROfficial Journ alof the EuropeanUnion L 342/117
1052 Chinomethionate 2439-01-2 219-455-3
1053 (
R)-α-Phen ylethylammonium 
(-)-(1R,2S)-(1,2-epoxypropyl)phosphon ate 
monohydrate25383-07-7 418-570-8
1054 5-Ethoxy-3-trichloromethyl-1,2,4-thiadiazole 
(Etridiazole 
- IS
O) 2593-15-9 219-991-8
1055 Disperse Yellow 3 2832-40-8 220-600-8
1056 1,2,4-Triazole 288-88-0 206-022-9
1057 Aldrin 
(ISO) 309-00-2 206-215-8
1058 Diuron 
(ISO) 330-54-1 206-354-4
1059 Linuron 
(ISO) 330-55-2 206-356-5
1060 Nickel 
carbonate 3333-67-3 222-068-2
1061 3-(4-Isopropylphenyl)-1,1-dimethylurea 
(Isoproturon 
- ISO) 3412
3-59-6 251-835-4
1062 Iprodione 36734-19-7 253-178-9
1063 Moved 
or deleted
1064 5-(2,4-Dioxo-1,2,3,4-tetrahydropyrimidin e)-3-fluoro-
2-hydroxymethyltetrahydrofuran41107-56-6 415-360-8
1065 Crotonaldehyde 4170-30-3 224-030-0
1066 Hexahydrocyclopen ta(c)pyrrole-1-(1 H
)-ammonium 
N
-ethoxycarb onyl-
N-(p-tolylsulfon yl)azanide418-350-1
1067 4,4′-Carb onimidoylbis[N,N-dimethylaniline] 
and 
its salts 492-80-8 207-762-5
1068 DNOC (ISO) 534-52-1 208-601-1
1069 Toluidinium 
chloride 540-23-8 208-740-8
1070 Toluidine 
sulphate (1:1) 540-25-0 208-741-3
1071 2-(4-tert.-Butylphen yl)ethanol 5406-86-0 410-020-5
1072 Fenthion 55-38-9 200-231-9
1073 Chlordane, 
pur 57-74-9 200-349-0
1074 Hexan-2-one 
(Methyl b utyl 
ketone) 591-78-6 209-731-1
1075 Fenarimol 60168-88-9 262-095-7
1076 Acetamide 60-35-5 200-473-5
1077 N
-Cyclohexyl-N-methoxy-2,5-dimethyl-3-furamide (Furmecyclox -
ISO)60568-05-0 262-302-0
1078 Dieldrin 60-57-1 200-484-5
1079 4,4′-Isobutylethylidenediphenol 6807-17-6 401-720-1
1080 Chlordimeform 6164-98-3 228-200-5
1081 Amitrole 61-82-5 200-521-5
1082 Carbaryl 63-25-2 200-555-0
1083 Distillates 
(petroleum), lig ht 
hydrocrack ed 64741-77-1 265-078-2
1084 1-Ethyl-1-methylmorpholinium 
bromide 65756-41-4 612-182-00-4
1085 (3-Chlorophen yl)-(4-methoxy-3-nitrophenyl)methanone 66938-41
-8423-290-4
1086 Fuels, diesel, except if the full refin ing history is k nown and it can be 
shown 
that the sub stance 
from which it is produced is n ot 
a 
carcinogen68334-30-5 269-822-7
1087 Fuel 
oil, no. 
2 68476-30-2 270-671-4
1088 Fuel oil, n o. 
4 68476-31-3 270-673-5
1089 Fuels, diesel, n o. 
2 68476-34-6 270-676-1N E 9 0 0 2 . 2 1 . 2 2
d c b ar e b m u n C E r e b m u n S A C N N I / e m a n l a c i m e h Cn o i t a c i f i t n e d i e c n a t s b u S
r e b m u ne c n e r e f e ROfficial Journ alof the EuropeanUnion 22.12.2009
1090 2,2-Dibromo-2-nitroethanol 69094-18-4 412-380-9
1091 1-Ethyl-1-methylpyrrolidinium 
bromide 69227-51-6 612-183-00-X
1092 Monocrotophos 6923-22-4 230-042-7
1093 Nickel 7440-02-0 231-111-4
1094 Bromomethan e 
(Methyl b romide 
- ISO) 74-83-9 200-813-2
1095 Chloromethan e 
(Methyl chloride) 74-87-3 200-817-4
1096 Iodomethane 
(Methyl iodide) 74-88-4 200-819-5
1097 Bromoethan e 
(Ethyl 
bromide) 74-96-4 200-825-8
1098 Heptachlor 76-44-8 200-962-3
1099 Fentin 
hydroxide 76-87-9 200-990-6
1100 Nickel 
sulphate 7786-81-4 232-104-9
1101 3,5,5-Trimethylcyclohex-2-en one 
(Isophorone) 78-59-1 201-126-0
1102 2,3-Dichloropropen e 78-88-6 201-153-8
1103 Fluazifop-P-b utyl 
(ISO) 79241-46-6 607-305-00-3
1104 (
S)-2,3-Dihydro-1H-in dole-carboxylic 
acid 79815-20-6 410-860-2
1105 Toxaphen e 8001-35-2 232-283-3
1106 (4-Hydrazin ophenyl)- N
-methylmethan esulfonamide 
hydrochloride 81880-96-8 406-090-1
1107 CI 
Solvent 
Yellow 14 842-07-9 212-668-2
1108 Chlozolin ate 84332-86-5 282-714-4
1109 Alkanes, 
C10-13, monochloro 85535-84-8 287-476-5
1110 Moved 
or deleted
1111 2,4,6-Trichlorophen ol 88-06-2 201-795-9
1112 Diethylcarb amoyl-chloride 88-10-8 201-798-5
1113 1-Vinyl-2-pyrrolidone 88-12-0 201-800-4
1114 Myclobutanil 
(ISO) 
(2-(4-chlorophen yl)-2-(1H
-1,2,4-triazol-1-ylmethyl)hexan enitrile)88671-89-0 410-400-0
1115 Fentin 
acetate 900-95-8 212-984-0
1116 Biphenyl-2-ylamine 90-41-5 201-990-9
1117 Trans
-4-cyclohexyl-L-prolin e 
monohydro-chloride 90657-55-9 419-160-1
1118 2-Methyl-m-phen ylene 
diisocyanate 
(Toluene 
2,6-diisocyan ate) 91
-08-7 202-039-0
1119 4-Methyl-m-phen ylene 
diisocyanate 
(Toluene 
2,4-diisocyan ate) 58
4-84-9 209-544-5
1120 m-Tolyliden e 
diisocyanate 
(Toluene 
diisocyanate) 26471-62-5 247-
722-4
1121 Fuels, jet aircraft, coal solven t 
extn., 
hydrocrack ed 
hydrogenated 94114-58-6 302-694-3
1122 Fuels, 
diesel, coal solven t 
extn., 
hydrocrack ed 
hydrogenated 94114
-59-7 302-695-9
1123 Pitch, if it con tains 
> 0,005 % w/w b enzo[a]pyrene 61789-60-4 263-072
-4
1124 2-Butanone oxime 96-29-7 202-496-6
1125 Hydrocarb ons, 
C16-20, solvent-dewaxed hydrocrack ed paraffinic distn. 
Residue97675-88-2 307-662-2
1126 α,α-Dichlorotoluen e 98-87-3 202-709-2N E 8 1 1 / 2 4 3 L
d c b ar e b m u n C E r e b m u n S A C N N I / e m a n l a c i m e h Cn o i t a c i f i t n e d i e c n a t s b u S
r e b m u ne c n e r e f e R1127 Mineral wool, with the exception  of those specified elsewhere in  this 
Annex; 
[Man-made 
vitreous (silicate)fib res 
with random 
orientation 
with 
alkaline 
oxide and 
alkali 
earth oxide (Na2O  +  K2O  +  C a O  +  M g O  
+ BaO) con tent 
greater 
than 
18 % by 
weight]
1128 Reaction 
product of acetophen one, 
formaldehyde, cyclohexylamin e, 
methanol 
and 
acetic acid406-230-1
1129 Moved or deleted
1130 Moved or deleted
1131 Trisodium b is(7-acetamido-2-(4-nitro-2-oxidophenylazo)-3-sul
fonato-
1-naphtholato)chromate(1-)400-810-8
1132 A 
mixture of: 4-allyl-2,6-b is(2,3-epoxypropyl)phenol, 
4-allyl-6-(3-(6-(3-(6-(3-(4-allyl-2,6-b is(2,3-epoxypropyl)-phen
oxy) 
2-hydroxypropyl)-4-allyl-2-(2,3-epoxypropyl)phen oxy)-
2-hydroxypropyl)-4-allyl-2-(2,3-epoxypropyl)-phen oxy-
2-hydroxypropyl-2-(2,3-epoxypropyl)phen ol, 
4-allyl-6-(3-(4-allyl-2,6-b is(2,3-epoxypropyl)phenoxy)-2-
hydroxypropyl)-2-(2,3-epoxypropyl)phen oxy)phenol 
and 
4-allyl-6-(3-(6-(3-(4-allyl-2,6-b is(2,3-epoxypropyl)-phenoxy
)-
2-hydroxypropyl)-4-allyl-2-(2,3-epoxypropyl)phen oxy) 
2-hydroxypropyl)-2-(2,3-epoxypropyl)phen ol417-470-1
1133 Costus 
root oil (Saussurea lappa Clark e), 
when 
used as a frag rance 
ingredient8023-88-9
1134 7-Ethoxy-4-methylcoumarin, 
when 
used as a frag rance 
ingredient 87-
05-8 201-721-5
1135 Hexahydrocoumarin , 
when 
used as a frag rance 
ingredient 700-82-3 211
-851-4
1136 Peru balsam 
(INCI 
name: 
Myroxylon  
pereirae), when  
used as a 
fragrance 
ingredient8007-00-9 232-352-8
1137 Isobutyl 
nitrite 542-56-2 208-819-7
1138 Isoprene 
(stabilized); 
(2-methyl-1,3-b utadiene) 78-79-5 201-143
-3
1139 1-Bromopropan e; 
n-Propyl 
bromide 106-94-5 203-445-0
1140 Chloropren e 
(stabilized); 
(2-Chlorob uta-1,3-diene) 126-99-8 204
-818-0
1141 1,2,3-Trichloropropan e 96-18-4 202-486-1
1142 Ethylene 
glycol 
dimethyl ether (E GDME) 110-71-4 203-794-9
1143 Dinocap 
(ISO) 39300-45-3 254-408-0
1144 Diaminotoluene, 
technical 
product -mixture of [4-methyl-m-
phenylenediamine]
 (4) and [2-methyl-m-phen ylenediamine]  (5)
Methyl-phen ylenediamine25376-45-8 246-910-3
1145 p
-Chlorobenzotrichloride 5216-25-1 226-009-1
1146 Diphenylether; 
octabromo 
derivate 32536-52-0 251-087-9
1147 1,2-bis(2-Methoxyethoxy)ethane; 
Triethylen e 
glycol 
dimethyl ether 
(TEGDME)112-49-2 203-977-3
1148 Tetrahydrothiopyran -3-carboxaldehyde 61571-06-0 407-330-8
1149 4,4′-bis(Dimethylamino)benzophenone 
(Michler’s k etone) 90-94-8 202-027-5
1150 Oxiranemethanol, 
4-methylb enzene-sulfonate, 
(S)- 70987-78-9 417-210-7
1151 1,2-Benzenedicarboxylic 
acid, dipen tylester, 
branched 
and 
linear 
[1]84777-06-0 [1] 284-032-2
n-Pentyl-isopentylphthalate 
[2]­
di-n-Pentyl 
phthalate [3] 131-18-0 [3] 205-017-9
Diisopentylphthalate 
[4] 605-50-5 [4] 210-088-49 1 1 / 2 4 3 L n o i n U n a e p o r u E e h t f o l a n r u o J l a i c i f f O N E 9 0 0 2 . 2 1 . 2 2
] 2 [d c b ar e b m u n C E r e b m u n S A C N N I / e m a n l a c i m e h Cn o i t a c i f i t n e d i e c n a t s b u S
r e b m u ne c n e r e f e ROfficial Journ alof the EuropeanUnion 22.12.2009
1152 Benzyl butyl phthalate (BBP) 85-68-7 201-622-7
1153 1,2-Benzenedicarboxylic 
acid, di-C7-11, branched and linear alkyl esters68515-42-4 271-084-6
1154 A 
mixture of: disodium 4-(3-ethoxycarb onyl-4-(5-(3-ethoxycarbon
yl-
5-hydroxy-1-(4-sulfon atophenyl) 
pyrazol-4-yl)pen ta-2,4-dienylidene)-4,5-dihydro-
5-oxopyrazol-1-yl)b enzenesulfonate 
and 
trisodium 
4-(3-ethoxycarb onyl-4-(5-(3-ethoxycarbonyl-5-oxido-
1-(4-sulfon atophenyl)pyrazol-4-yl)penta-2,4-dienylidene)-4,5-di
hydro-
5-oxopyrazol-1-yl)b enzenesulfonate402-660-9
1155 (Methylen ebis(4,1-phenylenazo(1-(3-(dimethylamino)propyl)-1
, 
2-dihydro-6-hydroxy-4-methyl-2-oxopyridin e-5,3-diyl))) 
-1,1′-dipyridin ium 
dichloride dihydrochloride401-500-5
1156 2-[2-Hydroxy-3-(2-chlorophen yl)carbamoyl-1-naphthylazo] 
-7-[2-hydroxy-3-(3-methylphen yl)carbamoyl-1-naphthylazo] 
fluoren-9-one420-580-2
1157 Azafenidin 68049-83-2
1158 2,4,5-Trimethylan iline 
[1] 137-17-7 [1] 205-282-0
2,4,5-Trimethylan iline 
hydrochloride [2] 21436-97-5 [2]
1159 4,4′-Thiodian iline 
and 
its salts 139-65-1 205-370-9
1160 4,4′-Oxydian iline 
(p-Aminophenyl 
ether) and 
its salts 101-80-4 202-977-0
1161 N,N,N′,N′-Tetramethyl-4,4′-methylen edianiline 101-61-1 202-959-2
1162 6-Methoxy-
m-toluidin e; 
(p-Cresidin e) 120-71-8 204-419-1
1163 3-Ethyl-2-methyl-2-(3-methylbutyl)-1,3-oxazolidine 143860-04
-2421-150-7
1164 A mixture of: 
1,3,5-tris(3-amin omethylphenyl)-1,3,5-(1H,3H,5H)-triazine-2,4,6
-trione 
and 
a mixture of olig omers 
of 3,5-bis(3-aminomethylphenyl)-1-poly 
[3,5-bis(3-aminomethylphenyl)-2,4,6-trioxo-1,3,5-(1H,3H,5H)-tri
azin-
1-yl]-1,3,5-(1H,3H,5H)-triazin e-2,4,6-trione421-550-1
1165 2-Nitrotoluen e 88-72-2 201-853-3
1166 Tributyl 
phosphate 126-73-8 204-800-2
1167 Naphthalen e 91-20-3 202-049-5
1168 Nonylphenol 
[1] 25154-52-3 [1] 246-672-0
4-Nonylphenol, 
branched 
[2] 84852-15-3 [2] 284-325-5
1169 1,1,2-Trichloroethan e 79-00-5 201-166-9
1170 Moved 
or deleted
1171 Moved or deleted
1172 allyl chloride; (3-Chloropropen e) 107-05-1 203-457-6
1173 1,4-Dichlorob enzene; 
(p-Dichlorob enzene) 106-46-7 203-400-5
1174 bis(2-Chloroethyl) 
ether 111-44-4 203-870-1
1175 Phenol 108-95-2 203-632-7
1176 Bisphenol 
A (4,4′-Isopropylidenediphenol) 80-05-7 201-245-8
1177 Trioxymethylen e 
(1,3,5-Trioxan ) 110-88-3 203-812-5
1178 Propargite 
(ISO) 2312-35-8 219-006-1
1179 1-Chloro-4-n itrobenzene 100-00-5 202-809-6
1180 Molinate 
(ISO) 2212-67-1 218-661-0
1181 Fenpropimorph 
(ISO) 67564-91-4 266-719-9
1182 Moved 
or deleted
1183 Methyl isocyan ate 624-83-9 210-866-3N E 0 2 1 / 2 4 3 L
d c b ar e b m u n C E r e b m u n S A C N N I / e m a n l a c i m e h Cn o i t a c i f i t n e d i e c n a t s b u S
r e b m u ne c n e r e f e ROfficial Journ alof the EuropeanUnion L 342/121
1184 N,N-Dimethylan ilinium tetrakis(pentafluorophenyl)borate 11861 2-00-3 422-050-6
1185 O,O′-(Ethenylmethylsilylene) 
di[(4-methylpen tan-2-one) 
oxime] 421-870-1
1186 A 2:1 mixture of: 
4-(7-hydroxy-2,4,4-trimethyl-2-chroman yl)resorcinol-4-yl-tris 
(6-diazo-5,6-dihydro-5-oxon aphthalen-1-sulfonate) 
and 
4-(7-hydroxy-2,4,4-trimethyl-2-chroman yl)resorcinolbis 
(6-diazo-5,6-dihydro-5-oxon aphthalen-1-sulfonate)140698-96-0 414-770-4
1187 A 
mixture of: reaction  
product of 
4,4′-methylen ebis[2-(4-hydroxybenzyl)-3,6-dimethylphenol] 
and 
6-diazo-5,6-dihydro-5-oxo-n aphthalenesulfonate 
(1:2) and 
reaction 
product of 
4,4′-methylen ebis[2-(4-hydroxybenzyl)-3,6-dimethylphenol] 
and 
6-diazo-5,6-dihydro-5-oxon aphthalenesulfonate 
(1:3)417-980-4
1188 Malachite g reen 
hydrochloride [1] 569-64-2 [1] 209-322-8
Malachite g reen 
oxalate [2] 18015-76-4 [2] 241-922-5
1189 1-(4-Chlorophen yl)-4,4-dimethyl-3-(1,2,4-triazol-1-ylmethyl
) 
pentan-3-ol107534-96-3 403-640-2
1190 5-(3-Butyryl-2,4,6-trimethylphen yl)-2-[1-(ethoxyimino)propy
l]-
3-hydroxycyclohex-2-en -1-one138164-12-2 414-790-3
1191 trans
-4-Phenyl-L-proline 96314-26-0 416-020-1
1192 Moved 
or deleted
1193 A mixture of: 5-[(4-[(7-amin o-1-hydroxy-3-sulfo-2-naphthyl)azo
]-
2,5-diethoxyphen yl)azo]-2-[(3-phosphonophenyl)azo]benzoic 
acid 
and 
5-[(4-[(7-amin o-1-hydroxy-3-sulfo-2-naphthyl)azo]-
2,5-diethoxyphen yl)azo]-3-[(3-phosphonophenyl)azo]benzoic 
acid163879-69-4 418-230-9
1194 2-{]4-(2-Ammoniopropylamino)-6-[}4-hydroxy-3-(5-methyl-
2-methoxy-4-sulfamoylphen ylazo)-2-sulfonatonaphth-7-ylamino{] 
-1,3,5-triazin -2-ylamino[}-2-aminopropyl 
formate424-260-3
1195 5-Nitro-o-toluidin e 
[1] 99-55-8 [1] 202-765-8
5-Nitro-o-toluidin e 
hydrochloride [2] 51085-52-0 [2] 256-960-8
1196 1-(1-Naphthylmethyl)quin olinium 
chloride 65322-65-8 406-220-7
1197 (R)-5-Bromo-3-(1-methyl-2-pyrrolidin ylmethyl)-1H-indole 1433
22-57-0 422-390-5
1198 Pymetrozin e 
(ISO) 123312-89-0 613-202-00-4
1199 Oxadiargyl 
(ISO) 39807-15-3 254-637-6
1200 Chlorotoluron  
(3-(3-chloro- p-tolyl)-1,1-dimethylurea) 15545-48-9 239-592-2
1201 N-[2-(3-Acetyl-5-n itrothiophen-2-ylazo)-5-diethylaminopheny
l] 
acetamide416-860-9
1202 1,3-bis(Vinylsulfonylacetamido)propane 93629-90-4 428-350-3
1203 p
-Phenetidine 
(4-Ethoxyaniline) 156-43-4 205-855-5
1204 m
-Phenylenediamine 
and 
its salts 108-45-2 203-584-7
1205 Residues (coal tar), creosote oil distn ., 
if it contains 
> 0,005 % w/w 
benzo[a]pyrene92061-93-3 295-506-3
1206 Creosote 
oil, acenaphthene 
fraction, 
wash oil, if it con tains 
> 0,005 % 
w/w benzo[a]pyrene90640-84-9 292-605-3
1207 Creosote 
oil, if it con tains 
> 0,005 % w/w b enzo[a]pyrene 61789-28-4 2
63-047-8
1208 Creosote, if it con tains 
> 0,005 % w/w b enzo[a]pyrene 8001-58-9 232-2
87-5
1209 Creosote oil, hig h-boiling 
distillate, wash oil, if it con tains 
> 0,005 % 
w/w benzo[a]pyrene70321-79-8 274-565-9
1210 Extract 
residues (coal), creosote oil acid, wash oil extract residue ,  i f  i t  
contains 
> 0,005 % w/w b enzo[a]pyrene122384-77-4 310-189-4
1211 Creosote 
oil, low-b oiling 
distillate, wash oil, if it con tains 
> 0,005  %  
w/w benzo[a]pyrene70321-80-1 274-566-4N E 9 0 0 2 . 2 1 . 2 2
d c b ar e b m u n C E r e b m u n S A C N N I / e m a n l a c i m e h Cn o i t a c i f i t n e d i e c n a t s b u S
r e b m u ne c n e r e f e ROfficial Journ alof the EuropeanUnion 22.12.2009
1212 6-Methoxy-2,3-Pyridin ediamine and its HCl salt, when  used as a 
substance 
in 
hair dye products94166-62-8 303-358-9
1213 2,3-Naphthalen ediol, 
when 
used as a sub stance 
in 
hair dye products 92-44-4 202-156-7
1214 2,4-Diamin odiphenylamine, 
when 
used as a sub stance 
in 
hair dye 
products136-17-4
1215 2,6-Bis(2-Hydroxyethoxy)-3,5-Pyridin ediamine 
and 
its HCl salt, when  
used 
as a substance 
in 
hair dye products117907-42-3
1216 2-Methoxymethyl- p-Aminophenol 
and 
its HCl salt, when  
used as a 
substance 
in 
hair dye products135043-65-1/ 
29785-47-5
1217 4,5-Diamin o-1-Methylpyrazole 
and 
its HCl salt, when  
used as a 
substance 
in 
hair dye products20055-01-0/ 21616-59-1
1218 4,5-Diamin
o-1-((4-Chlorophenyl)Methyl)-1H-Pyrazole 
Sulfate, when  
used 
as a substance 
in 
hair dye products163183-00-4
1219 4-Chloro-2-Amin ophenol, 
when 
used as a sub stance 
in 
hair dye 
products95-85-2 202-458-9
1220 4-Hydroxyin dole, 
when 
used as a sub stance 
in 
hair dye products 2380-94-1 219-177-2
1221 4-Methoxytoluen e-2,5-Diamine 
and 
its HCl salt, when  
used as a 
substance 
in 
hair dye products56496-88-9
1222 5-Amino-4-Fluoro-2-Methylphenol 
Sulfate, when  
used as a sub stance 
in 
hair dye products163183-01-5
1223 N,N-Diethyl-m-Amin ophenol, 
when 
used as a sub stance 
in 
hair dye 
products91-68-9/ 68239-84-9202-090-9/ 269-478-8
1224 N,N-Dimethyl-2,6-Pyridin
ediamine 
and 
its HCl salt, when  
used as a 
substance 
in 
hair dye products—
1225 N-Cyclopen tyl-m
-Aminophenol, 
when 
used as a sub stance 
in 
hair dye 
products104903-49-3
1226 N-(2-Methoxyethyl)- p-phenylenediamine 
and 
its HCl salt, when  
used as 
a substance 
in 
hair dye products72584-59-9/ 66566-48-1276-723-2
1227 2,4-Diamin
o-5-methylphenetol 
and 
its HCl salt, when  
used as a 
substance 
in 
hair dye products113715-25-6
1228 1,7-Naphthalen ediol, 
when 
used as a sub stance 
in 
hair dye products 575-38-2 209-383-0
1229 3,4-Diamin obenzoic 
acid, when  
used as a sub stance 
in 
hair dye 
products619-05-6 210-577-2
1230 2-Aminomethyl-p
-aminophenol 
and 
its HCl salt, when  
used as a 
substance 
in 
hair dye products79352-72-0
1231 Solvent 
Red 1 (CI  
12150), when  
used as a sub stance 
in 
hair dye 
products1229-55-6 214-968-9
1232 Acid Oran ge 
24 (CI 
20170), when  
used as a sub stance 
in 
hair dye 
products1320-07-6 215-296-9
1233 Acid Red 73 (CI  
27290), when  
used as a sub stance 
in 
hair dye 
products5413-75-2 226-502-1
1234 PEG-3,2′,2′-di-p-Phenylenediamine 144644-13-3
1235 6-Nitro-o-Toluidin e 570-24-1 209-329-6
1236 HC 
Yellow No 11 73388-54-2
1237 HC Orange 
No 3 81612-54-6
1238 HC Green  
No 1 52136-25-1 257-687-7
1239 HC Red No 8 an d 
its salts 13556-29-1/ 97404-14-3- / 306-778-0
1240 Tetrahydro-6-n
itroquinoxaline 
and 
its salts 158006-54-3/ 
41959-35-7/ 73855-45-5N E 2 2 1 / 2 4 3 L
d c b ar e b m u n C E r e b m u n S A C N N I / e m a n l a c i m e h Cn o i t a c i f i t n e d i e c n a t s b u S
r e b m u ne c n e r e f e ROfficial Journ alof the EuropeanUnion L 342/123
1241 Disperse Red 15, except as impurity in  Disperse Violet 1 116-85-8 204-163-0
1242 4-Amino-3-fluorophenol 399-95-1 402-230-0
1243 N,N′-dihexadecyl-N,N′-b is(2-hydroxyethyl)propanediamide
Bishydroxyethyl 
Biscetyl Malon amide149591-38-8 422-560-9
1244 1-Methyl-2,4,5-trihydroxyb enzene 
and 
its salts, when  
used as a sub ­
stance 
in 
hair dye products1124-09-0 214-390-7
1245 2,6-Dihydroxy-4-methylpyridin e 
and 
its salts, when  
used as a sub ­
stance 
in 
hair dye products4664-16-8 225-108-7
1246 5-Hydroxy-1,4-b enzodioxane 
and 
its salts, when  
used as a sub stance 
in 
hair 
dye products10288-36-5 233-639-0
1247 3,4-Methylen edioxyphenol 
and 
its salts, when  
used as a sub stance 
in 
hair 
dye products533-31-3 208-561-5
1248 3,4-Methylen edioxyaniline 
and 
its salts, when  
used as a sub stance 
in 
hair 
dye products14268-66-7 238-161-6
1249 Hydroxypyridin one 
and 
its salts, when  
used as a sub stance 
in 
hair dye 
products822-89-9 212-506-0
1250 3-Nitro-4-amin ophenoxyethanol 
and 
its salts, when  
used as a sub ­
stance 
in 
hair dye products50982-74-6
1251 2-methoxy-4-n itrophenol 
(4-Nitroguaiacol) 
and 
its salts, when  
used  a s  
a substance 
in 
hair dye products3251-56-7 221-839-0
1252 CI 
Acid Black  
131 and 
its salts, when  
used as a sub stance 
in 
hair dye 
products12219-01-1
1253 1,3,5-Trihydroxyb enzene 
(Phloroglucinol) 
and 
its salts, when  
used as a 
substance 
in 
hair dye products108-73-6 203-611-2
1254 1,2,4-Ben zenetriacetate 
and 
its salts, when  
used as a sub stance 
in 
hair 
dye products613-03-6 210-327-2
1255 Ethanol, 
2,2’-iminobis-, 
reaction 
products with epichlorohydrin  
and 
2-
nitro-1,4-benzenediamine 
(HC Blue No. 5) an d 
its salts, when  
used as a 
substance 
in 
hair dye products68478-64-8/ 
158571-58-5
1256 N-Methyl-1,4-diamin oanthraquinone, 
reaction 
products with epichlo­
rohydrin 
and 
monoethanolamine 
(HC Blue No. 4) an d 
its salts, when  
used 
as a substance 
in 
hair dye products158571-57-4
1257 4-Aminobenzenesulfonic 
acid (Sulfan ilic 
acid) and 
its salts, when  
used 
as a substance 
in 
hair dye products121-57-3/ 
515-74-2204-482-5/ 208-208-5
1258 3,3’-(Sulfon
ylbis(2-nitro-4,1-phenylene)imino)bis(6-(phenyl
amino)) 
benzenesulfonic 
acid and 
its salts, when  
used as a sub stance 
in 
hair dye 
products6373-79-1 228-922-0
1259 3(or5)-((4-(Ben zylmethylamino)phenyl)azo)-1,2-(or1,4)-dimet
hyl-1H-
1,2,4-triazolium an d 
its salts, when  
used as a sub stance 
in 
hair dye 
products89959-98-8/ 
12221-69-1289-660-0
1260 2,2’-((3-Chloro-4-((2,6-dichloro-4-
nitrophenyl)azo)phenyl)imino)bisethanol 
(Disperse Brown  
1) and 
its 
salts, when  
used as a sub stance 
in 
hair dye products23355-64-8 245-604-7
1261 Benzothiazolium, 
2-[[4-[ethyl(2-hydroxyethyl)amin o]phenyl]az
o]-6-
methoxy-3-methyl-, an d 
its salts, when  
used as a sub stance 
in 
hair dye 
products12270-13-2 235-546-0
1262 2-[(4-Chloro-2-n itrophenyl)azo]-N-(2-methoxyphenyl)-3-
oxobutanamide 
(Pigment 
Yellow 73) an d 
its salts, when  
used as a sub ­
stance 
in 
hair dye products13515-40-7 236-852-7N E 9 0 0 2 . 2 1 . 2 2
d c b ar e b m u n C E r e b m u n S A C N N I / e m a n l a c i m e h Cn o i t a c i f i t n e d i e c n a t s b u S
r e b m u ne c n e r e f e ROfficial Journ alof the EuropeanUnion 22.12.2009
1263 2,2’-[(3,3’-Dichloro[1,1’-b iphenyl]-4,4’-diyl)bis(azo)]bis[ 3-oxo-
N-phenylbutanamide] 
(Pigment 
Yellow 12) an d 
its salts, when  
used as 
a substance 
in 
hair dye products6358-85-6 228-787-8
1264 2,2’-(1,2-E thenediyl)bis[5-((4-ethoxyphenyl)azo]benzenesulf
onic 
acid) 
and 
its salts, when  
used as a sub stance 
in 
hair dye products2870-32-8 220-698-2
1265 2,3-Dihydro-2,2-dimethyl-6-[(4-(phen ylazo)-1-naphthalenyl)a
zo]-
1H-pyrimidin e 
(Solvent 
Black 
3) and 
its salts, when  
used as a 
substance 
in 
hair dye products4197-25-5 224-087-1
1266 3(or5)-[[4-[(7-amin o-1-hydroxy-3-sulphonato-2-naphthyl)azo]
-
1-naphthyl]azo]salicylic 
acid and 
its salts, when  
used as a sub stance 
in 
hair 
dye products3442-21-5/ 
34977-63-4222-351-0/ 252-305-5
1267 2-Naphthalen
esulfonic 
acid, 
7-(benzoylamino)-4-hydroxy-3-[[4-[(4-sulfophenyl)azo]phenyl]azo
]-, 
and 
its salts, when  
used as a sub stance 
in 
hair dye products2610-11-9 220-028-9
1268 (μ-((7,7’-Iminobis(4-hydroxy-3-((2-hydroxy-5-(N-methylsulph
amoyl) 
phenyl)azo)naphthalene-2-sulphonato))(6-)))dicuprate(2-) 
and 
its salts, 
when 
used as a sub stance 
in 
hair dye products37279-54-2 253-441-8
1269 3-[(4-(Acetylamin o)phenyl)azo]-4-hydroxy-7-[[[[5-hydroxy-
6-(phenylazo)-7-sulfo-2-naphthalenyl]amino]carbonyl]amino]-
2-naphthalenesulfonic 
acid and 
its salts, when  
used as a sub stance 
in 
hair 
dye products3441-14-3 222-348-4
1270 2-Naphthalen esulfonic 
acid, 
7,7’-(carbonyldiimino)bis(4-hydroxy-3-[[2-sulfo-4-[(4-sulfophen
yl) 
azo]phenyl]azo]-, 
and 
its salts, when  
used as a sub stance 
in 
hair dye 
products2610-10-8/ 
25188-41-4220-027-3
1271 Ethanaminium, 
N-(4-[bis[4-(diethylamino)phenyl]methylene]-2,
5-
cyclohexadien -1-ylidene)-N-ethyl-, 
and 
its salts, when  
used as a 
substance 
in 
hair dye products2390-59-2 219-231-5
1272 3H-Indolium, 
2-[[(4-methoxyphen yl)methylhydrazono]methyl]-1,
3,3-
trimethyl-, an d 
its salts, when  
used as a sub stance 
in 
hair dye products54060-92-3 258-946-7
1273 3H-Indolium, 
2-(2-((2,4-dimethoxyphen yl)amino)ethenyl)-1,3,3-trimethyl-, 
and 
its 
salts, when  
used as a sub stance 
in 
hair dye products4208-80-4 224-132-5
1274 Nigrosine 
spirit solub le 
(Solvent 
Black 
5), when 
used as a sub stance 
in 
hair 
dye products11099-03-9
1275 Phenoxazin-5-ium, 
3,7-bis(diethylamino)-, 
and 
its salts, when  
used  a s  a  
substance 
in 
hair dye products47367-75-9/ 
33203-82-6251-403-5
1276 Benzo[a]phenoxazin-7-ium, 
9-(dimethylamin o)-, 
and 
its salts, when  
used 
as a substance 
in 
hair dye products7057-57-0/ 966-62-1230-338-6/ 213-524-1
1277 6-Amin
o-2-(2,4-dimethylphenyl)-1H-benz[de]isoquinoline-1,3(
2H)-
dione 
(Solvent 
Yellow 44) an d 
its salts, when  
used as a sub stance 
in 
hair 
dye products2478-20-8 219-607-9
1278 1-Amino-4-[[4-[(dimethylamino)methyl]phenyl]amino]anthraqui
none 
and 
its salts, when  
used as a sub stance 
in 
hair dye products67905-56-0/ 12217-43-5267-677-4/ 235-398-7
1279 Laccaic Acid (CI
 
Natural Red 25) an d 
its salts, when  
used as a 
substance 
in 
hair dye products60687-93-6
1280 Benzenesulfonic 
acid, 5-[(2,4-din itrophenyl)amino]-2-(phenyla
mino)-, 
and 
its salts, when  
used as a sub stance 
in 
hair dye products6373-74-6/ 15347-52-1228-921-5/ 239-377-3
1281 4-[(4-Nitrophen
yl)azo]aniline 
(Disperse Oran ge 
3) and 
its salts, when  
used 
as a substance 
in 
hair dye products730-40-5/ 70170-61-5211-984-8
1282 4-Nitro-m-phen
ylenediamine 
and 
its salts, when  
used as a sub stance 
in 
hair 
dye products5131-58-8 225-876-3N E 4 2 1 / 2 4 3 L
d c b ar e b m u n C E r e b m u n S A C N N I / e m a n l a c i m e h Cn o i t a c i f i t n e d i e c n a t s b u S
r e b m u ne c n e r e f e ROfficial Journ alof the EuropeanUnion L 342/125
1283 1-Amino-4-(methylamino)-9,10-anthracenedione (Disperse Violet 4) 
and 
its salts, when  
used as a sub stance 
in 
hair dye products1220-94-6 214-944-8
1284 N-Methyl-3-n itro-p-phenylenediamine 
and 
its salts, when  
used as a 
substance 
in 
hair dye products2973-21-9 221-014-5
1285 N1-(2-Hydroxyethyl)-4-n itro-o-phenylenediamine 
(HC Yellow No. 5) 
and 
its salts, when  
used as a sub stance 
in 
hair dye products56932-44-6 260-450-0
1286 N1-(Tris(hydroxymethyl))methyl-4-n itro-1,2-phenylenediamine 
(HC 
Yellow No. 3) an d 
its salts, when  
used as a sub stance 
in 
hair dye 
products56932-45-7 260-451-6
1287 2-Nitro-N-hydroxyethyl-p-an isidine 
and 
its salts, when  
used as a 
substance 
in 
hair dye products57524-53-5
1288 N,N’-Dimethyl-N-Hydroxyethyl-3-n itro-p-phenylenediamine 
and 
its 
salts, when  
used as a sub stance 
in 
hair dye products10228-03-2 233-549-1
1289 3-(N-Methyl-N-(4-methylamin o-3-nitrophenyl)amino)propane-1,
2-diol 
and 
its salts, when  
used as a sub stance 
in 
hair dye products93633-79-5 403-440-5
1290 4-Ethylamino-3-nitrobenzoic 
acid (N-Ethyl-3-Nitro 
PABA) an d 
its salts, 
when 
used as a sub stance 
in 
hair dye products2788-74-1 412-090-2
1291 (8-[(4-Amin o-2-nitrophenyl)azo]-7-hydroxy-2-naphthyl) 
trimethylammon ium 
and 
its salts, except Basic Red 118 (CAS 
71134-97-9) as impurity in  
Basic Brown  
17, when 
used as a 
substance 
in 
hair dye products71134-97-9 275-216-3
1292 5-((4-(Dimethylamin o)phenyl)azo)-1,4-dimethyl-1H-1,2,4-tria
zolium 
and 
its salts, when  
used as a sub stance 
in 
hair dye products12221-52-2
1293 m-Phenylenediamine, 
4-(phenylazo)-, 
and 
its salts, when  
used as a 
substance 
in 
hair dye products495-54-5 207-803-7
1294 1,3-Benzenediamine, 
4-methyl-6-(phen ylazo)- 
and 
its salts, when  
used 
as a substance 
in 
hair dye products4438-16-8 224-654-3
1295 2,7-Naphthalen edisulfonic 
acid, 
5-(acetylamin o)-4-hydroxy-3-((2-methylphenyl)azo)-, 
and 
its salts, 
when 
used as a sub stance 
in 
hair dye products6441-93-6 229-231-7
1296 4,4’-[(4-Methyl-1,3-phen ylene)bis(azo)]bis[6-methyl-1, 
3-benzenediamine] 
(Basic Brown  
4) and 
its salts, when  
used as a 
substance 
in 
hair dye products4482-25-1 224-764-1
1297 Benzenaminium, 
3-[[4-[[diamin o(phenylazo)phenyl]azo]-2-methylphenyl]azo]-
N,N,N-trimethyl-, 
and 
its salts, when  
used as a sub stance 
in 
hair dye 
products83803-99-0 280-920-9
1298 Benzenaminium, 
3-[[4-[[diamin o(phenylazo)phenyl]azo]-1-naphthalenyl]azo]-
N,N,N-trimethyl-, 
and 
its salts, when  
used as a sub stance 
in 
hair dye 
products83803-98-9 280-919-3
1299 Ethanaminium, 
N-[4-[(4-(diethylamin o)phenyl)phenylmethylene]-2,5-cyclohexadie
n-
1-ylidene]-N-ethyl- 
and 
its salts, when  
used as a sub stance 
in 
hair dye 
products633-03-4 211-190-1
1300 9,10-Anthracenedione, 
1-[(2-hydroxyethyl)amin o]-4-(methylami
no)-, 
and 
its derivatives an d 
salts, when  
used as a sub stance 
in 
hair dye 
products2475-46-9/ 
86722-66-9219-604-2/ 289-276-3
1301 1,4-Diamin
o-2-methoxy-9,10-anthracenedione 
(Disperse Red 11) and 
its salts, when  
used as a sub stance 
in 
hair dye products2872-48-2 220-703-8
1302 1,4-Dihydroxy-5,8-b is[(2-hydroxyethyl)amino]anthraquinone 
(Disperse 
Blue 7) an d 
its salts, when  
used as a sub stance 
in 
hair dye products3179-90-6 221-666-0N E 9 0 0 2 . 2 1 . 2 2
d c b ar e b m u n C E r e b m u n S A C N N I / e m a n l a c i m e h Cn o i t a c i f i t n e d i e c n a t s b u S
r e b m u ne c n e r e f e ROfficial Journ alof the EuropeanUnion 22.12.2009
1303 1-[(3-Amin opropyl)amino]-4-(methylamino)anthraquinone and its 
salts, when  
used as a sub stance 
in 
hair dye products22366-99-0 244-938-0
1304 N-[6-[(2-Chloro-4-hydroxyphen yl)imino]-4-methoxy-3-oxo-
1,4-cyclohexadien -1-yl]acetamide 
(HC Yellow No. 8) an d 
its salts, 
when 
used as a sub stance 
in 
hair dye products66612-11-1 266-424-5
1305 [6-[[3-Chloro-4-(methylamin o)phenyl]imino]-4-methyl-3-
oxocyclohexa-1,4-dien -1-yl]urea 
(HC Red No. 9) an d 
its salts, when  
used 
as a substance 
in 
hair dye products56330-88-2 260-116-4
1306 Phenothiazin-5-ium, 
3,7-bis(dimethylamino)-, 
and 
its salts, when  
used 
as a substance 
in 
hair dye products61-73-4 200-515-2
1307 4,6-Bis(2-Hydroxyethoxy)-m-Phen ylenediamine 
and 
its salts, when  
used 
as a substance 
in 
hair dye products94082-85-6
1308 5-Amino-2,6-Dimethoxy-3-Hydroxypyridine 
and 
its salts, when  
used 
as a substance 
in 
hair dye products104333-03-1
1309 4,4’-Diamin odiphenylamine 
and 
its salts, when  
used as a sub stance 
in 
hair 
dye products537-65-5 208-673-4
1310 4-Diethylamin o-o-toluidine 
and 
its salts, when  
used as a sub stance 
in 
hair 
dye products148-71-0/ 
24828-38-4/ 2051-79-8205-722-1/ 246-484-9/ 218-130-3
1311 N,N-Diethyl-p-phen
ylenediamine 
and 
its salts, when  
used as a 
substance 
in 
hair dye products93-05-0/ 
6065-27-6/ 
6283-63-2202-214-1/ 
227-995-6/ 
228-500-6
1312 N,N-Dimethyl-p-phen ylenediamine 
and 
its salts, when  
used as a 
substance 
in 
hair dye products99-98-9/ 6219-73-4202-807-5/ 228-292-7
1313 Toluen
e-3,4-Diamine 
and 
its salts, when  
used as a sub stance 
in 
hair 
dye products496-72-0 207-826-2
1314 2,4-Diamin o-5-methylphenoxyethanol 
and 
its salts, when  
used as a 
substance 
in 
hair dye products141614-05-3/ 113715-27-8
1315 6-Amin
o-o-cresol 
and 
its salts, when  
used as a sub stance 
in 
hair dye 
products17672-22-9
1316 Hydroxyethylamin omethyl-p-aminophenol 
and 
its salts, when  
used as 
a substance 
in 
hair dye products110952-46-0/ 135043-63-9
1317 2-Amin
o-3-nitrophenol 
and 
its salts, when  
used as a sub stance 
in 
hair 
dye products603-85-0 210-060-1
1318 2-Chloro-5-n itro-N-hydroxyethyl-p-phenylenediamine 
and 
its salts, 
when 
used as a sub stance 
in 
hair dye products50610-28-1 256-652-3
1319 2-Nitro-p-phen ylenediamine 
and 
its salts, when  
used as a sub stance 
in 
hair 
dye products5307-14-2/ 18266-52-9226-164-5/ 242-144-9
1320 Hydroxyethyl-2,6-din
itro-p-anisidine 
and 
its salts, when  
used as a 
substance 
in 
hair dye products122252-11-3
1321 6-Nitro-2,5-pyridin ediamine 
and 
its salts, when  
used as a sub stance 
in 
hair 
dye products69825-83-8
1322 Phenazinium, 
3,7-diamin o-2,8-dimethyl-5-phenyl-, 
and 
its salts, when  
used 
as a substance 
in 
hair dye products477-73-6 207-518-8
1323 3-Hydroxy-4-[(2-hydroxyn aphthyl)azo]-7-nitronaphthalene-1-s
ulphonic 
acid 
and 
its salts, when  
used as a sub stance 
in 
hair dye products16279-54-2/ 5610-64-0240-379-1/ 227-029-3N E 6 2 1 / 2 4 3 L
d c b ar e b m u n C E r e b m u n S A C N N I / e m a n l a c i m e h Cn o i t a c i f i t n e d i e c n a t s b u S
r e b m u ne c n e r e f e ROfficial Journ alof the EuropeanUnion L 342/127
1324 3-[(2-nitro-4-(trifluoromethyl)phenyl)amino]propane-1,2-dio l (HC 
Yellow No. 6) an d 
its salts, when  
used as a sub stance 
in 
hair dye 
products104333-00-8
1325 2-[(4-chloro-2-n itrophenyl)amino]ethanol 
(HC Yellow No. 12) an d 
its 
salts, when  
used as a sub stance 
in 
hair dye products59320-13-7
1326 3-[[4-[(2-Hydroxyethyl)Methylamin o]-2-Nitrophenyl]Amino]-1, 
2-Propanediol 
and 
its salts, when  
used as a sub stance 
in 
hair dye 
products173994-75-7/ 
102767-27-1
1327 3-[[4-[Ethyl(2-Hydroxyethyl)Amino]-2-Nitrophenyl]Amino]-1, 
2-Propanediol 
and 
its salts, when  
used as a sub stance 
in 
hair dye 
products114087-41-1/ 114087-42-2
1328 E
thanaminium, 
N-[4-[[4-(diethylamin o)phenyl][4-(ethylamino)-1-naphthalenyl] 
methylene]-2,5-cyclohexadien-1-ylidene]-N-ethyl-, 
and 
its salts, when  
used 
as a substance 
in 
hair dye products2390-60-5 219-232-0
(1)OJ L 159, 29.6.1996, p. 1 
(2)Modified I NNM-name.  
(3)OJ L 273, 10.10.2002, p. 1. 
(4)for the individual ingredient see referen ce number 364 in Annex II.  
(5)for the individual ingredient see referen ce number 413 in Annex II.N E 9 0 0 2 . 2 1 . 2 2
d c b ar e b m u n C E r e b m u n S A C N N I / e m a n l a c i m e h Cn o i t a c i f i t n e d i e c n a t s b u S
r e b m u ne c n e r e f e RANNEX III
LIST OF SUBSTANCES WHICH COSMETIC PRODUCTS MUST NOT CONTAIN EXCEPT SUBJEC T TO THE RESTRICTIONS LAID DOWN  
s d 
s 
t r 
s o 
e 
b o r i c 
a 
( c
) ( ( c ) ( Not 
to be used in 
products for chil­
dren under 3 years of age 
s 
t r 
s o 
e 
b o r i( Not to be 9 0 0 2 . 2 1 . 2 2 n o i n U n a e p o r u E e h t f o l a n r u o J l a i c i f f O N E 8 2 1 / 2 4 3 L
l l e w e s n i R ) b ( ) d i c a c i r o b s a ( % 8 ) b ( s t c u d o r p r i a H ) b (e g a f o s r a e y3 r e d n u n e r d l i h cr o f d e s u e b o t t o N ) a (
e g a f os r a e y 3 r e d n u n e r d- l i h c r o f s t c u d o r pn i d e s u e b o t t o N ) a ( ) d i c a c i r o b s a ( % 8 1 ) a ( s t c u d o r p h t a B ) a (
) a 1o s l a e e s , s e t a r o b a r t e T b 1n i k sd e t a t i r r o g n i l e e pn o d e s u e b o t t o Ne g a f s r a e y3 r e d n u n e r d l i h cr o f d e s u e b o t t o N ) c (
) d i c a c i r o bs a ( % 5 , 1 s d e e c x es e t a r o b e l b u l o se e r f f o n o i t a r t- n e c n o c e h t f i n i k sd e t a t i r r i r o g n i l e e pn d e s u e o t t o Ng a f or a e y 3 r e d n u n e r d- l i h c o f s c u d o r pn i d e u e b o t t o N ) c ( ) d i c a c i r o b s a ( % 3 ) c (
) s t c u d o r p g n i v a wr i a h d n a s t c u d o r ph t a b g n i d u l c x e (s t c u d o r p r e h t O ) c (e g a f o s r a e y3 r e d n u n e r d l i h cr o f d e s u e b o t t o Nd e w o l l a w s ) b b
) d i c ai r o b s a % 1 , 0 b s t u d o r p l a r O ) bn i k sd e t a t i r r o g n i l e e pn o d e s u e b o t t o Ne g a f s r a e y3 r e d n u n e r d l i h cr o f d e s u e b o t t o N ) a (
) d i c a c i r o bs a ( % 5 , 1 s d e e c x es e t a r o b e l b u l o se e r f f o n o i t r t- n e c n o c e h t f i n i k sd e t a t i r r i r o g n i l e e pn d e s u e o t t o Ng a f or a e y 3 r e d n u n e r d- l i h c o f s c u d o r pn i d e u e b o t t o N ) a ( ) d i c a c i r o b s a ( % 5 ) a ( c l a T ) a (
4 - 3 4 3 - 4 3 2/ 2 - 9 3 1 - 3 3 2
1 - 0 5 - 3 1 1 1 1/ 3 - 5 3 - 3 4 0 0 1 d i c a c i r o B
I I x e n n An i 4 8 1 1 o N e c n a t s b u sf o n o i t p e c x e e h th t i w s e t a r o b a r t e t d n as e t a r o b , d i c a c i r o B a 1i h g f e d c b ar e h t On o i t a r a p e r p e s u r o f y d a e rn i n o i t a r t n e c n o c m u m i x a Ms t r a p y d o b , e p y t t c u d o r P r e b m u n C E r e b m u n S A Cy r a s s o l G t n e i d e r g n In o m m o C f o e m a NN N I / e m a n l a c i m e h Cs g n i n r a w d n a e s uf o s n o i t i d n o f o g n i r o Ws n o i t c i r t s e R n o i t a c i f i t n e d i e c n a t s b u S
r e b m u ne c n e r e f e ROfficial Journ alof the EuropeanUnion L 342/1292a Thioglycolic acid and 
its saltsThioglycolic acid 68-11-1 200-677-4 (a) Hair products 8 % General use
ready for use pH 7 
to 9,5Conditions of use:
(a) (b) (c)Avoid contact with eyesIn the event of contact 
with eyes, rinse immedi­
ately with plenty of water and seek medical advice
(a) (c)Wear suitable glovesWarnings:(a) (b) (c)Contains thioglycolateFollow the instructionsKeep out of reach of 
children
(a) For professional use 
only11 % Professional use
ready for use pH 7 
to 9,5
(b) Depilatories 5 % ready for use pH 7 to 12,7
(c) Hair rinse-off prod­ucts2  %
The abovementioned 
percentages are calcu­lated as thioglycolic acidready for use pH 7 to 9,5N E 9 0 0 2 . 2 1 . 2 2
i h g f e d c b ar e h t On o i t a r a p e r p e s u r o f y d a e rn i n o i t a r t n e c n o c m u m i x a Ms t r a p y d o b , e p y t t c u d o r P r e b m u n C E r e b m u n S A Cy r a s s o l G s t n e i d e r g n In o m m o C f o e m a NN N I / e m a n l a c i m e h Cs g n i n r a w d n a e s uf o s n o i t i d n o c f o g n i d r o Ws n o i t c i r t s e R n o i t a c i f i t n e d i e c n a t s b u S
r e b m u ne c n e r e f e ROfficial Journ alof the EuropeanUnion 22.12.20092b Thioglycolic acid 
estersHair waving or 
straightening products(a) 8 % General use
ready for use pH 6 
to 9,5Conditions of use:
(a) (b)May cause sensitization 
in the event of skin con­tact
Avoid contact with eyesIn the event of contact 
with eyes, rinse immedi­
ately with plenty of water and seek medical advice
Wear suitable glovesWarnings:Contains thioglycolateFollow the instructionsKeep out of reach of 
children
(b) 11 %
The abovemen­
tioned percentages are calculated as thioglycolic acidProfessional use
ready for use pH 6 
to 9,5(b) For professional use only
3 Oxalic acid, its esters 
and alkaline saltsOxalic acid 144-62-7 205-634-3 Hair products 5 % Professional use For professional use only
4 Ammonia Ammonia 7664-41-7/ 1336-21-6231-635-3/ 215-647-66 % (as NH
3) Above 2 %: Contains ammoniaN E 0 3 1 / 2 4 3 L
i h g f e d c b ar e h t On o i t a r a p e r p e s u r o f y d a e rn i n o i t a r t n e c n o c m u m i x a Ms t r a p y d o b , e p y t t c u d o r P r e b m u n C E r e b m u n S A Cy r a s s o l G s t n e i d e r g n In o m m o C f o e m a NN N I / e m a n l a c i m e h Cs g n i n r a w d n a e s uf o s n o i t i d n o c f o g n i d r o Ws n o i t c i r t s e R n o i t a c i f i t n e d i e c n a t s b u S
r e b m u ne c n e r e f e ROfficial Journ alof the EuropeanUnion L 342/1315 Tosylchloramide 
sodium (INN)Chloramine-T 127-65-1 204-854-7 0,2 %
6 Chlorates of alkali 
metalsSodium chlorate 7775-09-9 231-887-4 (a) Toothpaste
(b) Other products(a) 5 %
(b) 3 %
Potassium chlorate 3811-04-9 223-289-7
7 Dichloromethane Dichloromethane 75-09-2 200-838-9 35 % (when mixed with 
1,1,1-trichloro-ethane, 
total concentration must not exceed 35 %)0,2 % as maximum impurity content
8 p-Phenylenediamine, 
its N-substituted derivatives and its salts; N-substituted derivatives of o-Phenylene-diamine (
1), with the 
exception of those derivatives listed else­where in this Annex and under reference numbers 1309, 1311, and 1312 in Annex IIp-Phenylenediamine 106-50-3 203-404-7 Oxidising colouring 
agents for hair dyeing6 % (as free base) (a) General use
Not to be used on eyebrows(a) Can cause an allergic reaction
Contains phenylene­
diamines
Do not use to dye 
eyelashes or eye­brows
(b) Professional use (b) For professional use only
Contains phenylene­
diamines
Can cause an aller­
gic reaction
Wear suitable glovesN E 9 0 0 2 . 2 1 . 2 2
i h g f e d c b ar e h t On o i t a r a p e r p e s u r o f y d a e rn i n o i t a r t n e c n o c m u m i x a Ms t r a p y d o b , e p y t t c u d o r P r e b m u n C E r e b m u n S A Cy r a s s o l G s t n e i d e r g n In o m m o C f o e m a NN N I / e m a n l a c i m e h Cs g n i n r a w d n a e s uf o s n o i t i d n o c f o g n i d r o Ws n o i t c i r t s e R n o i t a c i f i t n e d i e c n a t s b u S
r e b m u ne c n e r e f e ROfficial Journ alof the EuropeanUnion 22.12.20099 Methylphenylene-
diamines, their 
N-substituted derivatives (
1) and 
their salts with the exception of substances under reference numbers 364, 413, 1144, 1310 
and 1313 in Annex IIToluene-2,5-diamine 95-70-5 202-442-1 Oxidising colouring 
agents for hair dyeing10 % (as free base) (a) General use
Not to be used on 
eyebrows(a) Can cause an allergic reaction
Contains phenylene-
diamines
Do not use to dye 
eyelashes or eye­brows
(b) Professional use (b) For professional use only
Contains phenylene-
diamines
Can cause an aller­
gic reaction
Wear suitable gloves
10 Diaminophenols  (
1) Oxidising colouring 
agents for hair dyeing10 % (as free base) (a) General use
Not to be used on eyebrows(a) Can cause an allergic reaction
Do not use to dye 
eyelashes or eye­brows
(b) Professional use (b) For professional use 
only
Can cause an aller­
gic reaction
Wear suitable gloves
11 Dichlorophen Dichlorophen 97-23-4 202-567-1 0,5 % Contains DichlorophenN E 2 3 1 / 2 4 3 L
i h g f e d c b ar e h t On o i t a r a p e r p e s u r o f y d a e rn i n o i t a r t n e c n o c m u m i x a Ms t r a p y d o b , e p y t t c u d o r P r e b m u n C E r e b m u n S A Cy r a s s o l G s t n e i d e r g n In o m m o C f o e m a NN N I / e m a n l a c i m e h Cs g n i n r a w d n a e s uf o s n o i t i d n o c f o g n i d r o Ws n o i t c i r t s e R n o i t a c i f i t n e d i e c n a t s b u S
r e b m u ne c n e r e f e ROfficial Journ alof the EuropeanUnion L 342/13312 Hydrogen peroxide, 
and other compounds 
or mixtures that release hydrogen peroxide, including carbamide peroxide and zinc peroxideHydrogen peroxide 7722-84-1 231-765-0 (a) Hair- products 12 % H
2O2 (40 vol­
umes), present or released(a) Wear suitable gloves
(a) (b) (c): 
Contains hydrogen per­
oxide
Avoid contact with eyesRinse eyes immediately if 
product comes into con­tact with them(b) Skin- products 4 % H
2O2, present or 
released
(c) Nail hardening products2 % of H
2O2, present or 
released
(d) Oral products 0,1 % of H2O2, present 
or released
13 Formaldehyde (2)Formaldehyde 50-00-0 200-001-8 Nail hardening products 5 % (as formaldehyde) For purposes other than 
inhibiting the develop­ment of micro-organisms in the product. This purpose has to be apparent from the presentation of the productProtect cuticles with grease or oil
Contains formalde­
hyde (
3)
14 Hydroquinone  (4)Hydroquinone 123-31-9 204-617-8 (a) Oxidising colouring 
agent for hair dye­ing0,3 % General use
Not to be used on eye­
browsDo not use to dye eye­lashes or eyebrows
Rinse eyes immediately if 
the product comes into contact with them
Contains Hydroquinone
Professional use For professional use onlyContains hydroquinoneRinse eyes immediately if 
product comes into con­tact with themN E 9 0 0 2 . 2 1 . 2 2
i h g f e d c b ar e h t On o i t a r a p e r p e s u r o f y d a e rn i n o i t a r t n e c n o c m u m i x a Ms t r a p y d o b , e p y t t c u d o r P r e b m u n C E r e b m u n S A Cy r a s s o l G s t n e i d e r g n In o m m o C f o e m a NN N I / e m a n l a c i m e h Cs g n i n r a w d n a e s uf o s n o i t i d n o c f o g n i d r o Ws n o i t c i r t s e R n o i t a c i f i t n e d i e c n a t s b u S
r e b m u ne c n e r e f e ROfficial Journ alof the EuropeanUnion 22.12.2009(b) Artificial nail sys­
tems0,02 % (after mixing for use)Professional use (b) For professional use only
Avoid skin contactRead directions for 
use carefully
15a Potassium or sodium 
hydroxidePotassium 
hydroxide/sodium 
hydroxide1310-58-3/ 
1310-73-2215-181-3/ 215-185-5(a) Nail cuticle solvent (a) 5 % (
5) (a) Contains alkali
Avoid contact with 
eyes
Can cause blindnessKeep out of reach of 
children
(b) Hair straightener 2 % (
5) General use Contains alkali
Avoid contact with eyesCan cause blindnessKeep out of reach of 
children
4 , 5  % (
5) Professional use For professional use only
Avoid contact with eyesCan cause blindness
(c) pH adjuster for 
depilatories(c) pH < 12,7 (c) Keep out of reach of children
Avoid contact with 
eyes
(d) Other uses as pH adjuster(d) pH < 11N E 4 3 1 / 2 4 3 L
i h g f e d c b ar e h t On o i t a r a p e r p e s u r o f y d a e rn i n o i t a r t n e c n o c m u m i x a Ms t r a p y d o b , e p y t t c u d o r P r e b m u n C E r e b m u n S A Cy r a s s o l G s t n e i d e r g n In o m m o C f o e m a NN N I / e m a n l a c i m e h Cs g n i n r a w d n a e s uf o s n o i t i d n o c f o g n i d r o Ws n o i t c i r t s e R n o i t a c i f i t n e d i e c n a t s b u S
r e b m u ne c n e r e f e ROfficial Journ alof the EuropeanUnion L 342/13515b Lithium hydroxide Lithium hydroxide 1310-65-2 215-183-4 (a) Hair straighteners 2 % (6) General use (a) Contains alkali
Avoid contact with 
eyes
Can cause blindness
Keep out of reach of 
children
4 , 5  % (6) Professional use Avoid contact with eyes
Can cause blindness
(b) pH adjuster for 
depilatoriespH < 12,7 (b) Contains alkali
Keep out of reach of 
children
Avoid contact with 
eyes
(c) Other uses as pH adjuster (for rinse-off products only)p H  <  1 1N E 9 0 0 2 . 2 1 . 2 2
i h g f e d c b ar e h t On o i t a r a p e r p e s u r o f y d a e rn i n o i t a r t n e c n o c m u m i x a Ms t r a p y d o b , e p y t t c u d o r P r e b m u n C E r e b m u n S A Cy r a s s o l G s t n e i d e r g n In o m m o C f o e m a NN N I / e m a n l a c i m e h Cs g n i n r a w d n a e s uf o s n o i t i d n o c f o g n i d r o Ws n o i t c i r t s e R n o i t a c i f i t n e d i e c n a t s b u S
r e b m u ne c n e r e f e ROfficial Journ alof the EuropeanUnion 22.12.200915c Calcium hydroxide Calcium hydroxide 1305-62-0 215-137-3 (a) Hair straighteners 
containing two 
components: cal­cium hydroxide and a guanidine salt(a) 7 % (as calcium hydroxide)(a) Contains alkali
Avoid contact with 
eyes
Keep out of reach of 
children
Can cause blindness
(b) pH adjuster for 
depilatories(b) pH < 12,7 (b) Contains alkali
Keep out of reach of 
children
Avoid contact with 
eyes
(c) Other uses (e.g. pH adjuster, processing aid)(c) pH < 11
16 1-Naphthol and its 
salts1-Naphtol 90-15-3 201-969-4 Oxidising colouring 
agents for hair dyeing2,0 % In combination with hydrogen peroxide the maximum use concen­tration upon application 
is 1,0 %Can cause an allergic 
reaction
17 Sodium nitrite Sodium nitrite 7632-00-0 231-555-9 Rust inhibitor 0,2 % Not to be used with secondary and/or ter­tiary amines or other substances forming nit­rosamines
18 Nitromethane Nitromethane 75-52-5 200-876-6 Rust inhibitor 0,3 %
19 Moved or deleted
20 Moved or deletedN E 6 3 1 / 2 4 3 L
i h g f e d c b ar e h t On o i t a r a p e r p e s u r o f y d a e rn i n o i t a r t n e c n o c m u m i x a Ms t r a p y d o b , e p y t t c u d o r P r e b m u n C E r e b m u n S A Cy r a s s o l G s t n e i d e r g n In o m m o C f o e m a NN N I / e m a n l a c i m e h Cs g n i n r a w d n a e s uf o s n o i t i d n o c f o g n i d r o Ws n o i t c i r t s e R n o i t a c i f i t n e d i e c n a t s b u S
r e b m u ne c n e r e f e ROfficial Journ alof the EuropeanUnion L 342/13721 Cinchonan-9-ol, 
6’-methoxy-, (8.alpha., 
9R)- and its saltsQuinine 130-95-0 205-003-2 (a) Hair rinse-off prod­ucts(a) 0,5 % (as quinine base)
(b) Hair leave-on prod­ucts(b) 0,2 % (as quinine base)
22 Resorcinol  (
4) Resorcinol 108-46-3 203-585-2 (a) Oxidising colouring 
agent for hair dye­ing5 % General use
Not to be used on eye­
browsContains resorcinol
Rinse hair well after 
application
Do not use to dye eye­
lashes or eyebrows
Rinse eyes immediately if 
product comes into con­
tact with them
Professional use For professional use only
Contains resorcinolRinse eyes immediately if 
product comes into con­tact with them
(b) Hair lotions and shampoos0,5 % Contains resorcinol
23 (a) Alkali sulphides (a) Depilatories (a) 2 % (as sulphur) pH ≤ 12,7 (a) (b) Keep out of reach 
of children
Avoid contact 
with eyes(b) Alkaline earth sulphides(b) Depilatories (b) 6 % (as sulphur)
24 Water-soluble zinc 
salts with the excep­
tion of zinc 4-hydroxy-benzenesulphonate (entry 25) and zinc pyrithione (entry 101 and Annex V, entry 8)Zinc acetate, zinc chloride, zinc glucon­ate, zinc glutamate1 % (as zinc)N E 9 0 0 2 . 2 1 . 2 2
i h g f e d c b ar e h t On o i t a r a p e r p e s u r o f y d a e rn i n o i t a r t n e c n o c m u m i x a Ms t r a p y d o b , e p y t t c u d o r P r e b m u n C E r e b m u n S A Cy r a s s o l G s t n e i d e r g n In o m m o C f o e m a NN N I / e m a n l a c i m e h Cs g n i n r a w d n a e s uf o s n o i t i d n o c f o g n i d r o Ws n o i t c i r t s e R n o i t a c i f i t n e d i e c n a t s b u S
r e b m u ne c n e r e f e ROfficial Journ alof the EuropeanUnion 22.12.200925 Zinc 
4-hydroxybenzene 
sulphonateZinc phenolsulfonate 127-82-2 204-867-8 Deodorants, 
antiperspirants and astringent lotions6 % (as % anhydrous substance)Avoid contact with eyes
26 Ammonium 
monofluorophosphateAmmonium monofluorophosphate20859-38-5/ 66115-19-3Oral products 0,15 % (as F). When mixed with other fluorine compounds permitted under this Annex, total F concentration must not exceed 0,15 %Contains ammonium monofluorophosphate
For any toothpaste con­
taining 0,1 to 0,15 % fluoride unless it is already labelled as contra-indicated for chil­dren (e.g. ‘for adult use 
only’) the following 
labelling is obligatory:
‘Children of 6 years and 
younger: Use a pea sized amount for supervised brushing to minimize swallowing. In case of intake of fluoride from other sources consult a 
dentist or doctor’
27 Disodium fluorophos­
phateSodium monofluoro­
phosphate10163-15-2/ 7631-97-2233-433-0/ 231-552-2Oral products 0,15 % (as F). When mixed with other fluo­rine compounds permit­ted under this Annex, total F concentration must not exceed 0,15 %Contains sodium monof­luorophosphate
For any toothpaste con­
taining 0,1 to 0,15 % fluoride unless it is already labelled as contra-indicated for chil­dren (e.g. ‘for adult use 
only’) the following 
labelling is obligatory:N E 8 3 1 / 2 4 3 L
i h g f e d c b ar e h t On o i t a r a p e r p e s u r o f y d a e rn i n o i t a r t n e c n o c m u m i x a Ms t r a p y d o b , e p y t t c u d o r P r e b m u n C E r e b m u n S A Cy r a s s o l G s t n e i d e r g n In o m m o C f o e m a NN N I / e m a n l a c i m e h Cs g n i n r a w d n a e s uf o s n o i t i d n o c f o g n i d r o Ws n o i t c i r t s e R n o i t a c i f i t n e d i e c n a t s b u S
r e b m u ne c n e r e f e ROfficial Journ alof the EuropeanUnion L 342/139‘Children of 6 years and 
younger: Use a pea sized amount for supervised brushing to minimize swallowing. In case of intake of fluoride from other sources consult a 
dentist or doctor’
28 Dipotassium fluoro­
phosphatePotassium monofluo­
rophosphate14104-28-0 237-957-0 Oral products 0,15 % (as F). When 
mixed with other fluo­rine compounds permit­ted under this Annex, total F concentration must not exceed 0,15 %Contains potassium monofluorophosphate
For any toothpaste con­
taining 0,1 to 0,15 % fluoride unless it is already labelled as contra-indicated for chil­dren (e.g. ‘for adult use 
only’) the following 
labelling is obligatory:
‘Children of 6 years and 
younger: Use a pea sized 
amount for supervised 
brushing to minimize swallowing. In case of intake of fluoride from other sources consult a dentist or doctor’
29 Calcium fluorophos­
phateCalcium monofluoro­phosphate7789-74-4 232-187-1 Oral products 0,15 % (as F). When 
mixed with other fluo­rine compounds permit­ted under this Annex, total F concentration must not exceed 0,15 %Contains calcium monofluorophosphateN E 9 0 0 2 . 2 1 . 2 2
i h g f e d c b ar e h t On o i t a r a p e r p e s u r o f y d a e rn i n o i t a r t n e c n o c m u m i x a Ms t r a p y d o b , e p y t t c u d o r P r e b m u n C E r e b m u n S A Cy r a s s o l G s t n e i d e r g n In o m m o C f o e m a NN N I / e m a n l a c i m e h Cs g n i n r a w d n a e s uf o s n o i t i d n o c f o g n i d r o Ws n o i t c i r t s e R n o i t a c i f i t n e d i e c n a t s b u S
r e b m u ne c n e r e f e ROfficial Journ alof the EuropeanUnion 22.12.2009For any toothpaste con­
taining 0,1 to 0,15 % fluoride unless it is already labelled as contra-indicated for chil­dren (e.g. ‘for adult use 
only’) the following 
labelling is obligatory:
‘Children of 6 years and 
younger: Use a pea sized amount for supervised brushing to minimize swallowing. In case of intake of fluoride from other sources consult a dentist or doctor’
30 Calcium fluoride Calcium fluoride 7789-75-5 232-188-7 Oral products 0,15 % (as F). When 
mixed with other fluo­rine compounds permit­
ted under this Annex, 
total F concentration must not exceed 0,15 %Contains calcium fluo­ride
For any toothpaste con­
taining 0,1 to 0,15 % fluoride unless it is already labelled as contra-indicated for chil­dren (e.g. ‘for adult use 
only’) the following 
labelling is obligatory:
‘Children of 6 years and 
younger: Use a pea sized amount for supervised brushing to minimize swallowing. In case of intake of fluoride from other sources consult a dentist or doctor’N E 0 4 1 / 2 4 3 L
i h g f e d c b ar e h t On o i t a r a p e r p e s u r o f y d a e rn i n o i t a r t n e c n o c m u m i x a Ms t r a p y d o b , e p y t t c u d o r P r e b m u n C E r e b m u n S A Cy r a s s o l G s t n e i d e r g n In o m m o C f o e m a NN N I / e m a n l a c i m e h Cs g n i n r a w d n a e s uf o s n o i t i d n o c f o g n i d r o Ws n o i t c i r t s e R n o i t a c i f i t n e d i e c n a t s b u S
r e b m u ne c n e r e f e ROfficial Journ alof the EuropeanUnion L 342/14131 Sodium fluoride Sodium fluoride 7681-49-4 231-667-8 Oral products 0,15 % (as F). When 
mixed with other 
fluorine compounds permitted under this Annex, total F concentration must not exceed 0,15 %Contains sodium fluoride
For any toothpaste con­
taining 0,1 to 0,15 % fluoride unless it is already labelled as contra-indicated for chil­
dren (e.g. ‘for adult use 
only’) the following 
labelling is obligatory:
‘Children of 6 years and 
younger: Use a pea sized amount for supervised brushing to minimize swallowing. In case of intake of fluoride from other sources consult a dentist or doctor’
32 Potassium fluoride Potassium fluoride 7789-23-3 232-151-5 Oral products 0,15 % (as F). When 
mixed with other fluo­
rine compounds permit­
ted under this Annex, total F concentration must not exceed 0,15 %Contains potassium fluo­ride
For any toothpaste con­
taining 0,1 to 0,15 % fluoride unless it is already labelled as contra-indicated for chil­dren (e.g. ‘for adult use 
only’) the following 
labelling is obligatory:
‘Children of 6 years and 
younger: Use a pea sized amount for supervised brushing to minimize swallowing. In case of intake of fluoride from other sources consult a dentist or doctor’N E 9 0 0 2 . 2 1 . 2 2
i h g f e d c b ar e h t On o i t a r a p e r p e s u r o f y d a e rn i n o i t a r t n e c n o c m u m i x a Ms t r a p y d o b , e p y t t c u d o r P r e b m u n C E r e b m u n S A Cy r a s s o l G s t n e i d e r g n In o m m o C f o e m a NN N I / e m a n l a c i m e h Cs g n i n r a w d n a e s uf o s n o i t i d n o c f o g n i d r o Ws n o i t c i r t s e R n o i t a c i f i t n e d i e c n a t s b u S
r e b m u ne c n e r e f e ROfficial Journ alof the EuropeanUnion 22.12.200933 Ammonium fluoride Ammonium fluoride 12125-01-8 235-185-9 Oral products 0,15 % (as F). When 
mixed with other 
fluorine compounds permitted under this Annex, total F concentration must not exceed 0,15 %Contains ammonium fluoride
For any toothpaste con­
taining 0,1 to 0,15 % fluoride unless it is already labelled as contra-indicated for chil­dren (e.g. ‘for adult use 
only’) the following 
labelling is obligatory:
‘Children of 6 years and 
younger: Use a pea sized amount for supervised brushing to minimize swallowing. In case of intake of fluoride from other sources consult a dentist or doctor’
34 Aluminium fluoride Aluminium fluoride 7784-18-1 232-051-1 Oral products 0,15 % (as F). When 
mixed with other fluo­rine compounds permit­ted under this Annex, total F concentration must not exceed 0,15 %Contains aluminium-fluoride
For any toothpaste con­
taining 0,1 to 0,15 % fluoride unless it is already labelled as contra-indicated for chil­dren (e.g. ‘for adult use 
only’) the following 
labelling is obligatory:
‘Children of 6 years and 
younger: Use a pea sized amount for supervised brushing to minimize swallowing. In case of intake of fluoride from other sources consult a dentist or doctor’N E 2 4 1 / 2 4 3 L
i h g f e d c b ar e h t On o i t a r a p e r p e s u r o f y d a e rn i n o i t a r t n e c n o c m u m i x a Ms t r a p y d o b , e p y t t c u d o r P r e b m u n C E r e b m u n S A Cy r a s s o l G s t n e i d e r g n In o m m o C f o e m a NN N I / e m a n l a c i m e h Cs g n i n r a w d n a e s uf o s n o i t i d n o c f o g n i d r o Ws n o i t c i r t s e R n o i t a c i f i t n e d i e c n a t s b u S
r e b m u ne c n e r e f e ROfficial Journ alof the EuropeanUnion L 342/14335 Tin difluoride Stannous fluoride 7783-47-3 231-999-3 Oral products 0,15 % (as F). When 
mixed with other 
fluorine compounds permitted under this Annex, total F concentration must not exceed 0,15 %Contains stannous fluo­ride
For any toothpaste con­
taining 0,1 to 0,15 % fluoride unless it is already labelled as contra-indicated for chil­dren (e.g. ‘for adult use 
only’) the following 
labelling is obligatory:
‘Children of 6 years and 
younger: Use a pea sized amount for supervised brushing to minimize swallowing. In case of intake of fluoride from other sources consult a dentist or doctor’
36 Hexadecyl ammonium 
fluorideCetylamine hydrofluo­ride3151-59-5 221-588-7 Oral products 0,15 % (as F). When 
mixed with other fluo­rine compounds permit­ted under this Annex, total F concentration must not exceed 0,15 %Contains Cetylamine hydrofluoride
For any toothpaste con­
taining 0,1 to 0,15 % fluoride unless it is already labelled as contra-indicated for chil­dren (e.g. ‘for adult use 
only’) the following 
labelling is obligatory:
‘Children of 6 years and 
younger: Use a pea sized amount for supervised brushing to minimize swallowing. In case of intake of fluoride from other sources consult a 
dentist or doctor’N E 9 0 0 2 . 2 1 . 2 2
i h g f e d c b ar e h t On o i t a r a p e r p e s u r o f y d a e rn i n o i t a r t n e c n o c m u m i x a Ms t r a p y d o b , e p y t t c u d o r P r e b m u n C E r e b m u n S A Cy r a s s o l G s t n e i d e r g n In o m m o C f o e m a NN N I / e m a n l a c i m e h Cs g n i n r a w d n a e s uf o s n o i t i d n o c f o g n i d r o Ws n o i t c i r t s e R n o i t a c i f i t n e d i e c n a t s b u S
r e b m u ne c n e r e f e ROfficial Journ alof the EuropeanUnion 22.12.200937 3-(N-Hexadecyl-
N-2-hydroxy-
ethylammonio) propylbis (2-hydroxyethyl) ammonium difluoride— — Oral products 0,15 % (as F). When mixed with other fluorine compounds permitted under this Annex, total F concentration must not exceed 0,15 %Contains 3-(N-Hexadecyl-N-2-hydroxyethylammonio) propylbis (2-hydroxyethyl) ammo­nium difluoride
For any toothpaste con­
taining 0,1 to 0,15 % 
fluoride unless it is 
already labelled as contra-indicated for chil­dren (e.g. ‘for adult use 
only’) the following 
labelling is obligatory:
‘Children of 6 years and 
younger: Use a pea sized amount for supervised brushing to minimize swallowing. In case of intake of fluoride from other sources consult a dentist or doctor’
38 N,N’,N’-Tris(polyoxyethylene)-N-hexadecyl-
propylenediamine dihydrofluoride— — Oral products 0,15 % (as F). When mixed with other fluo­rine compounds permit­ted under this Annex, total F concentration must not exceed 0,15 %Contains N,N’,N’-
Tris(polyoxyethylene)- N-
hexadecylpropylenediamine dihydrofluoride
For any toothpaste con­
taining 0,1 to 0,15 % fluoride unless it is already labelled as contra-indicated for chil­dren (e.g. ‘for adult use 
only’) the following 
labelling is obligatory:N E 4 4 1 / 2 4 3 L
i h g f e d c b ar e h t On o i t a r a p e r p e s u r o f y d a e rn i n o i t a r t n e c n o c m u m i x a Ms t r a p y d o b , e p y t t c u d o r P r e b m u n C E r e b m u n S A Cy r a s s o l G s t n e i d e r g n In o m m o C f o e m a NN N I / e m a n l a c i m e h Cs g n i n r a w d n a e s uf o s n o i t i d n o c f o g n i d r o Ws n o i t c i r t s e R n o i t a c i f i t n e d i e c n a t s b u S
r e b m u ne c n e r e f e ROfficial Journ alof the EuropeanUnion L 342/145‘Children of 6 years and 
younger: Use a pea sized amount for supervised brushing to minimize swallowing. In case of intake of fluoride from other sources consult a 
dentist or doctor’
39 9-Octadecenamine, 
hydrofluorideOctadecenyl-
ammonium fluoride2782-81-2 — Oral products 0,15 % (as F). When mixed with other fluo­rine compounds permit­ted under this Annex, total F concentration must not exceed 0,15 %Contains octadecenyl-ammonium fluoride
For any toothpaste con­
taining 0,1 to 0,15 % fluoride unless it is already labelled as contra-indicated for chil­dren (e.g. ‘for adult use 
only’) the following 
labelling is obligatory:
‘Children of 6 years and 
younger: Use a pea sized 
amount for supervised brushing to minimize swallowing. In case of intake of fluoride from other sources consult a dentist or doctor’
40 Disodium hexafluoro­
silicateSodium fluorosilicate 16893-85-9 240-934-8 Oral products 0,15 % (as F). When 
mixed with other fluo­rine compounds permit­ted under this Annex, total F concentration must not exceed 0,15 %Contains sodium fluoro­silicateN E 9 0 0 2 . 2 1 . 2 2
i h g f e d c b ar e h t On o i t a r a p e r p e s u r o f y d a e rn i n o i t a r t n e c n o c m u m i x a Ms t r a p y d o b , e p y t t c u d o r P r e b m u n C E r e b m u n S A Cy r a s s o l G s t n e i d e r g n In o m m o C f o e m a NN N I / e m a n l a c i m e h Cs g n i n r a w d n a e s uf o s n o i t i d n o c f o g n i d r o Ws n o i t c i r t s e R n o i t a c i f i t n e d i e c n a t s b u S
r e b m u ne c n e r e f e ROfficial Journ alof the EuropeanUnion 22.12.2009For any toothpaste con­
taining 0,1 to 0,15 % fluoride unless it is already labelled as contra-indicated for chil­dren (e.g. ‘for adult use 
only’) the following 
labelling is obligatory:
‘Children of 6 years and 
younger: Use a pea sized 
amount for supervised brushing to minimize swallowing. In case of intake of fluoride from other sources consult a dentist or doctor’
41 Dipotassium 
hexafluorosilicatePotassium fluorosili­cate16871-90-2 240-896-2 Oral products 0,15 % (as F). When 
mixed with other fluo­rine compounds permit­
ted under this Annex, 
total F concentration must not exceed 0,15 %Contains potassium fluo­rosilicate
For any toothpaste con­
taining 0,1 to 0,15 % fluoride unless it is already labelled as contra-indicated for chil­dren (e.g. ‘for adult use 
only’) the following 
labelling is obligatory:
‘Children of 6 years and 
younger: Use a pea sized amount for supervised brushing to minimize swallowing. In case of intake of fluoride from other sources consult a dentist or doctor’N E 6 4 1 / 2 4 3 L
i h g f e d c b ar e h t On o i t a r a p e r p e s u r o f y d a e rn i n o i t a r t n e c n o c m u m i x a Ms t r a p y d o b , e p y t t c u d o r P r e b m u n C E r e b m u n S A Cy r a s s o l G s t n e i d e r g n In o m m o C f o e m a NN N I / e m a n l a c i m e h Cs g n i n r a w d n a e s uf o s n o i t i d n o c f o g n i d r o Ws n o i t c i r t s e R n o i t a c i f i t n e d i e c n a t s b u S
r e b m u ne c n e r e f e ROfficial Journ alof the EuropeanUnion L 342/14742 Ammonium 
hexafluorosilicateAmmonium 
fluorosilicate16919-19-0 240-968-3 Oral products 0,15 % (as F). When 
mixed with other fluorine compounds permitted under this Annex, total F concentration must not exceed 0,15 %Contains ammonium fluorosilicate
For any toothpaste con­
taining 0,1 to 0,15 % fluoride unless it is already labelled as contra-indicated for chil­dren (e.g. ‘for adult use 
only’) the following 
labelling is obligatory:
‘Children of 6 years and 
younger: Use a pea sized amount for supervised brushing to minimize swallowing. In case of intake of fluoride from other sources consult a dentist or doctor’
43 Magnesium hexafluo­
rosilicateMagnesium fluorosili­cate16949-65-8 241-022-2 Oral products 0,15 % (as F). When 
mixed with other fluo­rine compounds permit­ted under this Annex, total F concentration must not exceed 0,15 %Contains magnesium fluorosilicate
For any toothpaste con­
taining 0,1 to 0,15 % fluoride unless it is already labelled as contra-indicated for chil­dren (e.g. ‘for adult use 
only’) the following 
labelling is obligatory:
‘Children of 6 years and 
younger: Use a pea sized amount for supervised brushing to minimize swallowing. In case of intake of fluoride from other sources consult a 
dentist or doctor’N E 9 0 0 2 . 2 1 . 2 2
i h g f e d c b ar e h t On o i t a r a p e r p e s u r o f y d a e rn i n o i t a r t n e c n o c m u m i x a Ms t r a p y d o b , e p y t t c u d o r P r e b m u n C E r e b m u n S A Cy r a s s o l G s t n e i d e r g n In o m m o C f o e m a NN N I / e m a n l a c i m e h Cs g n i n r a w d n a e s uf o s n o i t i d n o c f o g n i d r o Ws n o i t c i r t s e R n o i t a c i f i t n e d i e c n a t s b u S
r e b m u ne c n e r e f e ROfficial Journ alof the EuropeanUnion 22.12.200944 1,3-Bis 
(hydroxymethyl) 
imidazolidine-2-thioneDimethylol ethylene thiourea15534-95-9 239-579-1 (a) Hair- products (a) 2 % (a) Not to be used in 
aerosol dispensers (sprays)Contains Dimethylol ethylene thiourea
(b) Nail- products (b) 2 % (b) pH < 4
45 Benzyl alcohol (
7)Benzyl alcohol 100-51-6 202-859-9 Solvents, perfumes and 
flavouringsFor purposes other than inhibiting the develop­ment of micro-organisms in the product. This purpose has to be apparent from the presentation of the product
46 6-Methylcoumarin 6-Methylcoumarin 92-48-8 202-158-8 Oral products 0,003 %
47 3-Pyridinemethanol, 
hydrofluorideNicomethanol hydrof­luoride62756-44-9 — Oral products 0,15 % (as F). When mixed with other fluo­rine compounds permit­ted under this Annex, total F concentration must not exceed 0,15 %Contains nicomethanol hydrofluoride
For any toothpaste con­
taining 0,1 to 0,15 % fluoride unless it is already labelled as contra-indicated for chil­dren (e.g. ‘for adult use 
only’) the following 
labelling is obligatory:
‘Children of 6 years and 
younger: Use a pea sized amount for supervised brushing to minimize swallowing. In case of intake of fluoride from 
other sources consult a 
dentist or doctor’
48 Silver nitrate Silver nitrate 7761-88-8 231-853-9 Only for colouring eye­
lashes and eyebrows4 % Contains silver nitrate
Rinse eyes immediately if 
product comes into con­tact with themN E 8 4 1 / 2 4 3 L
i h g f e d c b ar e h t On o i t a r a p e r p e s u r o f y d a e rn i n o i t a r t n e c n o c m u m i x a Ms t r a p y d o b , e p y t t c u d o r P r e b m u n C E r e b m u n S A Cy r a s s o l G s t n e i d e r g n In o m m o C f o e m a NN N I / e m a n l a c i m e h Cs g n i n r a w d n a e s uf o s n o i t i d n o c f o g n i d r o Ws n o i t c i r t s e R n o i t a c i f i t n e d i e c n a t s b u S
r e b m u ne c n e r e f e ROfficial Journ alof the EuropeanUnion L 342/14949 Selenium sulfide Selenium disulphide 7488-56-4 231-303-8 Antidandruff shampoos 1 % Contains selenium disul­
phide
Avoid contact with eyes 
or damaged skin
50 Aluminium zirconium 
chloride hydroxide complexes
Al
xZr(OH)yClz and the 
aluminium zirconium 
chloride hydroxide glycine complexesAnti-perspirants 20 % (as anhydrous 
aluminium zirconium chloride hydroxide)
5,4 % (as zirconium)1. The ratio of the 
number of alu­minium atoms to 
that of zirconium 
atoms must be between 2 and 10
2. The ratio of the number of (Al + Zr) atoms to that of chlorine atoms must be between 0,9 and 2,1
3. Not to be used in aerosol dispensers (sprays)Do not apply to irritated or damaged skin
51 Quinolin-8-ol and bis 
(8-hydroxy-quinolium) sulphateOxyquinoline and oxyquinoline sulfate148-24-3/134-31-6 205-711-1/ 205-137-1Stabilizer for hydrogen peroxide in rinse-off hair- products0,3 % (as base)
Stabilizer for hydrogen peroxide in leave-on hair products0,03 % (as base)
52 Methanol Methyl alcohol 67-56-1 200-659-6 Denaturant for ethanol 
and isopropyl alcohol5 % (as a % ethanol and isopropyl alcohol)N E 9 0 0 2 . 2 1 . 2 2
i h g f e d c b ar e h t On o i t a r a p e r p e s u r o f y d a e rn i n o i t a r t n e c n o c m u m i x a Ms t r a p y d o b , e p y t t c u d o r P r e b m u n C E r e b m u n S A Cy r a s s o l G s t n e i d e r g n In o m m o C f o e m a NN N I / e m a n l a c i m e h Cs g n i n r a w d n a e s uf o s n o i t i d n o c f o g n i d r o Ws n o i t c i r t s e R n o i t a c i f i t n e d i e c n a t s b u S
r e b m u ne c n e r e f e ROfficial Journ alof the EuropeanUnion 22.12.200953 (1-Hydroxyethylidene-
diphosphonic acid) 
and its saltsEtidronic acid 2809-21-4 220-552-8 (a) Hair- product 1,5 % (as etidronic acid)
(b) Soap 0,2 % (as etidronic acid)
54 1-Phenoxypropan-2-
ol (8)Phenoxyisopropanol 770-35-4 212-222-7 Use only in rinse-off 
products
Not to be used in oral 
products2 % For purposes other than inhibiting the develop­ment of micro-organisms in the product. This purpose has to be apparent from the presentation of the product
55 Moved or deleted
56 Magnesium fluoride Magnesium fluoride 7783-40-6 231-995-1 Oral products 0,15 % (as F). When 
mixed with other fluo­rine compounds permit­ted under this Annex, total F concentration must not exceed 0,15 %Contains magnesium fluoride
For any toothpaste con­
taining 0,1 to 0,15 % fluoride unless it is already labelled as contra-indicated for chil­dren (e.g. ‘for adult use 
only’) the following 
labelling is obligatory:
‘Children of 6 years and 
younger: Use a pea sized amount for supervised brushing to minimize swallowing. In case of intake of fluoride from other sources consult a dentist or doctor’N E 0 5 1 / 2 4 3 L
i h g f e d c b ar e h t On o i t a r a p e r p e s u r o f y d a e rn i n o i t a r t n e c n o c m u m i x a Ms t r a p y d o b , e p y t t c u d o r P r e b m u n C E r e b m u n S A Cy r a s s o l G s t n e i d e r g n In o m m o C f o e m a NN N I / e m a n l a c i m e h Cs g n i n r a w d n a e s uf o s n o i t i d n o c f o g n i d r o Ws n o i t c i r t s e R n o i t a c i f i t n e d i e c n a t s b u S
r e b m u ne c n e r e f e ROfficial Journ alof the EuropeanUnion L 342/15157 Strontium chloride 
hexahydrateStrontium chloride 10476-85-4 233-971-6 (a) Oral products 3,5 % (as strontium). 
When mixed with other 
permitted strontium compounds the total strontium content must not exceed 3,5 %Contains strontium chlo­ride
Frequent use by children 
is not advisable
(b) Shampoo and face products2,1 % (as strontium). When mixed with other permitted strontium compounds the total strontium content must not exceed 2,1 %
58 Strontium acetate 
hemihydrateStrontium acetate 543-94-2 208-854-8 Oral products 3,5 % (as strontium). 
When mixed with other 
permitted strontium 
compounds the total strontium content must not exceed 3,5 %Contains strontium acetate
Frequent use by children 
is not advisable
59 Talc: Hydrated mag­
nesium silicateTalc 14807-96-6 238-877-9 (a) Powdery products intended to be used for children under 3 years of age
(b) Other products(a) Keep powder away from children’s nose and mouthN E 9 0 0 2 . 2 1 . 2 2
i h g f e d c b ar e h t On o i t a r a p e r p e s u r o f y d a e rn i n o i t a r t n e c n o c m u m i x a Ms t r a p y d o b , e p y t t c u d o r P r e b m u n C E r e b m u n S A Cy r a s s o l G s t n e i d e r g n In o m m o C f o e m a NN N I / e m a n l a c i m e h Cs g n i n r a w d n a e s uf o s n o i t i d n o c f o g n i d r o Ws n o i t c i r t s e R n o i t a c i f i t n e d i e c n a t s b u S
r e b m u ne c n e r e f e ROfficial Journ alof the EuropeanUnion 22.12.200960 Fatty acid 
dialkylamides and 
dialkanolamidesMaximum secondary amine content: 0,5 %—Not to be used with nitrosating systems 
—Maximum second­ary amine content: 5 % (applies to raw materials) 
—Maximum nitro­samine content: 50 μg/kg 
—Keep in nitrite-free containers
61 Monoalkylamines, 
monoalkanolamines and their saltsMaximum secondary amine content: 0,5 %—Not to be used with nitrosating systems- Minimum 
purity: 99 % 
—Maximum second­
ary amine content: 0,5 % (applies to raw materials) 
—Maximum nitro­samine content: 50 μg/kg 
—Keep in nitrite-free containersN E 2 5 1 / 2 4 3 L
i h g f e d c b ar e h t On o i t a r a p e r p e s u r o f y d a e rn i n o i t a r t n e c n o c m u m i x a Ms t r a p y d o b , e p y t t c u d o r P r e b m u n C E r e b m u n S A Cy r a s s o l G s t n e i d e r g n In o m m o C f o e m a NN N I / e m a n l a c i m e h Cs g n i n r a w d n a e s uf o s n o i t i d n o c f o g n i d r o Ws n o i t c i r t s e R n o i t a c i f i t n e d i e c n a t s b u S
r e b m u ne c n e r e f e ROfficial Journ alof the EuropeanUnion L 342/15362 Trialkylamines, 
trialkanolamines and 
their salts(a) Leave-on products
(b) Rinse-off products(a) 2,5 % (a) (b) —Not to be used with nitrosating systems 
—Minimum purity: 99 % 
—Maximum second­
ary amine content: 
0,5 % (applies to raw materials) 
—Maximum nitro­samine content: 50 μg/kg 
—Keep in nitrite-free containers 
63 Strontium hydroxide Strontium hydroxide 18480-07-4 242-367-1 pH adjuster for depila­
tories3,5 % (as strontium) pH ≤ 12,7 Keep out of reach of 
children
Avoid contact with eyes
64 Strontium peroxide Strontium peroxide 1314-18-7 215-224-6 Rinse-off hair products 4,5 % (as strontium) All products must meet 
the hydrogen peroxide release requirements
Professional useAvoid contact with eyesRinse eyes immediately if 
product comes into con­tact with them
For professional use onlyWear suitable glovesN E 9 0 0 2 . 2 1 . 2 2
i h g f e d c b ar e h t On o i t a r a p e r p e s u r o f y d a e rn i n o i t a r t n e c n o c m u m i x a Ms t r a p y d o b , e p y t t c u d o r P r e b m u n C E r e b m u n S A Cy r a s s o l G s t n e i d e r g n In o m m o C f o e m a NN N I / e m a n l a c i m e h Cs g n i n r a w d n a e s uf o s n o i t i d n o c f o g n i d r o Ws n o i t c i r t s e R n o i t a c i f i t n e d i e c n a t s b u S
r e b m u ne c n e r e f e ROfficial Journ alof the EuropeanUnion 22.12.200965 Benzalkonium 
chloride, bromide and 
saccharinate  (9)Benzalkonium bromide91080-29-4 293-522-5 Rinse-off hair (head) 
products3 % (as benzalkonium chloride)In the final products the concentrations of benzalkonium chloride, bromide and saccharinate with an alkyl chain of C
14,  o r  
less must not exceed 0,1 % (as benzalkonium chloride)Avoid contact with eyes
For purposes other than inhibiting the development of 
micro-organisms in the 
product. This purpose has to be apparent from the presentation of the productBenzalkonium chloride63449-41-2/ 68391-01-5/ 68424-85-1/ 85409-22-9264-151-6/ 269-919-4/ 270-325-2/ 287-089-1
Benzalkonium saccharinate68989-01-5 273-545-7
66 Polyacrylamides (a) Body- leave-on 
products(a) Maximum residual acrylamide content 0,1 mg/kg
(b) Other products (b) Maximum residual acrylamide content 0,5 mg/kg
67 2-Benzylideneheptanal Amyl cinnamal 122-40-7 204-541-5 The presence of the 
substance must be indi­cated in the list of ingre­dients referred to in Article 19(1)(g) when its concentration exceeds:
—0,001 % in 
leave-on products 
—0,01 % in rinse-off productsN E 4 5 1 / 2 4 3 L
i h g f e d c b ar e h t On o i t a r a p e r p e s u r o f y d a e rn i n o i t a r t n e c n o c m u m i x a Ms t r a p y d o b , e p y t t c u d o r P r e b m u n C E r e b m u n S A Cy r a s s o l G s t n e i d e r g n In o m m o C f o e m a NN N I / e m a n l a c i m e h Cs g n i n r a w d n a e s uf o s n o i t i d n o c f o g n i d r o Ws n o i t c i r t s e R n o i t a c i f i t n e d i e c n a t s b u S
r e b m u ne c n e r e f e ROfficial Journ alof the EuropeanUnion L 342/15568 Benzyl alcohol Benzyl alcohol 100-51-6 202-859-9 The presence of the 
substance must be indi­
cated in the list of ingre­dients referred to in Article 19(1)(g) when its concentration exceeds:
—0,001 % in 
leave-on products 
—0,01 % in rinse-off 
products
69 Cinnamyl alcohol Cinnamyl alcohol 104-54-1 203-212-3 The presence of the 
substance must be indi­cated in the list of ingre­dients referred to in Article 19(1)(g) when its concentration exceeds:
—0,001 % in 
leave-on products 
—0,01 % in rinse-off 
products
70 3,7-Dimethyl-2,6-
octadienalCitral 5392-40-5 226-394-6 The presence of the 
substance must be indi­
cated in the list of ingre­dients referred to in Article 19(1)(g) when its concentration exceeds:
—0,001 % in 
leave-on products 
—0,01 % in rinse-off productsN E 9 0 0 2 . 2 1 . 2 2
i h g f e d c b ar e h t On o i t a r a p e r p e s u r o f y d a e rn i n o i t a r t n e c n o c m u m i x a Ms t r a p y d o b , e p y t t c u d o r P r e b m u n C E r e b m u n S A Cy r a s s o l G s t n e i d e r g n In o m m o C f o e m a NN N I / e m a n l a c i m e h Cs g n i n r a w d n a e s uf o s n o i t i d n o c f o g n i d r o Ws n o i t c i r t s e R n o i t a c i f i t n e d i e c n a t s b u S
r e b m u ne c n e r e f e ROfficial Journ alof the EuropeanUnion 22.12.200971 Phenol, 2-methoxy-
4-(2-propenyl)Eugenol 97-53-0 202-589-1 The presence of the 
substance must be indi­
cated in the list of ingre­dients referred to in Article 19(1)(g) when its concentration exceeds:
—0,001 % in 
leave-on products 
—0,01 % in rinse-off 
products
72 7-Hydroxycitronellal Hydroxycitronellal 107-75-5 203-518-7 The presence of the 
substance must be indi­
cated in the list of ingre­dients referred to in Article 19(1)(g) when its concentration exceeds:
—0,001 % in 
leave-on products 
—0,01 % in rinse-off products
73 Phenol, 2-methoxy-4-
(1-propenyl)-Isoeugenol 97-54-1 202-590-7 The presence of the 
substance must be indi­cated in the list of ingre­dients referred to in Article 19(1)(g) when its concentration exceeds:
—0,001 % in 
leave-on products 
—0,01 % in rinse-off productsN E 6 5 1 / 2 4 3 L
i h g f e d c b ar e h t On o i t a r a p e r p e s u r o f y d a e rn i n o i t a r t n e c n o c m u m i x a Ms t r a p y d o b , e p y t t c u d o r P r e b m u n C E r e b m u n S A Cy r a s s o l G s t n e i d e r g n In o m m o C f o e m a NN N I / e m a n l a c i m e h Cs g n i n r a w d n a e s uf o s n o i t i d n o c f o g n i d r o Ws n o i t c i r t s e R n o i t a c i f i t n e d i e c n a t s b u S
r e b m u ne c n e r e f e ROfficial Journ alof the EuropeanUnion L 342/15774 2-Pentyl-
3-phenylprop-
2-en-1-olAmylcinnamyl alcohol101-85-9 202-982-8 The presence of the substance must be indi­cated in the list of ingre­dients referred to in Article 19(1)(g) when its concentration exceeds:
—0,001 % in 
leave-on products 
—0,01 % in rinse-off 
products
75 Benzyl salicylate Benzyl salicylate 118-58-1 204-262-9 The presence of the 
substance must be indi­cated in the list of ingre­dients referred to in Article 19(1)(g) when its concentration exceeds:
—0,001 % in 
leave-on products 
—0,01 % in rinse-off 
products
76 2-Propenal, 3-phenyl- Cinnamal 104-55-2 203-213-9 The presence of the 
substance must be indi­
cated in the list of ingre­dients referred to in Article 19(1)(g) when its concentration exceeds:
—0,001 % in 
leave-on products 
—0,01 % in rinse-off productsN E 9 0 0 2 . 2 1 . 2 2
i h g f e d c b ar e h t On o i t a r a p e r p e s u r o f y d a e rn i n o i t a r t n e c n o c m u m i x a Ms t r a p y d o b , e p y t t c u d o r P r e b m u n C E r e b m u n S A Cy r a s s o l G s t n e i d e r g n In o m m o C f o e m a NN N I / e m a n l a c i m e h Cs g n i n r a w d n a e s uf o s n o i t i d n o c f o g n i d r o Ws n o i t c i r t s e R n o i t a c i f i t n e d i e c n a t s b u S
r e b m u ne c n e r e f e ROfficial Journ alof the EuropeanUnion 22.12.200977 2H-1-Benzopyran-
2-oneCoumarin 91-64-5 202-086-7 The presence of the 
substance must be indi­
cated in the list of ingre­dients referred to in Article 19(1)(g) when its concentration exceeds:
—0,001 % in 
leave-on products 
—0,01 % in rinse-off 
products
78 2,6-Octadien-1-ol, 
3,7-dimethyl-, (2E)-Geraniol 106-24-1 203-377-1 The presence of the 
substance must be indi­
cated in the list of ingre­dients referred to in Article 19(1)(g) when its concentration exceeds:
—0,001 % in 
leave-on products 
—0,01 % in rinse-off products
79 3 and 4-(4-Hydroxy-
4-methylpentyl) cyclohex-3-ene-1-carbaldehydeHydroxyisohexyl 3-cyclohexene carbox­aldehyde51414-25-6/ 31906-04-4257-187-9/ 250-863-4The presence of the substance must be indi­cated in the list of ingre­dients referred to in Article 19(1)(g) when its concentration exceeds:
—0,001 % in 
leave-on products 
—0,01 % in rinse-off productsN E 8 5 1 / 2 4 3 L
i h g f e d c b ar e h t On o i t a r a p e r p e s u r o f y d a e rn i n o i t a r t n e c n o c m u m i x a Ms t r a p y d o b , e p y t t c u d o r P r e b m u n C E r e b m u n S A Cy r a s s o l G s t n e i d e r g n In o m m o C f o e m a NN N I / e m a n l a c i m e h Cs g n i n r a w d n a e s uf o s n o i t i d n o c f o g n i d r o Ws n o i t c i r t s e R n o i t a c i f i t n e d i e c n a t s b u S
r e b m u ne c n e r e f e ROfficial Journ alof the EuropeanUnion L 342/15980 4-Methoxybenzyl 
alcoholAnise alcohol 105-13-5 203-273-6 The presence of the 
substance must be indi­
cated in the list of ingre­dients referred to in Article 19(1)(g) when its concentration exceeds:
—0,001 % in 
leave-on products 
—0,01 % in rinse-off 
products
81 2-Propenoic acid, 
3-phenyl-, phenylm­ethyl esterBenzyl cinnamate 103-41-3 203-109-3 The presence of the 
substance must be indi­cated in the list of ingre­dients referred to in Article 19(1)(g) when its concentration exceeds:
—0,001 % in 
leave-on products 
—0,01 % in rinse-off 
products
82 2,6,10-Dodecatrien-1-
ol, 3,7,11-trimethyl-Farnesol 4602-84-0 225-004-1 The presence of the 
substance must be indi­
cated in the list of ingre­dients referred to in Article 19(1)(g) when its concentration exceeds:
—0,001 % in 
leave-on products 
—0,01 % in rinse-off productsN E 9 0 0 2 . 2 1 . 2 2
i h g f e d c b ar e h t On o i t a r a p e r p e s u r o f y d a e rn i n o i t a r t n e c n o c m u m i x a Ms t r a p y d o b , e p y t t c u d o r P r e b m u n C E r e b m u n S A Cy r a s s o l G s t n e i d e r g n In o m m o C f o e m a NN N I / e m a n l a c i m e h Cs g n i n r a w d n a e s uf o s n o i t i d n o c f o g n i d r o Ws n o i t c i r t s e R n o i t a c i f i t n e d i e c n a t s b u S
r e b m u ne c n e r e f e ROfficial Journ alof the EuropeanUnion 22.12.200983 2-(4-tert-Butylbenzyl) 
propionaldehydeButylphenyl 
methylpropional80-54-6 201-289-8 The presence of the substance must be indi­cated in the list of ingre­dients referred to in Article 19(1)(g) when its concentration exceeds:
—0,001 % in 
leave-on products 
—0,01 % in rinse-off 
products
84 1,6-Octadien-3-ol, 
3,7-dimethyl-Linalool 78-70-6 201-134-4 The presence of the 
substance must be indi­
cated in the list of ingre­dients referred to in Article 19(1)(g) when its concentration exceeds:
—0,001 % in 
leave-on products 
—0,01 % in rinse-off products
85 Benzyl benzoate Benzyl benzoate 120-51-4 204-402-9 The presence of the 
substance must be indi­cated in the list of ingre­dients referred to in Article 19(1)(g) when its concentration exceeds:
—0,001 % in 
leave-on products 
—0,01 % in rinse-off productsN E 0 6 1 / 2 4 3 L
i h g f e d c b ar e h t On o i t a r a p e r p e s u r o f y d a e rn i n o i t a r t n e c n o c m u m i x a Ms t r a p y d o b , e p y t t c u d o r P r e b m u n C E r e b m u n S A Cy r a s s o l G s t n e i d e r g n In o m m o C f o e m a NN N I / e m a n l a c i m e h Cs g n i n r a w d n a e s uf o s n o i t i d n o c f o g n i d r o Ws n o i t c i r t s e R n o i t a c i f i t n e d i e c n a t s b u S
r e b m u ne c n e r e f e ROfficial Journ alof the EuropeanUnion L 342/16186 Citronellol/(±) 
-3,7-dimethyloct-
6-en-1-olCitronellol 106-22-9/ 26489-01-0203-375-0/ 247-737-6The presence of the substance must be indi­cated in the list of ingre­dients referred to in Article 19(1)(g) when its concentration exceeds:
—0,001 % in 
leave-on products 
—0,01 % in rinse-off 
products
87 2-Benzylideneoctanal Hexyl cinnamal 101-86-0 202-983-3 The presence of the 
substance must be indi­cated in the list of ingre­dients referred to in Article 19(1)(g) when its concentration exceeds:
—0,001 % in 
leave-on products 
—0,01 % in rinse-off 
products
88 (4R)-1-Methyl-4-(1-
methylethenyl)cyclo­
hexeneLimonene 5989-27-5 227-813-5 The presence of the 
substance must be indi­cated in the list of ingre­dients referred to in Article 19(1)(g) when its concentration exceeds:
—0,001 % in 
leave-on products 
—0,01 % in rinse-off productsN E 9 0 0 2 . 2 1 . 2 2
i h g f e d c b ar e h t On o i t a r a p e r p e s u r o f y d a e rn i n o i t a r t n e c n o c m u m i x a Ms t r a p y d o b , e p y t t c u d o r P r e b m u n C E r e b m u n S A Cy r a s s o l G s t n e i d e r g n In o m m o C f o e m a NN N I / e m a n l a c i m e h Cs g n i n r a w d n a e s uf o s n o i t i d n o c f o g n i d r o Ws n o i t c i r t s e R n o i t a c i f i t n e d i e c n a t s b u S
r e b m u ne c n e r e f e ROfficial Journ alof the EuropeanUnion 22.12.200989 Methyl heptin 
carbonateMethyl 2-octynoate 111-12-6 203-836-6 The presence of the 
substance must be indi­
cated in the list of ingre­dients referred to in Article 19(1)(g) when its concentration exceeds:
—0,001 % in 
leave-on products 
—0,01 % in rinse-off 
products
90 3-Methyl-4-(2,6,6-
trimethyl-2-
cyclohexen-1-yl)-3-buten-2-onealpha-Isomethyl ion­one127-51-5 204-846-3 The presence of the substance must be indi­cated in the list of ingre­dients referred to in Article 19(1)(g) when its concentration exceeds:
—0,001 % in 
leave-on products 
—0,01 % in rinse-off products
91 Oak moss extract Evernia prunastri extract90028-68-5 289-861-3 The presence of the 
substance must be indi­cated in the list of ingre­dients referred to in Article 19(1)(g) when its concentration exceeds:
—0,001 % in 
leave-on products 
—0,01 % in rinse-off productsN E 2 6 1 / 2 4 3 L
i h g f e d c b ar e h t On o i t a r a p e r p e s u r o f y d a e rn i n o i t a r t n e c n o c m u m i x a Ms t r a p y d o b , e p y t t c u d o r P r e b m u n C E r e b m u n S A Cy r a s s o l G s t n e i d e r g n In o m m o C f o e m a NN N I / e m a n l a c i m e h Cs g n i n r a w d n a e s uf o s n o i t i d n o c f o g n i d r o Ws n o i t c i r t s e R n o i t a c i f i t n e d i e c n a t s b u S
r e b m u ne c n e r e f e ROfficial Journ alof the EuropeanUnion L 342/16392 Treemoss extract Evernia furfuracea 
extract90028-67-4 289-860-8 The presence of the substance must be indi­cated in the list of ingre­dients referred to in Article 19(1)(g) when its concentration exceeds:
—0,001 % in 
leave-on products 
—0,01 % in rinse-off products
93 2,4-
Pyrimidinediamine, 3-oxideDiaminopyrimidine oxide74638-76-9 — Hair products 1,5 %
94 Dibenzoyl peroxide Benzoyl peroxide 94-36-0 202-327-6 Artificial nail systems 0,7 % (after mixing for 
use)Professional use For professional use only
Avoid skin contactRead directions for use 
carefully
95 Hydroquinone 
methylether/Mequinolp-Hydroxyanisol 150-76-5 205-769-8 Artificial nail systems 0,02 % (after mixing for 
use)Professional use For professional use only
Avoid skin contactRead directions for use 
carefully
96 5-tert-Butyl-2,4,6-
trinitro-m-xyleneMusk xylene 81-15-2 201-329-4 All cosmetic products, 
with the exception of oral products(a) 1,0 % in fine fra­grance
(b) 0,4 % in eau de toilette
(c) 0,03 % in other productsN E 9 0 0 2 . 2 1 . 2 2
i h g f e d c b ar e h t On o i t a r a p e r p e s u r o f y d a e rn i n o i t a r t n e c n o c m u m i x a Ms t r a p y d o b , e p y t t c u d o r P r e b m u n C E r e b m u n S A Cy r a s s o l G s t n e i d e r g n In o m m o C f o e m a NN N I / e m a n l a c i m e h Cs g n i n r a w d n a e s uf o s n o i t i d n o c f o g n i d r o Ws n o i t c i r t s e R n o i t a c i f i t n e d i e c n a t s b u S
r e b m u ne c n e r e f e ROfficial Journ alof the EuropeanUnion 22.12.200997 4’-tert-Butyl-2’,6’-
dimethyl-3’,5’-
dinitroacetophenoneMusk ketone 81-14-1 201-328-9 All cosmetic products, 
with the exception of oral products(a) 1,4 % in fine fra­grance
(b) 0,56 % in eau de toilette
(c) 0,042 % in other products
98 Benzoic acid, 
2-hydroxy- (
10)Salicylic acid 69-72-7 200-712-3 (a) Rinse-off hair prod­ucts
(b) Other products(a) 3,0 %
(b) 2,0 %Not to be used in prepa­rations for children under 3 years of age, except for shampoos
For purposes other than 
inhibiting the develop­ment of micro-organisms in the product. This purpose has to be apparent from 
the presentation of the 
productNot to be used for chil­dren under 3 years of age (
11)
99 Inorganic sulfites and 
bisulfites (12)(a) Oxidative hair dye products(a) 0,67 % (as free SO
2)For purposes other than inhibiting the develop­ment of micro-organisms in the product. This purpose has to be apparent from the presentation of the 
product(b) Hair straightening 
products(b) 6,7 % (as free SO
2)
(c) Self-tanning prod­ucts for the face(c) 0,45 % (as free SO
2)
(d) Other self-tanning products(d) 0,40 % (as free SO
2)N E 4 6 1 / 2 4 3 L
i h g f e d c b ar e h t On o i t a r a p e r p e s u r o f y d a e rn i n o i t a r t n e c n o c m u m i x a Ms t r a p y d o b , e p y t t c u d o r P r e b m u n C E r e b m u n S A Cy r a s s o l G s t n e i d e r g n In o m m o C f o e m a NN N I / e m a n l a c i m e h Cs g n i n r a w d n a e s uf o s n o i t i d n o c f o g n i d r o Ws n o i t c i r t s e R n o i t a c i f i t n e d i e c n a t s b u S
r e b m u ne c n e r e f e ROfficial Journ alof the EuropeanUnion L 342/165100 1-(4-Chlorophenyl)-3-
(3,4-dichlorophenyl) 
urea (13)Triclocarban 101-20-2 202-924-1 Rinse-off products 1,5 % Purity criteria:
3,3’,4,4’-Tetrachloroazobenzene ≤ 1 ppm
3,3’,4,4’-
Tetrachloroazoxyben­zene ≤ 1 ppm
For purposes other than 
inhibiting the develop­
ment of micro-
organisms in the product. This purpose has to be apparent from the presentation of the product
101 Pyrithione zinc  (
14)Zinc pyrithione 13463-41-7 236-671-3 Leave-on hair products 0,1 % For purposes other than 
inhibiting the develop­ment of micro-organisms in the product. This purpose has to be apparent from the presentation of the product
102 1,2-Dimethoxy-4-(2-
propenyl)-benzeneMethyl eugenol 93-15-2 202-223-0 Fine fragrance 0,01 %
Eau de toilette 0,004 %
Fragrance cream 0,002 %
Other leave-on products and oral products0,0002 %
Rinse-off products 0,001 %N E 9 0 0 2 . 2 1 . 2 2
i h g f e d c b ar e h t On o i t a r a p e r p e s u r o f y d a e rn i n o i t a r t n e c n o c m u m i x a Ms t r a p y d o b , e p y t t c u d o r P r e b m u n C E r e b m u n S A Cy r a s s o l G s t n e i d e r g n In o m m o C f o e m a NN N I / e m a n l a c i m e h Cs g n i n r a w d n a e s uf o s n o i t i d n o c f o g n i d r o Ws n o i t c i r t s e R n o i t a c i f i t n e d i e c n a t s b u S
r e b m u ne c n e r e f e ROfficial Journ alof the EuropeanUnion 22.12.2009215 4-Amino-
3-nitrophenol and its 
salts4-Amino-3-nitrophenol 610-81-1 210-236-8 (a) Oxidising colouring 
agents for hair dye­ing(a) 3,0 % In combination with hydrogen peroxide the maximum use concen­tration upon application is 1,5 %
Not to be used after
31.12.2009(a) (b) Can cause aller­
gic reaction
(b) Non-oxidising colouring agents 
for hair dyeing(b) 3,0 %
216 2,7-Naphthalenediol 
and its saltsNaphthalene-2,7-diol 582-17-2 209-478-7 Oxidising colouring 
agents for hair dyeing1,0 % In combination with 
hydrogen peroxide the maximum use concen­tration upon application is 0,5 %
Not to be used after
31.12.2009
217 m-Aminophenol and 
its salts3-Aminophenol 591-27-5 209-711-2 Oxidising colouring 
agents for hair dyeing2,0 % In combination with 
hydrogen peroxide the 
maximum use concen­tration upon application is 1,0 %
Not to be used after
31.12.2009Can cause allergic reac­
tion
218 2,6-Dihydroxy-3,4-
dimethylpyridine and 
its salts2,6-Dihydroxy-3,4-dimethylpyridine84540-47-6 283-141-2 Oxidising colouring 
agents for hair dyeing2,0 % In combination with hydrogen peroxide the maximum use concen­tration upon application is 1,0 %
Not to be used after
31.12.2009N E 6 6 1 / 2 4 3 L
i h g f e d c b ar e h t On o i t a r a p e r p e s u r o f y d a e rn i n o i t a r t n e c n o c m u m i x a Ms t r a p y d o b , e p y t t c u d o r P r e b m u n C E r e b m u n S A Cy r a s s o l G s t n e i d e r g n In o m m o C f o e m a NN N I / e m a n l a c i m e h Cs g n i n r a w d n a e s uf o s n o i t i d n o c f o g n i d r o Ws n o i t c i r t s e R n o i t a c i f i t n e d i e c n a t s b u S
r e b m u ne c n e r e f e ROfficial Journ alof the EuropeanUnion L 342/167219 1-Hydroxy-3-nitro-
4-(3-hydroxypro 
pylamino)benzene and its salts4-Hydroxy-propylamino-3-nitrophenol92952-81-3 406-305-9 (a) Oxidising colouring agents for hair dye­ing(a) 5,2 % In combination with hydrogen peroxide the maximum use concen­tration upon application is 2,6 %
Not to be used after
31.12.2009(a) (b) Can cause aller­
gic reaction
(b) Non-oxidising 
colouring agents 
for hair dyeing(b) 2,6 %
220 1-[(2’-Methoxyethyl) 
amino]-2-nitro-4-[di-(2’-hydroxyethyl) amino]benzene and its saltsHC Blue No 11 23920-15-2 459-980-7 (a) Oxidising colouring 
agents for hair dye­ing(a) 3,0 % In combination with hydrogen peroxide the maximum use concen­tration upon application is 1,5 %
Not to be used after
31.12.2009(a) (b) Can cause aller­
gic reaction
(b) Non-oxidising colouring agents for hair dyeing(b) 2,0 %
221 1-Methyl-3-nitro-4-
(.beta.-hydroxyethyl) aminobenzene and its saltsHydroxyethyl-2-nitro-p-toluidine100418-33-5 408-090-7 (a) Oxidising colouring agents for hair dye­ing(a) 2,0 % In combination with hydrogen peroxide the maximum use concen­tration upon application 
is 1,0 %
Not to be used after
31.12.2009(a) (b) Can cause aller­
gic reaction
(b) Non-oxidising colouring agents for hair dyeing(b) 1,0 %
222 1-Hydroxy-2-.beta.-
hydroxyethylamino-4,6-dinitrobenzene and its salts2-Hydroxyethyl-picramic acid99610-72-7 412-520-9 (a) Oxidising colouring agents for hair dye­ing(a) 3,0 % In combination with hydrogen peroxide the maximum use concen­tration upon application is 1,5 %
Not to be used after
31.12.2009(a) (b) Can cause aller­
gic reaction
(b) Non-oxidising colouring agents for hair dyeing(b) 2,0 %N E 9 0 0 2 . 2 1 . 2 2
i h g f e d c b ar e h t On o i t a r a p e r p e s u r o f y d a e rn i n o i t a r t n e c n o c m u m i x a Ms t r a p y d o b , e p y t t c u d o r P r e b m u n C E r e b m u n S A Cy r a s s o l G s t n e i d e r g n In o m m o C f o e m a NN N I / e m a n l a c i m e h Cs g n i n r a w d n a e s uf o s n o i t i d n o c f o g n i d r o Ws n o i t c i r t s e R n o i t a c i f i t n e d i e c n a t s b u S
r e b m u ne c n e r e f e ROfficial Journ alof the EuropeanUnion 22.12.2009223 4-Methylaminophenol 
and its saltsp-Methylaminophenol 150-75-4 205-768-2 Oxidising colouring 
agent for hair dyeing3,0 % In combination with 
hydrogen peroxide the maximum use concen­tration upon application is 1,5 %
Not to be used after
31.12.2009Can cause allergic reac­tion
224 1-(3-Hydroxy-
propylamino)-2-nitro-4-bis(2-hydroxyethylamino) benzene and its saltsHC Violet No 2 104226-19-9 410-910-3 Non-oxidising colouring 
agent for hair dyeing2,0 % Not to be used after31.12.2009
225 1-(.beta.-
Hydroxyethyl) amino-2-nitro-4-N-ethyl-N-(.beta.-hydroxyethyl) aminobenzene and its saltsHC Blue No 12 104516-93-0 407-020-2 (a) Oxidising colouring 
agents for hair dye­ing(a) 1,5 % In combination with hydrogen peroxide the maximum use concen­tration upon application is 0,75 %
Not to be used after
31.12.2009(a) (b) Can cause aller­
gic reaction
(b) Non-oxidising colouring agents for hair dyeing(b) 1,5 %
226 4,4’-[1,3-
Propanediylbis (oxy)]bis-, benzene-1,3-diamine and its salts1,3-Bis-(2,4-diaminophenoxy)pro­pane81892-72-0 279-845-4 Oxidising colouring 
agents for hair dyeing2,0 % In combination with hydrogen peroxide the maximum use concen­tration upon application is 1,0 %
Not to be used after
31.12.2009Can cause allergic reac­tion
227 3-Amino-2,4-
dichlorophenol and its salts3-Amino-2,4-dichlorophenol61693-43-4 262-909-0 Oxidising colouring 
agents for hair dyeing2,0 % In combination with hydrogen peroxide the maximum use concen­tration upon application is 1,0 %
Not to be used after
31.12.2009Can cause allergic reac­tionN E 8 6 1 / 2 4 3 L
i h g f e d c b ar e h t On o i t a r a p e r p e s u r o f y d a e rn i n o i t a r t n e c n o c m u m i x a Ms t r a p y d o b , e p y t t c u d o r P r e b m u n C E r e b m u n S A Cy r a s s o l G s t n e i d e r g n In o m m o C f o e m a NN N I / e m a n l a c i m e h Cs g n i n r a w d n a e s uf o s n o i t i d n o c f o g n i d r o Ws n o i t c i r t s e R n o i t a c i f i t n e d i e c n a t s b u S
r e b m u ne c n e r e f e ROfficial Journ alof the EuropeanUnion L 342/169228 3-Methyl-1-phenyl-
5-pyrazolone and its 
saltsPhenyl methyl pyrazolone89-25-8 201-891-0 Oxidising colouring 
agents for hair dyeing0,5 % In combination with hydrogen peroxide the maximum use concen­tration upon application is 0,25 %
Not to be used after
31.12.2009
229 5-[(2-Hydroxyethyl) 
amino]-o-cresol and its salts2-Methyl-5-hydroxyethylami­nophenol55302-96-0 259-583-7 Oxidising colouring 
agents for hair dyeing2,0 % In combination with hydrogen peroxide the maximum use concen­tration upon application is 1,0 %
Not to be used after
31.12.2009Can cause allergic reac­tion
230 3,4-Dihydro-2H-1,4-
benzoxazin-6-ol and its saltsHydroxybenzomor­pholine26021-57-8 247-415-5 Oxidising colouring 
agents for hair dyeing2,0 % In combination with hydrogen peroxide the maximum use concen­tration upon application is 1,0 %
Not to be used after
31.12.2009Can cause allergic reac­tion
231 1,5-bis(.beta.-
Hydroxyethyl) amino-2-nitro-4-chlorobenzene and its saltsHC Yellow No 10 109023-83-8 416-940-3 Non-oxidising colouring 
agents for hair dyeing0,2 % Not to be used after31.12.2009
232 3,5-Diamino-2,6-
dimethoxypyridine and its salts2,6-Dimethoxy-3,5-pyridinediamine HCl85679-78-3/ 56216-28-5- / 260-062-1 Oxidising colouring 
agents for hair dyeing0,5 % In combination with hydrogen peroxide the maximum use concen­tration upon application is 0,25 %
Not to be used after
31.12.2009Can cause allergic reac­tionN E 9 0 0 2 . 2 1 . 2 2
i h g f e d c b ar e h t On o i t a r a p e r p e s u r o f y d a e rn i n o i t a r t n e c n o c m u m i x a Ms t r a p y d o b , e p y t t c u d o r P r e b m u n C E r e b m u n S A Cy r a s s o l G s t n e i d e r g n In o m m o C f o e m a NN N I / e m a n l a c i m e h Cs g n i n r a w d n a e s uf o s n o i t i d n o c f o g n i d r o Ws n o i t c i r t s e R n o i t a c i f i t n e d i e c n a t s b u S
r e b m u ne c n e r e f e ROfficial Journ alof the EuropeanUnion 22.12.2009233 1-(2-Aminoethyl) 
amino-4-
(2-hydroxyethyl)oxy-2-nitrobenzene and its saltsHC Orange No 2 85765-48-6 416-410-1 Non-oxidising colouring 
agents for hair dyeing1,0 % Not to be used after31.12.2009
234 Ethanol, 2-[(4-amino-
2-methyl-5-nitrophenyl) amino]-and its saltsHC Violet No 1 82576-75-8 417-600-7 (a) Oxidising colouring agents for hair dye­ing(a) 0,5 % In combination with hydrogen peroxide the maximum use concen­tration upon application is 0,25 %
Not to be used after
31.12.2009(b) Non-oxidising colouring agents for hair dyeing(b) 0,5 %
235 2-[3-(Methylamino)-4-
nitrophenoxy] ethanol and its salts3-Methylamino-4-nitro-phenoxyethanol59820-63-2 261-940-7 Non-oxidising colouring 
agents for hair dyeing1,0 % Not to be used after31.12.2009
236 2-[(2-Methoxy-4-
nitrophenyl)amino]et­hanol and its salts2-Hydroxy-
ethylamino-5-nitro-
anisole66095-81-6 266-138-0 Non-oxidising colouring 
agents for hair dyeing1,0 % Not to be used after
31.12.2009
237 2,2’-[(4-Amino-3-
nitrophenyl)imino­
]bisethanol hydrochloride and other saltsHC Red No 13 94158-13-1 303-083-4 (a) Oxidising colouring 
agents for hair dye­ing(a) 2,5 % In combination with hydrogen peroxide the maximum use concen­tration upon application is 1,25 %
Not to be used after
31.12.2009(b) Non-oxidising colouring agents for hair dyeing(b) 2,5 %
238 Naphthalene-1,5-diol 
and its salts1,5-Naphthalenediol 83-56-7 201-487-4 Oxidising colouring 
agents for hair dyeing1,0 % Not to be used after31.12.2009N E 0 7 1 / 2 4 3 L
i h g f e d c b ar e h t On o i t a r a p e r p e s u r o f y d a e rn i n o i t a r t n e c n o c m u m i x a Ms t r a p y d o b , e p y t t c u d o r P r e b m u n C E r e b m u n S A Cy r a s s o l G s t n e i d e r g n In o m m o C f o e m a NN N I / e m a n l a c i m e h Cs g n i n r a w d n a e s uf o s n o i t i d n o c f o g n i d r o Ws n o i t c i r t s e R n o i t a c i f i t n e d i e c n a t s b u S
r e b m u ne c n e r e f e ROfficial Journ alof the EuropeanUnion L 342/171239 Hydroxypropyl 
bis(N-hydroxyethyl-
p-phenylenediamine) and its saltsHydroxypropyl bis(N-hydroxyethyl-p-phenyldiamine) HCl128729-30-6 416-320-2 Oxidising colouring 
agents for hair dyeing3,0 % In combination with hydrogen peroxide the maximum use concen­tration upon application is 1,5 %
Not to be used after
31.12.2009Can cause allergic reac­tion
240 o-Aminophenol and 
its saltso-Aminophenol 95-55-6 202-431-1 Oxidising colouring 
agents for hair dyeing2,0 % In combination with hydrogen peroxide the maximum use concen­tration upon application is 1,0 %
Not to be used after
31.12.2009
241 5-Amino-o-cresol and 
its salts4-Amino-2-hydroxytoluene2835-95-2 220-618-6 Oxidising colouring 
agents for hair dyeing3,0 % In combination with hydrogen peroxide the 
maximum use concen­
tration upon application is 1,5 %
Not to be used after
31.12.2009
242 2,4-
Diaminophenoxyetha­nol and its salts2,4-Diaminophenoxyetha­nol HCl66422-95-5 266-357-1 Oxidising colouring 
agents for hair dyeing4,0 % In combination with hydrogen peroxide the maximum use concen­tration upon application is 2,0 %
Not to be used after
31.12.2009N E 9 0 0 2 . 2 1 . 2 2
i h g f e d c b ar e h t On o i t a r a p e r p e s u r o f y d a e rn i n o i t a r t n e c n o c m u m i x a Ms t r a p y d o b , e p y t t c u d o r P r e b m u n C E r e b m u n S A Cy r a s s o l G s t n e i d e r g n In o m m o C f o e m a NN N I / e m a n l a c i m e h Cs g n i n r a w d n a e s uf o s n o i t i d n o c f o g n i d r o Ws n o i t c i r t s e R n o i t a c i f i t n e d i e c n a t s b u S
r e b m u ne c n e r e f e ROfficial Journ alof the EuropeanUnion 22.12.2009243 1,3-Benzenediol, 
2-methyl-, and its 
salts -2-Methylresorcinol 608-25-3 210-155-8 Oxidising colouring 
agents for hair dyeing2,0 % In combination with hydrogen peroxide the maximum use concen­tration upon application is 1,0 %
Not to be used after
31.12.2009
244 4-Amino-m-cresol 
and its salts4-Amino-m-cresol 2835-99-6 220-621-2 Oxidising colouring 
agents for hair dyeing3,0 % In combination with hydrogen peroxide the maximum use concen­tration upon application is 1,5 %
Not to be used after
31.12.2009
245 2-[(3-amino-4-
methoxyphenyl)ami­no]ethanol and its salts2-Amino-4-hydroxyethylami­noanisole83763-47-7 280-733-2 Oxidising colouring 
agents for hair dyeing3,0 % In combination with hydrogen peroxide the maximum use concen­tration upon application is 1,5 %
Not to be used after
31.12.2009
246 Hydroxyethyl-3,4-
methylenedioxyaniline 
2-(1,3-benzodioxol-5-ylamino)ethanol hydrochloride and other saltsHydroxyethyl-3,4-methylenedioxyaniline HCI81329-90-0 303-085-5 Oxidising colouring 
agents for hair dyeing3,0 % In combination with hydrogen peroxide the maximum use concen­tration upon application is 1,5 %
Not to be used after
31.12.2009
247 2,2’-[[4-[(2-
Hydroxyethyl) amino]-3-nitrophenyl]imino­]bisethanol. and its saltsHC Blue No 2 33229-34-4 251-410-3 Non-oxidising colouring 
agents for hair dyeing2,8 % Not to be used after31.12.2009N E 2 7 1 / 2 4 3 L
i h g f e d c b ar e h t On o i t a r a p e r p e s u r o f y d a e rn i n o i t a r t n e c n o c m u m i x a Ms t r a p y d o b , e p y t t c u d o r P r e b m u n C E r e b m u n S A Cy r a s s o l G s t n e i d e r g n In o m m o C f o e m a NN N I / e m a n l a c i m e h Cs g n i n r a w d n a e s uf o s n o i t i d n o c f o g n i d r o Ws n o i t c i r t s e R n o i t a c i f i t n e d i e c n a t s b u S
r e b m u ne c n e r e f e ROfficial Journ alof the EuropeanUnion L 342/173248 4-[(2-Hydroxyethyl) 
amino]-3-nitrophenol 
and its salts3-Nitro-p-hydroxye-thylaminophenol65235-31-6 265-648-0 (a) Oxidising colouring agents for hair dye­ing(a) 6,0 % In combination with hydrogen peroxide the maximum use concen­tration upon application is 3,0 %
Not to be used after
31.12.2009(b) Non-oxidising 
colouring agents 
for hair dyeing(b) 6,0 %
249 1-(.beta.-Ureidoethy­
l)amino-4-nitroben­zene and its salts4-Nitrophenyl amino­ethylurea27080-42-8 410-700-1 (a) Oxidising colouring agents for hair dye­ing(a) 0,5 % In combination with hydrogen peroxide the maximum use concen­tration upon application is 0,25 %
Not to be used after
31.12.2009(b) Non-oxidising colouring agents for hair dyeing(b) 0,5 %
250 1-amino-2-nitro-4-
(2’,3’-dihydroxypropyl) 
amino-5-
chlorobenzene and 1,4-bis-(2’,3’-dihydroxypropyl) amino-2-nitro-5-chlorobenzene and its saltsHC Red No 10 and HC Red No 1195576-89-9 and 95576-92-4— (a) Oxidising colouring agents for hair dye­ing(a) 2,0 % In combination with hydrogen peroxide the maximum use concen­
tration upon application 
is 1,0 %
Not to be used after
31.12.2009(b) Non-oxidising colouring agents for hair dyeing(b) 1,0 %
251 Phenol, 2-chloro-6-
(ethylamino)-4-nitro-and its salts2-Chloro-6-ethylamino-4-nitrophenol131657-78-8 411-440-1 (a) Oxidising colouring agents for hair dye­ing(a) 3,0 % In combination with hydrogen peroxide the maximum use concen­tration upon application is 1,5 %
Not to be used after
31.12.2009(b) Non-oxidising colouring agents for hair dyeing(b) 3,0 %N E 9 0 0 2 . 2 1 . 2 2
i h g f e d c b ar e h t On o i t a r a p e r p e s u r o f y d a e rn i n o i t a r t n e c n o c m u m i x a Ms t r a p y d o b , e p y t t c u d o r P r e b m u n C E r e b m u n S A Cy r a s s o l G s t n e i d e r g n In o m m o C f o e m a NN N I / e m a n l a c i m e h Cs g n i n r a w d n a e s uf o s n o i t i d n o c f o g n i d r o Ws n o i t c i r t s e R n o i t a c i f i t n e d i e c n a t s b u S
r e b m u ne c n e r e f e ROfficial Journ alof the EuropeanUnion 22.12.2009252 2-Amino-6-chloro-
4-nitrophenol and its 
salts2-Amino-6-chloro-4-nitrophenol6358-09-4 228-762-1 (a) Oxidising colouring agents for hair dye­ing(a) 2,0 % In combination with hydrogen peroxide the maximum use concen­tration upon application is 1,0 %
Not to be used after
31.12.2009 (b) Non-oxidising colouring agents 
for hair dyeing(b) 2,0 %
253 [4-[[4-Anilino-1-
naphthyl][4-
(dimethylamino) phenyl]methylene] cyclohexa-2,5-dien-1-ylidene] dimethylammonium chloride (CI 44045) and other saltsBasic Blue 26 (CI 44045)2580-56-5 219-943-6 (a) Oxidising colouring agents for hair dye­ing(a) 0,5 % In combination with hydrogen peroxide the maximum use concen­tration upon application is 0,25 %
Not to be used after
31.12.2009
(b) Non-oxidising colouring agents for hair dyeing(b) 0,5 %
254 Disodium 5-amino-4-
hydroxy-3-(phenylazo) naphthalene-2,7-disulphonate (CI 17200) and other saltsAcid Red 33 (CI 17200)3567-66-6 222-656-9 Non-oxidising colouring 
agents for hair dyeing2,0 % Not to be used after31.12.2009
255 Disodium 3-[(2,4-
dimethyl-5-sulphonatophenyl) azo]-4-hydroxynaphthalene-1-sulphonate (CI 14700) and other saltsPonceau SX (CI 14700)4548-53-2 224-909-9 Non-oxidising colouring 
agents for hair dyeing2,0 % Not to be used after31.12.2009N E 4 7 1 / 2 4 3 L
i h g f e d c b ar e h t On o i t a r a p e r p e s u r o f y d a e rn i n o i t a r t n e c n o c m u m i x a Ms t r a p y d o b , e p y t t c u d o r P r e b m u n C E r e b m u n S A Cy r a s s o l G s t n e i d e r g n In o m m o C f o e m a NN N I / e m a n l a c i m e h Cs g n i n r a w d n a e s uf o s n o i t i d n o c f o g n i d r o Ws n o i t c i r t s e R n o i t a c i f i t n e d i e c n a t s b u S
r e b m u ne c n e r e f e ROfficial Journ alof the EuropeanUnion L 342/175256 (4-(4-Aminophenyl) 
(4-iminocyclohexa-
2,5-dienylidene) methyl)-2-methylaniline hydrochloride (CI 42510) and other 
saltsBasic Violet 14 
(CI 42510)632-99-5 211-189-6 (a) Oxidising colouring agents for hair dye­ing(a) 0,3 % In combination with hydrogen peroxide the maximum use concen­tration upon application is 0,15 %
Not to be used after
31.12.2009(b) Non-oxidising colouring agents for hair dyeing(b) 0,3 %
(1)These substances may be used singly or in combination provided that the sum of the ratios of the levels of each of them in the cosmetic product expressed with reference to the maximum level authorised for each of them does not exceed 1. 
(2)For use as a preservative, see Annex V, No. 5. 
(3)Only if the concentration exceeds 0,05 %. 
(4)These substances may be used singly or in combination provided that the sum of the ratios of the levels of each of them in the cosmetic product expressed with reference to the maximum level authorised for each of them does not exceed 2. 
(5)The quantity of sodium, potassium or lithium hydroxide is expressed as weight of sodium hydroxide. In cases of mixtures, the sum should not exceed the limits given in column g.  
(6)The concentration of sodium, potassium or lithium hydroxide is expressed as weight of sodium hydroxide. In case of mixtures, the sum should not exceed the limits given in column g.  
(7)For use as a preservative, see Annex V, No. 34. 
(8)For use as a preservative, see Annex V, No 43. 
(9)For use as a preservative, see Annex V, No. 54. 
(10)For use as a preservative, see Annex V, No 3. 
(11)Solely for products which might be used for children under 3 years of age and which remain in prolonged contact with the skin.  
(12)For use as a preservative, see Annex V, No 9. 
(13)For use as a preservative, see AnnexV, No 23. 
(14)For use as a preservative, see Annex V, No 8.N E 9 0 0 2 . 2 1 . 2 2
i h g f e d c b ar e h t On o i t a r a p e r p e s u r o f y d a e rn i n o i t a r t n e c n o c m u m i x a Ms t r a p y d o b , e p y t t c u d o r P r e b m u n C E r e b m u n S A Cy r a s s o l G s t n e i d e r g n In o m m o C f o e m a NN N I / e m a n l a c i m e h Cs g n i n r a w d n a e s uf o s n o i t i d n o c f o g n i d r o Ws n o i t c i r t s e R n o i t a c i f i t n e d i e c n a t s b u S
r e b m u ne c n e r e f e RANNEX IV
LIST OF COLORANTS ALLOWED IN COSMETIC PRODUCTS
Preamble
Without prejudice to other provisions in this Regulation, a colorant shall include its salts and lakes and when a colorant is expressed as a specific salt, its other salts and lakes shall also be included.  
o 
52-9 0 0 2 . 2 1 . 2 2 n o i n U n a e p o r u E e h t f o l a n r u o J l a i c i f f O N E 6 7 1 / 2 4 3 L
s e n a r b- m e m s u o c u m n o d e i l p p as t c u d o r p n i d e s u e b o t t o N d e R 0 1 0 2 1 l o h t h p a n ] o z a ) l y n e h p y x o h t E - 4 ( [ - 4 8e g n a r O 0 2 9 1 1 l o n i c r o s e r ) o z a l y n e h P ( - 4 7s t c u d o r p f f o - e s n i R e g n a r O 5 2 7 1 1
e d i m a r y t u b ) l y l o t - o ( - N- o x o - 3 - ] o z a ) l y n e h p o r t i n - 2 - y x o h t e M - 4 ( [ - 2 6s e n a r b- m e m s u o c u m n o d e i l p p as t c u d o r p n i d e s u e b o t t o N w o l l e Y 0 1 7 1 1
e d i m a r y t u b o x o - 3 - ) l y n e h p o r o l h c- 2 ( - N - ] o z a ) l y n e h p o r t i n - 2 - o r o l h C - 4 ( [ - 2 5s e n a r b- m e m s u o c u m n o d e i l p p as t c u d o r p n i d e s u e b o t t o N w o l l e Y 0 8 6 1 1
e d i m a r y t u b l y n e h p- N - o x o - 3 - ] o z a ) l y n e h p o r t i n - 2 - l y h t e M - 4 ( [ - 2 4s t c u- d o r p e y e n i d e s u e b o t t o N w o l l e Y 6 1 3 0 1
s t n e m g i p d n a s t l a s , s e k a l m u i n- o c r i z d n a m u i t n o r t s , m u i r a b e l b u l o s n is t i d n a e t a n o h p l u s - 2 - e n e l a h t h p a n o d i x o- 8 - o r t i n i d - 7 , 5 m u i d o s i D 3s e n a r b- m e m s u o c u m n o d e i l p p as t c u d o r p n i d e s u e b o t t o N n e e r G 0 2 0 0 1
) - 3 ( e t a r r e f ] 6 O , N - ) ( o t a n o h p l u s- 2 - e n e l a h t h p a n o x o - 6 - ) o n i m i y x o r d y h (- 5 - o r d y h i d - 6 , 5 [ s i r t m u i d o s i r T 2s t c u d o r p f f o - e s n i R n e e r G 6 0 0 0 1
) - 1 ( e t a r r e f ) ’ O , O - o t a m i x o - 1e n o n i u q o h t h p a n - 2 , 1 ( s i r t m u i d o S 1j i h g f e d c b ar e h t O
n o i t a r a p e r pe s u r o f y d a e rn i n o i t a r t n e c- n o c m u m i x a M
s t r a p y d o B , e p y t t c u d o r P r u o l o C r e b m u n C E r e b m u n S A C
y r a s s l Gs t n e i d e r g n I n o m m o Cf o e m a N / r e b m u Nx e d n i r u o l o C
e m a N l a c i m e h C s g n i n r a w d n ae s u f o s n o i t i d- n o c f o g n i d r o Ws n o i t i d n o C n o i t a c i f i t n e d i e c n a t s b u S
r e b m u ne c n e r e f e ROfficial Journ alof the EuropeanUnion L 342/1779 1-[(2-Chloro-4-nitrophenyl)azo]-2-
naphthol and its insoluble barium, stron­tium and zirconium lakes, salts and pigments12085 Red 3 %
10 1-[(4-Methyl-2-nitrophenyl)azo]-2-
naphthol12120 Red Rinse-off products
11 3-Hydroxy-N-(o-tolyl)-4-[(2,4,5-
trichlorophenyl)azo]naphthalene-2-carboxamide12370 Red Rinse-off products
12 N-(4-Chloro-2-methylphenyl)-4-[(4-
chloro-2-methylphenyl)azo]-3-hydroxynaphthalene-2-carboxamide12420 Red Rinse-off products
13 4-[(2,5-Dichlorophenyl)azo]-N-(2,5-
dimethoxyphenyl)-3-hydroxynaphthalene-2-carboxamide12480 Brown Rinse-off products
14 N-(5-Chloro-2,4-dimethoxyphenyl)-4-[[5-
[(diethylamino)sulphonyl]-2-methoxyphenyl]azo]-3-hydroxynaphthalene-2-carboxamide12490 Red
15 2,4-Dihydro-5-methyl-2-phenyl-4-
(phenylazo)-3H-pyrazol-3-one12700 Yellow Rinse-off products
16 Disodium 2-amino-5-[(4-
sulphonatophenyl)azo]benzenesulphonate13015 Yellow
17 Sodium 4-(2,4-
dihydroxyphenylazo)benzenesulphonate14270 Orange
18 Disodium 3-[(2,4-dimethyl-5-
sulphonatophenyl)azo]-4-hydroxynaphthalene-1-sulphonate14700 Red
19 Disodium 4-hydroxy-3-[(4-
sulphonatonaphthyl)azo]naphtha­lenesulphonate14720 222-657-4 Red Purity criteria as set out in Commission Directive 95/45/EC (E 122)N E 9 0 0 2 . 2 1 . 2 2
j i h g f e d c b ar e h t O
n o i t a r a p e r pe s u r o f y d a e rn i n o i t a r t n e c- n o c m u m i x a M
s t r a p y d o B , e p y t t c u d o r P r u o l o C r e b m u n C E r e b m u n S A C
y r a s s o l Gs t n e i d e r g n I n o m m o Cf o e m a N / r e b m u Nx e d n i r u o l o C
e m a N l a c i m e h C s g n i n r a w d n ae s u f o s n o i t i d- n o c f o g n i d r o Ws n o i t i d n o C n o i t a c i f i t n e d i e c n a t s b u S
r e b m u ne c n e r e f e ROfficial Journ alof the EuropeanUnion 22.12.200920 Disodium 6-[(2,4-dimethyl-6-
sulphonatophenyl)azo]-5-
hydroxynaphthalene-1-sulphonate14815 Red
21 Sodium 4-[(2-hydroxy-1-
naphthyl)azo]benzenesulphonate and its insoluble barium, strontium and zirco­nium lakes, salts and pigments15510 Orange Not to be used in eye prod­ucts
22 Calcium disodium bis[2-chloro-5-[(2-
hydroxy-1-naphthyl)azo]-4-sulphonatobenzoate]15525 Red
23 Barium bis[4-[(2-hydroxy-1-
naphthyl)azo]-2-methylbenzenesul-phonate]15580 Red
24 Sodium 4-[(2-Hydroxy-1-
naphthyl)azo]naphthalenesulphonate15620 Red Rinse-off products
25 Sodium 2-[(2-
hydroxynaphthyl)azo]naphthale­nesulphonate and its insoluble barium, strontium and zirconium lakes, salts and pigments15630 Red 3 %
26 Calcium bis[3-hydroxy-4-(phenylazo)-2-
naphthoate]15800 Red Not to be used in products applied on mucous mem­branes
27 Disodium 3-hydroxy-4-[(4-methyl-2-
sulphonatophenyl)azo]-2-naphthoate and its insoluble barium, strontium and zirco­nium lakes, salts and pigments15850 226-109-5 Red Purity criteria as set out in Commission Directive 95/45/EC (E 180)
28 Disodium 4-[(5-chloro-4-methyl-2-
sulphonatophenyl)azo]-3-hydroxy-2-naphthoate and its insoluble barium, strontium and zirconium lakes, salts and pigments15865 RedN E 8 7 1 / 2 4 3 L
j i h g f e d c b ar e h t O
n o i t a r a p e r pe s u r o f y d a e rn i n o i t a r t n e c- n o c m u m i x a M
s t r a p y d o B , e p y t t c u d o r P r u o l o C r e b m u n C E r e b m u n S A C
y r a s s o l Gs t n e i d e r g n I n o m m o Cf o e m a N / r e b m u Nx e d n i r u o l o C
e m a N l a c i m e h C s g n i n r a w d n ae s u f o s n o i t i d- n o c f o g n i d r o Ws n o i t i d n o C n o i t a c i f i t n e d i e c n a t s b u S
r e b m u ne c n e r e f e ROfficial Journ alof the EuropeanUnion L 342/17929 Calcium 3-hydroxy-4-[(1-sulphonato-2-
naphthyl)azo]-2-naphthoate15880 Red
30 Disodium 6-hydroxy-5-[(3-
sulphonatophenyl)azo]naphthalene-2-
sulphonate15980 Orange
31 Disodium 6-hydroxy-5-[(4-
sulphonatophenyl)azo]naphthalene-2-sulphonate and its insoluble barium, strontium and zirconium lakes, salts and pigments15985 220-491-7 Yellow Purity criteria as set 
out in Commission Directive 95/45/EC (E 110)
32 Disodium 6-hydroxy-5-[(2-methoxy-4-
sulphonato-m-tolyl)azo]naphthalene-2-sulphonate16035 247-368-0 Red Purity criteria as set out in Commission Directive 95/45/EC (E 129)
33 Trisodium 3-hydroxy-4-[(4’-
sulphonatonaphthyl)azo]naphthalene-2,7-disulphonate16185 213-022-2 Red Purity criteria as set out in Commission Directive 95/45/EC (E 123)
34 Disodium 7-hydroxy-8-
(phenylazo)naphthalene-1,3-disulphonate16230 Orange Not to be used in products applied on mucous mem­
branes
35 Trisodium 1-(1-naphthylazo)-2-
hydroxynaphthalene-4’,6,8-trisulphonate 
and its insoluble barium, strontium and zirconium lakes, salts and pigments16255 220-036-2 Red Purity criteria as set out in Commission Directive 95/45/EC (E 124)
36 Tetrasodium 7-hydroxy-8-[(4-sulphonato-
1-naphthyl)azo]naphthalene-1,3,6-trisulphonate16290 Red
37 Disodium 5-amino-4-hydroxy-3-
(phenylazo)naphthalene-2,7-disulphonate and its insoluble barium, strontium and zirconium lakes, salts and pigments17200 RedN E 9 0 0 2 . 2 1 . 2 2
j i h g f e d c b ar e h t O
n o i t a r a p e r pe s u r o f y d a e rn i n o i t a r t n e c- n o c m u m i x a M
s t r a p y d o B , e p y t t c u d o r P r u o l o C r e b m u n C E r e b m u n S A C
y r a s s o l Gs t n e i d e r g n I n o m m o Cf o e m a N / r e b m u Nx e d n i r u o l o C
e m a N l a c i m e h C s g n i n r a w d n ae s u f o s n o i t i d- n o c f o g n i d r o Ws n o i t i d n o C n o i t a c i f i t n e d i e c n a t s b u S
r e b m u ne c n e r e f e ROfficial Journ alof the EuropeanUnion 22.12.200938 Disodium 5-acetylamino-4-hydroxy-3-
(phenylazo)naphthalene-2,7-disulphonate18050 223-098-9 Red Not to be used in products 
applied on mucous mem­branesPurity criteria as set out in Commission Directive 95/45/EC (E 128)
39 2,7-Naphthalenedisulfonic acid, 3-((4-
cyclohexyl-2-methylphenyl)azo)-4-hydroxy-5-(((4-methylphenyl)sulfonyl)amino)-, disodium salt18130 Red Rinse-off products
40 Hydrogen bis[2-[(4,5-dihydro-3-methyl-5-
oxo-1-phenyl-1H-pyrazol-4-yl)azo]benzoato(2-)]chromate(1-)18690 Yellow Rinse-off products
41 Disodium hydrogen bis[5-chloro-3-[(4,5-
dihydro-3-methyl-5-oxo-1-phenyl-1H-pyrazol-4-yl)azo]-2-hydroxybenzenesulphonato(3-)]chromate(3-)18736 Red Rinse-off products
42 Sodium 4-(3-hydroxy-5-methyl-4-
(phenylazo)pyrazol-2-yl)benzenesulphonate18820 Yellow Rinse-off products
43 Disodium 2,5-dichloro-4-(5-hydroxy-3-
methyl-4-((sulphophenyl)azo)pyrazol-1-yl)benzenesulphonate18965 Yellow
44 Trisodium 5-hydroxy-1-(4-sulphophenyl)-
4-((4-sulphophenyl)azo)pyrazole-3-carboxylate and its insoluble barium, strontium and zirconium lakes, salts and pigments19140 217-699-5 Yellow Purity criteria as set 
out in Commission Directive 95/45/EC (E 102)
45 N,N’-(3,3’-Dimethyl[1,1’-biphenyl]-4,4’-
diyl)bis[2-[(2,4-dichlorophenyl)azo]-3-oxobutyramide]20040 Yellow Rinse-off products Maximum 3,3’-dimethylbenzidine concentration in the colouring agent: 5 ppm
46 Sodium 4-amino-5-hydroxy-3-((4-
nitrophenyl)azo)-6-(phenylazo)naphthalene-2,7-disulphonate20470 Black Rinse-off productsN E 0 8 1 / 2 4 3 L
j i h g f e d c b ar e h t O
n o i t a r a p e r pe s u r o f y d a e rn i n o i t a r t n e c- n o c m u m i x a M
s t r a p y d o B , e p y t t c u d o r P r u o l o C r e b m u n C E r e b m u n S A C
y r a s s o l Gs t n e i d e r g n I n o m m o Cf o e m a N / r e b m u Nx e d n i r u o l o C
e m a N l a c i m e h C s g n i n r a w d n ae s u f o s n o i t i d- n o c f o g n i d r o Ws n o i t i d n o C n o i t a c i f i t n e d i e c n a t s b u S
r e b m u ne c n e r e f e ROfficial Journ alof the EuropeanUnion L 342/18147 2,2’-[(3,3’-Dichloro[1,1’-biphenyl]-4,4’-
diyl)bis(azo)]bis[N-(2,4-dimethylphenyl)-
3-oxobutyramide]21100 Yellow Rinse-off products Maximum 3,3’-dimethylbenzidine concentration in the colouring agent: 5 ppm
48 2,2’-[(3,3’-Dichloro[1,1’-biphenyl]-4,4’-
diyl)bis(azo)]bis[N-(4-chloro-2,5-dimethoxyphenyl)-3-oxobutyramide]21108 Yellow Rinse-off products Maximum 3,3’-dimethylbenzidine concentration in the 
colouring agent: 
5 ppm
49 2,2’-[Cyclohexylidenebis[(2-methyl-4,1-
phenylene)azo]]bis[4-cyclohexylphenol]21230 Yellow Not to be used in products applied on mucous mem­branes
50 Disodium 4,6-dihydroxy-3-[[4-[1-[4-[[1-
hydroxy-7-[(phenylsulphonyl)oxy]-3-sulphonato-2-naphthyl]azo]phenyl]cyclohexyl] phenyl]azo]naphthalene-2-sulphonate24790 Red Rinse-off products
51 1-(4-(Phenylazo)phenylazo)-2-naphthol 26100 Red Not to be used in products 
applied on mucous mem­branesPurity criteria:
aniline ≤ 0,2 %2-naphtol ≤ 0,2 %4-aminoazobenzene 
≤ 0,1 %
1-(phenylazo)-2-
naphtol ≤ 3 %
1-[2-(phenylazo) 
phenylazo]-2-napthalenol ≤ 2 %
52 Tetrasodium 6-amino-4-hydroxy-3-[[7-
sulphonato-4-[(4-sulphonatophenyl)azo]-1-naphthyl]azo]naphthalene-2,7-disulphonate27755 Black
53 Tetrasodium 1-acetamido-2-hydroxy-3-(4-
((4-sulphonatophenylazo)-7-sulphonato-1-naphthylazo))naphthalene-4,6-disulphonate28440 219-746-5 Black Purity criteria as set 
out in Commission Directive 95/45/EC (E 151)N E 9 0 0 2 . 2 1 . 2 2
j i h g f e d c b ar e h t O
n o i t a r a p e r pe s u r o f y d a e rn i n o i t a r t n e c- n o c m u m i x a M
s t r a p y d o B , e p y t t c u d o r P r u o l o C r e b m u n C E r e b m u n S A C
y r a s s o l Gs t n e i d e r g n I n o m m o Cf o e m a N / r e b m u Nx e d n i r u o l o C
e m a N l a c i m e h C s g n i n r a w d n ae s u f o s n o i t i d- n o c f o g n i d r o Ws n o i t i d n o C n o i t a c i f i t n e d i e c n a t s b u S
r e b m u ne c n e r e f e ROfficial Journ alof the EuropeanUnion 22.12.200954 Benzenesulfonic acid, 2,2’-(1,2-
ethenediyl)bis[5-nitro-, disodium salt, 
reaction products with 4-[(4-aminophenyl)azo] benzenesulfonic acid, sodium salts40215 Orange Rinse-off products
55 beta Carotene 40800 230-636-6 Orange Purity criteria as set 
out in Commission Directive 95/45/EC (E160a)
56 8’-apo-.beta.-Caroten-8’-al 40820 Orange Purity criteria as set 
out in Commission Directive 95/45/EC (E 160e)
57 Ethyl 8’-apo-.beta.-caroten-8’-oate 40825 214-173-7 Orange Purity criteria as set 
out in Commission Directive 95/45/EC (E 160f)
58 Canthaxanthin 40850 208-187-2 Orange Purity criteria as set 
out in Commission Directive 95/45/EC (E 161g)
59 Ammonium, (4-(alpha-(p-
(diethylamino)phenyl)-2,4-disulfobenzylidene)-2,5-cyclohexadien-1-ylidene)diethyl-, hydroxide, monosodium 
salt42045 Blue Not to be used in products 
applied on mucous mem­branes
60 Ethanaminium, N-(4-((4-
(diethylamino)phenyl)(5-hydroxy-2,4-disulfophenyl)methylene)-2,5-cyclohexadien-1-ylidene)-N-ethyl-, hydroxide, inner salt, calcium salt (2:1) and its insoluble barium, strontium and zirconium lakes, salts and pigments42051 222-573-8 Blue Purity criteria as set out in Commission Directive 95/45/EC (E 131)
61 Benzene-methanaminium, N-ethyl-N-(4-
((4-(ethyl((3-sulfophenyl)methyl)amino) phenyl)(4-hydroxy-2-sulfophenyl)methylene)-2,5-cyclohexadien-1-ylidene)-3-sulfo-, hydroxide, inner salt, disodium salt42053 GreenN E 2 8 1 / 2 4 3 L
j i h g f e d c b ar e h t O
n o i t a r a p e r pe s u r o f y d a e rn i n o i t a r t n e c- n o c m u m i x a M
s t r a p y d o B , e p y t t c u d o r P r u o l o C r e b m u n C E r e b m u n S A C
y r a s s o l Gs t n e i d e r g n I n o m m o Cf o e m a N / r e b m u Nx e d n i r u o l o C
e m a N l a c i m e h C s g n i n r a w d n ae s u f o s n o i t i d- n o c f o g n i d r o Ws n o i t i d n o C n o i t a c i f i t n e d i e c n a t s b u S
r e b m u ne c n e r e f e ROfficial Journ alof the EuropeanUnion L 342/18362 Hydrogen (benzyl)[4-[[4-
[benzylethylamino]phenyl](2,4-
disulphonatophenyl)methylene]cyclohexa-2,5-dien-1-ylidene](ethyl)ammonium, sodium salt42080 Blue Rinse-off products
63 Benzene-methanaminium, N-ethyl-N-(4-
((4-(ethyl((3-sulfophenyl)methyl)amino) phenyl)(2-sulfophenyl)methylene)-2,5-
cyclohexadien-1-ylidene)-3-sulfo-, hydrox­
ide, inner salt, disodium salt42090 223-339-8 Blue Purity criteria as set 
out in Commission Directive 95/45/EC 
(E 133)
64 Hydrogen [4-[(2-chlorophenyl)[4-[ethyl 
(3-sulphonatobenzyl)amino]phenyl] 
methylene]cyclohexa-2,5-dien-1-ylidene](ethyl)(3-sulphonatobenzyl)ammonium, sodium salt42100 Green Rinse-off products
65 Hydrogen [4-[(2-chlorophenyl)[4-[ethyl(3-
sulphonatobenzyl)amino]-o-tolyl]methylene]-3-methylcyclohexa-2,5-dien-1-ylidene](ethyl)(3-sulphonatobenzyl)ammonium, sodium salt42170 Green Rinse-off products
66 (4-(4-Aminophenyl)(4-iminocyclohexa-
2,5-dienylidene)methyl)-2-methylaniline hydrochloride42510 Violet Not to be used in products applied on mucous mem­branes
67 4-[(4-Amino-m-tolyl)(4-imino-3-
methylcyclohexa-2,5-dien-1-ylidene)methyl]-o-toluidine monohydrochloride42520 Violet Rinse-off products 5ppm
68 Hydrogen [4-[[4-(diethylamino)phenyl][4-
[ethyl[(3-sulphonatobenzyl)amino]-o-tolyl]methylene]-3-methylcyclohexa-2,5-dien-1-ylidene](ethyl)(3-sulphonatobenzyl)ammonium, sodium salt42735 Blue Not to be used in products applied on mucous mem­branesN E 9 0 0 2 . 2 1 . 2 2
j i h g f e d c b ar e h t O
n o i t a r a p e r pe s u r o f y d a e rn i n o i t a r t n e c- n o c m u m i x a M
s t r a p y d o B , e p y t t c u d o r P r u o l o C r e b m u n C E r e b m u n S A C
y r a s s o l Gs t n e i d e r g n I n o m m o Cf o e m a N / r e b m u Nx e d n i r u o l o C
e m a N l a c i m e h C s g n i n r a w d n ae s u f o s n o i t i d- n o c f o g n i d r o Ws n o i t i d n o C n o i t a c i f i t n e d i e c n a t s b u S
r e b m u ne c n e r e f e ROfficial Journ alof the EuropeanUnion 22.12.200969 [4-[[4-Anilino-1-naphthyl][4-
(dimethylamino)phenyl]methylene] 
cyclohexa-2,5-dien-1-ylidene]dimethylammonium chloride44045 Blue Not to be used in products applied on mucous mem­branes
70 Hydrogen [4-[4-(dimethylamino)-.alpha.-
(2-hydroxy-3,6-disulphonato-1-naphthyl)benzylidene]cyclohexa-2,5-dien-1-ylidene]dimethylammonium, monosodium salt44090 221-409-2 Green Purity criteria as set 
out in Commission Directive 95/45/EC (E 142)
71 Hydrogen 3,6-bis(diethylamino)-9-(2,4-
disulphonatophenyl)xanthylium, sodium salt45100 Red Rinse-off products
72 Hydrogen 9-(2-carboxylatophenyl)-3-(2-
methylanilino)-6-(2-methyl-4-sulphoanilino)xanthylium, monosodium salt45190 Violet Rinse-off products
73 Hydrogen 9-(2,4-disulphonatophenyl)-
3,6-bis(ethylamino)-2,7-dimethylxanthylium, monosodium salt45220 Red Rinse-off products
74 Disodium 2-(3-oxo-6-oxidoxanthen-9-
yl)benzoate45350 Yellow 6 %
75 4’,5’-Dibromo-3’,6’-
dihydroxyspiro[isobenzofuran-1(3H),9’-[9H]xanthene]-3-one and its insoluble barium, strontium and zirconium lakes, 
salts and pigments45370 Orange Not more than 1 % 
2-(6-hydroxy-3-oxo-3H-xanthen-9-y1) benzoic acid and 2 % 
2-(bromo-6-hydroxy-
3-oxo-3H-xanthen-9-yl) benzoic acid
76 Disodium 2-(2,4,5,7-tetrabromo-6-oxido-
3-oxoxanthen-9-yl)benzoate and its insoluble barium, strontium and zirco­nium lakes, salts and pigments45380 Red Not more than 1 % 2-(6-hydroxy-3-oxo-3H-xanthen-9-y1) benzoic acid and 2 % 2-(bromo-6-hydroxy-3-oxo-3H-xanthen-9-yl) benzoic acid
77 3’,6’-Dihydroxy-4’,5’-
dinitrospiro[isobenzofuran-1(3H),9’-[9H]xanthene]-3-one45396 Orange 1 %, when used in lip productsOnly in free acid form, when used in lip productsN E 4 8 1 / 2 4 3 L
j i h g f e d c b ar e h t O
n o i t a r a p e r pe s u r o f y d a e rn i n o i t a r t n e c- n o c m u m i x a M
s t r a p y d o B , e p y t t c u d o r P r u o l o C r e b m u n C E r e b m u n S A C
y r a s s o l Gs t n e i d e r g n I n o m m o Cf o e m a N / r e b m u Nx e d n i r u o l o C
e m a N l a c i m e h C s g n i n r a w d n ae s u f o s n o i t i d- n o c f o g n i d r o Ws n o i t i d n o C n o i t a c i f i t n e d i e c n a t s b u S
r e b m u ne c n e r e f e ROfficial Journ alof the EuropeanUnion L 342/18578 Dipotassium 3,6-dichloro-2-(2,4,5,7-
tetrabromo-6-oxido-3-oxoxanthen-9-
yl)benzoate45405 Red Not to be used in eye prod­uctsNot more than 1 % 2-(6-hydroxy-3-oxo-3Η xanthen-9-yl) benzoic acid and 2 % 2-(bromo-6-hydroxy-3-oxo-3H-xanthen-9-yl) benzoic acid
79 3,4,5,6-Tetrachloro-2-(1,4,5,8-
tetrabromo-6-hydroxy-3-oxoxanthen-9-yl)benzoic acid and its insoluble barium, strontium and zirconium lakes, salts and pigments45410 Red Not more than 1 % 
2-(6-hydroxy-3-
oxo-3Η xanthen-9-yl) benzoic acid and 2 % 2-(bromo-6-hydroxy-3-oxo-3H-xanthen-9-yl) benzoic acid
80 Disodium 2-(2,4,5,7-tetraiodo-6-oxido-3-
oxoxanthen-9-yl)benzoate and its insoluble barium, strontium and zirco­nium lakes, salts and pigments45430 240-474-8 Red Purity criteria as set out in Commission Directive 95/45/EC (E 127)
81 1,3-Isobenzofurandione, reaction prod­
ucts with methylquinoline and quinoline47000 Yellow Not to be used in products applied on mucous mem­branes
82 1H-Indene-1,3(2H)-dione, 2-(2-
quinolinyl)-, sulfonated, sodium salts47005 305-897-5 Yellow Purity criteria as set 
out in Commission Directive 95/45/EC (E 104)
83 Hydrogen 9-[(3-methoxyphenyl)amino]-
7-phenyl-5-(phenylamino)-4,10-disulphonatobenzo[a]phenazinium, sodium salt50325 Violet Rinse-off products
84 Sulfonated nigrosine color 50420 Black Not to be used in products 
applied on mucous mem­branes
85 8,18-Dichloro-5,15-diethyl-5,15-
dihydrodiindolo[3,2-b:3’,2’-m]triphenodioxazine51319 Violet Rinse-off products
86 1,2-Dihydroxyanthraquinone 58000 Red
87 Trisodium 8-hydroxypyrene-1,3,6-
trisulphonate59040 Green Not to be used in products applied on mucous mem­branesN E 9 0 0 2 . 2 1 . 2 2
j i h g f e d c b ar e h t O
n o i t a r a p e r pe s u r o f y d a e rn i n o i t a r t n e c- n o c m u m i x a M
s t r a p y d o B , e p y t t c u d o r P r u o l o C r e b m u n C E r e b m u n S A C
y r a s s o l Gs t n e i d e r g n I n o m m o Cf o e m a N / r e b m u Nx e d n i r u o l o C
e m a N l a c i m e h C s g n i n r a w d n ae s u f o s n o i t i d- n o c f o g n i d r o Ws n o i t i d n o C n o i t a c i f i t n e d i e c n a t s b u S
r e b m u ne c n e r e f e ROfficial Journ alof the EuropeanUnion 22.12.200988 1-Anilino-4-hydroxyanthraquinone 60724 Violet Rinse-off products
89 1-Hydroxy-4-(p-toluidino)anthraquinone 60725 Violet
90 Sodium 4-[(9,10-dihydro-4-hydroxy-9,10-
dioxo-1-anthryl)amino]toluene-3-
sulphonate60730 Violet Not to be used in products applied on mucous mem­branes
91 1,4-bis(p-Tolylamino)anthraquinone 61565 Green
92 Disodium 2,2’-(9,10-dioxoanthracene-1,4-
diyldiimino)bis(5-methylsulphonate)61570 Green
93 Sodium 3,3’-(9,10-dioxoanthracene-1,4-
diyldiimino)bis(2,4,6-trimethylbenzenesulphonate)61585 Blue Rinse-off products
94 Sodium 1-amino-4-(cyclohexylamino)-
9,10-dihydro-9,10-dioxoanthracene-2-sulphonate62045 Blue Rinse-off products
95 6,15-Dihydroanthrazine-5,9,14,18-
tetrone69800 Blue
96 7,16-dichloro-6,15-dihydroanthrazine-
5,9,14,18-tetrone69825 Blue
97 Bisbenzimidazo[2,1-b:2’,1’-
i]benzo[lmn][3,8]phenanthroline-8,17-dione71105 Orange Not to be used in products 
applied on mucous mem­
branes
98 2-(1,3-Dihydro-3-oxo-2H-indazol-2-
ylidene)-1,2-dihydro-3H-indol-3-one73000 Blue
99 Disodium 5,5’-(2-(1,3-dihydro-3-oxo-2H-
indazol-2-ylidene)-1,2-dihydro-3H-indol-3-one)disulphonate73015 212-728-8 Blue Purity criteria as set 
out in Commission Directive 95/45/EC (E 132)
100 6-Chloro-2-(6-chloro-4-methyl-3-
oxobenzo[b]thien-2(3H)-ylidene)-4-methylbenzo[b]thiophene-3(2H)-one73360 RedN E 6 8 1 / 2 4 3 L
j i h g f e d c b ar e h t O
n o i t a r a p e r pe s u r o f y d a e rn i n o i t a r t n e c- n o c m u m i x a M
s t r a p y d o B , e p y t t c u d o r P r u o l o C r e b m u n C E r e b m u n S A C
y r a s s o l Gs t n e i d e r g n I n o m m o Cf o e m a N / r e b m u Nx e d n i r u o l o C
e m a N l a c i m e h C s g n i n r a w d n ae s u f o s n o i t i d- n o c f o g n i d r o Ws n o i t i d n o C n o i t a c i f i t n e d i e c n a t s b u S
r e b m u ne c n e r e f e ROfficial Journ alof the EuropeanUnion L 342/187101 5-Chloro-2-(5-chloro-7-methyl-3-
oxobenzo[b]thien-2(3H)-ylidene)-7-
methylbenzo[b]thiophene-3(2H)-one73385 Violet
102 5,12-Dihydroquino[2,3-b]acridine-7,14-
dione73900 Violet Rinse-off products
103 5,12-Dihydro-2,9-dimethylquino[2,3-
b]acridine-7,14-dione73915 Red Rinse-off products
104 29H,31H-Phthalocyanine 74100 Blue Rinse-off products
105 29H,31H-Phthalocyaninato(2-)-
N29,N30,N31,N32 copper74160 Blue
106 Disodium [29H,31H-
phthalocyaninedisulphonato (4-)-N29,N30,N31,N32] cuprate (2-)74180 Blue Rinse-off products
107 Polychloro copper phthalocyanine 74260 Green Not to be used in eye prod­
ucts
108 8,8’-diapo-.psi.,.psi.-Carotenedioic acid 75100 Yellow
109 Annatto 75120 215-735-4/ 289-561-2/ 230-248-7Orange Purity criteria as set out in Commission Directive 95/45/EC (E 160b)
110 Lycopene 75125 — Yellow Purity criteria as set 
out in Commission Directive 95/45/EC (E 160d)
111 CI Food Orange 5 75130 214-171-6 Orange Purity criteria as set 
out in Commission Directive 95/45/EC (E 160a)
112 (3R)-beta-4-Caroten-3-ol 75135 Yellow
113 2-Amino-1,7-dihydro-6H-purin-6-one 75170 WhiteN E 9 0 0 2 . 2 1 . 2 2
j i h g f e d c b ar e h t O
n o i t a r a p e r pe s u r o f y d a e rn i n o i t a r t n e c- n o c m u m i x a M
s t r a p y d o B , e p y t t c u d o r P r u o l o C r e b m u n C E r e b m u n S A C
y r a s s o l Gs t n e i d e r g n I n o m m o Cf o e m a N / r e b m u Nx e d n i r u o l o C
e m a N l a c i m e h C s g n i n r a w d n ae s u f o s n o i t i d- n o c f o g n i d r o Ws n o i t i d n o C n o i t a c i f i t n e d i e c n a t s b u S
r e b m u ne c n e r e f e ROfficial Journ alof the EuropeanUnion 22.12.2009114 Curcumins 75300 207-280-5 Yellow Purity criteria as set 
out in Commission 
Directive 95/45/EC (E 100)
115 Carmines 75470 215-680-6/ 215-023-3/ 215-724-4Red Purity criteria as set out in Commission Directive 95/45/EC (E 120)
116 Trisodium (2S-trans)-[18-carboxy-20-
(carboxymethyl)-13-ethyl-2,3-dihydro-3,7,12,17-tetramethyl-8-vinyl-21H,23H-porphine-2-propionato(5-)-N21,N22,N23,N24]cuprate(3-) (Chlorophylls)75810 215-800-7/ 207-536-6/ 208-272-4/ 287-483-3/ 239-830-5/ 246-020-5Green Purity criteria as set out in Commission Directive 95/45/EC (E 140, E 141)
117 Aluminium 77000 231-072-3 White Purity criteria as set 
out in Commission Directive 95/45/EC (E 173)
118 Aluminium hydroxide sulphate 77002 White
119 Natural hydrated aluminium silicate, 
Al
2O3.2SiO2.2H2O, containing calcium, 
magnesium or iron carbonates, ferric hydroxide, quartz-sand, mica, etc. as impurities77004 White
120 Lazurite 77007 Blue
121 Aluminum silicate coloured with ferric 
oxide77015 Red
122 Barium sulfate 77120 White
123 Bismuth chloride oxide 77163 WhiteN E 8 8 1 / 2 4 3 L
j i h g f e d c b ar e h t O
n o i t a r a p e r pe s u r o f y d a e rn i n o i t a r t n e c- n o c m u m i x a M
s t r a p y d o B , e p y t t c u d o r P r u o l o C r e b m u n C E r e b m u n S A C
y r a s s o l Gs t n e i d e r g n I n o m m o Cf o e m a N / r e b m u Nx e d n i r u o l o C
e m a N l a c i m e h C s g n i n r a w d n ae s u f o s n o i t i d- n o c f o g n i d r o Ws n o i t i d n o C n o i t a c i f i t n e d i e c n a t s b u S
r e b m u ne c n e r e f e ROfficial Journ alof the EuropeanUnion L 342/189124 Calcium carbonate 77220 207-439-9/ 
215-279-6White Purity criteria as set 
out in Commission Directive 95/45/EC (E 170)
125 Calcium sulfate 77231 White
126 Carbon black 77266 215-609-9 Black Purity criteria as set 
out in Commission 
Directive 95/45/EC 
(E 153)
127 Charcoal, bone. A fine black powder 
obtained by burning animal bones in a closed container. It consists primarily of calcium phosphate and carbon77267 Black
128 Coke black 77268:1 Black
129 Chromium (III) oxide 77288 Green free from chromate 
ion
130 Chromium (III) hydroxide 77289 Green free from chromate 
ion
131 Cobalt Aluminum Oxide 77346 Green
132 Copper 77400 Brown
133 Gold 77480 231-165-9 Brown Purity criteria as set 
out in Commission Directive 95/45/EC (E 175)
134 Iron oxide 77489 Orange
135 Iron Oxide Red 77491 215-168-2 Red Purity criteria as set 
out in Commission Directive 95/45/EC (E 172)N E 9 0 0 2 . 2 1 . 2 2
j i h g f e d c b ar e h t O
n o i t a r a p e r pe s u r o f y d a e rn i n o i t a r t n e c- n o c m u m i x a M
s t r a p y d o B , e p y t t c u d o r P r u o l o C r e b m u n C E r e b m u n S A C
y r a s s o l Gs t n e i d e r g n I n o m m o Cf o e m a N / r e b m u Nx e d n i r u o l o C
e m a N l a c i m e h C s g n i n r a w d n ae s u f o s n o i t i d- n o c f o g n i d r o Ws n o i t i d n o C n o i t a c i f i t n e d i e c n a t s b u S
r e b m u ne c n e r e f e ROfficial Journ alof the EuropeanUnion 22.12.2009136 Iron Oxide Yellow 77492 51274-00-1 257-098-5 Yellow Purity criteria as set 
out in Commission 
Directive 95/45/EC (E 172)
137 Iron Oxide Black 77499 235-442-5 Black Purity criteria as set 
out in Commission Directive 95/45/EC (E 172)
138 Ferric Ammonium Ferrocyanide 77510 Blue free from cyanide ions
139 Magnesium carbonate 77713 White
140 Ammonium manganese(3+) diphosphate 77742 Violet
141 Trimanganese bis (orthophosphate) 77745 Red
142 Silver 77820 231-131-3 White Purity criteria as set 
out in Commission Directive 95/45/EC (E 174)
143 Titanium dioxide (
1) 77891 236-675-5 White Purity criteria as set 
out in Commission Directive 95/45/EC (E 171)
144 Zinc oxide 77947 White
145 Riboflavin Lactoflavin 201-507-1/ 
204-988-6Yellow Purity criteria as set out in Commission Directive 95/45/EC (E 101)
146 Caramel Caramel 232-435-9 Brown Purity criteria as set 
out in Commission Directive 95/45/EC (E 150a-d)N E 0 9 1 / 2 4 3 L
j i h g f e d c b ar e h t O
n o i t a r a p e r pe s u r o f y d a e rn i n o i t a r t n e c- n o c m u m i x a M
s t r a p y d o B , e p y t t c u d o r P r u o l o C r e b m u n C E r e b m u n S A C
y r a s s o l Gs t n e i d e r g n I n o m m o Cf o e m a N / r e b m u Nx e d n i r u o l o C
e m a N l a c i m e h C s g n i n r a w d n ae s u f o s n o i t i d- n o c f o g n i d r o Ws n o i t i d n o C n o i t a c i f i t n e d i e c n a t s b u S
r e b m u ne c n e r e f e ROfficial Journ alof the EuropeanUnion L 342/191147 Paprika extract, Capsanthin, capsorubin Capsanthin, cap­
sorubin207-364-1/ 
207-425-2Orange Purity criteria as set 
out in Commission Directive 95/45/EC (E 160c)
148 Beetroot red Beetroot Red 7659-95-2 231-628-5 Red Purity criteria as set 
out in Commission Directive 95/45/EC (E 162)
149 Anthocyanins
(Cyanidin,
PeonidinMalvidinDelphinidinPetunidinPelargonidin)Anthocyanins 528-58-5
134-01-0
528-53-0643-84-5134-04-3208-438-6
205-125-6
211-403-8208-437-0—205-127-7Red Purity criteria as set 
out in Commission 
Directive 95/45/EC 
(E 163)
150 Aluminium, zinc, magnesium and calcium 
stearatesAluminum stearate
Zinc stearateMagnesium stearateCalcium stearate7047-84-9557-05-1557-04-0216-472-8230-325-5209-151-9209-150-3216-472-8White
151 Phenol, 4,4’-(3H-2,1-benzoxathiol-3-
ylidene)bis[2-bromo-3-methyl-6-(1-
methylethyl)-, S,S-dioxideBromothymol blue 76-59-5 200-971-2 Blue Rinse-off products
152 Phenol, 4,4’-(3H-2,1-benzoxathiol-3-
ylidene)bis[2,6-dibromo-3-methyl-,S,S-
dioxideBromocresol green 76-60-8 200-972-8 Green Rinse-off products
153 Sodium 4-[(4,5-dihydro-3-methyl-5-oxo-
1-phenyl-1H-pyrazol-4-yl)azo]-3-hydroxynaphthalene-1-sulphonateAcid red 195 12220-24-5 — Red Not to be used in products 
applied on mucous mem­branes
(1)For use as a UV-Filter, see Annex VI, No. 27.N E 9 0 0 2 . 2 1 . 2 2
j i h g f e d c b ar e h t O
n o i t a r a p e r pe s u r o f y d a e rn i n o i t a r t n e c- n o c m u m i x a M
s t r a p y d o B , e p y t t c u d o r P r u o l o C r e b m u n C E r e b m u n S A C
y r a s s o l Gs t n e i d e r g n I n o m m o Cf o e m a N / r e b m u Nx e d n i r u o l o C
e m a N l a c i m e h C s g n i n r a w d n ae s u f o s n o i t i d- n o c f o g n i d r o Ws n o i t i d n o C n o i t a c i f i t n e d i e c n a t s b u S
r e b m u ne c n e r e f e RANNEX V
LIST OF PRESERVATIVES ALLOWED IN COSMETIC PRODUCTS
Preamble
1. For the purposes of this list: —‘Salts’ is taken to mean: salts of the cations sodium, potassium, calcium, magnesium, ammonium and ethanolamines; salts of the anions chloride, bromide, sulphate, acetate.
—‘Esters’ is taken to mean: esters of methyl, ethyl, propyl, isopropyl, butyl, isobutyl, phenyl.
2. All finished products containing formaldehyde or substances in this Annex and which release formaldehyde must be labelled with the warning ‘contains formaldehyde’ where the concentration of formaldehyde in
the finished product exceeds 0,05 %.
S a
be n
29 0 0 2 . 2 1 . 2 2 n o i n U n a e p o r u E e h t f o l a n r u o J l a i c i f f O N E 2 9 1 / 2 4 3 L
) d i c a ( % 5 , 0
2 - 3 9 2 - 2 0 2, 6 - 1 6 3 - 3 1 2, 3 - 1 0 4 - 4 0 2, 7 - 2 5 2 - 5 0 2, 8 - 0 2 0 - 9 1 2, 3 - 4 8 2 - 2 0 2, 7 - 9 5 2 - 2 0 2, 2 - 7 8 3 - 4 2 2, 2 - 5 4 0 - 9 0 2, 3 - 1 8 4 - 9 0 2, 4 - 5 3 2 - 8 1 2, 9 - 8 6 4 - 7 1 2
2 - 9 9 - 3 9, 0 - 8 4 - 9 3 9 , 3 - 0 5 - 0 2 1 , 7 - 0 6 - 6 3 1, 6 - 8 6 - 5 1 3 2 , 0 - 9 8 - 3 9 , 3 - 8 5 - 3 9, 0 - 6 6 - 7 3 3 4 , 8 - 0 7 - 3 5 5 , 2 - 5 2- 2 8 5 , 3 - 5 0 - 0 9 0 2 , 4 - 3 6 - 3 6 8 1
e t a o z n e b l y n- e h p , e t a o z n e b l y p o r p o s i , e t a o z- n e b l y t u b o s i , e t a o z n e b l y t u b, e t a o z n e b l y p o r p , e t a o z n e b l y h t e, e t a o z n e b l y h t e m , e t a o z n e b- A E M , e t a o z n e b m u i s e n g a m, e t a o z n e b m u i s s a t o p , e t a o z n e bm u i c l a c , e t a o z n e b m u i n o m m A
d i c a c i o z n e b f o s r e t s e d n a 1 r e b- m u n e c n e r e f e r r e d n u d e t s i l t a h tn a h t r e h t o d i c a c i o z n e b f o s t l a S a 1) d i c a ( % 5 , 0 s t c u d o r p n o - e v a e L) d i c a ( % 7 , 1 s t c u d o r p l a r O) d i c a ( % 5 ,
s t c u- d o r p l a r o t p e c x e, s t c u d o r p f f o - e s n i R
8 - 4 3 5 - 8 0 22 - 8 1 6 - 0 0 2
1 - 2 3 - 2 3 50 - 5 8 - 5 6
e t a o z n e B m u i d o Sd i c a c i o z n e B t l a s m u i d o s s t i d n a d i c a c i o z n e B 1i h g f e d c b ar e h t O
n o i t a r a p e r pe s u r o f y d a e rn i n o i t a r t n e c n o cm u m i x a M
s t r a py d o B , e p y t t c u d o r Pr e b m u C E r m u n S A Cy r a s s o l G s t n e i d e r g n In o m m o C f o e m a NN N I / e m a n l a c i m e h C s g n i n r a w d n ae s u f o s n o i t i d n o cf o g n i d r o Ws n o i t i d n o C n o i t a c i f i t n e d i e c n t s b u
r e b m u ne c n e r e f e ROfficial Journ alof the EuropeanUnion L 342/1932 Propionic acid and its salts Propionic acid, ammonium pro­
pionate, calcium propionate,
magnesium propionate, potas­sium propionate, sodium propi­onate79-09-4, 17496-08-1, 4075-81-4, 557-27-7, 327-62-8, 137-40-6201-176-3,241-503-7,223-795-8,209-166-0,206-323-5,205-290-42 % (acid)
3 Salicylic acid (
1) and its salts Salicylic acid, calcium salicylate,
magnesium salicylate, MEA-salicylate, sodium salicylate,potassium salicylate, TEA-salicylate69-72-7, 824-35-1, 18917-89-0, 59866-70-5, 54-21-7,578-36-9, 2174-16-5200-712-3,212-525-4,242-669-3,261-963-2,200-198-0,209-421-6,218-531-30,5 % (acid) Not to be usedin products forchildren under3 years of age,except forshampoosNot to be usedfor childrenunder 3 years ofage (
2)
4 Hexa-2,4-dienoic acid and its saltsSorbic acid, calcium sorbate, sodium sorbate, potassium sor­bate110-44-1, 7492-55-9, 7757-81-5, 24634-61-5203-768-7, 231-321-6, 231-819-3, 
246-376-10,6 % (acid)
5 Formal-dehyde, paraformalde­
hyde (
3)Formaldehyde
Paraformaldehyde50-00-0, 30525-89-4 200-001-8 Oral products 0,1 % (free 
formaldehyde)Not to be used in aerosol dis­pensers (sprays)
Other products 0,2 % (free formaldehyde)
6 Moved or deleted
7 Biphenyl-2-ol, and its salts o-Phenylphenol, sodium 
o-phenylphenate, potassium o-phenylphenate, MEA o-phenylphenate90-43-7, 132-27-4, 13707-65-8, 84145-04-0201-993-5, 205-055-6, 237-243-9, 282-227-70,2 % (as phe­nol)
8 Pyrithione zinc  (
4) Zinc pyrithione 13463-41-7 236-671-3 Hair products 1,0 % Only in rinse-off products
Not to be used 
in oral products Other products 0,5 %N E 9 0 0 2 . 2 1 . 2 2
i h g f e d c b ar e h t O
n o i t a r a p e r pe s u r o f y d a e rn i n o i t a r t n e c n o cm u m i x a M
s t r a py d o B , e p y t t c u d o r Pr e b m u n C E r e b m u n S A Cy r a s s o l G s t n e i d e r g n In o m m o C f o e m a NN N I / e m a n l a c i m e h C s g n i n r a w d n ae s u f o s n o i t i d n o cf o g n i d r o Ws n o i t i d n o C n o i t a c i f i t n e d i e c n a t s b u S
r e b m u ne c n e r e f e ROfficial Journ alof the EuropeanUnion 22.12.20099 Inorganic sulphites and 
hydrogen- sulphites (5)Sodium sulfite, ammonium bisulfite, ammonium sulfite, potassium sulfite, potassium hydrogen sulfite, sodium bisulfite, sodium metabisulfite, potassium metabisulfite7757-83-7, 10192-30-0, 10196-04-0, 10117-38-1, 7773-03-7, 7631-90-5, 7681-57-4, 16731-55-8231-821-4, 233-469-7, 233-484-9, 233-321-1, 231-870-1, 231-548-0, 231-673-0, 240-795-30,2 % (as free SO
2)
10 Moved or deleted
11 Chlorobutanol Chlorobutanol 57-15-8 200-317-6 0,5 % Not to be used 
in aerosol dis­pensers (sprays)Contains Chlo­robutanol
12 4-Hydroxybenzoic acid and its salts and esters4-Hydroxybenzoic acid, meth­ylparaben, butylparaben, potas­sium ethylparaben, potassium paraben, propylparaben, isobu­tylparaben, sodium methylpara­ben, sodium ethylparaben, sodium propylparaben, sodium butylparaben, sodium isobu­tylparaben, ethylparaben, sodium paraben, isopropylpara­ben, potassium methylparaben, potassium butylparaben, potas­sium propylparaben, sodium propylparaben, calcium para­ben, phenylparaben99-96-7, 99-76-3, 94-26-8, 36457-19–9,16782-08-4, 94-13-3, 4247-02-3, 5026-62-0, 35285-68-8, 35285-69-9, 36457-20-2, 84930-15-4, 120-47-8, 114-63-6, 4191-73-5, 2611-07-2, 38566-94-8, 84930-17-4, 35285-69-9, 69959-44-0, 17696-62-7202-804-9, 202-785-7, 202-318-7, 253-048-1, 240-830-2, 202-307-7, 224-208-8, 225-714-1, 252-487-6, 252-488-1, 253-049-7, 284-595-4, 204-399-4, 204-051-1, 224-069-3, 
247-464-2, 
254-009-1, 284-597-5, 252-488-1, 274-235-4, 241-698-90,4 % (as acid) for single ester,
0,8 % (as acid) 
for mixtures of esters
13 3-Acetyl-6-methylpyran-2,4 (3H)-dione and its saltsDehydroacetic acid, sodium dehydroacetate520-45-6, 4418-26-2, 16807-48-0208-293-9, 224-580-10,6 % (as acid) Not to be used in aerosol dis­pensers (sprays)
14 Formic acid and its sodium salt Formic acid, sodium formate 64-18-6, 141-53-7 200-579-1, 205-488-00,5 % (as acid)N E 4 9 1 / 2 4 3 L
i h g f e d c b ar e h t O
n o i t a r a p e r pe s u r o f y d a e rn i n o i t a r t n e c n o cm u m i x a M
s t r a py d o B , e p y t t c u d o r Pr e b m u n C E r e b m u n S A Cy r a s s o l G s t n e i d e r g n In o m m o C f o e m a NN N I / e m a n l a c i m e h C s g n i n r a w d n ae s u f o s n o i t i d n o cf o g n i d r o Ws n o i t i d n o C n o i t a c i f i t n e d i e c n a t s b u S
r e b m u ne c n e r e f e ROfficial Journ alof the EuropeanUnion L 342/19515 3,3’-Dibromo-4,4’-
hexamethylenedioxydi-benzamidine and its salts (including isethionate)Dibromohexamidine Isethionate 93856-83-8 299-116-4 0,1 %
16 Thiomersal Thimerosal 54-64-8 200-210-4 Eye products 0,007 % (of Hg)
If mixed with 
other mercurial 
compounds authorised by this Regulation, the maximum concentration of Hg remains fixed at 0,007 %Contains Thi­omersal
17 Phenylmercuric salts (including borate)Phenyl Mercuric Acetate, Phenyl Mercuric Benzoate62-38-4, 94-43-9 200-532-5, 202-331-8Eye products 0,007 % (of Hg)
If mixed with 
other mercurial compounds authorised by this Regulation, the maximum 
concentration 
of Hg remains fixed at 0,007 %Contains Phe­nylmercuric compounds
18 Undec-10-enoic acid and its saltsUndecylenic acid, potassium undecylenate, sodium unde­cylenate, calcium undecylenate, TEA-undecylenate, MEA-undecylenate112-38-9, 6159-41-7, 3398-33-2, 1322-14-1, 84471-25-0, 56532-40-2203-965-8, 222-264-8, 215-331-8, 282-908-9, 260-247-70,2 % (as acid)
19 5- Pyrimidinamine, 1,3-bis (2-ethylhexyl) hexahydro-5-methyl-Hexetidine 141-94-6 205-513-5 0,1 %N E 9 0 0 2 . 2 1 . 2 2
i h g f e d c b ar e h t O
n o i t a r a p e r pe s u r o f y d a e rn i n o i t a r t n e c n o cm u m i x a M
s t r a py d o B , e p y t t c u d o r Pr e b m u n C E r e b m u n S A Cy r a s s o l G s t n e i d e r g n In o m m o C f o e m a NN N I / e m a n l a c i m e h C s g n i n r a w d n ae s u f o s n o i t i d n o cf o g n i d r o Ws n o i t i d n o C n o i t a c i f i t n e d i e c n a t s b u S
r e b m u ne c n e r e f e ROfficial Journ alof the EuropeanUnion 22.12.200920 5-Bromo-5-nitro-1,3-dioxane 5-Bromo-5-nitro-1,3-dioxane 30007-47-7 250-001-7 Rinse-off products 0,1 % Avoid forma­
tion of nitro­samines
21 Bronopol 2-Bromo-2-nitropropane-1,3-diol52-51-7 200-143-0 0,1 % Avoid forma­tion of nitro­samines
22 2,4-Dichlorobenzyl alcohol Dichlorobenzyl Alcohol 1777-82-8 217-210-5 0,15 %
23 1-(4-Chlorophenyl)-3-(3,4-dichlorophenyl) urea (
6)Triclocarban 101-20-2 202-924-1 0,2 % Purity criteria:
3,3’,4,4’-Tetrachloroa­zobenzene < 1 ppm
3,3’,4,4’-
Tetrachloroa­zoxybenzene 
< 1 ppm
24 Chlorocresol p-Chloro-m-Cresol 59-50-7 200-431-6 Not to be used in 
products applied 
on mucuous mem­branes0,2 %
25 5-Chloro-2- (2,4- dichlorophe­noxy) phenolTriclosan 3380-34-5 222-182-2 0,3 %
26 Chloro-xylenol Chloroxylenol 88-04-0 201-793-8 0,5 %
27 N,N″-methylenebis[N′-[3-(hydroxymethyl)-2,5-dioxoimidazolidin-4-yl]urea]Imidazolidinyl urea 39236-46-9 254-372-6 0,6 %
28 Poly(methylene),.alpha.,.omega.-bis[[[(aminoiminomethyl)ami­no]iminomethyl] amino]-, dihydrochloridePolyaminopropyl biguanide 70170-61-5, 28757-47-3, 133029-32-00,3 %
29 2-Phenoxyethanol Phenoxyethanol 122-99-6 204-589-7 1,0 %
30 Methenamine Methenamine 100-97-0 202-905-8 0,15 %N E 6 9 1 / 2 4 3 L
i h g f e d c b ar e h t O
n o i t a r a p e r pe s u r o f y d a e rn i n o i t a r t n e c n o cm u m i x a M
s t r a py d o B , e p y t t c u d o r Pr e b m u n C E r e b m u n S A Cy r a s s o l G s t n e i d e r g n In o m m o C f o e m a NN N I / e m a n l a c i m e h C s g n i n r a w d n ae s u f o s n o i t i d n o cf o g n i d r o Ws n o i t i d n o C n o i t a c i f i t n e d i e c n a t s b u S
r e b m u ne c n e r e f e ROfficial Journ alof the EuropeanUnion L 342/19731 Methenamine 
3-chloroallylochlorideQuaternium-15 4080-31-3 223-805-0 0,2 %
32 1-(4-Chlorophenoxy)-1-(imidazol-1-yl)-3,3-dimethylbutan-2-oneClimbazole 38083-17-9 253-775-4 0,5 %
33 1,3-Bis (hydroxymethyl)-5,5-dimethylimidazolidine-2,4-dioneDMDM Hydantoin 6440-58-0 229-222-8 0,6 %
34 Benzyl alcohol (
7) Benzyl alcohol 100-51-6 202-859-9 1,0 %
35 1-Hydroxy-4-methyl-6-(2,4,4-trimethylpentyl) 2-pyridon and its monoethanolamine salt1-Hydroxy-4-methyl-6-(2,4,4-trimethylpentyl) 2-pyridon, Piroctone Olamine50650-76-5, 68890-66-4 272-574-2 Rinse-off products 1,0 %
Other products 0,5 %
36 Moved or deleted
37 2,2’-methylenebis(6-bromo-4-chlorophenol)Bromochlorophene 15435-29-7 239-446-8 0,1 %
38 4-Isopropyl-m-cresol o-Cymen-5-ol 3228-02-2 221-761-7 0,1 %
39 Mixture of 5-Chloro-2-methyl-isothiazol-3(2H)-one and 2-methylisothiazol-3(2H)-one with magnesium chloride and magne­sium nitrateMethylchloroisothiazolinone and Methylisothiazolinone26172-55-4, 2682-20-4, 55965-84-9247-500-7, 220-239-60,0015 % (of a mixture in the ratio 3:1 of 5-chloro-2-methylisothia­zol 3(2H)-one and 2-methyl­isothiazol-3 (2H)-one
40 2-Benzyl-4-chlorophenol Chlorophene 120-32-1 204-385-8 0,2 %
41 2-Chloroacetamide Chloroacetamide 79-07-2 201-174-2 0,3 % Contains chloro­
acetamideN E 9 0 0 2 . 2 1 . 2 2
i h g f e d c b ar e h t O
n o i t a r a p e r pe s u r o f y d a e rn i n o i t a r t n e c n o cm u m i x a M
s t r a py d o B , e p y t t c u d o r Pr e b m u n C E r e b m u n S A Cy r a s s o l G s t n e i d e r g n In o m m o C f o e m a NN N I / e m a n l a c i m e h C s g n i n r a w d n ae s u f o s n o i t i d n o cf o g n i d r o Ws n o i t i d n o C n o i t a c i f i t n e d i e c n a t s b u S
r e b m u ne c n e r e f e ROfficial Journ alof the EuropeanUnion 22.12.200942 N,N″-bis(4-chlorophenyl)-3,12-
diimino-2,4,11,13-tetraazatetradecanediamidine and its digluconate, diacetate and dihydrochlorideChlorhexidine, Chlorhexidine Diacetate, Chlorhexidine Diglu­conate, Chlorhexidine Dihydro­chloride55-56-1, 56-95-1, 18472-51-0, 3697-42-5200-238-7, 200-302-4, 242-354-0, 223-026-60,3 % (as chlo­rhexidine)
43 1-Phenoxypropan-2-ol  (
8)Phenoxyisopropanol 770-35-4 212-222-7 Only for rinse-off 
products1,0 %
44 Alkyl (C  12-22) trimethyl ammo­
nium bromide and chlorideBehentrimonium chloride, cetri­monium bromide, cetrimonium chloride, laurtrimonium bro­mide, laurtrimonium chloride, steartrimonium bromide, steart­rimonium chloride17301-53-0, 57-09-0, 112-02-7, 1119-94-4, 112-00-5, 1120-02-1, 112-03-8241-327-0, 200-311-3, 203-928-6, 214-290-3, 203-927-0, 214-294-5, 203-929-10,1 %
45 4,4-Dimethyl-1,3-oxazolidine Dimethyl Oxazolidine 51200-87-4 257-048-2 0,1 % pH > 6
46 N-(Hydroxymethyl)-N-(dihydroxymethyl-1,3-dioxo-2,5-imidazolidinyl-4)-N’-(hydroxymethyl) ureaDiazolidinyl Urea 78491-02-8 278-928-2 0,5 %
47 Benzenecarboximidamide, 4,4’-(1,6-hexanediylbis (oxy))bis- and its salts (including isethionate and p-hydroxybenzoate)Hexamidine, Hexamidine diisethionate, Hexamidine para­ben3811-75-4, 659-40-5, 93841-83-9211-533-5, 299-055-30,1 %
48 Glutaraldehyde (Pentane-1,5-dial)Glutaral 111-30-8 203-856-5 0,1 % Not to be used in aerosols (sprays)Contains glut­aral (
9)
49 5-Ethyl-3,7-dioxa-1-azabicyclo [3.3.0] octane7-Ethylbicyclooxazolidine 7747-35-5 231-810-4 0,3 % Not to be used 
in oral products and in products applied on mucous mem­branesN E 8 9 1 / 2 4 3 L
i h g f e d c b ar e h t O
n o i t a r a p e r pe s u r o f y d a e rn i n o i t a r t n e c n o cm u m i x a M
s t r a py d o B , e p y t t c u d o r Pr e b m u n C E r e b m u n S A Cy r a s s o l G s t n e i d e r g n In o m m o C f o e m a NN N I / e m a n l a c i m e h C s g n i n r a w d n ae s u f o s n o i t i d n o cf o g n i d r o Ws n o i t i d n o C n o i t a c i f i t n e d i e c n a t s b u S
r e b m u ne c n e r e f e ROfficial Journ alof the EuropeanUnion L 342/19950 3-(p-Chlorophenoxy)-propane-
1,2 diolChlorphenesin 104-29-0 203-192-6 0,3 %
51 Sodium hydroxymethylamino acetateSodium Hydroxymethylglycinate 70161-44-3 274-357-8 0,5 %
52 Silver chloride deposited on 
titanium dioxideSilver chloride 7783-90-6 232-033-3 0,004 % (as 
AgCl)20 % AgCl (w/w) on TiO
2. 
Not to be used 
in products for children under 3 years of age, in oral products and in eye and lip products
53 Benzenemethanaminium, N,N-dimethyl-N-[2-[2-[4-(1,1,3,3,-tetramethylbutyl)phenoxy] ethoxy] ethyl]-, chlorideBenzethonium Chloride 121-54-0 204-479-9 (a) Rinse-off prod­
ucts
(b) Leave-on prod­ucts other than oral products0,1 %
54 Benzalkonium chloride, bro­mide and saccharinate  (
10)Benzalkonium chloride, benza­lkonium bromide, benzalko­nium saccharinate8001-54-5, 63449-41-2, 91080-29-4, 68989-01-5, 68424-85-1, 68391-01-5, 61789-71-7, 85409-22-9264-151-6, 293-522-5, 273-545-7, 270-325-2, 269-919-4, 263-080-8, 287-089-10,1 % (as benza­lkonium chlo­ride)Avoid contact with eyes
55 Methanol, (phenylmethoxy-) Benzylhemiformal 14548-60-8 238-588-8 Rinse-off products 0,15 %N E 9 0 0 2 . 2 1 . 2 2
i h g f e d c b ar e h t O
n o i t a r a p e r pe s u r o f y d a e rn i n o i t a r t n e c n o cm u m i x a M
s t r a py d o B , e p y t t c u d o r Pr e b m u n C E r e b m u n S A Cy r a s s o l G s t n e i d e r g n In o m m o C f o e m a NN N I / e m a n l a c i m e h C s g n i n r a w d n ae s u f o s n o i t i d n o cf o g n i d r o Ws n o i t i d n o C n o i t a c i f i t n e d i e c n a t s b u S
r e b m u ne c n e r e f e ROfficial Journ alof the EuropeanUnion 22.12.200956 3-Iodo-2-
propynylbutylcarbamateIodopropynyl butylcarbamate 55406-53-6 259-627-5 (a) Rinse-off prod­
ucts
(b) Leave-on prod­ucts
(c) Deo-dorants/anti-perspirants(a) 0,02 %
(b) 0,01 %,
(c) 0,0075 %Not to be used in oral and lip products
( a )  N o t  t o  b e  
used in prod­
ucts for chil­dren under 3 years of age, except in bath products/ 
shower gels 
and sham­poo
(b) Not to be used in body lotion and body cream (
13)
(b) and (c)   Not 
to be used in products for children under 3 years of age(a) Not to be used for chil­dren under 3 years of age (
11)
(b) and (c)   Not 
to be used for children under 3 years of age  (
12)
57 2-Methyl-2H-isothiazol-3-one Methylisothiazolinone 2682-20-4 220-239-6 0,01 %
(1)For use other than as a preservative, see Annex III, No. 98. 
(2)Solely for products which might be used for children under 3 years of age and which remain in prolonged contact with the skin.  
(3)For use other than as a preservative, see Annex III, No. 13. 
(4)For use other than as a preservative, see Annex III. No. 101. 
(5)For use other than as a preservative, see Annex III, No. 99. 
(6)For use other than as a preservative, see Annex III, No. 100. 
(7)For use other than as a preservative, see Annex III, No. 45, 68. 
(8)For use other than as a preservative, see Annex III, No. 54. 
(9)Only if the concentration exceeds 0,05 %. 
(10)For use other than as a preservative, see Annex III, No. 65. 
(11)Solely for products, other than bath products/shower gels and shampoo, which might be used for children under 3 years of age.  
(12)Solely for products which might be used for children under 3 years of age.  
(13)Concerns any products aimed to be applied on a large part of the body.N E 0 0 2 / 2 4 3 L
i h g f e d c b ar e h t O
n o i t a r a p e r pe s u r o f y d a e rn i n o i t a r t n e c n o cm u m i x a M
s t r a py d o B , e p y t t c u d o r Pr e b m u n C E r e b m u n S A Cy r a s s o l G s t n e i d e r g n In o m m o C f o e m a NN N I / e m a n l a c i m e h C s g n i n r a w d n ae s u f o s n o i t i d n o cf o g n i d r o Ws n o i t i d n o C n o i t a c i f i t n e d i e c n a t s b u S
r e b m u ne c n e r e f e RANNEX VI
LIST OF UV FILTERS ALLOWED IN COSMETIC PRODUCTS  
b c
N C 
e
4­2- Benz
o 12
0
  
o 
al 
a5
1
 
e6
12
 
6 
%
1 2­ 2- 522 10 
%1 0 2 / 2 4 3 L n o i n U n a e p o r u E e h t f o l a n r u o J l a i c i f f O N E 9 0 0 2 . 2 1 . 2 2
% 0 1 5 - 2 0 7 - 5 7 2 2 - 0 1 - 7 1 6 1 7 e t a m a n n i c y x o h t e M - p l y m a o s I e t a x o l i m A / e t a m a n n i c y x o h t e m - 4 - l y t n e p o s I 4 1% 0 1 4 - 7 2 - 2 4 2 6 1 1 A B A P 5 2 - G E P e t a o z n e b o n i m a - 4 - l y h t e d e t a l y x o h t E 3 1% 0 1 7 - 5 7 7 - 6 2 2 3 - 7 7 - 6 6 4 5 e t a m a n n i c y x o h t e M l y x e h l y h t E e t a x o n i t c O / e t a m a n n i c y x o h t e m - 4 l y x e h l y h t E - 2 2 1% 6 2 - 1 6 - 3 8 7 3 1 1
r o h p m a Ce n e d i l y z n e B l y h t e m o d i m a l y r c a y l o P
e d i m a l y r c a } l y z n e b ]- l y h t e m ) e n e d i l y - 3 - n r o b o x o - 2 ( [ - ) 4 d n a 2 ( { - N f o r e m y l o P 1 1) d i c a s a ( 8 - 0 2 - 8 4 - 0 3 - 7 9 1 6 e n e l y r c o t c O
e n e l i r c o t c O / r e t s el y x e h l y h t e , d i c a c i l y r c a l y n e h p i d - 3 , 3 - o n a y C 0) d i c a s a ( 8 - 8 5 - 9 3 0 6 5 d i c A c i n o f l u S r o h p m a C e n e d i l y z n e B
s t l a s s t i d n ad i c a c i n o h p l u s - 4 - e n e u l o t - ) e n e d i l y - 3 - n r o b o x O - 2 ( - a h p l a 9% 5 6 - 1 8 5 - 4 7 - 9 0 - 5 3 0 7 e n a h t e m l y o z n e b i d y x o h t e M l y t u B
e n o z n e b o v A / n o i d- 3 , 1 - e n a p o r p ) l y n e h p y x o h t e m - 4 ( - 3 - ) l y n e h p l y t u B - t r e t - 4 ( - 8) d i c a s a ( % 0 1 6 - 0 6 9 - 0 1 4
2 - 2 8 - 7 4 0 9, 7 - 6 2 - 1 6 7 2 9
d i c A c i n o f- l u S r o h p m a c i D e n e d i l y l a h t h p e r e T
e l u s m a c E / s t l ss t i d n a ) d i c a c i n o f u s e n h t e m - l y - 1 - t p e h ] 1 . 2 . 2 [ - o l c y c i b o x o- 2 - l y h t e m i d - 7 , 7 ( s i b ) e n e l y h t e m i d e n e l y n e h P - 4 , 1 ( - ’ 3 , 3 7) d i c a s a ( % 8 0 - 2 0 5 - 8 4 2 7 - 1 8 - 3 0 5 7 2 d i c A c i n o f l u S e l o z a d i m i z n e b l y n e h P
e l o z i l u s n E / s t l a s e n i m a l o n a h t e i r t d n a m u i d o s , m u i s- s a t o p s t i d n a d i c a c i n o f l u s - 5 - e l o z a d i m i z n e b l y n e h P - 2 6d e t e l e d r o d e v M 5)1( 3 - e n o n e h p o z n e Bs n i a t n o C % 0 1 5 - 1 3 0 - 5 0 2 7 - 7 5 - 1 3 1 3 - e n o n e h p o z n e B e n o z n e b y x O / e n o n e h p o z n e b y x o h t e m - 4 - y x o r d y H - 2 4% 0 1 8 - 0 6 2 - 4 0 2 9 - 6 5 - 8 1 1 e t a l a s o m o H
e t a l a s o m o H / r e t s el y x e h o l c y c l y h t e m i r t - 5 , 3 , 3 , - y x o r d y h - 2 , d i c a c i o z n e B 3% 6 8 - 9 - 8 5 2 - 7 9 - 3 9 7 2 5
e t a f- l u s o h t e M m u i n k l a r o h p m a C
e t a f l u s l y h t e m m u i n i l i n a) l y h t e m e n e d i l y - 3 - n r o b o x o ( - l y h t e m i r T - N,N,N 2% 5 0 - 3 5 7 - 5 0 2 0 - 3 1 - 0 5 1 A B A P d i c a c i o z n b o n i m A - 4 1i h g f e d c b ar e h t O
n o i t a r a p e r pe s u r o f y d a e rn i n o i t a r t n e c- n o c m u m i x a M
s t r a p y d o b, e p y t t c u d o r Pr e b m u n C E r e b m u n S A C y r a s s o l G s t n e i d e r g n I n o m m o f o e m a N N A X / N I / e m a n l a c i m e h C s g n i n r a w d n ae s u f o s n o i t i d- n o c f o g n i d r o Ws n o i t i d n o C n o i t a i f i t n e d i e c n a t s u S
r e b m u ne c n e r e f e ROfficial Journ alof the EuropeanUnion 22.12.200915 2,4,6-Trianilino-(p-carbo-2’-ethylhexyl-1’-oxy)-1,3,5-
triazineEthylhexyl Triazone 88122-99-0 402-070-1 5 %
16 Phenol,2-(2H-benzotriazol-2-yl)-4-methyl-6-(2-methyl-3-(1,3,3,3-tetramethyl-1-(trimethylsilyl)oxy)-disiloxanyl)propyl)Drometrizole Trisiloxane 155633-54-8 15 %
17 Benzoic acid, 4,4-((6-((4-(((1,1-dimethylethyl)amino)carbonyl)phenyl)amino)-1,3,5-
triazine-2,4-diyl)diimino)bis-, bis (2-ethylhexyl) 
ester/Iscotrizinol (USAN)Diethylhexyl Butamido Triazone 154702-15-5 10 %
18 3-(4-Methylbenzylidene)-d1 camphor/Enzacamene 4-Methylbenzylidene Camphor 38102-62-4/ 36861-47-9- / 253-242-6 4 %
19 3-Benzylidene camphor 3-Benzylidene Camphor 15087-24-8 239-139-9 2 %
20 2-Ethylhexyl salicylate/Octisalate Ethylhexyl Salicylate 118-60-5 204-263-4 5 %
21 2-Ethylhexyl 4-(dimethylamino)benzoate/Padimate O (USAN:BAN)Ethylhexyl Dimethyl PABA 21245-02-3 244-289-3 8 %
22 2-Hydroxy-4-methoxybenzophenone-5-sulfonic acid and its sodium salt/SulisobenzoneBenzophenone-4, Benzophenone-5 4065-45-6/ 6628-37-1223-772-2 / - 5 % (as acid)
23 2,2’-Methylene-bis(6-(2H-benzotriazol-2-yl)-4-(1,1,3,3-tetramethyl-butyl)phenol) / BisoctrizoleMethylene Bis-Benzotriazolyl Tet­ramethylbutylphenol103597-45-1 403-800-1 10 %
24 Sodium salt of 2,2’-bis(1,4-phenylene)-1H-benzimidazole-4,6-disulfonic acid) / Bisdisulizole diso­dium (USAN)Disodium Phenyl Dibenzimidazole Tetrasulfonate180898-37-7 429-750-0 10 % (as acid)
25 2,2’-(6-(4-Methoxyphenyl)-1,3,5-triazine-2,4-diyl)bis(5-((2-ethylhexyl)oxy)phenol) / BemotrizinolBis-Ethylhexyloxyphenol Methox­yphenyl Triazine187393-00-6 10 %
26 Dimethicodiethylbenzalmalonate Polysilicone-15 207574-74-1 426-000-4 10 %
27 Titanium dioxide (
2) Titanium Dioxide 13463-67-7/ 
1317-70-0/ 1317-80-2236-675-5/ 205-280-1/ 215-282-225 %
28 Benzoic acid, 2-[4-(diethylamino)-2-hydroxybenzoyl]-, hexylesterDiethylamino Hydroxybenzoyl Hexyl Benzoate302776-68-7 443-860-6 10 % in sun­
screen prod­ucts
(1)Not required if concentration is 0,5 % or less and when it is used only for product protection purposes. 
(2)For use other than as a colorant, see Annex IV, No. 143.N E 2 0 2 / 2 4 3 L
i h g f e d c b ar e h t O
n o i t a r a p e r pe s u r o f y d a e rn i n o i t a r t n e c- n o c m u m i x a M
s t r a p y d o b, e p y t t c u d o r Pr e b m u n C E r e b m u n S A C y r a s s o l G s t n e i d e r g n I n o m m o C f o e m a N N A X / N N I / e m a n l a c i m e h C s g n i n r a w d n ae s u f o s n o i t i d- n o c f o g n i d r o Ws n o i t i d n o C n o i t a c i f i t n e d i e c n a t s b u S
r e b m u ne c n e r e f e R22.12.2009 EN Official Journ alof the EuropeanUnion L 342/203
ANNEX VII
SYMBOLS USED  
ON PACKAGING/CONTAINER
1. Reference to enclosed or attached information
2. Period-after-opening
3.
 Date 
of minimu m 
durabilityOfficial Journ alof the EuropeanUnion 22.12.2009
ANNEX VIII
LIST OF 
VALIDATED 
ALTERNATIVE METHOD S 
TO ANIMAL TESTING
This Annex 
lists the altern ative 
methods validated b y 
the European 
Centre 
on 
Validation  
of Alternative 
Methods (E CVAM) 
of 
the Joint 
Research Cen tre 
available 
to meet the requiremen ts 
of this Regulation  
and 
which are n ot 
listed in 
Commission  
Regulation 
(EC) 
No 440/2008 of 30 May 2008 layin g 
down 
test methods pursuant to Reg ulation 
(EC) 
No 1907/2006 of 
the European
 Parliamen t
 and
 of the Coun cil
 on the Reg i
stration, E valuat
ion,
 Authorisation an d
 Restriction of Chemicals 
(REACH). 
As animal 
testing 
may not 
be 
replaced completely b y 
an 
alternativ
e method, it should b e 
mentioned 
in 
Annex 
VIII 
whether 
the alternative 
method fully or partially replaces an imal 
testing.
Reference number Validated alternative methods Nature of replacemen t full or partial
AB CN E 4 0 2 / 2 4 3 LOfficial Journ alof the EuropeanUnion L 342/205
ANNEX IX
PART A
Repealed D irective 
with its su ccessive 
amendments
(referred to in Article 33)
Council 
Directive 76/768/E EC 
of 27 July 1976 (OJ L 262, 27.9.1976, p. 169)
Council 
Directive 79/661/E EC 
of 24 July 1979 (OJ L 192, 31.7.1979, p. 35)
Commission  
Directive 82/147/E EC 
of 11 February 
1982 (OJ L 63, 6.3.1982, p. 26)
Council 
Directive 82/368/E EC 
of 17 May 1982 (OJ L 167, 15.6.1982, p. 1)
Commission  
Directive 83/191/E EC 
of 30 March 1983 (OJ L 109, 26.4.1983, p. 25)
Commission  
Directive 83/341/E EC 
of 29 June 
1983 (OJ L 188, 13.7.1983, p. 15 )
Commission  
Directive 83/496/E EC 
of 22 Septemb er 
1983 (OJ L 275, 8.10.1983 ,  p .  2 0)
Council 
Directive 83/574/E EC 
of 26 Octob er 
1983 (OJ L 332, 28.11.1983, p. 38)
Commission  
Directive 84/415/E EC 
of 18 July 1984 (OJ L 228, 25.8.1984, p. 31 )
Commission  
Directive 85/391/E EC 
of 16 July 1985 (OJ L 224, 22.8.1985, p. 40 )
Commission  
Directive 86/179/E EC 
of 28 February 
1986 (OJ L 138, 24.5.1986, p. 40)
Commission  
Directive 86/199/E EC 
of 26 March 1986 (OJ L 149, 3.6.1986, p. 38 )
Commission  
Directive 87/137/E EC 
of 2 February 
1987 (OJ L 56, 26.2.1987, p. 20)
Commission  
Directive 88/233/E EC 
of 2 March 1988 (OJ L 105, 26.4.1988, p. 11 )
Council 
Directive 88/667/E EC 
of 21 Decemb er 
1988 (OJ L 382, 31.12.1988, p. 46)
Commission  
Directive 89/174/E EC 
of 21 February 
1989 (OJ L 64, 8.3.1989, p. 10)
Council 
Directive 89/679/E EC 
of 21 Decemb er 
1989 (OJ L 398, 30.12.1989, p. 25)
Commission  
Directive 90/121/E EC 
of 20 February 
1990 (OJ L 71, 17.3.1990, p. 40)
Commission  
Directive 91/184/E EC 
of 12 March 1991 (OJ L 91, 12.4.1991, p. 59 )
Commission  
Directive 92/8/E EC 
of 18 February 
1992 (OJ L 70, 17.3.1992, p. 23)
Commission  
Directive 92/86/E EC 
of 21 Octob er 
1992 (OJ L 325, 11.11.1992, p. 18)
Council 
Directive 93/35/E EC 
of 14 June 
1993 (OJ L 151, 23.6.1993, p. 32)
Commission  
Directive 93/47/E EC 
of 22 June 
1993 (OJ L 203, 13.8.1993, p. 24)
Commission  
Directive 94/32/E C 
of 29 June 
1994 (OJ L 181, 15.7.1994, p. 31)
Commission  
Directive 95/17/E C 
of 19 June 
1995 (OJ L 140, 23.6.1995, p. 26)
Commission  
Directive 95/34/E C 
of 10 July 1995 (OJ L 167, 18.7.1995, p. 19)
Commission  Directive 96/41/E C of 25 June 1996 (OJ L 198, 8.8.1996, p. 36)
Commission  
Directive 97/1/E C 
of 10 January 
1997 (OJ L 16, 18.1.1997, p. 85)
Commission  
Directive 97/18/E C 
of 17 April 1997 (OJ L 114, 1.5.1997, p. 43)
Commission  
Directive 97/45/E C 
of 14 July 1997 (OJ L 196, 24.7.1997, p. 77)
Commission  
Directive 98/16/E C 
of 5 March 1998 (OJ L 77, 14.3.1998, p. 44)
Commission  
Directive 98/62/E C 
of 3 Septemb er 
1998 (OJ L 253, 15.9.1998, p. 20)
Commission  
Directive 2000/6/E C 
of 29 February 
2000 (OJ L 56, 1.3.2000, p. 42)
Commission  
Directive 2000/11/E C 
of 10 March 2000 (OJ L 65, 14.3.2000, p. 22 )
Commission  
Directive 2000/41/E C 
of 19 June 
2000 (OJ L 145, 20.6.2000, p. 25 )
Commission  
Directive 2002/34/E C 
of 15 April 2002 (OJ L 102, 18.4.2002, p. 19)
Commission  
Directive 2003/1/E C 
of 6 January 
2003 (OJ L 5, 10.1.2003, p. 14)N E 9 0 0 2 . 2 1 . 2 2Official Journ alof the EuropeanUnion 22.12.2009
Commission  Directive 2003/16/E C of 19 February 2003 (OJ L 46, 20.2.2003, p. 24)
Directive 2003/15/E C 
of the European 
Parliamen t 
and 
of the Coun cil 
of 27 
February 
2003(OJ L 66, 11.3.2003, p. 26)
Commission  
Directive 2003/80/E C 
of 5 Septemb er 
2003 (OJ L 224, 6.9.2003, p. 27)
Commission  
Directive 2003/83/E C 
of 24 Septemb er 
2003 (OJ L 238, 25.9.2003 ,  p .  2 3)
Commission  
Directive 2004/87/E C 
of 7 Septemb er 
2004 (OJ L 287, 8.9.2004, p.  4 )
Commission  
Directive 2004/88/E C 
of 7 Septemb er 
2004 (OJ L 287, 8.9.2004, p.  5 )
Commission  
Directive 2004/94/E C 
of 15 Septemb er 
2004 (OJ L 294, 17.9.2004 ,  p .  2 8)
Commission  
Directive 2004/93/E C 
of 21 Septemb er 
2004 (OJ L 300, 25.9.2004 ,  p .  1 3)
Commission  
Directive 2005/9/E C 
of 28 January 
2005 (OJ L 27, 29.1.2005, p. 46)
Commission  
Directive 2005/42/E C 
of 20 June 
2005 (OJ L 158, 21.6.2005, p. 17 )
Commission  
Directive 2005/52/E C 
of 9 Septemb er 
2005 (OJ L 234, 10.9.2005, p. 9)
Commission  
Directive 2005/80/E C 
of 21 Novemb er 
2005 (OJ L 303, 22.11.2005 ,  p .  3 2)
Commission  
Directive 2006/65/E C 
of 19 July 2006 (OJ L 198, 20.7.2006, p. 11 )
Commission  
Directive 2006/78/E C 
of 29 Septemb er 
2006 (OJ L 271, 30.9.2006 ,  p .  5 6)
Commission  
Directive 2007/1/E C 
of 29 January 
2007 (OJ L 25, 1.2.2007, p. 9)
Commission  
Directive 2007/17/E C 
of 22 March 2007 (OJ L 82, 23.3.2007, p. 27 )
Commission  
Directive 2007/22/E C 
of 17 April 2007 (OJ L 101, 18.4.2007, p. 11)
Commission  
Directive 2007/53/E C 
of 29 August 
2007 (OJ L 226, 30.8.2007, p. 19)
Commission  
Directive 2007/54/E C 
of 29 August 
2007 (OJ L 226, 30.8.2007, p. 21)
Commission  
Directive 2007/67/E C 
of 22 Novemb er 
2007 (OJ L 305, 23.11.2007 ,  p .  2 2)
Commission  
Directive 2008/14/E C 
of 15 February 
2008 OJ L 42, 16.2.2008, p. 43
Commission  
Directive 2008/42/E C 
of 3 April 2008 OJ L 93, 4.4.2008, p. 13
Commission  
Directive 2008/88/E C 
of 23 Septemb er 
2008 OJ L 256, 24.9.2008, p. 12
Commission  
Directive 2008/123/E C 
of 18 Decemb er 
2008 OJ L 340, 19.12.2008 ,  p .  7 1
Commission  
Directive 2009/6/E C 
of 4 February 
2009 OJ L 36, 5.2.2009, p. 15
Commission  
Directive 2009/36/E C 
of 16 April 2009 OJ L 98, 17.4.2009, p. 31
PART B
List of time- limits 
for transposition into national law and application
(referred to in Article 33)
Directive Time-limit for tran sposition
Council Directive 76/768/E EC of 27 July 1976 30.1.1978
Council 
Directive 79/661/E EC 
of 24 July 1979 30.7.1979
Commission  
Directive 82/147/E EC 
of 11 February 
1982 31.12.1982
Council 
Directive 82/368/E EC 
of 17 May 1982 31.12.1983
Commission  
Directive 83/191/E EC 
of 30 March 1983 31.12.1984
Commission  
Directive 83/341/E EC 
of 29 June 
1983 31.12.1984
Commission  
Directive 83/496/E EC 
of 22 Septemb er 
1983 31.12.1984
Council 
Directive 83/574/E EC 
of 26 Octob er 
1983 31.12.1984
Commission  
Directive 84/415/E EC 
of 18 July 1984 31.12.1985
Commission  
Directive 85/391/E EC 
of 16 July 1985 31.12.1986N E 6 0 2 / 2 4 3 LOfficial Journ alof the EuropeanUnion L 342/207
Commission  Directive 86/179/E EC of 28 February 1986 31.12.1986
Commission  
Directive 86/199/E EC 
of 26 March 1986 31.12.1986
Commission  
Directive 87/137/E EC 
of 2 February 
1987 31.12.1987
Commission  
Directive 88/233/E EC 
of 2 March 1988 30.9.1988
Council 
Directive 88/667/E EC 
of 21 Decemb er 
1988 31.12.1993
Commission  
Directive 89/174/E EC 
of 21 February 
1989 31.12.1989
Council 
Directive 89/679/E EC 
of 21 Decemb er 
1989 3.1.1990
Commission  
Directive 90/121/E EC 
of 20 February 
1990 31.12.1990
Commission  
Directive 91/184/E EC 
of 12 March 1991 31.12.1991
Commission  
Directive 92/8/E EC 
of 18 February 
1992 31.12.1992
Commission  
Directive 92/86/E EC 
of 21 Octob er 
1992 30.6.1993
Council 
Directive 93/35/E EC 
of 14 June 
1993 14.6.1995
Commission  
Directive 93/47/E EC 
of 22 June 
1993 30.6.1994
Commission  
Directive 94/32/E C 
of 29 June 
1994 30.6.1995
Commission  
Directive 95/17/E C 
of 19 June 
1995 30.11.1995
Commission  
Directive 95/34/E C 
of 10 July 1995 30.6.1996
Commission  
Directive 96/41/E C 
of 25 June 
1996 30.6.1997
Commission  
Directive 97/1/E C 
of 10 January 
1997 30.6.1997
Commission  
Directive 97/18/E C 
of 17 April 1997 31.12.1997
Commission  
Directive 97/45/E C 
of 14 July 1997 30.6.1998
Commission  
Directive 98/16/E C 
of 5 March 1998 1.4.1998
Commission  
Directive 98/62/E C 
of 3 Septemb er 
1998 30.6.1999
Commission  
Directive 2000/6/E C 
of 29 February 
2000 1.7.2000
Commission  
Directive 2000/11/E C 
of 10 March 2000 1.6.2000
Commission  
Directive 2000/41/E C 
of 19 June 
2000 29.6.2000
Commission  
Directive 2002/34/E C 
of 15 April 2002 15.4.2003
Commission  
Directive 2003/1/E C 
of 6 January 
2003 15.4.2003
Commission  
Directive 2003/16/E C 
of 19 February 
2003 28.2.2003
Directive 2003/15/E C 
of the European 
Parliamen t 
and 
of the Coun cil 
of 27 Febru­
ary 
200310.9.2004
Commission  
Directive 2003/80/E C 
of 5 Septemb er 
2003 11.9.2004
Commission  
Directive 2003/83/E C 
of 24 Septemb er 
2003 23.9.2004
Commission  
Directive 2004/87/E C 
of 7 Septemb er 
2004 1.10.2004
Commission  
Directive 2004/88/E C 
of 7 Septemb er 
2004 1.10.2004
Commission  
Directive 2004/94/E C 
of 15 Septemb er 
2004 21.9.2004
Commission  
Directive 2004/93/E C 
of 21 Septemb er 
2004 30.9.2004
Commission  
Directive 2005/9/E C 
of 28 January 
2005 16.2.2006
Commission  
Directive 2005/42/E C 
of 20 June 
2005 31.12.2005
Commission  
Directive 2005/52/E C 
of 9 Septemb er 
2005 1.1.2006
Commission  
Directive 2005/80/E C 
of 21 Novemb er 
2005 22.5.2006
Commission  
Directive 2006/65/E C 
of 19 July 2006 1.9.2006
Commission  
Directive 2006/78/E C 
of 29 Septemb er 
2006 30.3.2007N E 9 0 0 2 . 2 1 . 2 2
n o i t i s o p s n a r t r o f t i m i l - e m i T e v i t c e r i DOfficial Journ alof the EuropeanUnion 22.12.2009
Commission  Directive 2007/1/E C of 29 January 2007 21.8.2007
Commission  
Directive 2007/17/E C 
of 22 March 2007 23.9.2007
Commission  
Directive 2007/22/E C 
of 17 April 2007 18.1.2008
Commission  
Directive 2007/53/E C 
of 29 August 
2007 19.4.2008
Commission  
Directive 2007/54/E C 
of 29 August 
2007 18.3.2008
Commission  
Directive 2007/67/E C 
of 22 Novemb er 
2007 31.12.2007
Commission  
Directive 2008/14/E C 
of 15 February 
2008 16.8.2008
Commission  
Directive 2008/42/E C 
of 3 April 2008 4.10.2008
Commission  
Directive 2008/88/E C 
of 23 Septemb er 
2008 14.2.2009
Commission  
Directive 2008/123/E C 
of 18 Decemb er 
2008 8.7.2009
Commission  
Directive 2009/6/E C 
of 4 February 
2009 5.8.2009
Commission  
Directive 2009/36/E C 
of 16 April 2009 15.11.2009N E 8 0 2 / 2 4 3 L
n o i t i s o p s n a r t r o f t i m i l - e m i T e v i t c e r i DOfficial Journ alof the EuropeanUnion L 342/209
ANNEX X
CORRELATION TABLE
Directive 76/768/E EC This Regulation
Article 1 Article 2(1)(a)
Article 2 Article 3
Article 3 —
Article 4(1) Article 14(1)
Article 4(2) Article 17
Article 4a Article 18
Article 4b Article 15(1)
Article 5 —
Article 5a Article 33
Article 6(1),(2) Article 19(1),(2),(3),(4)
Article 6(3) Article 20
Article 7(1) Article 9
Article 7(2) Article 19(5), (6)
Article 7(3) Article 13
Article 7a (1) (h) Article 21
Article 7a(1),(2),(3) Article 10, 11, An nex 
I
Article 7a(4) Article 13
Article 7a(5) Article 29, 34
Article 8(1) Article 12
Article 8(2) Article 31
Article 8a —
Article 9 Article 35
Article 10 Article 32
Article 11 —
Article 12 Article 27
Article 13 Article 28
Article 14 —
Article 15 —
Annex 
I Preamble, 
No. 7
Annex 
II Annex 
II
Annex 
III Annex 
III
Annex 
IV Annex 
IV
Annex 
V —
Annex 
VI Annex 
V
Annex 
VII Annex 
VI
Annex 
VIII Annex 
VII
Annex 
VIIIa Annex 
VII
Annex 
IX Annex 
VIII
— Annex 
IX
— Annex 
XN E 9 0 0 2 . 2 1 . 2 2